FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Vanderlee, L
   Reid, JL
   White, CM
   Hobin, EP
   Acton, RB
   Jones, AC
   O'Neill, M
   Kirkpatrick, SI
   Hammond, D
AF Vanderlee, Lana
   Reid, Jessica L.
   White, Christine M.
   Hobin, Erin P.
   Acton, Rachel B.
   Jones, Amanda C.
   O'Neill, Meghan
   Kirkpatrick, Sharon I.
   Hammond, David
TI Evaluation of the online Beverage Frequency Questionnaire (BFQ)
SO NUTRITION JOURNAL
LA English
DT Article
DE Relative validity; Sugary drinks; Sugar sweetened beverages; Dietary
   assessment; Food frequency screener
ID SUGAR-SWEETENED BEVERAGES; BODY-MASS INDEX; ALCOHOL-CONSUMPTION;
   WEIGHT-GAIN; FOOD RECORDS; ADULTS; RISK; OBESITY; ENERGY; BIOMARKER
AB Background: The contribution of beverages to overall diet is of increasing interest to researchers and policymakers, particularly in terms of consumption of drinks high in added sugars; however, few tools to assess beverage intake have been developed and evaluated. This study aimed to evaluate the relative validity of a new online Beverage Frequency Questionnaire (BFQ) among young adults in Canada.
   Methods: A cross-sectional relative validation study was conducted among young adults aged 16-30 years (n = 50). Participants completed a 17-item BFQ, a 7-day food record (7dFR), and a single-item measure of sugary drink intake. Pearson correlations and paired t-tests were used to evaluate correlation and agreement between the measures for 17 individual beverage categories, total drink consumption, total alcoholic beverage consumption, and two definitions of drinks with excess sugars. Cognitive interviews were conducted to examine participant interpretation and comprehensiveness of the BFQ.
   Results: Estimates of beverage intake based on the BFQ and the 7dFR were highly correlated, specifically for the total number and volume of beverages consumed, total alcoholic beverage consumption, sugary drink intake, and each of the 17 beverage categories with 3 exceptions: coffee or tea with sugar or cream, specialty coffees, and hard alcohol with caloric mix. Paired t-tests between the BFQ and the 7dFR indicated that the average reported volume was significantly different only for sweetened fruit drinks. The single-item measure of sugary beverage intake was not significantly correlated with the 7dFR. Cognitive interviewing demonstrated high comprehension levels, and confirmed the appropriateness of the BFQ beverage categories and sizes.
   Conclusions: Overall, the results suggest that the BFQ performed well relative to a 7dFR and had high usability among this study population, indicating its promise for collecting population-level data on beverage intake, including sugar-sweetened beverages, which are known indicators of diet and health.
C1 [Vanderlee, Lana; Hobin, Erin P.] Univ Toronto, Dept Nutr Sci, Toronto, ON, Canada.
   [Vanderlee, Lana; Reid, Jessica L.; White, Christine M.; Acton, Rachel B.; Jones, Amanda C.; O'Neill, Meghan; Kirkpatrick, Sharon I.; Hammond, David] Univ Waterloo, Sch Publ Hlth & Hlth Syst, 200 Univ Ave W, Waterloo, ON, Canada.
   [Hobin, Erin P.] Publ Hlth Ontario, Toronto, ON, Canada.
   [Hobin, Erin P.; O'Neill, Meghan] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada.
C3 University of Toronto; University of Waterloo; Public Health Ontario;
   University of Toronto
RP Hammond, D (corresponding author), Univ Waterloo, Sch Publ Hlth & Hlth Syst, 200 Univ Ave W, Waterloo, ON, Canada.
EM dhammond@uwaterloo.ca
RI Hammond, David/JPW-9267-2023; Kirkpatrick, Sharon/AEX-6257-2022
OI Vanderlee, Lana/0000-0001-5384-1821; Kirkpatrick,
   Sharon/0000-0001-9896-5975; Reid, Jessica/0000-0001-9909-6265; Jones,
   Amanda C/0000-0001-8426-8407
FU Public Health Agency of Canada (PHAC); PHAC - Canadian Institutes of
   Health Research (CIHR) Chair in Applied Public Health
FX This project has been made possible through funding from the Public
   Health Agency of Canada (PHAC). The views expressed herein do not
   necessarily represent the view of the Public Health Agency of Canada.
   Additional funding for this project has been provided by a PHAC -
   Canadian Institutes of Health Research (CIHR) Chair in Applied Public
   Health, which supports Professor Hammond, staff, and students at the
   University of Waterloo. LV is a CIHR Banting Postdoctoral Fellow.
CR [Anonymous], THE HLTH AND EC IMPA
   [Anonymous], BODY MASS INDEX BMI
   Auerbach BJ, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2016-2454
   Battista K, 2017, HEALTH PROMOT CHRON, V37, P194, DOI 10.24095/hpcdp.37.6.03
   Beasley JM, 2016, PUBLIC HEALTH NUTR, V19, P3256, DOI 10.1017/S1368980016001580
   Di Angelantonio E, 2016, LANCET, V388, P776, DOI 10.1016/S0140-6736(16)30175-1
   Falbe J, 2016, AM J PUBLIC HEALTH, V106, P1865, DOI 10.2105/AJPH.2016.303362
   Forouzanfar MH, 2015, LANCET, V386, P2287, DOI 10.1016/S0140-6736(15)00128-2
   Garriguet Didier, 2008, Health Rep, V19, P23
   Garriguet Didier, 2008, Health Rep, V19, P17
   Han E, 2013, J ACAD NUTR DIET, V113, P43, DOI 10.1016/j.jand.2012.09.016
   Hedrick VE, 2012, J ACAD NUTR DIET, V112, P840, DOI 10.1016/j.jand.2012.01.023
   Hedrick VE, 2010, J AM DIET ASSOC, V110, P1227, DOI 10.1016/j.jada.2010.05.005
   Kipnis V, 2003, AM J EPIDEMIOL, V158, P14, DOI 10.1093/aje/kwg091
   Kodama S, 2014, OBES REV, V15, P202, DOI 10.1111/obr.12129
   Langlois Kellie, 2011, Health Rep, V22, P23
   Lauby-Secretan B, 2016, NEW ENGL J MED, V375, P794, DOI 10.1056/NEJMsr1606602
   Lu Y, 2014, LANCET, V383, P970, DOI 10.1016/S0140-6736(13)61836-X
   Malik VS, 2006, AM J CLIN NUTR, V84, P274
   Malik VS, 2013, AM J CLIN NUTR, V98, P1084, DOI 10.3945/ajcn.113.058362
   Malik VS, 2010, DIABETES CARE, V33, P2477, DOI 10.2337/dc10-1079
   Malik VS, 2010, CIRCULATION, V121, P1356, DOI 10.1161/CIRCULATIONAHA.109.876185
   MORENGA LT, 2013, BMJ-BRIT MED J, V346, DOI DOI 10.1136/BMJ.E7492
   Nelson MC, 2009, J AM DIET ASSOC, V109, P730, DOI 10.1016/j.jada.2008.12.027
   Nissensohn M, 2013, INT J FOOD SCI NUTR, V64, P801, DOI 10.3109/09637486.2013.801406
   O'Connor TM, 2006, PEDIATRICS, V118, pE1010, DOI 10.1542/peds.2005-2348
   Park S, 2014, PREV CHRONIC DIS, V11, DOI 10.5888/pcd11.130304
   Popkin BM, 2015, ADV NUTR, V6, P625, DOI 10.3945/an.115.008425
   Prentice RL, 2011, AM J EPIDEMIOL, V174, P591, DOI 10.1093/aje/kwr140
   Rebro SM, 1998, J AM DIET ASSOC, V98, P1163, DOI 10.1016/S0002-8223(98)00269-7
   Sayon-Orea C, 2011, NUTR REV, V69, P419, DOI 10.1111/j.1753-4887.2011.00403.x
   Singh GM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065174
   Subar AF, 2003, AM J EPIDEMIOL, V158, P1, DOI 10.1093/aje/kwg092
   Subar AF, 2012, J ACAD NUTR DIET, V112, P1134, DOI 10.1016/j.jand.2012.04.016
   Tasevska N, 2015, NUTRIENTS, V7, P5816, DOI 10.3390/nu7075255
   Te Morenga LA, 2014, AM J CLIN NUTR, V100, P65, DOI 10.3945/ajcn.113.081521
   Traversy G, 2015, CURR OBES REP, V4, P122, DOI 10.1007/s13679-014-0129-4
   Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4
   Xi B, 2015, BRIT J NUTR, V113, P709, DOI 10.1017/S0007114514004383
   Yeomans MR, 2010, PHYSIOL BEHAV, V100, P82, DOI 10.1016/j.physbeh.2010.01.012
NR 40
TC 21
Z9 21
U1 0
U2 6
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1475-2891
J9 NUTR J
JI Nutr. J.
PD AUG 1
PY 2018
VL 17
AR 73
DI 10.1186/s12937-018-0380-8
PG 10
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Nutrition & Dietetics
GA GO9TU
UT WOS:000440451300001
PM 30068342
OA Green Published, gold
DA 2025-04-28
ER

PT J
AU Kumari, S
   Pattnaik, AK
AF Kumari, Shivangi
   Pattnaik, Ashok Kumar
TI Unraveling the anti-obesity potential of Haldina cordifolia
   bioactive fractions in 3T3-L1 adipocytes differentiation: in vitro,
   high-performance thin-layer chromatography-multistage mass spectrometry
   and in silico studies
SO JPC-JOURNAL OF PLANAR CHROMATOGRAPHY-MODERN TLC
LA English
DT Article
DE Haldina cordifolia; Obesity; Bioactive fraction; In silico;
   High-performance thin-layer chromatography-multistage mass spectrometry
   (HPTLC-MSn)
ID LIQUID-CHROMATOGRAPHY; BETA-SITOSTEROL; PLANT-EXTRACTS; ANTIOXIDANT;
   IDENTIFICATION; INHIBITION
AB The anti-obesity activity of the bioactive fractions of Haldina cordifolia (HC) was investigated in pursuit of a novel herbal plant targeting obesity, as its anti-obesity potential has not yet been investigated. This innovative study examined the HC bioactive fraction to select the most significant fraction using an array of studies targeting obesity. Initially, a quantitative phytochemical assessment including total phenolic, flavonoid, and steroidal contents was performed. Additionally, a series of in vitro antioxidant ABTS, DPPH, nitric oxide, and hydrogen peroxide scavenging assays were implemented, whereas, alpha-glucosidase, alpha-amylase, and pancreatic lipase assays were conducted for the inhibition of enzyme capabilities. The findings demonstrated that fractions F2 and F3 have better efficacy, based on IC50 values. Subsequently, the anti-obesity potential of fractions was assessed utilizing cultured 3T3-L1 adipocytes, oil red O staining, and triglyceride content, as markers of accumulation of lipid which showed significant results. Furthermore, high-performance thin-layer chromatography-multistage mass spectrometry (HPTLC-MSn) was employed to identify the phytoconstituents within these fractions, particularly the anti-obesity agent, beta-sitosterol. HPTLC-MSn analysis revealed the presence of five major compounds in fraction F2: caffeine, quercetin, beta-sitosterol naringin, and ascorbic acid along with retro Diels-Alder fragmentation. Finally, an in silico study was designed which subsequently established the optimal binding activity of the obtained compounds towards the particular receptors targeting obesity. Overall, fraction F2 showed the most potent activity. The study unveiled the promising anti-obesity potential of bioactive fractions from HC and a potential treatment strategy has been established to combat obesity.
C1 [Kumari, Shivangi; Pattnaik, Ashok Kumar] Birla Inst Technol, Dept Pharmaceut Sci & Technol, Ranchi, India.
C3 Birla Institute of Technology Mesra
RP Pattnaik, AK (corresponding author), Birla Inst Technol, Dept Pharmaceut Sci & Technol, Ranchi, India.
EM ashokp@bitmesra.ac.in
OI KUMARI, SHIVANGI/0009-0002-9838-3427
FU Department of Pharmaceutical Sciences and Technology; NCCS, Pune
FX The authors are thankful to the Department of Pharmaceutical Sciences
   and Technology, the Central Instrument Facility of Birla Institute of
   Technology, Mesra, Ranchi for providing all the necessary chemicals,
   equipment, and analytical tools for the study. The authors are also
   thankful to NCCS, Pune for providing the 3T3-L1 cell line and Eurofins
   Advinus, Bangalore for providing their lab to conduct the cell line
   study.
CR Al-Dalahmeh Y, 2022, MOLECULES, V27, DOI 10.3390/molecules27030859
   Aranda M, 2007, RAPID COMMUN MASS SP, V21, P1297, DOI 10.1002/rcm.2949
   Ashraf GJ, 2021, BIOMED CHROMATOGR, V35, DOI 10.1002/bmc.5230
   Bhatti Muhammad Zeeshan, 2015, BMC Res Notes, V8, P279, DOI 10.1186/s13104-015-1228-3
   El-Shiekh RA, 2019, S AFR J BOT, V123, P43, DOI 10.1016/j.sajb.2019.01.022
   Fenoll J, 2011, FOOD CHEM, V127, P340, DOI 10.1016/j.foodchem.2010.12.140
   Gong LX, 2020, FOOD SCI NUTR, V8, P6320, DOI 10.1002/fsn3.1987
   Gravina C, 2023, INT J MOL SCI, V24, DOI 10.3390/ijms24098038
   Hossain M. A. A., 2015, American Journal of Plant Sciences, V6, P633, DOI 10.4236/ajps.2015.65068
   Jaradat Nidal, 2017, Medicines (Basel), V4, DOI 10.3390/medicines4040089
   Jug U, 2018, JPC-J PLANAR CHROMAT, V31, P13, DOI 10.1556/1006.2018.31.1.2
   Kasote D, 2015, PHYTOCHEM LETT, V11, P326, DOI 10.1016/j.phytol.2014.08.017
   Kifle ZD, 2020, J EVID-BASED INTEGR, V25, DOI 10.1177/2515690X20935827
   Lianza M, 2022, J ENZYM INHIB MED CH, V37, P554, DOI 10.1080/14756366.2021.2022658
   Liu YZ, 2015, MOLECULES, V20, P8583, DOI 10.3390/molecules20058583
   Mallick S. S., 2014, ADV CHEM SER, P1, DOI [10.1155/2014/143948, DOI 10.1155/2014/143948]
   Mohanty S, 2021, INDIAN J PHARM EDUC, V55, pS535, DOI 10.5530/ijper.55.2s.125
   Pan MH, 2019, FOOD FUNCT, V10, P7667, DOI 10.1039/c9fo02235j
   Pérez VT, 2023, MAR DRUGS, V21, DOI 10.3390/md21050284
   Podsedek A, 2020, J FUNCT FOODS, V73, DOI 10.1016/j.jff.2020.104111
   Quazi A, 2022, EVID-BASED COMPL ALT, V2022, DOI 10.1155/2022/1577957
   Raypal P, 2018, Int J Curr Microbiol Appl Sci, V7, P3007, DOI [10.20546/ijcmas.2018.711.345, DOI 10.20546/IJCMAS.2018.711.345]
   Roh C, 2012, INT J MOL SCI, V13, P1710, DOI 10.3390/ijms13021710
   Saha K, 2004, J ETHNOPHARMACOL, V92, P263, DOI [10.1016/j.jep.2004.03.007, 10.1016/j/jep.2004.03.007]
   Sellami M, 2017, INT J FOOD SCI NUTR, V68, P313, DOI 10.1080/09637486.2016.1237479
   Sharma A, 2018, MOLECULES, V23, DOI 10.3390/molecules23112985
   Singh RP, 2023, 3 BIOTECH, V13, DOI 10.1007/s13205-023-03603-1
   Starek M, 2007, JPC-J PLANAR CHROMAT, V20, P327, DOI 10.1556/JPC.20.2007.5.3
   Starek M, 2023, JPC-J PLANAR CHROMAT, V36, P99, DOI 10.1007/s00764-023-00234-3
   Taira N, 2017, J FUNCT FOODS, V29, P19, DOI 10.1016/j.jff.2016.11.030
   Tang DS, 2007, SEP PURIF TECHNOL, V56, P291, DOI 10.1016/j.seppur.2007.01.040
   Unuofin JO, 2019, PROCESSES, V7, DOI 10.3390/pr7110841
   Yadav S, 2021, PHYTOTAXA, V501, P281, DOI 10.11646/phytotaxa.501.2.3
   Zhang X, 2005, STEROIDS, V70, P896, DOI 10.1016/j.steroids.2005.06.004
   Zhang YJ, 2015, MOLECULES, V20, P21138, DOI 10.3390/molecules201219753
   Zhou HM, 2020, NAT PRODUCT BIOPROSP, V10, P163, DOI 10.1007/s13659-020-00245-1
NR 36
TC 0
Z9 0
U1 1
U2 1
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0933-4173
EI 1789-0993
J9 JPC-J PLANAR CHROMAT
JI JPC-J. Planar Chromatogr.-Mod. TLC
PD JUN
PY 2024
VL 37
IS 3
BP 283
EP 297
DI 10.1007/s00764-024-00308-w
EA JUL 2024
PG 15
WC Chemistry, Analytical
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Chemistry
GA D4L7A
UT WOS:001280816500001
DA 2025-04-28
ER

PT J
AU Semenova, EA
   Pranckeviciene, E
   Bondareva, EA
   Gabdrakhmanova, LJ
   Ahmetov, II
AF Semenova, Ekaterina A.
   Pranckeviciene, Erinija
   Bondareva, Elvira A.
   Gabdrakhmanova, Leysan J.
   Ahmetov, Ildus I.
TI Identification and Characterization of Genomic Predictors of Sarcopenia
   and Sarcopenic Obesity Using UK Biobank Data
SO NUTRIENTS
LA English
DT Article
DE sarcopenia; sarcopenic obesity; genetics; DNA; nutrition; physical
   activity; testosterone; height; fat-free mass; weakness
ID WIDE ASSOCIATION; SKELETAL-MUSCLE; ELDERLY-PATIENTS; RISK; TRAITS; MASS;
   POLYMORPHISM; STRENGTH; GENE; TESTOSTERONE
AB The substantial decline in skeletal muscle mass, strength, and gait speed is a sign of severe sarcopenia, which may partly depend on genetic risk factors. So far, hundreds of genome-wide significant single nucleotide polymorphisms (SNPs) associated with handgrip strength, lean mass and walking pace have been identified in the UK Biobank cohort; however, their pleiotropic effects on all three phenotypes have not been investigated. By combining summary statistics of genome-wide association studies (GWAS) of handgrip strength, lean mass and walking pace, we have identified 78 independent SNPs (from 73 loci) associated with all three traits with consistent effect directions. Of the 78 SNPs, 55 polymorphisms were also associated with body fat percentage and 25 polymorphisms with type 2 diabetes (T2D), indicating that sarcopenia, obesity and T2D share many common risk alleles. Follow-up bioinformatic analysis revealed that sarcopenia risk alleles were associated with tiredness, falls in the last year, neuroticism, alcohol intake frequency, smoking, time spent watching television, higher salt, white bread, and processed meat intake; whereas protective alleles were positively associated with bone mineral density, serum testosterone, IGF1, and 25-hydroxyvitamin D levels, height, intelligence, cognitive performance, educational attainment, income, physical activity, ground coffee drinking and healthier diet (muesli, cereal, wholemeal or wholegrain bread, potassium, magnesium, cheese, oily fish, protein, water, fruit, and vegetable intake). Furthermore, the literature data suggest that single-bout resistance exercise may induce significant changes in the expression of 26 of the 73 implicated genes in m. vastus lateralis, which may partly explain beneficial effects of strength training in the prevention and treatment of sarcopenia. In conclusion, we have identified and characterized 78 SNPs associated with sarcopenia and 55 SNPs with sarcopenic obesity in European-ancestry individuals from the UK Biobank.
C1 [Semenova, Ekaterina A.; Bondareva, Elvira A.; Ahmetov, Ildus I.] Dept Mol Biol & Genet, Fed Res & Clin Ctr Phys, Chem Med Fed Med Biol Agcy, Moscow 119435, Russia.
   [Semenova, Ekaterina A.] Volga Reg State Univ Phys Culture, Res Inst Phys Culture & Sport, Sport & Tourism, Kazan 420138, Russia.
   [Pranckeviciene, Erinija] Vilnius Univ, Biomed Sci Inst, Fac Med, Dept Human & Med Genet, LT-01513 Vilnius, Lithuania.
   [Pranckeviciene, Erinija] Vytautas Magnus Univ, Fac Informat, Dept Syst Anal, LT-44404 Kaunas, Lithuania.
   [Gabdrakhmanova, Leysan J.; Ahmetov, Ildus I.] Kazan State Med Univ, Lab Genet Aging & Longev, Kazan 420012, Russia.
   [Ahmetov, Ildus I.] Plekhanov Russian Univ Econ, Dept Phys Educ, Moscow 115093, Russia.
   [Ahmetov, Ildus I.] Liverpool John Moores Univ, Res Inst Sport & Exercise Sci, Liverpool L3 5AE, England.
C3 Lopukhin Federal Research & Clinical Center of Physical-Chemical
   Medicine of Federal Medical Biological Agency; Vilnius University;
   Vytautas Magnus University; Kazan State Medical University; Plekhanov
   Russian University of Economics; Liverpool John Moores University
RP Ahmetov, II (corresponding author), Dept Mol Biol & Genet, Fed Res & Clin Ctr Phys, Chem Med Fed Med Biol Agcy, Moscow 119435, Russia.; Ahmetov, II (corresponding author), Kazan State Med Univ, Lab Genet Aging & Longev, Kazan 420012, Russia.; Ahmetov, II (corresponding author), Plekhanov Russian Univ Econ, Dept Phys Educ, Moscow 115093, Russia.; Ahmetov, II (corresponding author), Liverpool John Moores Univ, Res Inst Sport & Exercise Sci, Liverpool L3 5AE, England.
EM i.akhmetov@ljmu.ac.uk
RI Gabdrakhmanova, Leysan/AAG-2002-2021; Semenova, Ekaterina/ABC-6546-2021;
   Semenova, Ekaterina/W-8789-2018; Ahmetov, Ildus/C-6163-2009;
   Pranckeviciene, Erinija/G-7777-2017
OI Semenova, Ekaterina/0000-0003-1248-2855; Ahmetov,
   Ildus/0000-0002-6335-4020; Pranckeviciene, Erinija/0000-0003-1365-3564
FU Russian Science Foundation [22-75-10122]
FX I.I.A. and E.A.B. have been supported by a grant from the Russian
   Science Foundation (grant no. 22-75-10122: "Evaluation of the influence
   of endogenous and exogenous factors for the development of various types
   of obesity"). E.A.S., E.P. and L.J.G. have not received any funding to
   conduct this study.
CR Abney M, 2001, AM J HUM GENET, V68, P1302, DOI 10.1086/320112
   Aguet F, 2020, SCIENCE, V369, P1318, DOI 10.1126/science.aaz1776
   Ahmetov II, 2008, B EXP BIOL MED+, V146, P630, DOI 10.1007/s10517-009-0364-y
   Akhmetov I I, 2007, Mol Biol (Mosk), V41, P852
   Barton AR, 2021, NAT GENET, V53, P1260, DOI 10.1038/s41588-021-00892-1
   Batsis JA, 2017, J GERONTOL A-BIOL, V72, P1445, DOI 10.1093/gerona/glx002
   Cordero AIH, 2019, AM J HUM GENET, V105, P1222, DOI 10.1016/j.ajhg.2019.10.014
   Cruz-Jentoft AJ, 2019, AGE AGEING, V48, P16, DOI 10.1093/ageing/afy169
   de Souza LF, 2022, GERIATR NURS, V48, P123, DOI 10.1016/j.gerinurse.2022.09.007
   Dirks-Naylor AJ, 2015, LIFE SCI, V143, P182, DOI 10.1016/j.lfs.2015.11.005
   Donini LM, 2022, CLIN NUTR, V41, P990, DOI 10.1016/j.clnu.2021.11.014
   ensembl, ENS PROJ PORT
   Fuku N, 2012, GERIATR GERONTOL INT, V12, P292, DOI 10.1111/j.1447-0594.2011.00768.x
   Gao QQ, 2021, NUTRIENTS, V13, DOI 10.3390/nu13124291
   Gao QQ, 2021, CLIN NUTR, V40, P4633, DOI 10.1016/j.clnu.2021.06.009
   Gedmantaite A, 2020, MECH AGEING DEV, V189, DOI 10.1016/j.mad.2020.111269
   Gim JA, 2022, J KOREAN MED SCI, V37, DOI 10.3346/jkms.2022.37.e346
   Grishina EE, 2019, J STRENGTH COND RES, V33, P2602, DOI 10.1519/JSC.0000000000003304
   Groza T, 2023, NUCLEIC ACIDS RES, V51, pD1038, DOI 10.1093/nar/gkac972
   gtexportal, HOM IND HTML
   Guilherme JPLF, 2022, GENES-BASEL, V13, DOI 10.3390/genes13101710
   Guilherme JPLF, 2021, ANN HUM BIOL, V48, P142, DOI 10.1080/03014460.2021.1919204
   Guilherme JPLF, 2022, EUR J APPL PHYSIOL, V122, P415, DOI 10.1007/s00421-021-04851-w
   Guilherme JPLF, 2022, J STRENGTH COND RES, V36, P1884, DOI 10.1519/JSC.0000000000003756
   Guo YF, 2013, HUM GENET, V132, P189, DOI 10.1007/s00439-012-1236-5
   Hall ECR, 2022, GENES-BASEL, V13, DOI 10.3390/genes13030397
   Han TT, 2022, DIABET METAB SYND OB, V15, P1197, DOI 10.2147/DMSO.S360942
   Hayashida I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111810
   He LX, 2020, J CACHEXIA SARCOPENI, V11, P1548, DOI 10.1002/jcsm.12585
   Hirani V, 2017, AGE AGEING, V46, P413, DOI 10.1093/ageing/afw214
   Hong SH, 2022, NUTRIENTS, V14, DOI 10.3390/nu14163266
   Jin H, 2022, SCI REP-UK, V12, DOI 10.1038/s41598-022-07567-9
   Johns N, 2017, J CACHEXIA SARCOPENI, V8, P122, DOI 10.1002/jcsm.12138
   Jones G, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-20918-w
   Khadra D, 2019, WORLD J DIABETES, V10, P311, DOI 10.4239/wjd.v10.i5.311
   Khanal P, 2022, GENES-BASEL, V13, DOI 10.3390/genes13060982
   Khanal P, 2020, GENES-BASEL, V11, DOI 10.3390/genes11121459
   Kikuchi N, 2022, GENES-BASEL, V13, DOI 10.3390/genes13010025
   Klimentidis YC, 2018, INT J OBESITY, V42, P1161, DOI 10.1038/s41366-018-0120-3
   Kuo YW, 2022, NUTRIENTS, V14, DOI 10.3390/nu14163254
   Lee JJ, 2018, NAT GENET, V50, P1112, DOI 10.1038/s41588-018-0147-3
   Lin YH, 2021, BMC GERIATR, V21, DOI 10.1186/s12877-021-02361-0
   Liu C, 2022, FRONT ENDOCRINOL, V13, DOI 10.3389/fendo.2022.975647
   Liu XG, 2009, AM J HUM GENET, V84, P418, DOI 10.1016/j.ajhg.2009.02.004
   Luo J, 2023, CONNECT TISSUE RES, V64, P117, DOI 10.1080/03008207.2022.2104160
   Moctezuma-Velázquez C, 2018, ANN HEPATOL, V17, P615, DOI 10.5604/01.3001.0012.0930
   Moreland E, 2022, J STRENGTH COND RES, V36, P2509, DOI 10.1519/JSC.0000000000003901
   Morris JA, 2019, NAT GENET, V51, P258, DOI 10.1038/s41588-018-0302-x
   mousephenotype, INT MOUS PHEN CONS I
   Nagel M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03242-8
   Nezameddin R, 2020, CURR DIABETES REV, V16, P957, DOI 10.2174/1573399816666200109091449
   opentargets, OP TARG GEN
   Pei YF, 2020, COMMUN BIOL, V3, DOI 10.1038/s42003-020-01334-0
   Pei YF, 2019, SKELET MUSCLE, V9, DOI 10.1186/s13395-019-0212-3
   Petermann-Rocha F, 2022, J CACHEXIA SARCOPENI, V13, P86, DOI 10.1002/jcsm.12783
   Petermann-Rocha F, 2020, MATURITAS, V133, P60, DOI 10.1016/j.maturitas.2020.01.004
   Pratt J, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9010012
   Ran S, 2020, MOL GENET GENOM MED, V8, DOI 10.1002/mgg3.1267
   Ran S, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-61272-z
   Rasmussen LJH, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.13123
   Remelli F, 2019, NUTRIENTS, V11, DOI 10.3390/nu11122861
   Revez JA, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15421-7
   Rossini-Venturini AC, 2022, BMC SPORTS SCI MED R, V14, DOI 10.1186/s13102-022-00559-2
   Roth SM, 2004, J GERONTOL A-BIOL, V59, P10
   Ruth KS, 2020, NAT MED, V26, P252, DOI 10.1038/s41591-020-0751-5
   Savage JE, 2018, NAT GENET, V50, P912, DOI 10.1038/s41588-018-0152-6
   Scott D, 2014, OBESITY, V22, P1568, DOI 10.1002/oby.20734
   Seaborne RA, 2019, J PHYSIOL-LONDON, V597, P3727, DOI 10.1113/JP278073
   Sudlow C, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001779
   Swan L, 2022, J FRALITY AGING, V11, P398, DOI 10.14283/jfa.2022.32
   Tikkanen E, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24735-y
   Timmins IR, 2020, COMMUN BIOL, V3, DOI 10.1038/s42003-020-01357-7
   Tolea MI, 2012, J RES PERS, V46, P264, DOI 10.1016/j.jrp.2012.02.002
   Veronese N, 2019, EUR GERIATR MED, V10, P853, DOI 10.1007/s41999-019-00233-w
   Vissing K, 2014, SCI DATA, V1, DOI 10.1038/sdata.2014.41
   Walsh S, 2016, AGING CLIN EXP RES, V28, P435, DOI 10.1007/s40520-015-0447-8
   Welch AA, 2017, NUTRIENTS, V9, DOI 10.3390/nu9111189
   Willems SM, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms16015
   Wu SE, 2021, J INFLAMM RES, V14, P5969, DOI 10.2147/JIR.S338724
   Yao XM, 2020, J CLIN LAB ANAL, V34, DOI 10.1002/jcla.23485
   Yoon KJ, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-82003-y
   Yoshida Y, 2020, NUTRIENTS, V12, DOI 10.3390/nu12113474
   Yu F, 2007, ACTA PHYSIOL, V190, P229, DOI 10.1111/j.1748-1716.2007.01699.x
   Zempo H, 2017, SCAND J MED SCI SPOR, V27, P1537, DOI 10.1111/sms.12804
   Zhao HT, 2022, INT J ENV RES PUB HE, V19, DOI 10.3390/ijerph192315491
NR 85
TC 27
Z9 29
U1 6
U2 44
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2072-6643
J9 NUTRIENTS
JI Nutrients
PD FEB
PY 2023
VL 15
IS 3
AR 758
DI 10.3390/nu15030758
PG 15
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA 8W1KK
UT WOS:000931079100001
PM 36771461
OA Green Published, Green Accepted, gold
DA 2025-04-28
ER

PT J
AU Marques-Vidal, P
   Bochud, M
   Paccaud, F
   Mooser, V
   Waeber, G
   Vollenweider, P
AF Marques-Vidal, Pedro
   Bochud, Murielle
   Paccaud, Fred
   Mooser, Vincent
   Waeber, Gerard
   Vollenweider, Peter
TI Distribution of plasma levels of adiponectin and leptin in an adult
   Caucasian population
SO CLINICAL ENDOCRINOLOGY
LA English
DT Article
ID CARDIOVASCULAR RISK-FACTORS; BODY-FAT; CIGARETTE-SMOKING; LIFE-STYLE;
   INSULIN SENSITIVITY; DIETARY FACTORS; NORMAL-WEIGHT; ASSOCIATION; WOMEN;
   OBESITY
AB P>Objectives
   Little is known regarding the distribution and the determinants of leptin and adiponectin levels in the general population.
   Design
   Cross-sectional study.
   Patients
   Women (3004) and men (2552) aged 35-74 living in Lausanne, Switzerland.
   Measurements
   Plasma levels of leptin and adiponectin (ELISA measurement).
   Results
   Women had higher leptin and adiponectin levels than men. In both genders, leptin and adiponectin levels increased with age. After adjusting for fat mass, leptin levels were significantly and negatively associated with age in women: 18 center dot 1 +/- 0 center dot 3, 17 center dot 1 +/- 0 center dot 3, 16 center dot 7 +/- 0 center dot 3 and 15 center dot 5 +/- 0 center dot 4 ng/ml (adjusted mean +/- SE) for age groups [35-44], [45-54], [55-64] and [65-75], respectively, P < 0 center dot 001. A similar but nonsignificant trend was also found in men. Conversely, the age-related increase of adiponectin was unrelated to body fat in both genders. Post-menopausal women had higher leptin and adiponectin levels than premenopausal women, independently of hormone replacement therapy. Although body fat mass was associated with leptin and adiponectin, the associations were stronger with body mass index (BMI), waist and hip in both genders. Finally, after adjusting for age and anthropometry, no relationships were found between leptin or adiponectin levels with alcohol, caffeine consumption and physical activity, whereas smoking and diabetes decreased leptin and adiponectin levels in women only.
   Conclusions
   The age-related increase in leptin levels is attributable to changes in fat mass in women and probably also in men. Leptin and adiponectin levels are more related to BMI than to body fat mass. The effects of smoking and diabetes appear to be gender-specific.
C1 [Marques-Vidal, Pedro] Univ Lausanne, Ctr Cardiovasc & Metab Res Cardiomet, CH-1015 Lausanne, Switzerland.
   [Marques-Vidal, Pedro; Bochud, Murielle; Paccaud, Fred] Univ Lausanne, Inst Social & Prevent Med IUMSP, CH-1015 Lausanne, Switzerland.
   [Mooser, Vincent] GlaxoSmithKline, Div Genet, Philadelphia, PA USA.
   [Waeber, Gerard; Vollenweider, Peter] CHU Vaudois, Dept Med, CH-1005 Lausanne, Switzerland.
C3 University of Lausanne; University of Lausanne; GlaxoSmithKline;
   Glaxosmithkline USA; University of Lausanne; Centre Hospitalier
   Universitaire Vaudois (CHUV)
RP Marques-Vidal, P (corresponding author), CHU Vaudois, Inst Social & Prevent Med IUMSP, Bugnon 17, CH-1005 Lausanne, Switzerland.
EM Pedro-Manuel.Marques-Vidal@chuv.ch
RI Bochud, Murielle/A-3981-2010; paccaud, fred/M-7516-2019; Vollenweider,
   Peter/Q-4603-2016; Marques-Vidal, Pedro/C-9449-2009
OI Vollenweider, Peter/0000-0002-0765-896X; Waeber,
   Gerard/0000-0003-4193-788X; Marques-Vidal, Pedro/0000-0002-4548-8500
FU GlaxoSmithKline; Faculty of Biology and Medicine of Lausanne,
   Switzerland; Fonds National Suisse de la recherche [33CSCO-122661];
   Swiss National Foundation for Science [111362/1, 11361/1]
FX The CoLaus study was supported by research grants from GlaxoSmithKline
   and from the Faculty of Biology and Medicine of Lausanne, Switzerland
   and the Fonds National Suisse de la recherche (Grant No.:
   33CSCO-122661). Murielle Bochud is supported by a grant from the Swiss
   National Foundation for Science (PROSPER: 111362/1 and 111361/1).
   Vincent Mooser is a full-time employee of GlaxoSmithKline.
CR Chiesa C, 2008, CLIN CHEM, V54, P550, DOI 10.1373/clinchem.2007.095299
   Chu NF, 2001, INT J OBESITY, V25, P106, DOI 10.1038/sj.ijo.0801468
   Cnop M, 2003, DIABETOLOGIA, V46, P459, DOI 10.1007/s00125-003-1074-z
   Donahue RP, 1999, ANN EPIDEMIOL, V9, P108, DOI 10.1016/S1047-2797(98)00037-4
   Dufour MC, 1999, ALCOHOL RES HEALTH, V23, P5
   Firmann M, 2008, BMC CARDIOVASC DISOR, V8, DOI 10.1186/1471-2261-8-6
   Fruehwald-Schultes B, 2002, METABOLISM, V51, P531, DOI 10.1053/meta.2002.31332
   Gable DR, 2007, ANN HUM GENET, V71, P453, DOI 10.1111/j.1469-1809.2006.00340.x
   Galea S, 2007, ANN EPIDEMIOL, V17, P643, DOI 10.1016/j.annepidem.2007.03.013
   Hart CL, 1999, BMJ-BRIT MED J, V318, P1725, DOI 10.1136/bmj.318.7200.1725
   Hughes VA, 2004, AM J CLIN NUTR, V80, P475, DOI 10.1093/ajcn/80.2.475
   Im JA, 2006, MATURITAS, V54, P65, DOI 10.1016/j.maturitas.2005.08.008
   Isidori AM, 2000, J CLIN ENDOCR METAB, V85, P1954, DOI 10.1210/jc.85.5.1954
   Iwashima Y, 2005, HYPERTENSION, V45, P1094, DOI 10.1161/01.HYP.0000169444.05588.4c
   Kennedy A, 1997, J CLIN ENDOCR METAB, V82, P1293, DOI 10.1210/jc.82.4.1293
   Kim OY, 2006, CLIN CHIM ACTA, V370, P63, DOI 10.1016/j.cca.2006.01.021
   Koh SJ, 2008, CLIN CHIM ACTA, V389, P45, DOI 10.1016/j.cca.2007.11.017
   Kotani K, 2007, ARCH MED RES, V38, P887, DOI 10.1016/j.arcmed.2007.06.008
   Kutner M.H., 2004, Applied Linear Regression Models, V4
   Kwon K, 2005, INT J CARDIOL, V101, P385, DOI 10.1016/j.ijcard.2004.03.050
   Lagiou P, 1999, ANN NUTR METAB, V43, P23, DOI 10.1159/000012763
   LEAN MEJ, 1995, BRIT MED J, V311, P158, DOI 10.1136/bmj.311.6998.158
   Lee HJ, 2006, NEUROSCI LETT, V409, P47, DOI 10.1016/j.neulet.2006.09.013
   Manigrasso MR, 2005, J CLIN ENDOCR METAB, V90, P5876, DOI 10.1210/jc.2005-0281
   Marques-Vidal P, 2001, ATHEROSCLEROSIS, V157, P431, DOI 10.1016/S0021-9150(00)00734-6
   Marshall JA, 2000, OBES RES, V8, P543, DOI 10.1038/oby.2000.70
   Martin LJ, 2003, INT J OBESITY, V27, P334, DOI 10.1038/sj.ijo.0802232
   Miller GD, 2001, NUTRITION, V17, P105, DOI 10.1016/S0899-9007(00)00511-6
   Miyata G, 2000, NUTRITION, V16, P141, DOI 10.1016/S0899-9007(99)00223-3
   Morton GJ, 2007, J PHYSIOL-LONDON, V583, P437, DOI 10.1113/jphysiol.2007.135590
   Panarotto D, 2000, METABOLISM, V49, P1055, DOI 10.1053/meta.2000.7745
   Pischon T, 2005, AM J CLIN NUTR, V81, P780, DOI 10.1093/ajcn/81.4.780
   Reseland JE, 2005, PROSTAG LEUKOTR ESS, V73, P43, DOI 10.1016/j.plefa.2005.04.006
   Rokling-Andersen MH, 2007, AM J CLIN NUTR, V86, P1293, DOI 10.1093/ajcn/86.5.1293
   Rosenbaum M, 1996, J CLIN ENDOCR METAB, V81, P3424, DOI 10.1210/jc.81.9.3424
   Ruhl CE, 2001, AM J CLIN NUTR, V74, P295
   Salas-Salvadó J, 2007, METABOLISM, V56, P1486, DOI 10.1016/j.metabol.2007.06.014
   Sandhu MS, 2008, LANCET, V371, P483, DOI 10.1016/S0140-6736(08)60208-1
   Santos JL, 2006, EUR J NUTR, V45, P454, DOI 10.1007/s00394-006-0619-6
   Sieminska L, 2005, METABOLISM, V54, P1610, DOI 10.1016/j.metabol.2005.06.008
   Soares MJ, 2000, INT J OBESITY, V24, P1592, DOI 10.1038/sj.ijo.0801450
   Sowers MR, 2008, MATURITAS, V59, P149, DOI 10.1016/j.maturitas.2007.12.006
   Wang ZH, 2007, ENDOCRINOLOGY, V148, P2845, DOI 10.1210/en.2006-1313
   WARWICK PM, 1993, EUR J CLIN NUTR, V47, P600
   Weyer C, 2001, J CLIN ENDOCR METAB, V86, P1930, DOI 10.1210/jc.86.5.1930
   Williams CJ, 2008, DIABETES CARE, V31, P504, DOI 10.2337/dc07-1952
   Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984
NR 47
TC 39
Z9 40
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0300-0664
EI 1365-2265
J9 CLIN ENDOCRINOL
JI Clin. Endocrinol.
PD JAN
PY 2010
VL 72
IS 1
BP 38
EP 46
DI 10.1111/j.1365-2265.2009.03628.x
PG 9
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA 532SX
UT WOS:000272771200008
PM 19473178
DA 2025-04-28
ER

PT J
AU Shaneshin, M
   Rashidkhani, B
   Rabiei, S
AF Shaneshin, Mahboubeh
   Rashidkhani, Bahram
   Rabiei, Samira
TI Accuracy of Energy Intake Reporting: Comparison of Energy Intake and
   Resting Metabolic Rate and their Relation to Anthropometric and
   Sociodemographic Factors among Iranian Women
SO ARCHIVES OF IRANIAN MEDICINE
LA English
DT Article
DE Anthropometric characteristics; energy intake; energy reporting; resting
   metabolism; sociodemographic factors
ID FOOD-INTAKE; DIETARY PATTERNS; WEIGHT STATUS; AFFLUENT SOCIETIES;
   BODY-WEIGHT; LIFE-STYLE; OBESE; EXPENDITURE; RECALL; ADULTS
AB Background: This study assesses the accuracy of energy intake (El) reporting and its relation to anthropometric characteristics and sociodemographic factors. In addition, we attempt to identify foods for which under- or over-reporting is more prevalent.
   Methods: El was assessed for 187 women using a semi-quantitative 168-item food frequency questionnaire (FFQ). Resting metabolic rate (RMR) was measured with an indirect calorimeter. We calculated the El/RMR ratio to assess the accuracy of El reporting. This study defined under-reporters as those with an El/RMR of <= 1.34 and over-reporters as those with an El/RMR of >= 2.4. We measured anthropometric characteristics and collected sociodemographic information. The chi-square test, ANOVA and multiple linear regressions were used for statistical analyses.
   Results: Among participants, the under-reporting rate was 35.5% and the over-reporting rate was 7.5%. The El/RMR ratio was significantly higher for younger women compared to older women (P < 0.04). Under-reporters had higher weight, waist circumference (WC), body mass index (BMI) and resting metabolism compared to accurate reporters (P < 0.05). Resting metabolism was significantly lower among over-reporters than accurate reporters. After adjusting for energy, the consumption of fish, high-fat dairy products, hydrogenated oil, sweets and coffee was lower, whereas consumption of unsaturated oils, tea, salt and yellow vegetables was higher among under-reporters compared to accurate reporters.
   Conclusion: Under-reporting of El is more frequent than over-reporting among Iranian women. Among various factors that may affect the accuracy of El reporting, age and anthropometric characteristics might have a significant effect.
C1 [Shaneshin, Mahboubeh; Rashidkhani, Bahram; Rabiei, Samira] Shahid Beheshti Univ Med Sci & Hlth Serv, Natl Nutr & Food Technol Res Inst, Fac Nutr Sci & Food Technol, Community Nutr Dept, Tehran, Iran.
C3 Shahid Beheshti University Medical Sciences
RP Rashidkhani, B (corresponding author), Shahid Beheshti Univ Med Sci, Fac Nutr Sci & Food Technol, Natl Nutr & Food Technol Res Inst, Tehran, Iran.
EM b_rashidkhani@sbmu.ac.ir
RI rashidkhani, bahram/ABG-9304-2021; Rabiei, Samira/T-8057-2017
OI Rabiei, Samira/0000-0002-3606-8969
FU National Nutrition and Food Technology Research Institute of Shahid
   Beheshti University of Medical Sciences
FX The authors would like to thank the subjects for their enthusiastic
   support. We also thank the members of National Nutrition and Food
   Technology Research Institute for their kind collaboration. This work
   was: supported by the National Nutrition and Food Technology Research
   Institute of Shahid Beheshti University of Medical Sciences. None of the
   authors had any personal or financial conflicts of interest. M.SH and
   B.R designed the study collected and analyzed the data. S.R wrote the
   manuscript and provided consultation.
CR [Anonymous], DOUBL LAB WAT METH M
   Asbeck I, 2002, PUBLIC HEALTH NUTR, V5, P683, DOI 10.1079/PHN2002337
   Azar M, Food composition table of Iran: National Nutrition and food research institute
   Bailey RL, 2007, J AM DIET ASSOC, V107, P64, DOI 10.1016/j.jada.2006.10.009
   BallardBarbash R, 1996, EUR J CLIN NUTR, V50, P98
   Bedard D, 2004, PUBLIC HEALTH NUTR, V7, P675, DOI 10.1079/PHN2003578
   Berg CM, 2008, AM J CLIN NUTR, V88, P289
   BLACK AE, 1991, EUR J CLIN NUTR, V45, P583
   Black AE, 1997, EUR J CLIN NUTR, V51, P405, DOI 10.1038/sj.ejcn.1600425
   Black AE, 1996, EUR J CLIN NUTR, V50, P72
   Briefel RR, 1997, AM J CLIN NUTR, V65, P1203
   Delisle HF, 2009, NUTR J, V8, DOI 10.1186/1475-2891-8-3
   DEVRIES JHM, 1994, AM J CLIN NUTR, V60, P855, DOI 10.1093/ajcn/60.6.855
   Drummond SE, 1998, INT J OBESITY, V22, P105, DOI 10.1038/sj.ijo.0800552
   Energy WHO, 1985, WHO TECHN REP SER, V724
   Esmaillzadeh A, 2008, J NUTR, V138, P358, DOI 10.1093/jn/138.2.358
   Forman JN, 1998, INT J OBESITY, V22, P215, DOI 10.1038/sj.ijo.0800569
   Ghaffarpour M., 1999, TEHRAN NASHRE OLUME, V7, P42
   Goris AHC, 2000, AM J CLIN NUTR, V71, P130
   Harrison GG, 2000, J NUTR, V130, P2049, DOI 10.1093/jn/130.8.2049
   HEITMANN BL, 1995, BRIT MED J, V311, P986
   Johansson G, 2001, PUBLIC HEALTH NUTR, V4, P919, DOI 10.1079/PHN2001124
   Johansson L, 1998, AM J CLIN NUTR, V68, P266, DOI 10.1093/ajcn/68.2.266
   Johnson RK, 1998, J AM DIET ASSOC, V98, P1136, DOI 10.1016/S0002-8223(98)00263-6
   Lafay L, 2000, INT J OBESITY, V24, P1500, DOI 10.1038/sj.ijo.0801392
   LISSNER L, 1989, AM J CLIN NUTR, V49, P320, DOI 10.1093/ajcn/49.2.320
   Livingstone MBE, 2003, J NUTR, V133, p895S, DOI 10.1093/jn/133.3.895S
   LIVINGSTONE MBE, 1995, BRIT J BIOMED SCI, V52, P58
   Mendez MA, 2004, PUBLIC HEALTH NUTR, V7, P9, DOI 10.1079/PHN2003508
   Mirmiran P, 2006, ASIA PAC J CLIN NUTR, V15, P459
   Novotny J, 2003, J AM DIET ASSOC, V103, P1146, DOI 10.1016/S0002-8223(03)00975-1
   Okubo H, 2006, PUBLIC HEALTH NUTR, V9, P651, DOI 10.1079/PHN2005894
   Poppitt SD, 1998, INT J OBESITY, V22, P303, DOI 10.1038/sj.ijo.0800584
   Prentice AM, 1996, EUR J CLIN NUTR, V50, P93
   Rezazadeh A, 2010, NUTRITION, V26, P337, DOI 10.1016/j.nut.2009.06.019
   Samaras K, 1999, INT J OBESITY, V23, P881, DOI 10.1038/sj.ijo.0800967
   Scagliusi FB, 2008, BRIT J NUTR, V100, P1060, DOI 10.1017/S0007114508971300
   Wang J, 2003, AM J CLIN NUTR, V77, P379, DOI 10.1093/ajcn/77.2.379
   Willett WC, 1999, NEW ENGL J MED, V341, P427, DOI 10.1056/NEJM199908053410607
   Willett WC, 1998, NUTR EPIDEMIOLOGY
NR 40
TC 8
Z9 8
U1 0
U2 9
PU ACAD MEDICAL SCIENCES I R IRAN
PI TEHRAN
PA PO BOX 19395-5655, TEHRAN, 00000, IRAN
SN 1029-2977
EI 1735-3947
J9 ARCH IRAN MED
JI Arch. Iran. Med.
PD NOV
PY 2012
VL 15
IS 11
BP 681
EP 687
PG 7
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA 049EQ
UT WOS:000311965400005
PM 23102244
DA 2025-04-28
ER

PT J
AU Bucher, T
   Siegrist, M
AF Bucher, Tamara
   Siegrist, Michael
TI Children's and parents' health perception of different soft drinks
SO BRITISH JOURNAL OF NUTRITION
LA English
DT Article
DE Beverages; Soft drinks; Children; Health perception; Multidimensional
   scaling
ID CARBONATED MINERAL-WATER; CHILDHOOD OBESITY; ENERGY DRINKS; FOOD;
   CONSUMPTION; ADOLESCENTS; BEVERAGES; PREVENTION
AB Beverages are among the first independent product choices that school-aged children will make and unhealthy choices can be a threat to children's health. The present study investigated which beverage attributes shape adults' and children's health perceptions. For this purpose, 100 children (fifty-two boys; mean age 8.8 (SD 1.1) years) and their parents were invited to independently perform a beverage-sorting task. Participants were asked to place twenty commonly consumed soft drinks in a line ranging from 'unhealthy' to 'healthy'. The sorting data were analysed using multidimensional scaling with property fitting and hierarchical clustering. Sugar content (beta parents = 20.78, beta(children) = 20.68; P<0.001), artificial sweeteners (beta(parents) = 20.68, beta(children) = 20.66; P<0.001), fruit content (beta(parents) = 0.33, beta(children) = 0.36; P<0.05) and caffeine content (beta(parents) = 20.45, beta(children) = 20.46; P<0.01) were found to be the predictors of parents' and children's health perceptions. Parents' and children's estimates were strongly related (r(s) 0.70 (SD 0.15)); both groups classified the beverages into similar clusters. However, compared with their parents, children perceived beverages such as fruit juices and grapefruit soda to be healthier. In conclusion, parents' and children's health perceptions were strongly related based on the same relevant attributes for evaluation. However, fruit content was considered a more important criterion by children, which might lead to differences in the health perception between children and their parents. Low fruit content and the belief of beverages being 'natural' could positively bias perceptions. Therefore, certain soft drinks such as squashes or fruit lemonades are problematic, and the consumer's awareness of their low nutritional quality should be raised.
C1 [Bucher, Tamara; Siegrist, Michael] ETH, Dept Hlth Sci & Technol D HEST, IFNH, CH-8092 Zurich, Switzerland.
C3 Swiss Federal Institutes of Technology Domain; ETH Zurich
RP Bucher, T (corresponding author), ETH, Dept Hlth Sci & Technol D HEST, IFNH, CHN J 75-3,Univ Str 16, CH-8092 Zurich, Switzerland.
EM tbucher@ethz.ch
RI Siegrist, Michael/A-1032-2008; Bucher, Tamara/AAR-9797-2020
OI Bucher, Tamara/0000-0003-3244-5867
FU Swiss Foundation for Nutrition Research (SFEFS)
FX The present study was partially supported by the Swiss Foundation for
   Nutrition Research (SFEFS). The SFEFS had no role in the design and
   analysis of the study or in the writing of this article.
CR Academy of Nutrition and Dietetics, 2006, CHILDH OV EV AN PROJ
   [Anonymous], 2002, Expert consultation on diet, nutrition and the prevention of chronic diseases
   [Anonymous], 2013, OB OV, DOI DOI 10.1017/S1368980023000988
   Atik D, 2013, INT J CONSUM STUD, V37, P59, DOI 10.1111/j.1470-6431.2011.01049.x
   Backhaus K., 2011, Fortgeschrittene Multivarate Analysemethoden. Eine anwendungsorientierte Einfuhrung
   Bere E, 2008, PUBLIC HEALTH NUTR, V11, P49, DOI 10.1017/S1368980007000122
   Bevelander KE, 2013, THESIS AMSTERDAM
   Borg I, 2007, Modern Multidimensional Scaling: Theory and Applications
   Bray GA, 2004, AM J CLIN NUTR, V79, P537
   Chandon P, 2007, J CONSUM RES, V34, P301, DOI 10.1086/519499
   Cohen Jacob, 1988, Statistical Power Analysis for the Behavioral Sciences
   Croll JK, 2001, J NUTR EDUC, V33, P193, DOI 10.1016/S1499-4046(06)60031-6
   Cuomo R, 2002, EUR J GASTROEN HEPAT, V14, P991, DOI 10.1097/00042737-200209000-00010
   Currie C., 2012, Health Policy for Children and Adolescents, V6
   Davis MM, 2007, PEDIATRICS, V120, pS229, DOI 10.1542/peds.2007-2329E
   Dohle S, 2014, FOOD QUAL PREFER, V33, P14, DOI 10.1016/j.foodqual.2013.11.001
   Elliott CD, 2009, CAN J COMMUN, V34, P359, DOI 10.22230/cjc.2009v34n3a2220
   Federal Office of Public Health (FOPH), 2013, SWISS NAT DRINK WAT
   Fitzgerald A, 2010, HEALTH PROMOT INT, V25, P289, DOI 10.1093/heapro/daq021
   Golan M, 2004, NUTR REV, V62, P39, DOI [10.1301/nr.2004.jan.39-50, 10.1111/j.1753-4887.2004.tb00005.x]
   Harris JL, 2009, ANNU REV PUBL HEALTH, V30, P211, DOI 10.1146/annurev.publhealth.031308.100304
   Herzig M, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-139
   Kruskal J.B., 1986, Multidimensional Scaling
   Lähteenmäki L, 2013, FOOD QUAL PREFER, V27, P196, DOI 10.1016/j.foodqual.2012.03.006
   Ludwig DS, 2001, LANCET, V357, P505, DOI 10.1016/S0140-6736(00)04041-1
   Mooi E, 2011, CONCISE GUIDE TO MARKET RESEARCH: THE PROCESS, DATA, AND METHODS USING IBM SPSS STATISTICS, P285, DOI 10.1007/978-3-642-12541-6_10
   Nestle M, 2000, PUBLIC HEALTH REP, V115, P308, DOI 10.1093/phr/115.4.308
   Parry J, 2001, J ORAL REHABIL, V28, P766, DOI 10.1046/j.1365-2842.2001.00795.x
   Reissig CJ, 2009, DRUG ALCOHOL DEPEN, V99, P1, DOI 10.1016/j.drugalcdep.2008.08.001
   Rivella AG, 2012, RIVELLA KENNZAHLEN 2
   Romine CB, 2004, ARCH CLIN NEUROPSYCH, V19, P1027, DOI 10.1016/j.acn.2003.12.009
   Rozin P, 2004, APPETITE, V43, P147, DOI 10.1016/j.appet.2004.03.005
   Schoppen S, 2005, BRIT J NUTR, V93, P339, DOI 10.1079/BJN20041332
   Schoppen S, 2004, J NUTR, V134, P1058, DOI 10.1093/jn/134.5.1058
   Schornoz L, 2006, ALIMENTA ONLINE DUNN
   Seifert SM, 2011, PEDIATRICS, V127, P511, DOI 10.1542/peds.2009-3592
   Siegrist M, 2013, 10 PANGB SENS SCI S
   SSP (Swiss Society of Paediatrics), 2008, PEDIATRICA
   Story Mary, 2004, Int J Behav Nutr Phys Act, V1, P3, DOI 10.1186/1479-5868-1-3
   Strachan J, 2008, INT J MARKET RES, V50, P13, DOI 10.1177/147078530805000104
   Toumpakari Z, 2013, ISBNPA 2013 ANN M GH
   Troiano RP, 2000, AM J CLIN NUTR, V72, p1343S, DOI 10.1093/ajcn/72.5.1343s
   Tucker KL, 2006, AM J CLIN NUTR, V84, P936, DOI 10.1093/ajcn/84.4.936
   van der Horst K, 2007, HEALTH EDUC RES, V22, P295, DOI 10.1093/her/cyl080
   Vartanian LR, 2007, AM J PUBLIC HEALTH, V97, P667, DOI 10.2105/AJPH.2005.083782
   von Normann K, 2009, INT J CONSUM STUD, V33, P382, DOI 10.1111/j.1470-6431.2009.00786.x
NR 46
TC 42
Z9 46
U1 1
U2 51
PU CAMBRIDGE UNIV PRESS
PI CAMBRIDGE
PA EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND
SN 0007-1145
EI 1475-2662
J9 BRIT J NUTR
JI Br. J. Nutr.
PD FEB 14
PY 2015
VL 113
IS 3
BP 526
EP 535
DI 10.1017/S0007114514004073
PG 10
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Nutrition & Dietetics
GA CC3FB
UT WOS:000350230300015
PM 25612601
OA Bronze, Green Published
DA 2025-04-28
ER

PT J
AU Rogers, PJ
AF Rogers, Peter J.
TI Food and drug addictions: Similarities and differences
SO PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
LA English
DT Review
DE Addiction; Appetite; Attribution; Food; Drugs; Reward; Obesity; Craving;
   Bingeing
ID DOPAMINE D2 RECEPTORS; REWARD; APPETITE; CAFFEINE; BRAIN; CUES;
   INTERMITTENT; ASSOCIATION; EXPOSURE; OBESITY
AB This review examines the merits of 'food addiction' as an explanation of excessive eating (i.e., eating in excess of what is required to maintain a healthy body weight). It describes various apparent similarities in appetites for foods and drugs. For example, conditioned environmental cues can arouse food and drug-seeking behaviour, 'craving' is an experience reported to precede eating and drug taking, 'bingeing' is associated with both eating and drug use, and conditioned and unconditioned tolerance occurs to food and drug ingestion. This is to be expected, as addictive drugs tap into the same processes and systems that evolved to motivate and control adaptive behaviours, including eating. The evidence, however, shows that drugs of abuse have more potent effects than foods, particularly in respect of their neuroadaptive effects that make them 'wanted.' While binge eating has been conceptualised as form of addictive behaviour, it is not a major cause of excessive eating, because binge eating has a far lower prevalence than obesity. Rather, it is proposed that obesity results from recurrent overconsumption of energy dense foods. Such foods are, relatedly, both attractive and (calorie for calorie) weakly satiating. Limiting their availability could partially decrease excessive eating and consequently decrease obesity. Arguably, persuading policy makers that these foods are addictive could support such action. However, blaming excessive eating on food addiction could be counterproductive, because it risks trivialising serious addictions, and because the attribution of excessive eating to food addiction implies an inability to control one's eating. Therefore, attributing everyday excessive eating to food addiction may neither explain nor significantly help reduce this problem. (C) 2017 The Author. Published by Elsevier Inc. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
C1 [Rogers, Peter J.] Univ Bristol, Nutr & Behav Unit, Sch Expt Psychol, 12a Priory Rd, Bristol BS8 1TU, Avon, England.
C3 University of Bristol
RP Rogers, PJ (corresponding author), Univ Bristol, Nutr & Behav Unit, Sch Expt Psychol, 12a Priory Rd, Bristol BS8 1TU, Avon, England.
EM peter.rogers@bristol.ac.uk
OI Rogers, Peter/0000-0003-3525-3473
FU Sugar Nutrition UK [47190]; International Sweeteners Association; BBSRC
   DRINC [BB/L02554X/1]; European Union [607310]; BBSRC [BB/L02554X/1]
   Funding Source: UKRI
FX The author has received funding for research on the effects of sugar on
   appetite and satiety from Sugar Nutrition UK (grant ref. 47190). He has
   provided consultancy services to Coca-Cola Great Britain and received
   speaker's fees from the International Sweeteners Association. The ideas
   relating food reward, post-prandial satiety and energy balance were
   developed in part during the preparation of a grant funded by BBSRC
   DRINC (BB/L02554X/1). Part of the research leading to this review
   received funding from the European Union Seventh Framework Programme for
   research, technological development and demonstration under grant
   agreement no. 607310.
CR Altman J, 1996, PSYCHOPHARMACOLOGY, V125, P285, DOI 10.1007/BF02246016
   [Anonymous], COCHRANE DATABASE SY
   [Anonymous], 2013, OVERCOMING BINGE EAT
   [Anonymous], THEORY OF ADDICTION
   Avena NM, 2008, NEUROSCI BIOBEHAV R, V32, P20, DOI 10.1016/j.neubiorev.2007.04.019
   Berridge KC, 1996, NEUROSCI BIOBEHAV R, V20, P1, DOI 10.1016/0149-7634(95)00033-B
   BLUM K, 1990, JAMA-J AM MED ASSOC, V263, P2055, DOI 10.1001/jama.263.15.2055
   Blum K, 1996, AM SCI, V84, P132
   Bryant EJ, 2008, OBES REV, V9, P409, DOI 10.1111/j.1467-789X.2007.00426.x
   Carelli RM, 2002, PHYSIOL BEHAV, V76, P379, DOI 10.1016/S0031-9384(02)00760-6
   Carter MJ, 2014, THER RECREAT J, V48, P275
   Cassady BA, 2012, AM J CLIN NUTR, V95, P587, DOI 10.3945/ajcn.111.025437
   Cassin SE, 2007, APPETITE, V49, P687, DOI 10.1016/j.appet.2007.06.012
   Colantuoni C, 2002, OBES RES, V10, P478, DOI 10.1038/oby.2002.66
   CORNELL CE, 1989, PHYSIOL BEHAV, V45, P695, DOI 10.1016/0031-9384(89)90281-3
   Corr PJ, 2008, REINFORCEMENT SENSITIVITY THEORY OF PERSONALITY, P1
   Davies J.B., 1992, MYTH ADDICTION
   de Araujo IE, 2008, NEURON, V57, P930, DOI 10.1016/j.neuron.2008.01.032
   deWit H, 1996, EXP CLIN PSYCHOPHARM, V4, P5, DOI 10.1037/1064-1297.4.1.5
   Di Chiara G, 2005, PHYSIOL BEHAV, V86, P9, DOI 10.1016/j.physbeh.2005.06.020
   Epstein DH, 2010, NAT NEUROSCI, V13, P529, DOI 10.1038/nn0510-529
   Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579
   Ferriday D, 2011, INT J OBESITY, V35, P142, DOI 10.1038/ijo.2010.117
   Gable PA, 2016, PSYCHOL ADDICT BEHAV, V30, P377, DOI 10.1037/adb0000130
   Gearhardt AN, 2016, PSYCHOL ADDICT BEHAV, V30, P113, DOI 10.1037/adb0000136
   Gearhardt AN, 2011, ARCH GEN PSYCHIAT, V68, P808, DOI 10.1001/archgenpsychiatry.2011.32
   Gearhardt AN, 2011, ADDICTION, V106, P1208, DOI 10.1111/j.1360-0443.2010.03301.x
   Gearhardt AN, 2009, APPETITE, V52, P430, DOI 10.1016/j.appet.2008.12.003
   Geliebter A, 2001, PHYSIOL BEHAV, V74, P743, DOI 10.1016/S0031-9384(01)00619-9
   Hardman CA, 2014, INT J OBESITY, V38, P730, DOI 10.1038/ijo.2013.144
   Hardman CA, 2015, APPETITE, V91, P179, DOI 10.1016/j.appet.2015.04.052
   Hardman CA, 2012, PHYSIOL BEHAV, V105, P1202, DOI 10.1016/j.physbeh.2011.12.022
   Heatherton T., 1994, Losing control: How and why people fail at self-regulation
   Hebebrand J, 2014, NEUROSCI BIOBEHAV R, V47, P295, DOI 10.1016/j.neubiorev.2014.08.016
   Herz RS, 2001, PERCEPTION, V30, P381, DOI 10.1068/p3179
   Johnson PM, 2010, NAT NEUROSCI, V13, P635, DOI 10.1038/nn.2519
   Kaplan R, 1996, AUST NZ J PSYCHIAT, V30, P698, DOI 10.3109/00048679609062670
   Koob GF, 2016, LANCET PSYCHIAT, V3, P760, DOI 10.1016/S2215-0366(16)00104-8
   Koob GF, 2014, DRUGS, ADDICTION, AND THE BRAIN, P1
   LEGOFF DB, 1988, APPETITE, V11, P15, DOI 10.1016/S0195-6663(88)80018-7
   Long CG, 2015, OBESITY FACTS, V8, P386, DOI 10.1159/000442403
   Meule Adrian, 2015, Yale Journal of Biology and Medicine, V88, P295
   Munafò MR, 2007, MOL PSYCHIATR, V12, P454, DOI 10.1038/sj.mp.4001938
   Nader MA, 2005, AM J PSYCHIAT, V162, P1473, DOI 10.1176/appi.ajp.162.8.1473
   Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8
   Peciña S, 2005, J NEUROSCI, V25, P11777, DOI 10.1523/JNEUROSCI.2329-05.2005
   Pedram P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074832
   Petrovich GD, 2002, J NEUROSCI, V22, P8748
   ROBINSON TE, 1993, BRAIN RES REV, V18, P247, DOI 10.1016/0165-0173(93)90013-P
   Rogers PJ, 2016, PHYSIOL BEHAV, V164, P465, DOI 10.1016/j.physbeh.2016.03.038
   Rogers PJ, 2015, APPETITE, V90, P1, DOI 10.1016/j.appet.2015.02.032
   Rogers PJ, 2013, PSYCHOPHARMACOLOGY, V226, P229, DOI 10.1007/s00213-012-2889-4
   ROGERS PJ, 1985, PHYSIOL BEHAV, V35, P493, DOI 10.1016/0031-9384(85)90129-5
   Rogers PJ, 2000, PHARMACOL BIOCHEM BE, V66, P3, DOI 10.1016/S0091-3057(00)00197-0
   Rogers PJ, 1999, P NUTR SOC, V58, P59, DOI 10.1079/PNS19990009
   Salamone JD, 2013, BIOL PSYCHIAT, V73, pE15, DOI 10.1016/j.biopsych.2012.09.027
   Schulte EM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117959
   Stice E, 2016, PSYCHOL BULL, V142, P447, DOI 10.1037/bul0000044
   STRAIN EC, 1994, JAMA-J AM MED ASSOC, V272, P1043, DOI 10.1001/jama.272.13.1043
   STUNKARD AJ, 1985, J PSYCHOSOM RES, V29, P71, DOI 10.1016/0022-3999(85)90010-8
   Teff KL, 2011, PHYSIOL BEHAV, V103, P44, DOI 10.1016/j.physbeh.2011.01.012
   Tellez LA, 2016, NAT NEUROSCI, V19, P465, DOI 10.1038/nn.4224
   Tiffany S.T., 1995, Addictive behaviour: Cue exposure theory andpractice, P137
   Tunstall BJ, 2016, ADDICT BIOL, V21, P282, DOI 10.1111/adb.12195
   Wang GJ, 2001, LANCET, V357, P354, DOI 10.1016/S0140-6736(00)03643-6
   WEINGARTEN HP, 1983, SCIENCE, V220, P431, DOI 10.1126/science.6836286
   WIEPKEMA PR, 1971, BEHAVIOUR, V39, P266, DOI 10.1163/156853971X00258
   WOODS SC, 1991, PSYCHOL REV, V98, P488, DOI 10.1037/0033-295X.98.4.488
   World Health Organization, 1992, ICD 10 CLASS MENT BE
   Yeomans MR, 1996, APPETITE, V27, P119, DOI 10.1006/appe.1996.0040
   Yeomans MR, 1998, PSYCHOPHARMACOLOGY, V137, P401, DOI 10.1007/s002130050636
   Ziauddeen H, 2012, NAT REV NEUROSCI, V13, P279, DOI 10.1038/nrn3212
NR 72
TC 91
Z9 106
U1 2
U2 90
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0091-3057
EI 1873-5177
J9 PHARMACOL BIOCHEM BE
JI Pharmacol. Biochem. Behav.
PD FEB
PY 2017
VL 153
BP 182
EP 190
DI 10.1016/j.pbb.2017.01.001
PG 9
WC Behavioral Sciences; Neurosciences; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Behavioral Sciences; Neurosciences & Neurology; Pharmacology & Pharmacy
GA EJ5HJ
UT WOS:000393248100018
PM 28063947
OA hybrid, Green Published
DA 2025-04-28
ER

PT J
AU Kim, SY
   Kim, SM
AF Kim, Seok-Young
   Kim, Se Min
TI Energy intake and snack choice by the meal patterns of employed people
SO NUTRITION RESEARCH AND PRACTICE
LA English
DT Article
DE Snack; meal; energy intake; meal pattern
ID EATING PATTERNS; NUTRIENT INTAKE; DIETARY-INTAKE; FOOD CHOICES;
   FREQUENCY; TIME; OBESITY; WEIGHT; ADULTS; WOMEN
AB The aim of this study was to provide descriptive information on meal and snack patterns and to investigate snacks in relation to energy intake and food choice according to the meal patterns of employed people in Korea. 683 employed people (292 males, 391 females) were interviewed to collect one day dietary data by using 24-h dietary recall. A recorded day was divided into 3 meal and 3 snack periods by the respondent's criteria and the time of consumption. To analyze the eating pattern participants were divided as the more frequent snack eaters (MFSE) and the less frequent snack eaters (LFSE). They were also categorized into 6 groups according to the frequency of all eating occasions. The common meal pattern in nearly half of the subjects (47.6%) was composed of three meals plus one or two snacks per day. A trend of an increasing the number of snacks in between main meals emerges, although the conventional meal pattern is still retained in most employed Korean adults. Women, aged 30-39, and urban residents, had a higher number of being MFSE than LFSE. Increasing eating occasions was associated with higher energy, protein, and carbohydrate intakes, with the exception of fat intakes. 16.8% of the total daily energy intake came from snack consumption, while the 3 main meals contributed 83.2%. Energy and macronutrient intakes from snacks in the MFSE were significantly higher than the LFSE. Instant coffee was the most popular snack in the morning and afternoon, whereas heavy snacks and alcohol were more frequently consumed by both of the meal skipper groups (<= 2M+2,3S and <= 2M+0,1S) in the evening. In conclusion, meal pattern is changing to reflect an increase of more snacks between the three main meals. Meal and snack patterns may be markers for the energy and macronutrient intakes of employed people in Korea.
C1 [Kim, Seok-Young] Gyeoungsang Natl Univ, Dept Food & Nutr, Jinju 660701, Gyeongnam, South Korea.
   [Kim, Se Min] Gyeoungsang Natl Univ, Grad Sch Educ, Jinju 660701, Gyeongnam, South Korea.
C3 Gyeongsang National University; Gyeongsang National University
RP Kim, SY (corresponding author), Gyeoungsang Natl Univ, Dept Food & Nutr, 900 Gajwa Dong, Jinju 660701, Gyeongnam, South Korea.
EM sykim@gnu.ac.kr
RI Kim, Hong/AAR-4892-2020
CR Andersson J, 2003, APPETITE, V41, P149, DOI 10.1016/S0195-6663(03)00052-7
   BASDEVANT A, 1993, APPETITE, V21, P17, DOI 10.1006/appe.1993.1033
   Bellisle F, 2003, PHYSIOL BEHAV, V79, P183, DOI 10.1016/S0031-9384(03)00088-X
   Bellisle F, 1999, APPETITE, V32, P46, DOI 10.1006/appe.1998.0195
   Berg C, 2009, APPETITE, V52, P21, DOI 10.1016/j.appet.2008.07.008
   Bertéus-Forslund H, 2005, INT J OBESITY, V29, P711, DOI 10.1038/sj.ijo.0802950
   Carlson O, 2007, METABOLISM, V56, P1729, DOI 10.1016/j.metabol.2007.07.018
   de Castro JM, 2004, J NUTR, V134, P104, DOI 10.1093/jn/134.1.104
   De Castro JM, 2007, BRIT J NUTR, V98, P1077, DOI 10.1017/S0007114507754296
   de Graaf C, 2006, APPETITE, V47, P18, DOI 10.1016/j.appet.2006.02.007
   Dubois L, 2009, PUBLIC HEALTH NUTR, V12, P19, DOI 10.1017/S1368980008001894
   Forslund HB, 2002, EUR J CLIN NUTR, V56, P740, DOI 10.1038/sj.ejcn.1601387
   Gatenby SJ, 1997, BRIT J NUTR, V77, pS7, DOI 10.1079/BJN19970100
   Giskes K, 2006, PUBLIC HEALTH NUTR, V9, P75, DOI 10.1079/PHN2005758
   최미경, 2003, [Journal of The Korean Society of Food Culture, 한국식생활문화학회지], V18, P45
   Haveman-Nies A, 1998, J AM DIET ASSOC, V98, P1297, DOI 10.1016/S0002-8223(98)00290-9
   Jabs J, 2006, APPETITE, V47, P196, DOI 10.1016/j.appet.2006.02.014
   Kerver JM, 2006, J AM DIET ASSOC, V106, P46, DOI 10.1016/j.jada.2005.09.045
   Mazlan N, 2006, PHYSIOL BEHAV, V87, P679, DOI 10.1016/j.physbeh.2006.01.032
   Neuhouser ML, 2000, J AM DIET ASSOC, V100, P576, DOI 10.1016/S0002-8223(00)00176-0
   Nicklas TA, 1998, AM J CLIN NUTR, V67, p757S, DOI 10.1093/ajcn/67.4.757S
   Ovaskainen ML, 2006, EUR J CLIN NUTR, V60, P494, DOI 10.1038/sj.ejcn.1602343
   PARK JW, TOP SALES ITEM WAS C
   Roos E, 1997, APPETITE, V29, P11, DOI 10.1006/appe.1996.0095
   SCHLETTWEINGSEL.D, 1996, EUROPEAN J CLIN N S2, V50, P56
   Sjöberg A, 2003, EUR J CLIN NUTR, V57, P1569, DOI 10.1038/sj.ejcn.1601726
   SUMMERBELL CD, 1995, EUR J CLIN NUTR, V49, P33
   Wahlqvist ML, 1999, APPETITE, V32, P23, DOI 10.1006/appe.1998.0192
   Wang ZH, 2008, ASIA PAC J CLIN NUTR, V17, P123
   Zizza C, 2001, PREV MED, V32, P303, DOI 10.1006/pmed.2000.0817
   Zizza CA, 2007, J AM DIET ASSOC, V107, P800, DOI 10.1016/j.jada.2007.02.002
NR 31
TC 13
Z9 14
U1 0
U2 10
PU KOREAN NUTRITION SOC
PI SEOUL
PA 804 KST CTR, 635-4 YEOGSAM-SONG KANGNAM-KU, SEOUL, 135-703, SOUTH KOREA
SN 1976-1457
EI 2005-6168
J9 NUTR RES PRACT
JI Nutr. Res. Pract.
PD FEB
PY 2010
VL 4
IS 1
BP 43
EP 50
DI 10.4162/nrp.2010.4.1.43
PG 8
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA 562BS
UT WOS:000275024700007
PM 20198208
OA Green Submitted, Green Published
DA 2025-04-28
ER

PT J
AU Antunes, ABS
   Cunha, DB
   Baltar, VT
   Steluti, J
   Pereira, RA
   Yokoo, EM
   Sichieri, R
   Marchioni, DM
AF Souza Antunes, Anna Beatriz
   Cunha, Diana Barbosa
   Baltar, Valeria Troncoso
   Steluti, Josiane
   Pereira, Rosangela Alves
   Yokoo, Edna Massae
   Sichieri, Rosely
   Marchioni, Dirce Maria
TI Dietary patterns of Brazilian adults in 2008-2009 and 2017-2018
SO REVISTA DE SAUDE PUBLICA
LA English
DT Article
DE Adult; Feeding Behavior; Factor Analysis; Socioeconomic Factors; Diet
   Surveys
ID RISK; ASSOCIATIONS; OBESITY; DISEASE
AB OBJECTIVES: To identify dietary patterns among Brazilian adults based on the National Dietary Surveys (INA - Inqueritos Nacionais de Alimentacao) in 2008-2009 and 2017-2018, and to verify in the second period the adherence to the patterns according to sociodemographic factors and Brazilian regions.
   METHODS: We analyzed the first of two days of adults' food consumption (19-59 years) in INA data from 2008-2009 (n = 21,630) and 2017-2018 (n = 28,901). Dietary patterns were derived by exploratory factor analysis from 19 food groups, considering the complexity of the sample design. We evaluated the factor scores according to sex, age group, region, per capita income, and education for the INA data in 2017-2018.
   RESULTS: We identified three patterns in the two surveys: (1) "traditional", characterized by rice, beans, and meat; (2) "breads and butter/margarine", characterized by breads, oils, and fats (including margarine/butter) and, coffee and teas in 2008-2009; and (3) "western", characterized by sodas, pizzas, snacks, flour, pasta, and sweets in 2017-2018. The "traditional" pattern had greater adherence among men, residents of the Midwest region and individuals with incomplete primary education. "Bread and butter/margarine" pattern had greater adherence among males, individuals aged between 40 and 59 years, from the Southeast region, and with income between 1 and 2 minimum wages per capita. Male individuals, aged between 19 and 39 years, from the South region, with per capita income greater than two minimum wages, and education level equal to or greater than primary education showed greater adherence to the "western" pattern.
   CONCLUSION: The dietary patterns identified in 2008-2009 and 2017-2018 were similar, and we observed the maintenance of the "traditional" pattern, which includes rice, beans, and meat. Adherence to the dietary patterns varies according to sex, age group, region, per capita income, and education level.
C1 [Souza Antunes, Anna Beatriz] Univ Estado Rio de Janeiro, Inst Med Social, Programa Posgrad Saude Colet, Rio De Janeiro, RJ, Brazil.
   [Cunha, Diana Barbosa; Sichieri, Rosely] Univ Estado Rio de Janeiro, Inst Med Social, Dept Epidemiol, Rio De Janeiro, RJ, Brazil.
   [Baltar, Valeria Troncoso; Yokoo, Edna Massae] Univ Fed Fluminense, Inst Saude Colet, Dept Epidemiol & Bioestat, Niteroi, RJ, Brazil.
   [Steluti, Josiane] Univ Fed Sao Paulo, Inst Saude & Soc, Dept Polit Publ & Saude Colet, Santos, SP, Brazil.
   [Pereira, Rosangela Alves] Univ Fed Rio de Janeiro, Inst Nutr Josue de Castro, Dept Nutr Social & Aplicada, Rio De Janeiro, RJ, Brazil.
   [Marchioni, Dirce Maria] Univ Sao Paulo, Fac Saude Publ, Dept Nutr, Sao Paulo, SP, Brazil.
C3 Universidade do Estado do Rio de Janeiro; Universidade do Estado do Rio
   de Janeiro; Universidade Federal Fluminense; Universidade Federal de Sao
   Paulo (UNIFESP); Universidade Federal do Rio de Janeiro; Universidade de
   Sao Paulo
RP Antunes, ABS (corresponding author), Univ Estado Rio de Janeiro, Inst Med Social, Rua Sao Francisco Xavier,524,7 Andar,Bloco E, BR-20550900 Rio De Janeiro, RJ, Brazil.
EM antunes.abnutri@gmail.com
RI Brito, Flavia/ADC-5052-2022; Baltar, Valeria/AFM-7189-2022; Steluti,
   Josiane/A-5017-2015; Marchioni, Dirce/C-6053-2012; Pereira,
   Rosangela/D-8830-2013
OI Barbosa Cunha, Diana/0000-0003-0900-5628
FU Conselho Nacional Cientifico e Tecnologico (CNPq) [443369/2016-0];
   Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Capes)
   [001]; Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ
   -CNE/2015)
FX Conselho Nacional Cientifico e Tecnologico (CNPq -Process
   443369/2016-0). Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior (Capes -Funding code 001). Fundacao de Amparo a Pesquisa do
   Estado do Rio de Janeiro (FAPERJ -CNE/2015).
CR [Anonymous], 2007, Applied Multivariate Statistical Analysis
   Baltar VT, 2018, CAD SAUDE PUBLICA, V34, DOI [10.1590/0102-311x00111917, 10.1590/0102-311X00111917]
   Martins APB, 2013, REV SAUDE PUBL, V47, P656, DOI 10.1590/S0034-8910.2013047004968
   Cardoso LD, 2016, CAD SAUDE PUBLICA, V32, DOI 10.1590/0102-311X00066215
   Conway JM, 2003, AM J CLIN NUTR, V77, P1171, DOI 10.1093/ajcn/77.5.1171
   Cunha DB, 2010, BRIT J NUTR, V104, P908, DOI 10.1017/S0007114510001479
   de Carvalho AM, 2016, BRIT J NUTR, V115, P2011, DOI 10.1017/S0007114516000969
   Selem SSD, 2014, J ACAD NUTR DIET, V114, P1216, DOI 10.1016/j.jand.2014.01.007
   Vilela AAF, 2014, CAD SAUDE PUBLICA, V30, P502, DOI 10.1590/0102-311X00167512
   Instituto Brasileiro de Geografia e Estatistica, 2011, DIR PESQ COORD TRAB
   Instituto Brasileiro de Geografia e Estatistica, 2020, DIR PESQ COORD TRAB
   Jaime PC, 2015, EPIDEMIOL SERV SAUDE, V24, P267, DOI 10.5123/S1679-49742015000200009
   Kerver JM, 2003, AM J CLIN NUTR, V78, P1103, DOI 10.1093/ajcn/78.6.1103
   Levy RB, 2012, REV SAUDE PUBL, V46, P6, DOI 10.1590/S0034-89102011005000088
   Arruda SPM, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-654
   Massarani FA, 2015, CAD SAUDE PUBLICA, V31, P2535, DOI 10.1590/0102-311X00090314
   McEvoy CT, 2014, J ACAD NUTR DIET, V114, P1759, DOI 10.1016/j.jand.2014.05.001
   Medina Lhais de Paula Barbosa, 2019, Rev. bras. epidemiol., V22, pE190011.SUPL.2, DOI 10.1590/1980-549720190011.supl.2
   Medina-Remón A, 2018, CRIT REV FOOD SCI, V58, P262, DOI 10.1080/10408398.2016.1158690
   Michels KB, 2005, NUTR RES REV, V18, P241, DOI 10.1079/NRR2005107
   Pan A, 2012, ARCH INTERN MED, V172, P555, DOI 10.1001/archinternmed.2011.2287
   Rezagholizadeh F, 2017, NUTR RES, V41, P1, DOI 10.1016/j.nutres.2017.01.006
   Romeiro Ariane Cristina Thoaldo, 2020, Rev. bras. epidemiol., V23, pe200090, DOI 10.1590/1980-549720200090
   Santos Iolanda Karla Santana dos, 2020, Rev. bras. epidemiol., V23, pe200035, DOI 10.1590/1980-549720200035
   Santos RD, 2015, BRIT J NUTR, V114, P822, DOI 10.1017/S0007114515002445
   Satija A, 2018, TRENDS CARDIOVAS MED, V28, P437, DOI 10.1016/j.tcm.2018.02.004
   Sichieri R, 2002, OBES RES, V10, P42, DOI 10.1038/oby.2002.6
   Souza AD, 2013, REV SAUDE PUBL, V47, pS190, DOI 10.1590/S0034-89102013000700005
   Willett W, 2019, LANCET, V393, P447, DOI 10.1016/S0140-6736(18)31788-4
NR 29
TC 18
Z9 18
U1 1
U2 3
PU REVISTA DE SAUDE PUBLICA
PI SAO PAULO
PA FACULDADE SAUDE PUBL DA USP, AV DR ARNALDO 715, 01246-904SP SAO PAULO,
   BRAZIL
SN 0034-8910
EI 1518-8787
J9 REV SAUDE PUBL
JI Rev. Saude Publica
PY 2021
VL 55
SU 1
DI 10.11606/s1518-8787.2021055003437
PG 11
WC Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Public, Environmental & Occupational Health
GA XI8UA
UT WOS:000726378000004
PM 34852165
OA Green Published, gold
DA 2025-04-28
ER

PT J
AU Souza, TN
   Andrade, GC
   Rauber, F
   Levy, RB
   Louzada, MLD
AF Souza, Thays Nascimento
   Andrade, Giovanna Calixto
   Rauber, Fernanda
   Levy, Renata Bertazzi
   da Costa Louzada, Maria Laura
TI Consumption of ultra-processed foods and the eating location: can they
   be associated?
SO BRITISH JOURNAL OF NUTRITION
LA English
DT Article
DE Food consumption; Food quality; Industrialised foods; Fast food;
   Collective feeding; Food environment; Ultra-processed foods
ID SCHOOL; OBESITY
AB Studies indicate that eating locations can influence food choices. However, the relationship with ultra-processed foods has been little explored. The objective was to assess the association between eating locations and ultra-processed foods consumption in the UK in 2014-2016. Data from 2,449 individuals aged 4 years or older from the NDNS were analysed cross-sectionally. Food consumption information was collected through 4-day food diaries. Recorded foods were classified into NOVA system. The eating locations were grouped into nine categories (home, institutional places, sit-down restaurants, on the go, coffee shops, leisure and sports clubs, fast food, friends and relatives' house, and other places). Linear regression models were carried out. The coefficients represent the increment in the contribution of ultra-processed foods to total energy intake for each percentage point increase in the contribution of each eating location to total energy intake. Among children, consumption at home was inversely associated with ultra-processed foods consumption (beta: -0.10; 95% CI -0.17, -0.03), while in leisure and sports places (0.47; 0.20, 0.73) directly associated. For adolescents, eating at home (-0.12; -0.19, -0.05) was inversely associated with the consumption of ultra-processed foods, as well as sit-down restaurants (-0.21; -0.38, -0.03). Fast food (0.29; 0.12, 0.47) were directly associated with the consumption of ultra-processed foods for adolescents. Finally, for adults, sit-down restaurants (-0.13; -0.22, -0.03) showed to be inversely associated with the consumption of ultra-processed foods while in fast food restaurants (0.77; 0.38, 1.17) it was directly associated. Our results showed that the eating locations have different impacts on diet quality.
C1 [Souza, Thays Nascimento; Rauber, Fernanda; da Costa Louzada, Maria Laura] Univ Sao Paulo, Sch Publ Hlth, Dept Nutr, BR-01246904 Sao Paulo, Brazil.
   [Andrade, Giovanna Calixto; Rauber, Fernanda; Levy, Renata Bertazzi] Univ Sao Paulo, Sch Med, Dept Prevent Med, BR-01246903 Sao Paulo, Brazil.
   [Souza, Thays Nascimento; Andrade, Giovanna Calixto; Rauber, Fernanda; Levy, Renata Bertazzi; da Costa Louzada, Maria Laura] Univ Sao Paulo, Ctr Epidemiol Res Nutr & Hlth, BR-01246904 Sao Paulo, Brazil.
C3 Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de
   Sao Paulo
RP Souza, TN (corresponding author), Univ Sao Paulo, Sch Publ Hlth, Dept Nutr, BR-01246904 Sao Paulo, Brazil.; Souza, TN (corresponding author), Univ Sao Paulo, Ctr Epidemiol Res Nutr & Hlth, BR-01246904 Sao Paulo, Brazil.
EM thaysnascimento.souza@gmail.com
RI Rauber, Fernanda/H-6162-2016; Louzada, Maria Laura/G-1851-2012; Bertazzi
   Levy, Renata/F-8931-2012; Calixto Andrade, Giovanna/ABE-6487-2020
OI Rauber, Fernanda/0000-0001-9693-7954; Louzada, Maria
   Laura/0000-0002-3756-2301; Bertazzi Levy, Renata/0000-0001-5388-7002;
   Calixto Andrade, Giovanna/0000-0002-1901-3093; Nascimento Souza,
   Thays/0000-0001-5405-5398
FU Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)
   [88887362789/201900]; Fundacao de Amparo a Pesquisa do Estado de Sao
   Paulo (FAPESP) [2016/14302-7]
FX Weare grateful for the financial support from CAPES and FAPESP and also
   to the scientific technical support from the School of Public Health at
   the University of Sao Paulo.This work was supported by the Coordenacao
   de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), grant number
   88887362789/201900 and Fundacao de Amparo a Pesquisa do Estado de Sao
   Paulo (FAPESP), grant number 2016/14302-7. CAPES and FAPESP had no role
   in study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Marrón-Ponce JA, 2019, NUTRIENTS, V11, DOI 10.3390/nu11010045
   Andrade GC., 2017, THESIS U SAO PAULO
   Andrade GC, 2018, NUTRIENTS, V10, DOI 10.3390/nu10020218
   Askari M, 2020, INT J OBESITY, V44, P2080, DOI 10.1038/s41366-020-00650-z
   Association S, 2020, ULTRA PROCESSED FOOD
   Caraher M, 2016, APPETITE, V103, P208, DOI 10.1016/j.appet.2016.04.016
   Caraher M, 2014, BRIT FOOD J, V116, P472, DOI 10.1108/BFJ-02-2012-0042
   Chen XJ, 2020, NUTR J, V19, DOI 10.1186/s12937-020-00604-1
   Costa CS, 2018, PUBLIC HEALTH NUTR, V21, P148, DOI 10.1017/S1368980017001331
   Louzada MLD, 2021, CAD SAUDE PUBLICA, V37, DOI 10.1590/0102-311X00323020
   dAngelo C., 2020, Food consumption in the UK: Trends, attitudes and drivers
   Elizabeth L, 2020, NUTRIENTS, V12, DOI 10.3390/nu12071955
   Fardet A, 2016, FOOD FUNCT, V7, P2338, DOI [10.1039/c6fo00107f, 10.1039/C6FO00107F]
   Forde CG, 2020, CURR DEV NUTR, V4, DOI 10.1093/cdn/nzaa019
   Fulkerson JA, 2018, PHYSIOL BEHAV, V193, P252, DOI 10.1016/j.physbeh.2018.04.005
   Global Panel, 2023, Nutrition and food systems
   Kaushik JS, 2011, INDIAN PEDIATR, V48, P97, DOI 10.1007/s13312-011-0035-8
   Kim H, 2020, ENVIRON RES, V182, DOI 10.1016/j.envres.2019.109070
   Monteiro CA, 2013, OBES REV, V14, P21, DOI 10.1111/obr.12107
   Monteiro CA, 2019, PUBLIC HEALTH NUTR, V22, P936, DOI 10.1017/S1368980018003762
   Moubarac JC, 2013, PUBLIC HEALTH NUTR, V16, P2240, DOI 10.1017/S1368980012005009
   Müller K, 2013, APPETITE, V71, P332, DOI 10.1016/j.appet.2013.09.002
   Nago ES, 2014, CRIT REV FOOD SCI, V54, P1103, DOI 10.1080/10408398.2011.627095
   Nielsen SJ, 2007, J AM DIET ASSOC, V107, P792, DOI 10.1016/j.jada.2007.02.003
   Onita BM, 2021, APPETITE, V157, DOI 10.1016/j.appet.2020.105007
   Orfanos P, 2017, EUR J CLIN NUTR, V71, P407, DOI 10.1038/ejcn.2016.219
   Pagliai G, 2021, BRIT J NUTR, V125, P308, DOI 10.1017/S0007114520002688
   PHE, 2018, APP B METH YEARS 7 8
   PHE, 2018, APP DIET DAT COLL ED
   Poti JM, 2017, CURR OBES REP, V6, P420, DOI 10.1007/s13679-017-0285-4
   Rauber F, 2022, BRIT J NUTR, V127, P112, DOI 10.1017/S0007114521000854
   Rauber F, 2021, EUR J NUTR, V60, P2169, DOI 10.1007/s00394-020-02367-1
   Rauber F, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0232676
   Rauber F, 2018, NUTRIENTS, V10, DOI 10.3390/nu10050587
   Roberts C.S., 2018, NATL DIET NUTR SURVE
   Meneguelli TS, 2020, INT J FOOD SCI NUTR, V71, P678, DOI 10.1080/09637486.2020.1725961
   Steele EM, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0236738
   Swinburn BA, 2019, LANCET, V393, P791, DOI 10.1016/S0140-6736(18)32822-8
   Swinburn BA, 2011, LANCET, V378, P804, DOI 10.1016/S0140-6736(11)60813-1
   Theis DRZ, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0222773
   Toumpakari Z, 2019, PUBLIC HEALTH NUTR, V22, P74, DOI 10.1017/S1368980018002860
   Tyrrell RL., 2016, J PUBLIC HEALTH-UK, V39
   Vandevijvere S, 2019, OBES REV, V20, P10, DOI 10.1111/obr.12860
   Venn D, 2017, PUBLIC HEALTH NUTR, V20, P2549, DOI [10.1017/S136898001600255X, 10.1017/s136898001600255x]
   Wills W., 2015, INFLUENCE DEPRIVATIO, DOI [10.18745/PB.16072, DOI 10.18745/PB.16072]
   Young M, 2019, J NUTR EDUC BEHAV, V51, P817, DOI 10.1016/j.jneb.2019.04.018
   Ziauddeen N, 2018, AM J CLIN NUTR, V107, P992, DOI 10.1093/ajcn/nqy057
   Ziauddeen N, 2017, NUTRIENTS, V9, DOI 10.3390/nu9121315
   Zinöcker MK, 2018, NUTRIENTS, V10, DOI 10.3390/nu10030365
NR 49
TC 16
Z9 17
U1 0
U2 22
PU CAMBRIDGE UNIV PRESS
PI CAMBRIDGE
PA EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND
SN 0007-1145
EI 1475-2662
J9 BRIT J NUTR
JI Br. J. Nutr.
PD OCT 28
PY 2022
VL 128
IS 8
BP 1587
EP 1594
AR PII S0007114521004992
DI 10.1017/S0007114521004992
EA DEC 2021
PG 8
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA 5E9OG
UT WOS:000742525600001
PM 34915943
DA 2025-04-28
ER

PT J
AU Crocketta, RA
   King, SE
   Marteau, TM
   Prevost, AT
   Bignardi, G
   Roberts, NW
   Stubbs, B
   Hollands, GJ
   Jebb, SA
AF Crocketta, Rachel A.
   King, Sarah E.
   Marteau, Theresa M.
   Prevost, A. T.
   Bignardi, Giacomo
   Roberts, Nia W.
   Stubbs, Brendon
   Hollands, Gareth J.
   Jebb, Susan A.
TI Nutritional labelling for healthier food or non-alcoholic drink
   purchasing and consumption
SO COCHRANE DATABASE OF SYSTEMATIC REVIEWS
LA English
DT Review
ID SCHOOL VENDING MACHINES; CALORIC INFORMATION; PORTION SIZES;
   ENERGY-INTAKE; IMPACT; MENU; CONSUMER; CHOICES; INTERVENTIONS; BEHAVIORS
AB Background
   Nutritional labelling is advocated as a means to promote healthier food purchasing and consumption, including lower energy intake. Internationally, many different nutritional labelling schemes have been introduced. There is no consensus on whether such labelling is effective in promoting healthier behaviour.
   Objectives
   To assess the impact of nutritional labelling for food and non-alcoholic drinks on purchasing and consumption of healthier items. Our secondary objective was to explore possible effect moderators of nutritional labelling on purchasing and consumption.
   Search methods
   We searched 13 electronic databases including CENTRAL, MEDLINE and Embase to 26 April 2017. We also handsearched references and citations and sought unpublished studies through websites and trials registries.
   Selection criteria
   Eligible studies: were randomised or quasi-randomised controlled trials (RCTs/Q-RCTs), controlled before-and-after studies, or interrupted time series (ITS) studies; compared a labelled product (with information on nutrients or energy) with the same product without a nutritional label; assessed objectively measured purchasing or consumption of foods or non-alcoholic drinks in real-world or laboratory settings.
   Data collection and analysis
   Two authors independently selected studies for inclusion and extracted study data. We applied the Cochrane 'Risk of bias' tool and GRADE to assess the quality of evidence. We pooled studies that evaluated similar interventions and outcomes using a random-effects meta-analysis, and we synthesised data from other studies in a narrative summary.
   Main results
   We included 28 studies, comprising 17 RCTs, 5 Q-RCTs and 6 ITS studies. Most (21/28) took place in the USA, and 19 took place in university settings, 14 of which mainly involved university students or staff. Most (20/28) studies assessed the impact of labelling on menus or menu boards, or nutritional labelling placed on, or adjacent to, a range of foods or drinks from which participants could choose. Eight studies provided participants with only one labelled food or drink option (in which labelling was present on a container or packaging, adjacent to the food or on a display board) and measured the amount consumed. The most frequently assessed labelling type was energy (i.e. calorie) information (12/28).
   Eleven studies assessed the impact of nutritional labelling on purchasing food or drink options in real-world settings, including purchases from vending machines (one cluster-RCT), grocery stores (one ITS), or restaurants, cafeterias or coffee shops (three RCTs, one QRCT and five ITS). Findings on vending machines and grocery stores were not interpretable, and were rated as very low quality. A meta-analysis of the three RCTs, all of which assessed energy labelling on menus in restaurants, demonstrated a statistically significant reduction of 47 kcal in energy purchased (MD 46.72 kcal, 95% CI 78.35, 15.10, N = 1877). Assuming an average meal of 600 kcal, energy labelling on menus would reduce energy purchased per meal by 7.8% (95% CI 2.5% to 13.1%). The quality of the evidence for these three studies was rated as low, so our confidence in the effect estimate is limited and may change with further studies. Of the remaining six studies, only two (both ITS studies involving energy labels on menus or menus boards in a coffee shop or cafeteria) were at low risk of bias, and their results support the meta-analysis. The results of the other four studies which were conducted in a restaurant, cafeterias (2 studies) or a coffee shop, were not clearly reported and were at high risk of bias.
   Seventeen studies assessed the impact of nutritional labels on consumption in artificial settings or scenarios (henceforth referred to as laboratory studies or settings). Of these, eight (all RCTs) assessed the effect of labels on menus or placed on a range of food options. A meta-analysis of these studies did not conclusively demonstrate a reduction in energy consumed during a meal (MD 50 kcal, 95% CI 104.41, 3.88, N = 1705). We rated the quality of the evidence as low, so our confidence in the effect estimate is limited and may change with further studies.
   Six laboratory studies (four RCTs and two Q-RCTs) assessed the impact of labelling a single food or drink option (such as chocolate, pasta or soft drinks) on energy consumed during a snack or meal. A meta-analysis of these studies did not demonstrate a statistically significant difference in energy (kcal) consumed (SMD 0.05, 95% CI 0.17 to 0.27, N = 732). However, the confidence intervals were wide, suggesting uncertainty in the true effect size. We rated the quality of the evidence as low, so our confidence in the effect estimate is limited and may change with further studies.
   There was no evidence that nutritional labelling had the unintended harm of increasing energy purchased or consumed. Indirect evidence came from five laboratory studies that involved mislabelling single nutrient content (i.e. placing low energy or low fat labels on high-energy foods) during a snack or meal. A meta-analysis of these studies did not demonstrate a statistically significant increase in energy (kcal) consumed (SMD 0.19, 95% CI 0.14to 0.51, N = 718). The effect was small and the confidence intervals wide, suggesting uncertainty in the true effect size. We rated the quality of the evidence from these studies as very low, providing very little confidence in the effect estimate.
   Authors' conclusions
   Findings from a small body of low-quality evidence suggest that nutritional labelling comprising energy information on menus may reduce energy purchased in restaurants. The evidence assessing the impact on consumption of energy information on menus or on a range of food options in laboratory settings suggests a similar effect to that observed for purchasing, although the evidence is less definite and also of low quality.
   Accordingly, and in the absence of observed harms, we tentatively suggest that nutritional labelling on menus in restaurants could be used as part of a wider set of measures to tackle obesity. Additional high-quality research in real-world settings is needed to enable more certain conclusions.
   Further high-quality research is also needed to address the dearth of evidence from grocery stores and vending machines and to assess potential moderators of the intervention effect, including socioeconomic status.
C1 [Crocketta, Rachel A.] Univ Stirling, Div Psychol, Stirling, Scotland.
   [King, Sarah E.; Marteau, Theresa M.; Bignardi, Giacomo; Hollands, Gareth J.] Univ Cambridge, Behav & Hlth Res Unit, Forvie Site,Robinson Way, Cambridge CB2 0SR, England.
   [Prevost, A. T.] Imperial Coll London, Sch Publ Hlth, London, England.
   [Roberts, Nia W.] Univ Oxford, Bodleian Hlth Care Lib, Oxford, England.
   [Stubbs, Brendon] Kings Coll London, Inst Psychiat Psychol & Neurosci, London, England.
   [Jebb, Susan A.] Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Oxford, England.
C3 University of Stirling; University of Cambridge; Imperial College
   London; University of Oxford; University of London; King's College
   London; University of Oxford
RP Marteau, TM (corresponding author), Univ Cambridge, Behav & Hlth Res Unit, Forvie Site,Robinson Way, Cambridge CB2 0SR, England.
EM theresa.marteau@medschl.cam.ac.uk
RI Stubbs, Brendon/X-1904-2018; Stubbs, Brendon/C-5696-2015; Roberts, Nia
   Wyn/F-9842-2010
OI Bignardi, Giacomo/0000-0002-1153-0838; Jebb, Susan/0000-0001-9190-2920;
   Hollands, Gareth/0000-0002-0492-3924; Prevost, A.
   Toby/0000-0003-1723-0796; King, Sarah/0000-0002-0637-7672; Stubbs,
   Brendon/0000-0001-7387-3791; Roberts, Nia Wyn/0000-0002-1142-6440
FU King's College London, UK; University of Cambridge, UK; University of
   Stirling, UK; National Institutes for Health Research, UK; National
   Institute of Health Research Senior Investigator Award
   [NF-SI-0513-10101]; Postdoctoral Research Fellowship; National
   Institutes of Health Research (NIHR) [ICA-CL-2017-03-001] Funding
   Source: National Institutes of Health Research (NIHR); MRC
   [MC_UU_00005/2, MC_U105960389] Funding Source: UKRI
FX Internal sourcesKing's College London, UK.Provides support and resources
   for two authors (RAC, TMM)University of Cambridge, UK.Provides support
   for three authors (GJH, TMM, SAJ)University of Stirling, UK.Provides
   support and resources for one author (RAC)External sourcesNational
   Institutes for Health Research, UK.Postdoctoral Research Fellowship
   (RAC)National Institute of Health Research Senior Investigator Award
   (NF-SI-0513-10101) (TM)
CR AARON JI, 1995, NUTR RES, V15, P1251, DOI 10.1016/0271-5317(95)02001-C
   ALBRIGHT CL, 1990, HEALTH EDUC QUART, V17, P157, DOI 10.1177/109019819001700203
   Allan JL, 2015, HEALTH PSYCHOL, V34, P750, DOI 10.1037/hea0000173
   [Anonymous], 2007, TACKLING OBESITIES F
   [Anonymous], 2011, National Diet and Nutrition Survey headline results from years 1, 2 and 3 (combined) of the rolling programme (2008/2009-2010/11)
   [Anonymous], COCHRANE DATABASE SY, DOI [10.1002/14651858.CD012573, DOI 10.1002/14651858.CD012573]
   [Anonymous], COCHRANE LIB
   [Anonymous], 2011, Cochrane handbook for systematic reviews of intervention
   [Anonymous], 2014, REVIEW MANAGER REVMA
   [Anonymous], 2011, COCHRANE HDB SYSTEMA
   Babio N, 2014, PUBLIC HEALTH NUTR, V17, P1403, DOI 10.1017/S1368980013001274
   Balasubramanian SK, 2002, J MARKETING, V66, P112, DOI 10.1509/jmkg.66.3.112.18502
   Balshem H, 2011, J CLIN EPIDEMIOL, V64, P401, DOI 10.1016/j.jclinepi.2010.07.015
   Bergen D, 2006, J AM DIET ASSOC, V106, P1866, DOI 10.1016/j.jada.2006.08.002
   Berning JP, 2011, AM J AGR ECON, V93, P364, DOI 10.1093/ajae/aaq104
   Bleich SN, 2017, OBESITY, V25, P2018, DOI 10.1002/oby.21940
   Bleich SN, 2014, AM J PUBLIC HEALTH, V104, P2417, DOI 10.2105/AJPH.2014.302150
   Blewett N, 2011, LABELLING LOGIC REVI
   Bollinger B, AMERICAN ECONOMIC JO
   Brownell KD, 2006, GLOBALIZATION HEALTH, V2, DOI 10.1186/1744-8603-2-11
   Bucher T, 2015, ANN NUTR METAB, V67, P147
   Callaghan C, 2010, CAN J DIET PRACT RES, V71, P186, DOI 10.3148/71.4.2010.186
   Campos S, 2011, PUBLIC HEALTH NUTR, V14, P1496, DOI 10.1017/S1368980010003290
   Cantor J, 2015, HEALTH AFFAIR, V34, P1893, DOI 10.1377/hlthaff.2015.0623
   Cantu-Jungles TM, 2017, NUTRIENTS, V9, DOI 10.3390/nu9101088
   Cavanagh KV, 2014, APPETITE, V82, P1, DOI 10.1016/j.appet.2014.06.100
   Cawley J, 2015, PUBLIC HEALTH NUTR, V18, P8, DOI 10.1017/S1368980014001529
   Cecchini M, 2016, OBES REV, V17, P201, DOI 10.1111/obr.12364
   Chu Y. H., 2014, Journal of Foodservice Business Research, V17, P215, DOI 10.1080/15378020.2014.926739
   Chu YH, 2009, FASEB J, V23
   Chu YH, 2012, FASEB JOURNAL SUPPLE, V26, P8
   Chu YH, 2009, AM J PUBLIC HEALTH, V99, P2001, DOI 10.2105/AJPH.2008.153205
   Cioffi CE, 2015, APPETITE, V92, P7, DOI 10.1016/j.appet.2015.04.053
   Cioffi CE, 2012, AN EXAMINATION OF TH
   Cohen Jacob, 1988, Statistical Power Anaylsis for the Behavior Sciences, V2nd, DOI DOI 10.4324/9780203771587
   Cowburn G, 2005, PUBLIC HEALTH NUTR, V8, P21, DOI [10.1079/PHN2005666, 10.1079/PHN2004666]
   Crockett RA, 2014, APPETITE, V81, P12, DOI 10.1016/j.appet.2014.05.024
   Das P, 2012, LANCET, V380, P189, DOI 10.1016/S0140-6736(12)61024-1
   DeGroot MH, 2012, PROBABILITY STATISTI
   Department of Health and Aging (Australia), 2013, FINAL COMMUNIQUE LEG
   Department of Health (UK), 2013, TECHNICAL GUIDANCE O
   Dingman DA, 2015, J PUBLIC HEALTH POL, V36, P110, DOI 10.1057/jphp.2014.38
   Dobbs R., 2014, OVERCOMING OBESITY A
   Dubbert PM, 1984, J APPL B, V17
   Ducrot P, 2016, AM J PREV MED, V50, P627, DOI 10.1016/j.amepre.2015.10.020
   Dumanovsky T, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d4464
   Ebneter DS, 2013, APPETITE, V68, P92, DOI 10.1016/j.appet.2013.04.023
   Effective Practice and Organisation of Care (EPOC), 2015, EPOC TAX
   Effective Public Health Practice Project, 2010, QUALITY ASSESSMENT T
   Elbel B, 2011, INT J OBESITY, V35, P493, DOI 10.1038/ijo.2011.4
   Elbel B, 2013, AM J PREV MED, V45, P49, DOI 10.1016/j.amepre.2013.02.023
   Elbel B, 2011, OBESITY, V19, pS53
   Ellison B., 2014, Journal of Agricultural and Applied Economics, V46, P173
   Ellison B, 2013, JOURNAL OF BEHAVIOUR, V10, P1
   Ellison B, 2014, ECON INQ, V52, P666, DOI 10.1111/ecin.12069
   Engbers LH, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-253
   European Commission, 2011, PROVISION OF FOOD IN
   European Commission, 1990, OFFICIAL JOURNAL OF, P40
   European Food Information Council, 2013, GLOBAL UPDATE ON NUT
   European Union, 2011, OFFICIAL J EUROPEAN, DOI DOI 10.1075/TTWIA.27.04KER
   Finkelstein EA, 2011, AM J PREV MED, V40, P122, DOI 10.1016/j.amepre.2010.10.019
   FREEDMAN MR, 2009, OBESITY S2, V17, pS161
   Giesen JCAH, 2011, AM J CLIN NUTR, V93, P689, DOI 10.3945/ajcn.110.008193
   Girz L, 2012, INT J OBESITY, V36, P1340, DOI 10.1038/ijo.2011.135
   Girz L., IN PROCESS
   Gittelsohn J, 2013, J NUTR, V143, P1494, DOI 10.3945/jn.112.165266
   Gomez P, 2015, MARKET LETT, V28, P15
   Graham DJ, 2017, PUBLIC HEALTH NUTR, V20, P774, DOI [10.1017/S1368980016002676, 10.1017/s1368980016002676]
   Grech A, 2015, OBES REV, V16, P1030, DOI 10.1111/obr.12311
   Grunert KG, 2007, J PUBLIC HEALTH-HEID, V15, P385, DOI 10.1007/s10389-007-0101-9
   Hammond D, 2013, PREV MED, V57, P860, DOI 10.1016/j.ypmed.2013.09.020
   Harnack LJ., 2008, Int J Behav Nutr Phys Act, V5
   Harnack LJ, 2008, INTERNATIONAL JOURNA, V5
   Hassan LM, 2010, J CONSUM AFF, V44, P499, DOI 10.1111/j.1745-6606.2010.01180.x
   Health Canada, FINAL AMENDMENTS TO
   Helfer P, 2014, ANN NY ACAD SCI, V1331, P174, DOI 10.1111/nyas.12461
   Higgins J., 2011, COCHRANE HDB SYSTEMA, V5
   Hobin E., 2015, Canadian Journal of Diabetes, V39, pS32, DOI 10.1016/j.jcjd.2015.01.128
   HOERR SM, 1993, J SCHOOL HEALTH, V63, P386, DOI 10.1111/j.1746-1561.1993.tb06167.x
   Hollands GJ, 2017, NAT HUM BEHAV, V1, DOI 10.1038/s41562-017-0140
   Hollands GJ, 2016, HEALTH PSYCHOL REV, V10, P381, DOI 10.1080/17437199.2015.1138093
   Hollands GJ, 2015, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD009164.pub2, 10.1002/14651858.CD011045.pub2]
   Hollands GJ, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1218
   Hollands GJ, 2013, ALTERING CHOICE ARCH, P1
   Holmes A, 2011, ANNUAL MEETING
   Holmes AS, 2013, APPETITE, V62, P198, DOI 10.1016/j.appet.2012.05.029
   Horgen KB, 2002, HEALTH PSYCHOL, V21, P505, DOI 10.1037/0278-6133.21.5.505
   Jackson N, 2010, SYSTEMATIC REVIEWS O
   James A, 2015, AM J HEALTH PROMOT, V29, P294, DOI 10.4278/ajhp.130522-QUAN-267
   Kiesel K., 2009, DISSERT ABSTR, V69, P3668
   Kiesel K, 2013, INTERANTIONAL JOURNA, V31, P115
   Kocken PL, 2012, J SCHOOL HEALTH, V82, P115, DOI 10.1111/j.1746-1561.2011.00674.x
   Koenigstorfer J, 2014, J PUBLIC POLICY MARK, V33, P65, DOI 10.1509/jppm.12.091
   Kral TVE, 2002, APPETITE, V39, P137, DOI 10.1006/appe.2002.0498
   Krieger JW, 2013, AM J PREV MED, V44, P595, DOI 10.1016/j.amepre.2013.01.031
   Lassen AD, 2014, APPETITE, V75, P128, DOI 10.1016/j.appet.2013.12.005
   Malam S, 2009, COMPREHENSION AND US
   Marteau TM, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h5863
   Marteau TM, 2012, SCIENCE, V337, P1492, DOI 10.1126/science.1226918
   Mathios AD, 2000, J LAW ECON, V43, P651, DOI 10.1086/467468
   Mathios AD, 1996, J PUBLIC POLICY MARK, V15, P45, DOI 10.1177/074391569601500104
   McNeill R, 2014, INT J BEHAV MED, V21, pS77
   Mhurchu CN, 2007, AUST NZ J PUBL HEAL, V31, P105, DOI 10.1111/j.1753-6405.2007.00026.x
   Newton JN, 2015, LANCET, V386, P2257, DOI 10.1016/S0140-6736(15)00195-6
   Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8
   Nikolaou C, 2014, OBES REV, V15, P184
   Nikolaou CK, 2016, EUR J CLIN NUTR, V70, P386, DOI 10.1038/ejcn.2015.175
   Nikolaou CK, 2014, PREV MED, V67, P160, DOI 10.1016/j.ypmed.2014.07.027
   Obesity Policy Coalition, 2014, POLICY BRIEF KILOJOU
   Ogden J, 2007, HEALTH EDUC RES, V22, P397, DOI [10.1093/her/cyl090, 10.1093/her/cy1090]
   Platkin Charles, 2014, BMC Obes, V1, P21, DOI 10.1186/s40608-014-0021-5
   Public Health England, 2015, SUG RED EV ACT
   Pulos E, 2010, AM J PUBLIC HEALTH, V100, P1035, DOI 10.2105/AJPH.2009.174839
   Rayner M, 2013, OBES REV, V14, P70, DOI 10.1111/obr.12077
   Reale Sophie, 2016, BMC Obes, V3, P17, DOI 10.1186/s40608-016-0095-3
   Reeves B, 2011, COCHRANE HDB SYSTEMA, P391
   Roberto CA, 2012, APPETITE, V58, P651, DOI 10.1016/j.appet.2012.01.003
   Roberto CA, 2010, AM J PUBLIC HEALTH, V100, P312, DOI 10.2105/AJPH.2009.160226
   Sacks G, 2011, AUST NZ J PUBL HEAL, V35, P122, DOI 10.1111/j.1753-6405.2011.00684.x
   Sacks G, 2009, HEALTH PROMOT INT, V24, P344, DOI 10.1093/heapro/dap032
   Sato J. N., 2013, Journal of Foodservice Business Research, V16, P155, DOI 10.1080/15378020.2013.782235
   SCHMITZ MF, 1986, J NUTR EDUC, V18, pS65
   SCHUCKER RE, 1992, J NUTR EDUC, V24, P75
   Schunemann HJ, 2011, COCHRANE HANDBOOK FO, P259
   Schwartz J, 2012, HEALTH AFFAIR, V31, P399, DOI 10.1377/hlthaff.2011.0224
   Seward MW, 2016, AM J PUBLIC HEALTH, V106, P1808, DOI 10.2105/AJPH.2016.303301
   Sharma S., 2011, Journal of Foodservice Business Research, V14, P146, DOI 10.1080/15378020.2011.574540
   Shemilt I, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-016-3956-2
   Sinclair SE, 2014, J ACAD NUTR DIET, V114, P1375, DOI 10.1016/j.jand.2014.05.014
   Stutts MA, 2011, J CONSUM AFF, V45, P52, DOI 10.1111/j.1745-6606.2010.01192.x
   Sutherland LA, 2010, AM J CLIN NUTR, V91, p1090S, DOI 10.3945/ajcn.2010.28450C
   Swartz JJ, INTERNATIONAL JOURNA, V8, P135
   Temple JL, 2011, APPETITE, V57, P184, DOI 10.1016/j.appet.2011.04.018
   Temple JL, 2010, J AM DIET ASSOC, V110, P1094, DOI 10.1016/j.jada.2010.04.006
   Thorndike A, 2015, CIRCULATION, V131, pA34
   Thorndike AN, 2014, AM J PREV MED, V46, P143, DOI 10.1016/j.amepre.2013.10.002
   Trudel R, 2015, JOURNAL OF EXPERIMEN, V21
   US Food Drug Administration, 2016, MENU AND VENDING MAC
   US Food Drug Administration, 1994, GUIDE TO NUTRITION L
   Vadiveloo MK, 2011, INTERNATIONAL JOURNA, V8
   VanEpps EM, 2016, J PUBLIC POLICY MARK, V35, P26, DOI 10.1509/jppm.14.112
   Vermeer WM, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-438
   Volkova E, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-968
   Vyth EL, 2011, J AM DIET ASSOC, V111, P131, DOI 10.1016/j.jada.2010.10.003
   Wang EY, 2016, FOOD POLICY, V64, P63, DOI 10.1016/j.foodpol.2016.09.004
   Wansink B, 2004, J FOOD SCI, V69, pS340, DOI 10.1111/j.1365-2621.2004.tb09946.x
   Wansink B, 2006, J MARKETING RES, V43, P605, DOI 10.1509/jmkr.43.4.605
   WARDLE J, 1994, HEALTH PSYCHOL, V13, P180, DOI 10.1037/0278-6133.13.2.180
   Webb KL, 2011, J HUNGER ENVIRON NUT, V6, P166, DOI 10.1080/19320248.2011.576210
   WHITAKER RC, 1994, J PEDIATR-US, V125, P535, DOI 10.1016/S0022-3476(94)70004-4
   World Health Organisation, 2013, GLOBAL ACTION FOR TH
   World Health Organization, GLOBAL STRATEGY ON D
   World Health Organization, 10 FACTS ON OBESITY
   Yach D, 2006, NAT MED, V12, P62, DOI 10.1038/nm0106-62
NR 154
TC 174
Z9 179
U1 5
U2 77
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1469-493X
EI 1361-6137
J9 COCHRANE DB SYST REV
JI Cochrane Database Syst Rev.
PY 2018
IS 2
AR CD009315
DI 10.1002/14651858.CD009315.pub2
PG 127
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC General & Internal Medicine
GA FY0CC
UT WOS:000426476500006
PM 29482264
OA Green Published
DA 2025-04-28
ER

PT J
AU Truthmann, J
   Schienkiewitz, A
   Busch, MA
   Mensink, GBM
   Du, Y
   Bosy-Westphal, A
   Knopf, H
   Scheidt-Nave, C
AF Truthmann, Julia
   Schienkiewitz, Anja
   Busch, Markus A.
   Mensink, Gert B. M.
   Du, Yong
   Bosy-Westphal, Anja
   Knopf, Hildtraud
   Scheidt-Nave, Christa
TI Changes in mean serum lipids among adults in Germany: results from
   National Health Surveys 1997-99 and 2008-11
SO BMC PUBLIC HEALTH
LA English
DT Article
DE Total cholesterol; Triglycerides; High density lipoprotein-cholesterol;
   Lifestyle; Lipid-lowering medication
ID HEART-DISEASE; ALCOHOL-CONSUMPTION; CHOLESTEROL LEVELS; LOWERING DRUGS;
   TIME TRENDS; INTERVIEW; DETERMINANTS; LIPOPROTEINS; POPULATION; FOOD
AB Background: Monitoring of serum lipid concentrations at the population level is an important public health tool to describe progress in cardiovascular disease risk control and prevention. Using data from two nationally representative health surveys of adults 18-79 years, this study identified changes in mean serum total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C), and triglycerides (TG) in relation to changes in potential determinants of serum lipids between 1997-99 and 2008-11 in Germany.
   Methods: Sex-specific multivariable linear regression analyses were performed with serum lipids as dependent variables and survey wave as independent variable and adjusted for the following covariables: age, fasting duration, educational status, lifestyle, and use of medication.
   Results: Mean TC declined between the two survey periods by 13 % (5.97 mmol/l vs. 5.19 mmol/l) among men and by 12 % (6.03 mmol/l vs. 5.30 mmol/l) among women. Geometric mean TG decreased by 14 % (1.66 mmol/l vs. 1.42 mmol/l) among men and by 8 % (1.20 mmol/l vs. 1.10 mmol/l) among women. Mean HDL-C remained unchanged among men (1.29 mmol/l vs. 1.27 mmol/l), but decreased by 5 % among women (1.66 mmol/l vs. 1.58 mmol/l). Sports activity and coffee consumption increased, while smoking and high alcohol consumption decreased only in men. Processed food consumption increased and wholegrain bread consumption decreased in both sexes, and obesity increased among men. The use of lipid-lowering medication, in particular statins nearly doubled over time in both sexes. Among women, hormonal contraceptive use increased and postmenopausal hormone therapy halved over time. The changes in lipid levels between surveys remained significant after adjusting for covariables.
   Conclusion: Serum TC and TG considerably declined over one decade in Germany, which can be partly explained by increased use of lipid-lowering medication and improved lifestyle among men. The decline in serum lipids among women, however, remains unexplained.
C1 [Truthmann, Julia; Schienkiewitz, Anja; Busch, Markus A.; Mensink, Gert B. M.; Du, Yong; Knopf, Hildtraud; Scheidt-Nave, Christa] Robert Koch Inst, Dept Epidemiol & Hlth Monitoring, Berlin, Germany.
   [Bosy-Westphal, Anja] Univ Hohenheim, Inst Nutr Med, Stuttgart, Germany.
C3 Robert Koch Institute; University Hohenheim
RP Truthmann, J (corresponding author), Robert Koch Inst, Dept Epidemiol & Hlth Monitoring, Berlin, Germany.
EM TruthmannJ@rki.de
RI Truthmann, Julia/Q-5911-2019; Mensink, Gert/B-2447-2009; Schienkiewitz,
   Anja/A-8463-2019
OI Truthmann, Julia/0000-0002-2849-7608; Mensink, Gert/0000-0001-6268-5998;
   Schienkiewitz, Anja/0000-0003-3821-9772; Busch,
   Markus/0000-0003-4936-983X
FU German Ministry of Health (BMG)
FX The authors thank Daniel Grams for support with figure formatting, Thea
   Riedel for information on the laboratory analyses, and Ronny Kuhnert and
   Angelika Schaffrath Rosario for support with statistical analyses (all
   affiliated to the Robert Koch Institute). DEGS1 is primarily funded by
   the German Ministry of Health (BMG).
CR Adams SP, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008226.pub3
   Bellach B M, 1998, Gesundheitswesen, V60 Suppl 2, pS59
   Brauns H., 1999, ZUMA-Nachrichten, V44, P7
   Brien SE, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d636
   Brown L, 1999, AM J CLIN NUTR, V69, P30
   Burger M, 2004, PUBLIC HEALTH NUTR, V7, P879, DOI 10.1079/PHN2004631
   Cai L, 2012, EUR J CLIN NUTR, V66, P872, DOI 10.1038/ejcn.2012.68
   Carroll MD, 2012, JAMA-J AM MED ASSOC, V308, P1545, DOI 10.1001/jama.2012.13260
   Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486
   Craig-Schmidt MC, 2006, ATHEROSCLEROSIS SUPP, V7, P1, DOI 10.1016/j.atherosclerosissup.2006.04.001
   Du Yong, 2007, BMC Womens Health, V7, P19, DOI 10.1186/1472-6874-7-19
   Durstine JL, 2001, SPORTS MED, V31, P1033, DOI 10.2165/00007256-200131150-00002
   Eliasson M, 2006, J INTERN MED, V260, P551, DOI 10.1111/j.1365-2796.2006.01730.x
   Ellison RC, 2004, AM HEART J, V147, P529, DOI 10.1016/j.ahj.2003.10.033
   Farzadfar F, 2011, LANCET, V377, P578, DOI 10.1016/S0140-6736(10)62038-7
   Ferrières J, 2009, ARCH CARDIOVASC DIS, V102, P293, DOI 10.1016/j.acvd.2009.02.002
   Ford ES, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065228
   Jansson JH, 2003, SCAND J PUBLIC HEALT, V31, P43, DOI 10.1080/14034950310001397
   Kamtsiuris P, 2013, BUNDESGESUNDHEITSBLA, V56, P620, DOI 10.1007/s00103-012-1650-9
   Klose G, 2014, ARZNEIMITTELVERORDNU
   Knopf H, 2013, BUNDESGESUNDHEITSBLA, V56, P868, DOI 10.1007/s00103-013-1667-8
   Krachler B, 2005, PUBLIC HEALTH NUTR, V8, P628, DOI 10.1079/PHN2004710
   Laaser U, 2006, TRENDS RISK FACTOR C, V2
   Lampert T, 2013, BUNDESGESUNDHEITSBLA, V56, P631, DOI 10.1007/s00103-012-1663-4
   LAW MR, 1994, EUR J CLIN NUTR, V48, P305
   Libuda L, 2014, BRIT J NUTR, V111, P141, DOI 10.1017/S0007114513002031
   Mensink GBM, 2013, BUNDESGESUNDHEITSBLA, V56, P779, DOI 10.1007/s00103-012-1651-8
   Mensink GBM, 2004, EUR J CLIN NUTR, V58, P1000, DOI 10.1038/sj.ejcn.1601923
   Mozaffarian D, 2009, EUR J CLIN NUTR, V63, pS22, DOI 10.1038/sj.ejcn.1602976
   Mozaffarian D, 2009, EUR J CLIN NUTR, V63, pS5, DOI 10.1038/sj.ejcn.1602973
   Naz F, 2012, Pak J Biol Sci, V15, P947
   Nordestgaard BG, 2014, LANCET, V384, P626, DOI 10.1016/S0140-6736(14)61177-6
   Perk J, 2012, EUR HEART J, V33, P1635, DOI 10.1093/eurheartj/ehs092
   Rader DJ, 2014, LANCET, V384, P618, DOI 10.1016/S0140-6736(14)61217-4
   Rauber F, 2015, NUTR METAB CARDIOVAS, V25, P116, DOI 10.1016/j.numecd.2014.08.001
   Rehm J, 2000, EUR J EPIDEMIOL, V16, P669, DOI 10.1023/A:1007693009604
   Reiner Z, 2011, ESC EAS GUIDELINES M, V14
   Rubner-Institut Max, 2008, NATL VERZEHRSSTUDI 2
   Sai AJ, 2011, MENOPAUSE, V18, P1101, DOI 10.1097/gme.0b013e318217d41d
   Scheidt-Nave C, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-730
   Siri-Tarino PW, 2010, AM J CLIN NUTR, V91, P502, DOI 10.3945/ajcn.2008.26285
   Stender S, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-000859
   STONE NJ, 1994, MED CLIN N AM, V78, P117, DOI 10.1016/S0025-7125(16)30179-1
   Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270
   Valsta LM, 2010, PUBLIC HEALTH NUTR, V13, P932, DOI 10.1017/S1368980010001126
   Walley T, 2005, BRIT J CLIN PHARMACO, V60, P543, DOI 10.1111/j.1365-2125.2005.02478.x
   WHO, 2003, WHO TECHN REP SER
   WHO, 2000, WHO TECHN REP SER, V894
NR 48
TC 19
Z9 21
U1 1
U2 7
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-2458
J9 BMC PUBLIC HEALTH
JI BMC Public Health
PD MAR 8
PY 2016
VL 16
AR 240
DI 10.1186/s12889-016-2826-2
PG 10
WC Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Public, Environmental & Occupational Health
GA DG2DS
UT WOS:000371877000001
PM 26956524
OA gold, Green Published
DA 2025-04-28
ER

PT J
AU Vajdi, M
   Farhangi, MA
   Nikniaz, L
AF Vajdi, Mandi
   Farhangi, Mandieh Abbasalizad
   Nikniaz, Leila
TI Diet-derived nutrient patterns and components of metabolic syndrome: a
   cross-sectional community- based study
SO BMC ENDOCRINE DISORDERS
LA English
DT Article
DE Obesity; Nutrient pattern; Factor analysis; Metabolic syndrome; Iranian
   population
ID IRANIAN POPULATION; LOWER PREVALENCE; HABITUAL COFFEE; VITAMIN-D; SERUM;
   RISK; CONSUMPTION; POTASSIUM; CALCIUM; FAT
AB BackgroundMetabolic syndrome (MetS) is one of the main public health problems worldwide. Although some relations between dietary intakes and MetS have been found, few studies have focused on association between dietary nutrients interactions and the risk of the MetS and its components. The aim of the present study was to examine the association between nutrient patterns and MetS and its components among Iranian adult population.MethodsA total of 588 subjects (aged 18-64years, 271 males and 317 females) enrolled in the cross sectional study. Dietary consumption was evaluated using an 80-item food frequency questionnaire (FFQ). Biochemical assessments including fasting blood sugar (FBS), aspartate aminotransferase (AST), alanine amino transferase (ALT) and serum lipids were performed by enzymatic methods. Nutrient patterns were obtained by factor analysis procedure using principal component method. Multinational logistic regression analysis was used to evaluate the association between nutrient patterns and MetS and its components.ResultsThree nutrient patterns explaining 53.66% of the variance in dietary nutrients intake, were recognized in the current study. Animal-sourced nutrient pattern was significantly associated with the higher odds of MetS and high triglyceride (TG) levels. Plant-sourced nutrient pattern (high intake of fiber, carbohydrate, vitamins B-6, B-3, C, B-1, E, D, magnesium, potassium, and linoleic acid) was significantly associated with lower risk of MetS and lower blood pressure (p<0.05). Third nutrient pattern (mixed-source) was significantly related to higher risk of MetS, high waist circumference (WC) and high systolic blood pressure (SBP).ConclusionThis present study confirms the important effect of nutrients and their patterns on MetS risk. Our results suggest that adherence to the nutrient pattern rich in fiber, carbohydrate, vitamins D, B-6, B-3, C, B-1, E, magnesium, potassium, linoleic acid, and docosahexaenoic acid (DHA) is associated with a lower risk of MetS, while animal- and mixed-sourced nutrient patterns are positively associated with greater odds of MetS; However, further longitudinal and interventional studies are required to make a clear conclusion.
C1 [Vajdi, Mandi] Tabriz Univ Med Sci, Nutr Res Ctr, Tabriz, Iran.
   [Farhangi, Mandieh Abbasalizad] Tabriz Univ Med Sci, Drug Appl Res Ctr, Tabriz, Iran.
   [Nikniaz, Leila] Tabriz Univ Med Sci, Tabriz Hlth Serv Management Res Ctr, Hlth Management & Safety Promot Res Inst, Tabriz, Iran.
C3 Tabriz University of Medical Science; Tabriz University of Medical
   Science; Tabriz University of Medical Science
RP Farhangi, MA (corresponding author), Tabriz Univ Med Sci, Drug Appl Res Ctr, Tabriz, Iran.
EM abbasalizadfarhangim@gmail.com
RI Nikniaz, Leila/M-5747-2017; Farhangi, Mahdieh/AAC-6758-2019; Vajdi,
   Mahdi/GZG-7674-2022
OI Vajdi, Mahdi/0000-0002-2828-1161
FU Tabriz University of Medical Sciences, Iran [IR.TBZMED.REC.1398.077];
   Tabriz University of Medical Sciences
FX This document was part of an MSc thesis approved by Tabriz University of
   Medical Sciences, Iran (Registration number: IR.TBZMED.REC.1398.077).
   Current work has been financially supported by a grant from Tabriz
   University of Medical Sciences. The funders had no role in hypothesis
   generation, designing and recruiting the study. Their role was only
   financial supporting.
CR Afolabi OK, 2013, ARH HIG RADA TOKSIKO, V64, P521, DOI 10.2478/10004-1254-64-2013-2351
   Ahmadi A, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/906019
   Allés B, 2016, NUTRIENTS, V8, DOI 10.3390/nu8040225
   Asghari G, 2016, J PEDIATR-US, V174, P178, DOI 10.1016/j.jpeds.2016.03.077
   Baquer NZ, 2003, J BIOSCIENCES, V28, P215, DOI 10.1007/BF02706221
   Beydoun MA, 2012, J NUTR, V142, P1693, DOI 10.3945/jn.112.160416
   Bian SS, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-106
   Brady LM, 2004, P NUTR SOC, V63, P115, DOI 10.1079/PNS2003318
   Cai XL, 2016, NUTRIENTS, V8, DOI 10.3390/nu8040183
   Chikowore T, 2017, NUTRIENTS, V9, DOI 10.3390/nu9010009
   Costacou T, 2016, ACTA DIABETOL, V53, P243, DOI 10.1007/s00592-015-0770-8
   Dalvand S, 2017, IRAN J PUBLIC HEALTH, V46, P456
   Dibaba DT, 2014, DIABETIC MED, V31, P1301, DOI 10.1111/dme.12537
   Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7
   Esmaillzadeh A, 2006, AM J CLIN NUTR, V84, P1489, DOI 10.1093/ajcn/84.6.1489
   Filippini T, 2017, INT J CARDIOL, V230, P127, DOI 10.1016/j.ijcard.2016.12.048
   Ford ES, 2005, DIABETES CARE, V28, P1228, DOI 10.2337/diacare.28.5.1228
   FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499
   Fulgoni VL, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-1
   Castanho GKF, 2013, CIENC SAUDE COLETIVA, V18, P385, DOI 10.1590/S1413-81232013000200010
   Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404
   Guo H, 2012, NUTR METAB CARDIOVAS, V22, P277, DOI 10.1016/j.numecd.2010.06.006
   Hino A, 2007, DIABETES RES CLIN PR, V76, P383, DOI 10.1016/j.diabres.2006.09.033
   Hong S, 2012, METABOLISM, V61, P883, DOI 10.1016/j.metabol.2011.10.018
   Hosseinpour-Niazi S, 2015, J HEALTH POPUL NUTR, V33, DOI 10.1186/s41043-015-0015-z
   Hu CY, 2012, BIOL TRACE ELEM RES, V150, P297, DOI 10.1007/s12011-012-9482-x
   Hu FB, 2002, CURR OPIN LIPIDOL, V13, P3, DOI 10.1097/00041433-200202000-00002
   Huang HY, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/943020
   Huang XJ, 2006, SENSORS-BASEL, V6, P756, DOI 10.3390/s6070756
   *I MED US STAND CO, 1998, DIET REF INT THIAM R
   Iwasaki Y, 2019, NUTRIENTS, V11, DOI 10.3390/nu11050990
   Kastorini CM, 2011, J AM COLL CARDIOL, V57, P1299, DOI 10.1016/j.jacc.2010.09.073
   Keller U, 2011, INT J VITAM NUTR RES, V81, P125, DOI 10.1024/0300-9831/a000059
   Khayyatzadeh SS, 2016, EUR J CLIN INVEST, V46, P840, DOI 10.1111/eci.12666
   Lee Yeon-Kyung, 2015, Clin Nutr Res, V4, P259, DOI 10.7762/cnr.2015.4.4.259
   Leidy HJ, 2015, AM J CLIN NUTR, V101, p1320S, DOI 10.3945/ajcn.114.084038
   Li D, 2010, WORLD J GASTROENTERO, V16, P2378, DOI 10.3748/wjg.v16.i19.2378
   Li YR, 2013, ASIA PAC J CLIN NUTR, V22, P60, DOI 10.6133/apjcn.2013.22.1.06
   Liu S, 2005, DIABETES CARE, V28, P2926, DOI 10.2337/diacare.28.12.2926
   Lu YJ, 2017, AGING-US, V9, P1623, DOI 10.18632/aging.101257
   Lutsey PL, 2008, CIRCULATION, V117, P754, DOI 10.1161/CIRCULATIONAHA.107.716159
   Marshall JA, 1997, DIABETOLOGIA, V40, P430, DOI 10.1007/s001250050697
   Nava LT, 2015, J CLIN NURS, V24, P3024, DOI 10.1111/jocn.12921
   Newby PK, 2004, NUTR REV, V62, P177, DOI 10.1301/rn.2004.may.177-203
   Nikniaz L, 2017, BRIT FOOD J, V119, P1337, DOI 10.1108/BFJ-09-2016-0415
   Pereira AG, 2017, J TRACE ELEM MED BIO, V39, P140, DOI 10.1016/j.jtemb.2016.09.007
   Ranasinghe P, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4041-1
   Rodríguez-Monforte M, 2017, EUR J NUTR, V56, P925, DOI 10.1007/s00394-016-1305-y
   Sahyoun NR, 2006, AM J CLIN NUTR, V83, P124
   Saltevo J, 2011, EUR J ENDOCRINOL, V165, P429, DOI 10.1530/EJE-11-0066
   Samara A, 2013, NUTRITION, V29, P519, DOI 10.1016/j.nut.2012.08.013
   Saris NEL, 2000, CLIN CHIM ACTA, V294, P1, DOI 10.1016/S0009-8981(99)00258-2
   Schulze MB, 2004, JAMA-J AM MED ASSOC, V292, P927, DOI 10.1001/jama.292.8.927
   Seo EH, 2019, NUTRIENTS, V11, DOI 10.3390/nu11092042
   Siti HN, 2015, VASC PHARMACOL, V71, P40, DOI 10.1016/j.vph.2015.03.005
   Sluijs I, 2009, J NUTR, V139, P987, DOI 10.3945/jn.108.101451
   Srikanthan K, 2016, INT J MED SCI, V13, P25, DOI 10.7150/ijms.13800
   Stutz B, 2018, NUTR METAB CARDIOVAS, V28, P470, DOI 10.1016/j.numecd.2018.01.011
   Sun K, 2014, CLIN NUTR, V33, P521, DOI 10.1016/j.clnu.2013.07.010
   Tabrizi JS, 2018, IRAN J PUBLIC HEALTH, V47, P1396
   Vasheghani-Farahani Ali, 2011, Asian J Sports Med, V2, P106
   Vega GL, 2001, AM HEART J, V142, P1108, DOI 10.1067/mhj.2001.119790
   Wang MeiLing Wang MeiLing, 2011, Scientia Agricultura Sinica, V44, P3850
   Wei J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130876
   Wilsgaard T, 2007, DIABETES RES CLIN PR, V78, P217, DOI 10.1016/j.diabres.2007.03.006
   Yousefi M, 2018, BIOL TRACE ELEM RES, V185, P282, DOI 10.1007/s12011-018-1269-2
   Zhou BA, 2016, BRIT J NUTR, V116, P853, DOI 10.1017/S0007114516002580
   Zhou SS, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-746
NR 68
TC 23
Z9 23
U1 1
U2 8
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1472-6823
J9 BMC ENDOCR DISORD
JI BMC Endocr. Disord.
PD MAY 19
PY 2020
VL 20
IS 1
DI 10.1186/s12902-020-0547-0
PG 13
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA LS9CG
UT WOS:000536676000003
PM 32429966
OA Green Published, gold
DA 2025-04-28
ER

PT J
AU Beauvois, MC
   Arredouani, A
   Jonas, JC
   Rolland, JF
   Schuit, F
   Henquin, JC
   Gilon, P
AF Beauvois, MC
   Arredouani, A
   Jonas, JC
   Rolland, JF
   Schuit, F
   Henquin, JC
   Gilon, P
TI Atypical Ca<SUP>2+</SUP>-induced Ca<SUP>2+</SUP> release from a
   sarco-endoplasmic reticulum Ca<SUP>2+</SUP>-ATPase 3-dependent
   Ca<SUP>2+</SUP> pool in mouse pancreatic β-cells
SO JOURNAL OF PHYSIOLOGY-LONDON
LA English
DT Article
ID INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR; RAPID COOLING CONTRACTURES;
   INDUCED CALCIUM-RELEASE; RYANODINE RECEPTOR; INSULIN-SECRETION;
   2-AMINOETHOXYDIPHENYL BORATE; CARDIAC MYOCYTES; SKELETAL-MUSCLE;
   CYCLIC-AMP; A7R5 CELLS
AB The contribution of Ca2+ release from intracellular stores to the rise in the free cytosolic Ca2+ concentration ([Ca2+](c)) triggered by Ca2+ influx was investigated in mouse pancreatic beta-cells. Depolarization of beta-cells by 45 mM K+ (in the presence of 15 mM glucose and 0.1 mM diazoxide) evoked two types of [Ca2+](c) responses: a monotonic and sustained elevation; or a sustained elevation superimposed by a transient [Ca2+](c) peak (TCP) (40-120 s after the onset of depolarization). Simultaneous measurements of [Ca2+](c) and voltage-dependent Ca2+ current established that the TCP did not result from a larger Ca2+ current. Abolition of the TCP by thapsigargin and its absence in sarco-endoplasmic reticulum Ca2+-ATPase 3 (SERCA3) knockout mice show that it is caused by Ca2+ mobilization from the endoplasmic reticulum. A TCP could not be evoked by the sole depolarization of beta-cells but required a rise in [Ca2+](c) pointing to a Ca2+-induced Ca2+ release (CICR). This CICR did not involve inositol 1,4,5-trisphosphate (IP3) receptors (IP(3)Rs) because it was resistant to heparin. Nor did it involve ryanodine receptors (RyRs) because it persisted after blockade of RyRs with ryanodine, and was not mimicked by caffeine, a RyR agonist. Moreover, RyR1 and RyR2 mRNA were not found and RyR3 mRNA was only slightly expressed in purified beta-cells. A CICR could also be detected in a limited number of cells in response to glucose. Our data demonstrate, for the first time in living cells, the existence of an atypical CICR that is independent from the IP3R and the RyR. This CICR is prominent in response to a supraphysiological stimulation with high K+, but plays little role in response to glucose in non-obese mouse pancreatic beta-cells.
C1 Univ Louvain, Fac Med, Unite Endocrinol & Metab, Brussels, Belgium.
   Free Univ Brussels, Diabet Res Ctr, Brussels, Belgium.
C3 Universite Catholique Louvain; Universite Libre de Bruxelles
RP Univ Louvain, Fac Med, Unite Endocrinol & Metab, Brussels, Belgium.
EM gilon@endo.ucl.ac.be
RI Rolland, Jennifer/E-7543-2011; arredouani, abdelilah/Q-9650-2019; Jonas,
   Jean-Christophe/C-6766-2011
OI Rolland, Jean-Francois/0000-0002-7420-8272; arredouani,
   abdelilah/0000-0002-5060-916X; Jonas,
   Jean-Christophe/0000-0001-9882-5438
CR Arredouani A, 2002, DIABETES, V51, P3245, DOI 10.2337/diabetes.51.11.3245
   Arredouani A, 2002, AM J PHYSIOL-ENDOC M, V282, pE982, DOI 10.1152/ajpendo.00347.2001
   ASHCROFT FM, 1989, PROG BIOPHYS MOL BIO, V54, P87, DOI 10.1016/0079-6107(89)90013-8
   Bak J, 2002, BIOCHEM BIOPH RES CO, V295, P806, DOI 10.1016/S0006-291X(02)00761-1
   Bak J, 1999, CURR BIOL, V9, P751, DOI 10.1016/S0960-9822(99)80335-2
   Barg S, 2001, BIOPHYS J, V81, P3308, DOI 10.1016/S0006-3495(01)75964-4
   Barg S, 2000, DIABETES, V49, P1500, DOI 10.2337/diabetes.49.9.1500
   Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155
   Berridge MJ, 1997, J PHYSIOL-LONDON, V499, P291, DOI 10.1113/jphysiol.1997.sp021927
   BERS DM, 1989, J PHYSIOL-LONDON, V417, P537, DOI 10.1113/jphysiol.1989.sp017817
   BERS DM, 1987, CAN J PHYSIOL PHARM, V65, P610, DOI 10.1139/y87-103
   Bers DR, 1999, CARDIOVASC RES, V42, P339, DOI 10.1016/S0008-6363(99)00038-3
   BIDEN TJ, 1987, J BIOL CHEM, V262, P3567
   Chini EN, 1996, BIOCHEM J, V316, P709, DOI 10.1042/bj3160709
   De Backer F, 2002, J PHYSIOL-LONDON, V542, P855, DOI 10.1113/jphysiol.2002.020487
   De Smet P, 1999, CELL CALCIUM, V26, P9
   Dyachok O, 2004, CELL CALCIUM, V36, P1, DOI 10.1016/j.ceca.2003.11.004
   EHRLICH BE, 1994, TRENDS PHARMACOL SCI, V15, P145, DOI 10.1016/0165-6147(94)90074-4
   FOURNIER L, 1994, J BIOL CHEM, V269, P1120
   Gafni J, 1997, NEURON, V19, P723, DOI 10.1016/S0896-6273(00)80384-0
   Galione A, 2002, CELL CALCIUM, V32, P343, DOI 10.1016/S0143416002001902
   Gamberucci A, 1999, FEBS LETT, V446, P309, DOI 10.1016/S0014-5793(99)00220-3
   Gilon P, 1999, J BIOL CHEM, V274, P20197, DOI 10.1074/jbc.274.29.20197
   GILON P, 1992, J BIOL CHEM, V267, P20713
   GRAPENGIESSER E, 1991, J BIOL CHEM, V266, P12207
   Gromada J, 1996, BIOCHEM J, V314, P339, DOI 10.1042/bj3140339
   Henquin JC, 2000, DIABETES, V49, P1751, DOI 10.2337/diabetes.49.11.1751
   Holz GG, 1999, J BIOL CHEM, V274, P14147, DOI 10.1074/jbc.274.20.14147
   ISLAM MS, 1995, BIOCHEM J, V306, P679, DOI 10.1042/bj3060679
   Islam MS, 2002, DIABETES, V51, P1299, DOI 10.2337/diabetes.51.5.1299
   Islam MS, 1998, P NATL ACAD SCI USA, V95, P6145, DOI 10.1073/pnas.95.11.6145
   Jensen J, 1996, J BIOL CHEM, V271, P18749, DOI 10.1074/jbc.271.31.18749
   Johnson JD, 2004, FASEB J, V18, P878, DOI 10.1096/fj.03-1280fje
   Jonas JC, 1999, J BIOL CHEM, V274, P14112, DOI 10.1074/jbc.274.20.14112
   Jonkers FC, 1999, J PHYSIOL-LONDON, V520, P839, DOI 10.1111/j.1469-7793.1999.00839.x
   Kasri NN, 2003, J BIOL CHEM, V278, P27548, DOI 10.1074/jbc.M302026200
   Lee B, 2001, BIOCHEM PHARMACOL, V61, P327, DOI 10.1016/S0006-2952(00)00559-1
   Lemmens R, 2001, J BIOL CHEM, V276, P9971, DOI 10.1074/jbc.M009463200
   Liu LH, 1997, J BIOL CHEM, V272, P30538, DOI 10.1074/jbc.272.48.30538
   Liu YJ, 1996, ARCH BIOCHEM BIOPHYS, V334, P295, DOI 10.1006/abbi.1996.0458
   LLANO I, 1994, NEURON, V12, P663, DOI 10.1016/0896-6273(94)90221-6
   LUND PE, 1994, N-S ARCH PHARMACOL, V349, P503, DOI 10.1007/BF00169140
   Macianskiene R, 2002, AM J PHYSIOL-HEART C, V282, pH1879, DOI 10.1152/ajpheart.00952.2001
   Maruyama T, 1997, J BIOCHEM-TOKYO, V122, P498
   Missiaen L, 2001, CELL CALCIUM, V29, P111, DOI 10.1054/ceca.2000.0163
   Murayama T, 2002, TRENDS CARDIOVAS MED, V12, P305, DOI 10.1016/S1050-1738(02)00179-2
   NABAUER M, 1989, SCIENCE, V244, P800, DOI 10.1126/science.2543067
   NILSSON T, 1988, FEBS LETT, V229, P211, DOI 10.1016/0014-5793(88)80829-9
   Pinton P, 1998, EMBO J, V17, P5298, DOI 10.1093/emboj/17.18.5298
   PIPELEERS DG, 1985, ENDOCRINOLOGY, V117, P806, DOI 10.1210/endo-117-3-806
   Ravier MA, 2002, DIABETOLOGIA, V45, P1154, DOI 10.1007/s00125-002-0883-9
   Rolland JF, 2002, DIABETES, V51, P376, DOI 10.2337/diabetes.51.2.376
   Rorsman P, 2000, NEWS PHYSIOL SCI, V15, P72
   RUTTER GA, 1994, CELL CALCIUM, V16, P71, DOI 10.1016/0143-4160(94)90002-7
   Satin LS, 2000, ENDOCRINE, V13, P251, DOI 10.1385/ENDO:13:3:251
   SCHNEIDER MF, 1994, ANNU REV PHYSIOL, V56, P463, DOI 10.1146/annurev.ph.56.030194.002335
   SEINO S, 1992, P NATL ACAD SCI USA, V89, P584, DOI 10.1073/pnas.89.2.584
   Shmigol A, 1995, J PHYSIOL-LONDON, V489, P627, DOI 10.1113/jphysiol.1995.sp021078
   SMITH GL, 1988, J GEN PHYSIOL, V92, P351, DOI 10.1085/jgp.92.3.351
   Sutko JL, 1996, PHYSIOL REV, V76, P1027, DOI 10.1152/physrev.1996.76.4.1027
   Takasawa S, 1998, J BIOL CHEM, V273, P2497, DOI 10.1074/jbc.273.5.2497
   Tengholm A, 1998, DIABETES, V47, P1224, DOI 10.2337/diabetes.47.8.1224
   Tengholm A, 1999, J BIOL CHEM, V274, P36883, DOI 10.1074/jbc.274.52.36883
   TRUBE G, 1986, PFLUG ARCH EUR J PHY, V407, P493, DOI 10.1007/BF00657506
   Wissing F, 2002, BIOCHEM J, V361, P605, DOI 10.1042/0264-6021:3610605
   WORLEY JF, 1994, J BIOL CHEM, V269, P14359
   Wuytack F, 2002, CELL CALCIUM, V32, P279, DOI 10.1016/S0143416002001847
   Yang SN, 1999, P NATL ACAD SCI USA, V96, P10164, DOI 10.1073/pnas.96.18.10164
NR 68
TC 26
Z9 30
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-3751
EI 1469-7793
J9 J PHYSIOL-LONDON
JI J. Physiol.-London
PD AUG 15
PY 2004
VL 559
IS 1
BP 141
EP 156
DI 10.1113/jphysiol.2004.067454
PG 16
WC Neurosciences; Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology; Physiology
GA 849XK
UT WOS:000223574700013
PM 15218077
OA Green Published
DA 2025-04-28
ER

PT J
AU Mostad, IL
   Langaas, M
   Grill, V
AF Mostad, Ingrid Lovold
   Langaas, Mette
   Grill, Valdemar
TI Central obesity is associated with lower intake of whole-grain bread and
   less frequent breakfast and lunch: results from the HUNT study, an adult
   all-population survey
SO APPLIED PHYSIOLOGY NUTRITION AND METABOLISM
LA English
DT Article
DE HUNT; central obesity; waist/hip ratio; dietary intake; whole-grain
   bread; meal frequency; all-population survey; nutrition epidemiology
ID BODY-MASS INDEX; DOUBLY LABELED WATER; FOOD-INTAKE PATTERNS; WAIST
   CIRCUMFERENCE; DIETARY PATTERNS; ABDOMINAL OBESITY; RISK-FACTORS;
   WEIGHT-GAIN; CARDIOVASCULAR-DISEASE; ARTIFICIAL SWEETENERS
AB All-population and area-based investigations of diet in central obesity are scarce. We used cross-sectional data from 50 339 individuals who responded to the HUNT3 survey of 2006-2008, which recruited from all county-residing adults 20 years and older, to investigate whether those with central obesity eat and drink differently than others. Answers to dietary questions were recoded and analyzed with multiple linear regression, using waist/hip ratio (WHR), age, and sex as explanatory variables. Frequencies of consumption or amounts of food, beverages, and meals were compared among WHR quartiles. Central obesity was present in the quartile with the highest WHR, WHR4(WHR >= 0.917 for women and 0.981 for men) but not in the quartile with the lowest WHR, WHR1 (WHR<0.817 for women and 0.895 for men). Dietary variables differed markedly by age and sex. After adjustment for these factors and for multiple testing, we found significant differences between WHR4 and WHR1 for 19 of 30 dietary variables. Central obesity was associated with a lower intake of any bread, and of whole-grain bread in particular. Intake of fruits and berries, vegetables, and pasta and rice was less, and intake of sausages and hamburgers and boiled potatoes was more frequent. Intake of alcohol, tea, and fruit juice was lower in those with central obesity, whereas intake of sugar-free soft drinks and coffee was higher. The frequency of breakfast and lunch was lower and of nightly meals was higher in those with central obesity. In conclusion, in this large area-based population, central obesity was associated with differences in dietary habits, some of which (such as decreased consumption of whole-grain bread and increased intake of sugar-free drinks) are of possible clinical significance.
C1 [Mostad, Ingrid Lovold] Univ Trondheim Hosp, St Olavs Hosp, Clin Clin Serv, Dept Clin Nutr, NO-7006 Trondheim, Norway.
   [Mostad, Ingrid Lovold; Grill, Valdemar] NTNU, Fac Med, Dept Canc Res & Mol Med, NO-7491 Trondheim, Norway.
   [Langaas, Mette] NTNU, Fac Informat Technol Math & Elect Engn, Dept Math Sci, NO-7491 Trondheim, Norway.
C3 Norwegian University of Science & Technology (NTNU); Norwegian
   University of Science & Technology (NTNU); Norwegian University of
   Science & Technology (NTNU)
RP Mostad, IL (corresponding author), Univ Trondheim Hosp, St Olavs Hosp, Clin Clin Serv, Dept Clin Nutr, Box 3250 Sluppen, NO-7006 Trondheim, Norway.
EM ingrid.l.mostad@ntnu.no
RI Langaas, Mette/G-7423-2012
OI Langaas, Mette/0000-0002-5714-0288
FU Central Norway Regional Health Authority; Norwegian University of
   Science and Technology
FX The Nord-Trondelag Health Study (the HUNT study) is collaboration
   between the HUNT Research Centre (Faculty of Medicine, Norwegian
   University of Science and Technology), the Nord-Trondelag County
   Council, the Central Norway Health Authority, and the Norwegian
   Institute of Public Health. Our investigation of the HUNT3 survey was
   supported by the liaison committee between the Central Norway Regional
   Health Authority and the Norwegian University of Science and Technology.
CR Alinia S, 2009, OBES REV, V10, P639, DOI 10.1111/j.1467-789X.2009.00582.x
   Anderson JW, 2009, NUTR REV, V67, P188, DOI 10.1111/j.1753-4887.2009.00189.x
   [Anonymous], 2008, J AM DIET ASSOC, V108, P1716, DOI 10.1016/j.jada.2008.08.007
   [Anonymous], 2010, R LANG ENV STAT COMP
   Bautista-Castaño I, 2012, NUTR REV, V70, P218, DOI 10.1111/j.1753-4887.2012.00454.x
   Berg C, 2009, APPETITE, V52, P21, DOI 10.1016/j.appet.2008.07.008
   Bigaard J, 2005, INT J OBESITY, V29, P778, DOI 10.1038/sj.ijo.0802976
   Brown RJ, 2010, INT J PEDIATR OBES, V5, P305, DOI 10.3109/17477160903497027
   Cunha DB, 2010, BRIT J NUTR, V104, P908, DOI 10.1017/S0007114510001479
   DeCaria JE, 2012, INT J OBESITY, V36, P1141, DOI 10.1038/ijo.2012.29
   Droyvold WB, 2006, INT J OBESITY, V30, P935, DOI 10.1038/sj.ijo.0803178
   Du HD, 2010, AM J CLIN NUTR, V91, P329, DOI 10.3945/ajcn.2009.28191
   Forslund HB, 2002, EUR J CLIN NUTR, V56, P740, DOI 10.1038/sj.ejcn.1601387
   Halkjær J, 2006, AM J CLIN NUTR, V84, P789, DOI 10.1093/ajcn/84.4.789
   Halkjer J, 2009, J AM DIET ASSOC, V109, P1356, DOI 10.1016/j.jada.2009.05.015
   Harland JI, 2008, PUBLIC HEALTH NUTR, V11, P554, DOI 10.1017/S1368980007001279
   Hill RJ, 2001, BRIT J NUTR, V85, P415, DOI 10.1079/BJN2000281
   Hostmark AT, 2010, APPL PHYSIOL NUTR ME, V35, P816, DOI 10.1139/H10-080
   Hsiao Pao Ying, 2011, Journal of Nutrition in Gerontology and Geriatrics, V30, P204, DOI 10.1080/21551197.2011.591266
   Hu FB, 1999, AM J CLIN NUTR, V69, P243
   JACOBSEN BK, 1987, J CHRON DIS, V40, P795, DOI 10.1016/0021-9681(87)90131-7
   Kahn HS, 1997, INT J OBESITY, V21, P903, DOI 10.1038/sj.ijo.0800490
   Kjollesdal MR, 2010, BRIT J NUTR, V104, P1230, DOI 10.1017/S0007114510001868
   Koh-Banerjee P, 2004, AM J CLIN NUTR, V80, P1237, DOI 10.1093/ajcn/80.5.1237
   Koh-Banerjee P, 2003, P NUTR SOC, V62, P25, DOI 10.1079/PNS2002232
   Koh-Banerjee P, 2003, AM J CLIN NUTR, V78, P719, DOI 10.1093/ajcn/78.4.719
   Krachler B, 2006, NUTR J, V5, DOI 10.1186/1475-2891-5-34
   Krokstad S, 2013, INT J EPIDEMIOL, V42, P968, DOI 10.1093/ije/dys095
   Laitinen J, 2004, EUR J CLIN NUTR, V58, P180, DOI 10.1038/sj.ejcn.1601765
   Langhammer A, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-143
   Lee CMY, 2008, J CLIN EPIDEMIOL, V61, P646, DOI 10.1016/j.jclinepi.2007.08.012
   Lin B. H., 2002, FoodReview, V25, P28
   Lissner L, 2002, PUBLIC HEALTH NUTR, V5, P889, DOI 10.1079/PHN2002388
   Lissner L, 2007, INT J OBESITY, V31, P956, DOI 10.1038/sj.ijo.0803527
   Lissner L, 2000, BRIT J NUTR, V83, pS21
   Liu SM, 2003, AM J CLIN NUTR, V78, P920, DOI 10.1093/ajcn/78.5.920
   McKeown NM, 2010, AM J CLIN NUTR, V92, P1165, DOI 10.3945/ajcn.2009.29106
   Midthjell K, 2013, CLIN OBES, V3, P12, DOI 10.1111/cob.12009
   Moreira Pedro, 2006, Eat Behav, V7, P220, DOI 10.1016/j.eatbeh.2005.08.008
   Mosdol A., 2004, THESIS U OSLO OSLO
   Nasjonalt rad for ernaering (National Nutrition Council), 2011, KOSTR FREMM FOLK FOR
   Newby P, 2003, AM J CLIN NUTR, V77, P1417, DOI 10.1093/ajcn/77.6.1417
   O'Neil CE, 2011, NUTR RES, V31, P122, DOI 10.1016/j.nutres.2011.01.007
   Price GM, 2006, AM J CLIN NUTR, V84, P449
   Romaguera D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023384
   Rossi M, 2008, PUBLIC HEALTH NUTR, V11, P214, DOI 10.1017/S1368980007000833
   Shi Z, 2008, INT J OBESITY, V32, P975, DOI 10.1038/ijo.2008.21
   Srikanthan P, 2009, ANN EPIDEMIOL, V19, P724, DOI 10.1016/j.annepidem.2009.05.003
   Thane CW, 2009, EUR J CLIN NUTR, V63, P229, DOI 10.1038/sj.ejcn.1602911
   Togo P, 2001, INT J OBESITY, V25, P1741, DOI 10.1038/sj.ijo.0801819
   Trabulsi J, 2001, AM J PHYSIOL-ENDOC M, V281, pE891, DOI 10.1152/ajpendo.2001.281.5.E891
   van Dijk SB, 2012, NETH HEART J, V20, P208, DOI 10.1007/s12471-011-0237-7
   Walker SP, 1996, AM J EPIDEMIOL, V144, P1143, DOI 10.1093/oxfordjournals.aje.a008892
   Wei M, 1997, OBES RES, V5, P16, DOI 10.1002/j.1550-8528.1997.tb00278.x
   WILLETT WC, 1987, J AM DIET ASSOC, V87, P43
   Wolongevicz DM, 2010, J OBES, V2010, DOI 10.1155/2010/945987
   Yang Qing, 2010, Yale Journal of Biology and Medicine, V83, P101
   Zhang C, 2008, CIRCULATION, V117, P1658, DOI 10.1161/CIRCULATIONAHA.107.739714
   [No title captured]
   [No title captured]
NR 60
TC 12
Z9 12
U1 1
U2 25
PU CANADIAN SCIENCE PUBLISHING, NRC RESEARCH PRESS
PI OTTAWA
PA 65 AURIGA DR, SUITE 203, OTTAWA, ON K2E 7W6, CANADA
SN 1715-5312
EI 1715-5320
J9 APPL PHYSIOL NUTR ME
JI Appl. Physiol. Nutr. Metab.
PD JUL
PY 2014
VL 39
IS 7
BP 819
EP 828
DI 10.1139/apnm-2013-0356
PG 10
WC Nutrition & Dietetics; Physiology; Sport Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics; Physiology; Sport Sciences
GA AO7GE
UT WOS:000341519700010
PM 24833275
OA Bronze
DA 2025-04-28
ER

PT J
AU Kumma, WP
   Loha, E
AF Kumma, Wondimagegn Paulos
   Loha, Eskindir
TI Dietary patterns and their association with cardiovascular risk factors
   in Ethiopia: A community-based cross-sectional study
SO FRONTIERS IN NUTRITION
LA English
DT Article
DE dietary patterns; coexistence; cardiovascular disease risk factors;
   Wolaita; southern Ethiopia
ID OBESITY; DISEASE; PREVALENCE; NUTRITION; EDUCATION; QUALITY; FAMINE;
   ENERGY; ADULTS
AB PurposeTo identify the dietary patterns and their association with cardiovascular risk factors among adult people in urban and rural areas of Wolaita, southern Ethiopia. MethodsA total of 2,483 participants aged 25-64 years were selected using a three-stage random sampling. Data for this study were collected using structured questionnaires, the previous 24-h dietary intake assessment, anthropometric, blood pressure, and biochemical measurements. We used factor analysis to identify dietary patterns. Factors associated with dietary patterns were analyzed using multiple linear regression models. The adjusted regression coefficients with their 95% CI were used to ascertain the association. ResultWe identified three major dietary patterns that explained 51% of the variance in food consumption. The western dietary pattern was characterized by the consumption of meat/organ meat, biscuits/sweets, chicken stew, pasta-macaroni recipes, butter, white wheat bread, egg recipe, and Ethiopian dish shiro-wet, and was positively associated with urban residence, obesity, hypertension, blood glucose, and total cholesterol levels. Adherence to the consumption of tubers, whole-grain maize products, coffee leaves-and-herbs beverage, legumes, and sweet potatoes featured the traditional dietary pattern. The traditional dietary pattern showed a positive relationship with rural residence, physical activity, and obesity, and it had a negative relationship with hypertension. The healthy dietary pattern was characterized by the intake of green leafy vegetables, green pepper, and whole-grain maize products, and negatively related to obesity, and hypertension, while positively related to urban residence. ConclusionThe coexistence of western, traditional, and healthy dietary patterns in the present study indicates the transition to a new dietary pattern in the study area. All dietary patterns were associated with one or more cardiovascular risk factors, but the western dietary pattern was associated with most of these, while the traditional diet showed fewer such associations. Therefore, it might be useful to promote healthy and traditional dietary patterns along with physical activity. Interventions related to the current findings, if initiated early in life, may benefit the public in preventing cardiovascular risk factors such as obesity, hypertension, and type 2-diabetes.
C1 [Kumma, Wondimagegn Paulos; Loha, Eskindir] Hawassa Univ, Sch Publ Hlth, Hawassa, Ethiopia.
   [Kumma, Wondimagegn Paulos; Loha, Eskindir] Univ Bergen, Ctr Int Hlth, Bergen, Norway.
   [Kumma, Wondimagegn Paulos] Wolaita Sodo Univ, Sch Publ Hlth, Wolaita Sodo, Ethiopia.
   [Loha, Eskindir] Chr Michelsen Inst, Bergen, Norway.
C3 Hawassa University; University of Bergen
RP Kumma, WP (corresponding author), Hawassa Univ, Sch Publ Hlth, Hawassa, Ethiopia.; Kumma, WP (corresponding author), Univ Bergen, Ctr Int Hlth, Bergen, Norway.; Kumma, WP (corresponding author), Wolaita Sodo Univ, Sch Publ Hlth, Wolaita Sodo, Ethiopia.
EM wondimagegnk@yahoo.com
RI Shumbullo, Eskindir Loha/ABB-6422-2021
OI Kumma, Wondimagegn Paulos/0000-0001-6319-6715
FU Norwegian Program for Capacity Development in Higher Education and
   Research for Development [ETH-13-0025]
FX This study was granted by the Norwegian Program for Capacity Development
   in Higher Education and Research for Development. Award/grant number:
   ETH-13-0025.
CR Abrahams Z, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-801
   Alangea DO, 2018, BMC NUTR, V4, DOI 10.1186/s40795-018-0230-2
   Alemayehu AA, 2011, NUTRITION, V27, P919, DOI 10.1016/j.nut.2010.10.015
   Asadi Z, 2019, J HUM NUTR DIET, V32, P789, DOI 10.1111/jhn.12669
   Badesso BB., 2020, IJESNR, V25, P104, DOI [10.19080/IJESNR.2020.25.556164, DOI 10.19080/IJESNR.2020.25.556164]
   Boateng D, 2019, J NUTR, V149, P755, DOI 10.1093/jn/nxz002
   Canale MP, 2021, NUTRIENTS, V13, DOI 10.3390/nu13041162
   Casas R, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19123988
   Cefalu WT, 2019, DIABETES CARE, V42, pS34, DOI 10.2337/dc19-S004
   Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486
   Deer J, 2015, METABOLISM, V64, P163, DOI 10.1016/j.metabol.2014.08.013
   Delisle H., 1990, Patterns of urban food consumption in developing countries: perspective from the 1980s
   Denova-Gutiérrez E, 2016, J NUTR, V146, P90, DOI 10.3945/jn.115.217539
   Dorosh P., 2012, WIDER WORKING PAPER
   Dorosh P., 2010, URBANIZATION EC TRAN
   Gutiérrez-Pliego LE, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3527-6
   Eng JY, 2020, NUTRIENTS, V12, DOI 10.3390/nu12103092
   Federal Ministry of Finance and Economic Development Ethiopia, 2010, 2010 MDGS REP TRENDS, P1
   FERGUSON EL, 1989, ECOL FOOD NUTR, V23, P273, DOI 10.1080/03670244.1989.9991110
   Fernandez ML, 2022, NUTRIENTS, V14, DOI 10.3390/nu14102168
   FerroLuzzi A, 1995, WHO TECH REP SER, V854, P1
   Fung TT, 2001, AM J CLIN NUTR, V73, P61
   Fuster V, 2014, J AM COLL CARDIOL, V64, P520, DOI 10.1016/j.jacc.2014.06.1151
   Galbete C, 2017, FOOD NUTR RES, V61, DOI 10.1080/16546628.2017.1341809
   Gao M, 2021, BMC MED, V19, DOI 10.1186/s12916-021-01958-x
   Gaziano TA, 2010, CURR PROB CARDIOLOGY, V35, P72, DOI 10.1016/j.cpcardiol.2009.10.002
   Gebreyes YF, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194819
   Gecho Y., 2014, Science Publishing Group, V3, P92, DOI [10.11648/j.ss.20140303.15, DOI 10.11648/J.SS.20140303.15]
   Gibson R S., 2008, HarvestPlus
   Gibson R.S., 2005, PRINCIPLES NUTR ASSE
   Hicklin T., 2017, How dietary factors influence disease risk | National Institutes of Health (NIH)
   IPAQ, 2005, GUIDELINES DATA PROC
   Jufare A.T., 2008, ENV DEV STUDIES DEP
   Kearney J, 2010, PHILOS T R SOC B, V365, P2793, DOI 10.1098/rstb.2010.0149
   Kim J, 2012, J ACAD NUTR DIET, V112, P246, DOI 10.1016/j.jada.2011.10.005
   Kumma WP, 2022, BMJ OPEN, V12, DOI 10.1136/bmjopen-2021-057930
   Kumma WP, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0260403
   Lee JE, 2011, NUTRITION, V27, P26, DOI 10.1016/j.nut.2009.10.011
   LINDTJORN B, 1990, BMJ-BRIT MED J, V301, P1123, DOI 10.1136/bmj.301.6761.1123
   LINDTJORN B, 1987, ANN TROP PAEDIATR, V7, P1
   Mahase E, 2019, BMJ-BRIT MED J, V366, DOI 10.1136/bmj.l5368
   McKeown NM, 2004, DIABETES CARE, V27, P538, DOI 10.2337/diacare.27.2.538
   Melesse MB, 2021, ECOL FOOD NUTR, V60, P244, DOI 10.1080/03670244.2020.1835655
   Miller V, 2022, NAT FOOD, V3, P694, DOI 10.1038/s43016-022-00594-9
   Na Woori, 2019, Clin Nutr Res, V8, P219, DOI 10.7762/cnr.2019.8.3.219
   Nasreddine L, 2019, EUR J NUTR, V58, P91, DOI 10.1007/s00394-017-1574-0
   Neuhouser ML, 2019, NUTR RES, V70, P3, DOI 10.1016/j.nutres.2018.06.002
   Nkondjock A, 2010, EUR J CLIN NUTR, V64, P1014, DOI 10.1038/ejcn.2010.109
   Panagiotakos D, 2009, NUTR METAB CARDIOVAS, V19, P253, DOI 10.1016/j.numecd.2008.06.005
   Paradis AM, 2009, INT J OBESITY, V33, P1419, DOI 10.1038/ijo.2009.179
   Penney TL, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007161
   Popkin BM, 2012, NUTR REV, V70, P3, DOI 10.1111/j.1753-4887.2011.00456.x
   Random.org, 2022, RANDOM INTEGER GENER
   Romieu I, 2017, CANCER CAUSE CONTROL, V28, P247, DOI 10.1007/s10552-017-0869-z
   Ruan Y, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-6003-7
   Sabaté J, 2015, BRIT J NUTR, V113, pS136, DOI 10.1017/S0007114514004139
   Sadika S., 2013, HLTH ENV J, V4
   Schulz CA, 2021, EUR J NUTR, V60, P4115, DOI 10.1007/s00394-021-02545-9
   Shahavandi M, 2021, NUTR HEALTH-UK, V27, P27, DOI 10.1177/0260106020952591
   Shang XW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043183
   Shridhar K, 2018, NUTR J, V17, DOI 10.1186/s12937-018-0327-0
   Sodjinou R, 2009, EUR J CLIN NUTR, V63, P222, DOI 10.1038/sj.ejcn.1602906
   Tain YL, 2022, ANTIOXIDANTS-BASEL, V11, DOI 10.3390/antiox11030511
   Tegenu T., 2010, Urbanization in Ethiopia: Study on growth, patterns, functions and alternative policy strategy
   The World Health Organization, Healthy Diet
   Trübswasser U, 2021, PUBLIC HEALTH NUTR, V24, P3615, DOI 10.1017/S1368980020002487
   U.S. Department of Health and Human Services U.S. Department of Agriculture, 2020, 2020 2025 DIET GUID
   Villa Julia Khede Dourado, 2015, Rev Paul Pediatr, V33, P303, DOI 10.1016/j.rpped.2015.05.001
   Wang YY, 2021, BMC PUBLIC HEALTH, V21, DOI 10.1186/s12889-021-11341-3
   Willett W., 2012, NUTR EPIDEMIOLOGY, DOI DOI 10.1093/ACPROF:OSO/9780199754038.001.0001
   Williams B, 2018, Eur Heart J, V39, P3021, DOI [10.1093/eurheartj/ehy339, DOI 10.1093/EURHEARTJ/EHY339]
   World Health Organization, 2022, CHRON DIS HLTH PROM
   World Health Organization and Food and Agriculture Organization, 2002, EXPERT CONSULTATION
   Zeba AN, 2014, J NUTR SCI, V3, DOI 10.1017/jns.2014.11
NR 74
TC 6
Z9 6
U1 1
U2 10
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 2296-861X
J9 FRONT NUTR
JI Front. Nutr.
PD MAR 23
PY 2023
VL 10
AR 1074296
DI 10.3389/fnut.2023.1074296
PG 12
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA D2ZL5
UT WOS:000967456700001
PM 37032774
OA gold, Green Published
DA 2025-04-28
ER

PT J
AU Otton, R
   Petrovic, N
   Cannon, B
   Nedergaard, J
AF Otton, Rosemari
   Petrovic, Natasa
   Cannon, Barbara
   Nedergaard, Jan
TI On the Validity of Adipogenic Cell Lines as Model Systems for Browning
   Processes: In Authentic Brown, Brite/Beige, and White Preadipocytes,
   There is No Cell-Autonomous Thermogenic Recruitment by Green Tea
   Compounds
SO FRONTIERS IN NUTRITION
LA English
DT Article
DE thermogenesis; adipogenesis; polyphenols; PPAR gamma; green tea
   (Camellia sinensis L.)
ID ADIPOSE-TISSUE; PPAR-GAMMA; UNCOUPLING PROTEIN-1; WEIGHT-LOSS; CAFFEINE;
   BEIGE; ADIPOCYTES; ACTIVATION; COMPETENT; INDUCTION
AB The potential ability of nutritional compounds to induce or enhance the browning of adipocytes has attracted large interest as a workable means of combatting the obesity epidemic. Green tea compounds are discussed as such inducers of an enhanced thermogenic capacity and activity. However, the cell-autonomous effects of green tea compounds on adipocytes have until now only been demonstrated in adipogenic cell lines (3T3-L1 and 3T3-F442A), i.e., cells of undefined tissue lineage. In this study, we examine the ability of green tea compounds to cell-autonomously induce thermogenic recruitment in authentic brown and brite/beige adipocytes in vitro. In primary brown adipocytes, the green tea compounds suppressed basal UCP1 gene expression, and there was no positive interaction between the compounds and adrenergic stimulation. In white adipocytes, green tea compounds decreased both basal and norepinephrine-induced UCP1 mRNA levels, and this was associated with the suppression of cell differentiation, indicated by reduced lipogenic gene expression and lipid accumulation. A lack of interaction between rosiglitazone and green tea compounds suggests that the green tea compounds do not directly interact with the PPAR gamma pathway. We conclude that there is a negative effect of the green tea compounds on basal UCP1 gene expression, in both brown and white primary adipocytes, in contrast to the positive effects earlier reported from studies in adipogenic cell lines. We posit that the epigenetic status of the adipogenic cell lines is fundamentally different from that of genuine brown and white adipocytes, reflected, e.g., in several-thousand-fold differences in UCP1 gene expression levels. Thus, results obtained with adipogenic cell lines cannot unreservedly be extrapolated as being relevant for authentic effects in brown and white adipocytes. We suggest that this conclusion can be of general concern for studies attempting to establish physiologically relevant cell-autonomous effects.
C1 [Otton, Rosemari] Cruzeiro Univ, Interdisciplinary Post Grad Programme Hlth Sci, Sao Paulo, Brazil.
   [Otton, Rosemari; Petrovic, Natasa; Cannon, Barbara; Nedergaard, Jan] Stockholm Univ, Wenner Gren Inst, Dept Mol Biosci, Stockholm, Sweden.
C3 Universidade Cruzeiro do Sul; Stockholm University
RP Otton, R (corresponding author), Cruzeiro Univ, Interdisciplinary Post Grad Programme Hlth Sci, Sao Paulo, Brazil.; Otton, R (corresponding author), Stockholm Univ, Wenner Gren Inst, Dept Mol Biosci, Stockholm, Sweden.
EM rosemari.otton@cruzeirodosul.edu.br
RI Cannon, Barbara/B-3089-2016; Nedergaard, Jan/Q-8286-2019; Otton,
   Rosemari/C-6531-2012
OI Otton, Rosemari/0000-0001-5503-3967
FU Sao Paulo Research Foundation (FAPESP) [2019/19049-6]; Magnus Bergvalls
   Stiftelse; Carl Tryggers Stiftelse; Swedish Science Research Council
FX This research was supported by the Sao Paulo Research Foundation
   (FAPESP, 2019/19049-6), Magnus Bergvalls Stiftelse, Carl Tryggers
   Stiftelse, and The Swedish Science Research Council.
CR Abreu-Vieira G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8433
   Barak Y, 1999, MOL CELL, V4, P585, DOI 10.1016/S1097-2765(00)80209-9
   Barberá MJ, 2001, J BIOL CHEM, V276, P1486, DOI 10.1074/jbc.M006246200
   Bolin AP, 2020, J NUTR BIOCHEM, V83, DOI 10.1016/j.jnutbio.2020.108429
   Bolin AP, 2020, J NUTR BIOCHEM, V78, DOI 10.1016/j.jnutbio.2019.108322
   Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003
   Cannon B, 2001, Methods Mol Biol, V155, P213
   Choo JJ, 2003, J NUTR BIOCHEM, V14, P671, DOI 10.1016/j.jnutbio.2003.08.005
   de Jong JMA, 2018, ADIPOCYTE, V7, P166, DOI 10.1080/21623945.2018.1479578
   Djeridane A, 2006, FOOD CHEM, V97, P654, DOI 10.1016/j.foodchem.2005.04.028
   Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040
   Ferreira LT, 2020, J FUNCT FOODS, V64, DOI 10.1016/j.jff.2019.103679
   FoellmiAdams LA, 1996, BIOCHEM PHARMACOL, V52, P693, DOI 10.1016/0006-2952(96)00345-0
   Golzarand M, 2018, J FUNCT FOODS, V46, P320, DOI 10.1016/j.jff.2018.04.002
   Harms M, 2013, NAT MED, V19, P1252, DOI 10.1038/nm.3361
   Hursel R, 2009, INT J OBESITY, V33, P956, DOI 10.1038/ijo.2009.135
   Ishibashi J, 2010, SCIENCE, V328, P1113, DOI 10.1126/science.1190816
   Kajimura S, 2015, CELL METAB, V22, P546, DOI 10.1016/j.cmet.2015.09.007
   Kim HS, 2019, CHEM BIODIVERS, V16, DOI 10.1002/cbdv.201900347
   Kraus NA, 2016, ADIPOCYTE, V5, P351, DOI 10.1080/21623945.2016.1240137
   KUUSELA P, 1986, LIFE SCI, V38, P589, DOI 10.1016/0024-3205(86)90052-4
   Lee MS, 2017, FOOD NUTR RES, V61, DOI 10.1080/16546628.2017.1325307
   Merlin J, 2018, CELL SIGNAL, V42, P54, DOI 10.1016/j.cellsig.2017.09.023
   Mi YS, 2018, FOOD FUNCT, V9, P3374, DOI 10.1039/c8fo00167g
   Nedergaard J, 2007, AM J PHYSIOL-ENDOC M, V293, pE444, DOI 10.1152/ajpendo.00691.2006
   Nomura S, 2008, J NUTR BIOCHEM, V19, P840, DOI 10.1016/j.jnutbio.2007.11.005
   Petrovic N, 2008, AM J PHYSIOL-ENDOC M, V295, pE287, DOI 10.1152/ajpendo.00035.2008
   Petrovic N, 2010, J BIOL CHEM, V285, P7153, DOI 10.1074/jbc.M109.053942
   Sadie-Van Gijsen H, 2019, J CELL PHYSIOL, V234, P2399, DOI 10.1002/jcp.27266
   Saito M, 2020, FRONT ENDOCRINOL, V11, DOI 10.3389/fendo.2020.00222
   Saito Masayuki, 2015, Adv Food Nutr Res, V76, P1, DOI 10.1016/bs.afnr.2015.07.002
   Shixian Q, 2006, J MED FOOD, V9, P451, DOI 10.1089/jmf.2006.9.451
   Silvester AJ, 2019, J NUTR BIOCHEM, V64, P1, DOI 10.1016/j.jnutbio.2018.09.028
   Vegiopoulos A, 2010, SCIENCE, V328, P1158, DOI 10.1126/science.1186034
   Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949
   Yoneshiro T, 2017, AM J CLIN NUTR, V105, P873, DOI 10.3945/ajcn.116.144972
   Zhou JH, 2018, NUTRIENTS, V10, DOI 10.3390/nu10111681
NR 37
TC 3
Z9 3
U1 1
U2 4
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 2296-861X
J9 FRONT NUTR
JI Front. Nutr.
PD AUG 17
PY 2021
VL 8
AR 715859
DI 10.3389/fnut.2021.715859
PG 15
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA UM0VN
UT WOS:000693058400001
PM 34485365
OA gold, Green Published
DA 2025-04-28
ER

PT J
AU Pachura, N
   Wlodarczyk, M
   Bazanów, B
   Pogorzelska, A
   Gebarowski, T
   Kupczynski, R
   Szumny, A
AF Pachura, Natalia
   Wlodarczyk, Maciej
   Bazanow, Barbara
   Pogorzelska, Aleksandra
   Gebarowski, Tomasz
   Kupczynski, Robert
   Szumny, Antoni
TI Antiviral and Cytotoxic Activities of Ilex aquifolium Silver
   Queen in the Context of Chemical Profiling of Two Ilex Species
SO MOLECULES
LA English
DT Article
DE Ilex; terpenoids; saponins; phenolic acids; antiviral activity;
   anticancer activity; cytotoxic activity
ID COMPRESSA TEA EXTRACTS; CAMELLIA-SINENSIS; YERBA MATE; PARAGUARIENSIS;
   ANTIOXIDANT; TRITERPENOIDS; SAPONINS; LEAVES; VIRUS
AB The leaves of Ilex paraguariensis (known as Yerba mate), used as a popular beverage, are a very well-recognized plant material with various biological activities, including analeptic (because of caffeine), anti-obesity (phenolics, saponins), antimicrobial, and antiviral (phenolics, saponins). Here, the chemical compositions of the leaves of two European Ilex species (x meserveae and aquifolium) with three varieties each were investigated. The terpenoid, saponin, and polyphenolic fractions were submitted for LC-MS or GC-MS analysis against a standard Mate leaf. In addition, the aroma profiles of all the species were analysed using HS-SPME-Arrow prior to GC-MS analysis. All fractions were subjected to antiviral and cytotoxic assays. We found 86 compounds in all accessions, with limonene, linalool, and p-cymene being predominant. There were minor similarities between the volatile compositions of the European and South American species. We found ursolic and oleanolic acid to be the main compounds in the terpenoid fraction. Mono-caffeoylquinic acids and di-caffeoylquinic acids were the main constituents of the polar fractions. About 180 compounds from the saponin group were tentatively identified, of which 9 and 3 were selected as distinctive markers for I. meserveae and I. aquifolium, respectively. Based on chemical screening, I. aquifolium Silver Queen was chosen as the source of terpenoid and saponin fractions and polyphenol extracts. The most substantial inhibition of cancer cell growth was observed with saponin in the case of the MCF7 (human breast cancer) cell line, while for LoVo and L929 cell lines (human colorectal cancer and reference mouse fibroblasts), it was slightly weaker. These results should be analysed further as a promising chemoprevention of colorectal and gastrointestinal cancers. Saponin and polyphenolic extracts exhibited similar activities against HSV-1 and HAdV-5, with 4-log reduction in virus titres. This study focuses our attention on a field of potential antiviral formulations derived from European holly.
C1 [Pachura, Natalia; Szumny, Antoni] Wroclaw Univ Environm & Life Sci, Fac Biotechnol & Food Sci, Dept Biocatalysis & Food Chem, Norwida 25, PL-50375 Wroclaw, Poland.
   [Wlodarczyk, Maciej] Wroclaw Med Univ, Fac Pharm, Dept Pharmacognosy & Herbal Med, Borowska 211a, PL-50556 Wroclaw, Poland.
   [Bazanow, Barbara; Pogorzelska, Aleksandra] Wroclaw Univ Environm & Life Sci, Fac Vet Med, Dept Pathol, Div Microbiol, 31 C K Norwida St, PL-50573 Wroclaw, Poland.
   [Gebarowski, Tomasz] Wroclaw Univ Environm & Life Sci, Fac Vet Med, Dept Biostruct & Anim Physiol, PL-50375 Wroclaw, Poland.
   [Kupczynski, Robert] Wroclaw Univ Environm & Life Sci, Fac Biol & Anim Sci, Dept Environm Anim Hyg & Welf, Chelmonskiego 38C, PL-51630 Wroclaw, Poland.
C3 Wroclaw University of Environmental & Life Sciences; Wroclaw Medical
   University; Wroclaw University of Environmental & Life Sciences; Wroclaw
   University of Environmental & Life Sciences; Wroclaw University of
   Environmental & Life Sciences
RP Pachura, N (corresponding author), Wroclaw Univ Environm & Life Sci, Fac Biotechnol & Food Sci, Dept Biocatalysis & Food Chem, Norwida 25, PL-50375 Wroclaw, Poland.
EM natalia.pachura@upwr.edu.pl; tomasz.gebarowski@upwr.edu.pl
RI Pogorzelska, Aleksandra/HGE-9334-2022; Pachura, Natalia/ABC-4060-2020;
   Gębarowski, Tomasz/ABE-8149-2021; Wlodarczyk, Maciej/H-9137-2015;
   Kupczynski, Robert/C-5542-2016
OI Bazanow, Barbara/0000-0002-6694-2872; Chwirot,
   Aleksandra/0000-0001-5245-1733; Gebarowski, Tomasz/0000-0002-8742-0790;
   Pachura, Natalia/0000-0003-2583-5197; Kupczynski,
   Robert/0000-0003-0796-6273
FU Wroclaw University of Environmental and Life Sciences
FX This article is part of a PhD dissertation titled "Forgotten essential
   oil plants-analysis ofcomposition and biological properties" prepared
   during doctoral studies at the Wroclaw University of Environmental and
   Life Sciences. The APC/BPC is financed by Wroclaw University of
   Environmental and Life Sciences.
CR Adnan A, 2019, BMC COMPLEM ALTERN M, V19, DOI 10.1186/s12906-019-2586-5
   [Anonymous], 2011, Din EN 14476
   Arbiser JL, 2005, J INVEST DERMATOL, V125, P207, DOI 10.1111/j.0022-202X.2005.23809.x
   Berté KAS, 2011, J AGR FOOD CHEM, V59, P5523, DOI 10.1021/jf2008343
   Bojic M, 2013, J ANAL METHODS CHEM, V2013, DOI 10.1155/2013/658596
   CadenaCarrera S, 2019, J SUPERCRIT FLUID, V152, DOI 10.1016/j.supflu.2019.104543
   Contreras-Esquivel JC, 2023, BIOTECNIA, V25, P61, DOI 10.18633/biotecnia.v25i1.1762
   de Vasconcellos AC, 2022, PLANT FOOD HUM NUTR, V77, P495, DOI 10.1007/s11130-022-01008-8
   Filip R, 2001, FITOTERAPIA, V72, P774, DOI 10.1016/S0367-326X(01)00331-8
   Gerber T, 2023, PHYTOTHER RES, V37, P527, DOI 10.1002/ptr.7632
   Hsieh CF, 2022, J VIROL, V96, DOI 10.1128/jvi.00542-21
   Jaiswal R, 2014, PHYTOCHEMISTRY, V106, P141, DOI 10.1016/j.phytochem.2014.07.018
   Jaros SW, 2024, ACS APPL MATER INTER, V16, P13411, DOI 10.1021/acsami.3c15606
   Jaros SW, 2021, INORG CHEM, V60, P15435, DOI 10.1021/acs.inorgchem.1c02110
   José MFB, 2023, NUTR REV, V81, P1163, DOI 10.1093/nutrit/nuac109
   Kaltbach P, 2022, FOOD CHEM, V374, DOI 10.1016/j.foodchem.2021.131756
   Kelebek H, 2024, FOODS, V13, DOI 10.3390/foods13050694
   Kuropka P, 2021, FOODS, V10, DOI 10.3390/foods10040818
   Lencina CL, 2011, QUIM NOVA, V34, P222, DOI 10.1590/S0100-40422011000200010
   Lückemeyer DD, 2012, PHYTOTHER RES, V26, P535, DOI 10.1002/ptr.3590
   Márquez V, 2013, FOOD RES INT, V53, P808, DOI 10.1016/j.foodres.2013.02.016
   Mateos R, 2017, J FOOD COMPOS ANAL, V63, P164, DOI 10.1016/j.jfca.2017.08.003
   Negrin A, 2019, J AGR FOOD CHEM, V67, P5687, DOI 10.1021/acs.jafc.8b07168
   Nothias-Scaglia LF, 2015, J NAT PROD, V78, P1277, DOI 10.1021/acs.jnatprod.5b00073
   Orosco F., 2024, J. Adv. Biotechnol. Exp. Ther., V7, P221
   Pachura N, 2022, MOLECULES, V27, DOI 10.3390/molecules27113376
   Pachura N, 2022, FOODS, V11, DOI 10.3390/foods11010047
   Paluch E, 2021, MOLECULES, V26, DOI 10.3390/molecules26247442
   Pérez JM, 2014, TROP J PHARM RES, V13, P1279, DOI 10.4314/tjpr.v13i8.12
   Puangpraphant S, 2012, ACS SYM SER, V1109, P307
   Ramirez-Mares MV, 2004, MUTAT RES-FUND MOL M, V554, P53, DOI 10.1016/j.mrfmmm.2004.03.002
   Rzasa-Duran E, 2022, ANTIOXIDANTS-BASEL, V11, DOI 10.3390/antiox11020371
   Saleh AJ, 2021, FUNCT FOODS HEALTH D, V11, P499, DOI 10.31989/ffhd.v11i10.828
   Simoes CMO, 1999, PHYTOTHER RES, V13, P323, DOI 10.1002/(SICI)1099-1573(199906)13:4<323::AID-PTR448>3.0.CO;2-C
   Song NE, 2019, APPL BIOL CHEM, V62, DOI 10.1186/s13765-019-0424-6
   Taketa ATC, 2004, J NAT PROD, V67, P1697, DOI 10.1021/np040059+
   Taketa ATC, 2000, PHYTOCHEMISTRY, V53, P901, DOI 10.1016/S0031-9422(99)00517-8
   Tavakoli R., 2017, Tradit. Integr. Med, V2, P102
   Ramirez-Mares MV, 2016, TOXICOL REP, V3, P269, DOI 10.1016/j.toxrep.2016.01.013
   Wang F, 2023, J ETHNOPHARMACOL, V309, DOI 10.1016/j.jep.2023.116322
   Wlodarczyk M, 2022, PLANTA MED, V88, P576, DOI 10.1055/a-1586-1915
   Xu CC, 2018, J SEP SCI, V41, P6, DOI 10.1002/jssc.201700201
   Xu L, 2022, FRONT MICROBIOL, V13, DOI 10.3389/fmicb.2022.1025605
   Zapata FJ, 2020, J FUNCT FOODS, V64, DOI 10.1016/j.jff.2019.103646
   Zhang W, 2019, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.03325
   Zhu F, 2009, J AGR FOOD CHEM, V57, P6082, DOI 10.1021/jf901020h
   Ziegler M, 2019, CHROMATOGRAPHIA, V82, P635, DOI 10.1007/s10337-018-3659-1
NR 47
TC 1
Z9 1
U1 2
U2 5
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1420-3049
J9 MOLECULES
JI Molecules
PD JUL
PY 2024
VL 29
IS 13
AR 3231
DI 10.3390/molecules29133231
PG 20
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Chemistry
GA YJ6U7
UT WOS:001268169600001
PM 38999188
OA gold, Green Published
DA 2025-04-28
ER

PT J
AU Cai, JS
   Liu, SZ
   Li, Y
   Liu, QM
   Xu, M
   Mo, CB
   Mai, TY
   Xu, X
   Tang, X
   Chen, QH
   Nong, CT
   Lu, HX
   He, HY
   Tang, JX
   Zhang, JL
   Wei, CM
   Tan, DC
   Qin, J
   Zhang, ZY
AF Cai, Jiansheng
   Liu, Shuzhen
   Li, You
   Liu, Qiumei
   Xu, Min
   Mo, Chunbao
   Mai, Tingyu
   Xu, Xia
   Tang, Xu
   Chen, Quanhui
   Nong, Chuntao
   Lu, Huaxiang
   He, Haoyu
   Tang, Jiexia
   Zhang, Junling
   Wei, Chunmei
   Tan, Dechan
   Qin, Jian
   Zhang, Zhiyong
TI Effects of Oil Tea on Obesity and Dyslipidemia: A Cross-Sectional Study
   in China
SO DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY
LA English
DT Article
DE abdominal obesity; blood lipid; HDL-C
ID GREEN TEA; METABOLIC SYNDROME; LIPID PROFILE; CONSUMPTION; FAT;
   CAFFEINE; ASSOCIATION; ADULTS; RATS; INTERVENTION
AB Background: Animal experiments have found that oil tea reduces body weight and improves blood lipid levels. However, the effect of oil tea on human health has not been confirmed yet. This study aims to explore the relationship between oil tea consumption and obesity and dyslipidemia.
   Methods: In a cross-sectional population study in Guangxi, China, a semi-quantitative questionnaire was used to investigate the oil tea consumed and food consumption frequency in adults aged 30 years and over. Anthropometric variables and serum biochemical indicators were measured. A total of 2001 adults were divided into five groups based on their non-consumption status and quartile of consumption (groups non-drink oil tea, Q1-Q4).
   Results: The risk of abdominal obesity tended to decrease significantly with increasing consumption of oil tea (P for trend<0.05) in the overall participants (Q3 group, OR = 0.545, 95% CI = 0.336-0.884; Q4 group, OR = 0.520, 95% CI = 0.311-0.871) and in women (Q2 group, OR = 0.502, 95% CI = 0.274-0.920; Q3 group, OR = 0.397, 95% CI = 0.213-0.740; Q4 group, OR = 0.421, 95% CI = 0.228-0.780). Oil tea consumption Q1, Q2, Q3 and Q4 group significantly reduced the risk of abnormal HDL-cholesterol (P < 0.05). Oil tea consumption Q2 group significantly increased the risk of abnormal LDL-cholesterol (OR = 2.600, 95% CI = 1.033-6.546) in women. Oil tea consumption Q1 (OR = 0.081, 95% CI=0.008-0.864) and Q3 (OR = 0.057, 95% CI = 0.004-0.913) groups significantly reduced the risk of abnormal HDL-cholesterol in women.
   Conclusion: Oil tea consumption may be associated with a low risk of abdominal obesity. High-dose oil tea consumption may be associated with a low risk of abnormal HDL-cholesterol. Prospective studies with large sample sizes would be required to further investigate this association.
C1 [Cai, Jiansheng; Liu, Shuzhen; Liu, Qiumei; Xu, Min; Xu, Xia; Tang, Xu; Chen, Quanhui; Nong, Chuntao; Lu, Huaxiang; He, Haoyu; Zhang, Junling; Wei, Chunmei; Qin, Jian; Zhang, Zhiyong] Guangxi Med Univ, Sch Publ Hlth, Dept Environm & Occupat Hlth, Shuangyong Rd 22, Nanning 530021, Guangxi, Peoples R China.
   [Cai, Jiansheng] Guilin Med Univ, Guangxi Key Lab Tumor Immunol & Microenvironm Reg, Guilin, Peoples R China.
   [Li, You; Mo, Chunbao; Mai, Tingyu; Lu, Huaxiang; Tan, Dechan; Zhang, Zhiyong] Guilin Med Univ, Sch Publ Hlth, Dept Environm Hlth & Occupat Med, Guilin, Peoples R China.
   [He, Haoyu] Guangxi Med Univ, Affiliated Hosp Stomatol, Qual Management Dept, Nanning, Peoples R China.
   [Tang, Jiexia] Guangxi Ctr Dis Prevent & Control, Nanning, Peoples R China.
C3 Guangxi Medical University; Guilin Medical University; Guilin Medical
   University; Guangxi Medical University
RP Qin, J; Zhang, ZY (corresponding author), Guangxi Med Univ, Sch Publ Hlth, Dept Environm & Occupat Hlth, Shuangyong Rd 22, Nanning 530021, Guangxi, Peoples R China.
EM qinjian@gxmu.edu.cn; rpazz@163.com
RI Liu, Shuzhen/IQW-6980-2023; Huaxiang, Lu/AGC-0970-2022; Zhang,
   Zhiyong/AFD-8294-2022
FU National Natural Science Foundation of China [81760577, 81560523,
   81960583]; Guangxi Science and Technology Development Project
   [AD17129003, AD18050005]; Natural Science Foundation for Innovation
   Research Team of Guangxi [2019GXNSFGA245002]; Guangxi Scholarship Fund
   of Guangxi Education Department of China
FX The study was supported by the National Natural Science Foundation of
   China (grant No.81760577, 81560523 and 81960583) , the Guangxi Science
   and Technology Development Project (grant No. AD17129003 and AD18050005)
   , the Natural Science Foundation for Innovation Research Team of Guangxi
   (grant No. 2019GXNSFGA245002) and the Guangxi Scholarship Fund of
   Guangxi Education Department of China.
CR Bae UJ, 2018, AM J CHINESE MED, V46, P617, DOI [10.1142/s0192415x18500325, 10.1142/S0192415X18500325]
   Baladia E, 2014, NUTR HOSP, V29, P479, DOI [10.3305/nh.2014.29.3.7118, 10.3305/NH.2014.29.3.7118]
   Barba C, 2004, LANCET, V363, P157, DOI 10.1016/s0140-6736(03)15268-3
   Bouchard DR, 2010, OBESITY FACTS, V3, P345, DOI 10.1159/000322915
   Chen LH, 2017, FOOD NUTR RES, V61, DOI 10.1080/16546628.2017.1347480
   Chen YJ, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7633-0
   Chooi YC, 2019, METABOLISM, V92, P6, DOI 10.1016/j.metabol.2018.09.005
   Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486
   Diepvens K, 2007, AM J PHYSIOL-REG I, V292, pR77, DOI 10.1152/ajpregu.00832.2005
   Du P, 2017, J EPIDEMIOL, V27, P282, DOI 10.1016/j.je.2017.03.001
   Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040
   Erba D, 2005, J NUTR BIOCHEM, V16, P144, DOI 10.1016/j.jnutbio.2004.11.006
   Finkelstein EA, 2009, HEALTH AFFAIR, V28, pW822, DOI 10.1377/hlthaff.28.5.w822
   Glade MJ, 2010, NUTRITION, V26, P932, DOI 10.1016/j.nut.2010.08.004
   Huang J, 2014, EUR J CLIN NUTR, V68, P1075, DOI 10.1038/ejcn.2014.143
   Huang JB, 2018, MOL NUTR FOOD RES, V62, DOI 10.1002/mnfr.201700696
   Huang LH, 2018, BMC COMPLEM ALTERN M, V18, DOI 10.1186/s12906-018-2355-x
   Huang YX, 2014, POPUL HEALTH METR, V12, DOI 10.1186/s12963-014-0028-7
   Hursel R, 2011, OBES REV, V12, pE573, DOI 10.1111/j.1467-789X.2011.00862.x
   Jurgens TM, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008650.pub2
   Lin R, 2018, NUTR RES, V57, P67, DOI 10.1016/j.nutres.2018.05.004
   Liu XD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134627
   Maharlouei N, 2019, CRIT REV FOOD SCI, V59, P1753, DOI 10.1080/10408398.2018.1427044
   Micek A, 2018, INT J FOOD SCI NUTR, V69, P358, DOI 10.1080/09637486.2017.1362690
   Nabuco HCG, 2018, EXP GERONTOL, V103, P132, DOI 10.1016/j.exger.2018.01.013
   Nagao T, 2007, OBESITY, V15, P1473, DOI 10.1038/oby.2007.176
   Ng M, 2014, LANCET, V384, P746
   Pastoriza S, 2017, FOOD FUNCT, V8, P2650, DOI [10.1039/c7fo00611j, 10.1039/C7FO00611J]
   RACOTTA IS, 1994, PHARMACOL BIOCHEM BE, V48, P887, DOI 10.1016/0091-3057(94)90196-1
   Rocha A, 2016, EUR J NUTR, V55, P2231, DOI 10.1007/s00394-015-1033-8
   Saravanan G, 2014, J SCI FOOD AGR, V94, P2972, DOI 10.1002/jsfa.6642
   Sun Y, 2019, FOOD FUNCT, V10, P3502, DOI [10.1039/C9FO00162J, 10.1039/c9fo00162j]
   Toeller M, 1999, EXP CLIN ENDOCR DIAB, V107, P512, DOI 10.1055/s-0029-1232560
   Uchiyama S, 2011, NUTRITION, V27, P287, DOI 10.1016/j.nut.2010.01.019
   Vernarelli JA, 2013, EUR J NUTR, V52, P1039, DOI 10.1007/s00394-012-0410-9
   Wang CJ, 2018, PSYCHIAT RES, V260, P123, DOI 10.1016/j.psychres.2017.11.052
   Wang J, 2019, J NUTR BIOCHEM, V70, P105, DOI 10.1016/j.jnutbio.2019.05.001
   Wu T, 2018, FOOD NUTR RES, V62, DOI 10.29219/fnr.v62.1599
   Xu RJ, 2012, FOOD CHEM TOXICOL, V50, P2473, DOI 10.1016/j.fct.2011.10.047
   Yang YX, 2009, INGREDIENT LIST CHIN, V6th
   Yi DQ, 2014, BRIT J NUTR, V111, P1421, DOI 10.1017/S0007114513003644
   Zhu ZJ, 2017, FOOD FUNCT, V8, P1680, DOI 10.1039/c7fo00089h
NR 42
TC 5
Z9 5
U1 3
U2 14
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
SN 1178-7007
J9 DIABET METAB SYND OB
JI Diabetes Metab. Syndr. Obes.
PY 2021
VL 14
BP 3173
EP 3185
DI 10.2147/DMSO.S312280
PG 13
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA TH9TE
UT WOS:000672424900001
PM 34285525
OA gold, Green Published
DA 2025-04-28
ER

PT J
AU Martin, BJ
   Tan, RB
   Gillen, JB
   Percival, ME
   Gibala, MJ
AF Martin, Brian J.
   Tan, Rachel B.
   Gillen, Jenna B.
   Percival, Michael E.
   Gibala, Martin J.
TI No Effect of Short-Term Green Tea Extract Supplementation on Metabolism
   at Rest or During Exercise in the Fed State
SO INTERNATIONAL JOURNAL OF SPORT NUTRITION AND EXERCISE METABOLISM
LA English
DT Article
DE GTE; tea catechins; fat oxidation; substrate utilization
ID FAT OXIDATION; CATECHIN-POLYPHENOLS; SUBSTRATE OXIDATION; ENDURANCE
   CAPACITY; ENERGY-EXPENDITURE; CAFFEINE; EPIGALLOCATECHIN-3-GALLATE;
   INGESTION; OBESITY; CONSUMPTION
AB Supplementation with green tea extract (GTE) in animals has been reported to induce numerous metabolic adaptations including increased fat oxidation during exercise and improved performance. However, data regarding the metabolic and physiological effects of GTE during exercise in humans are limited and equivocal. Purpose: To examine the effects of short-term GTE treatment on resting energy expenditure (REE), whole-body substrate utilization during exercise and time trial performance. Methods: Fifteen active men (24 +/- 3 y; VO(2)peak = 48 +/- 7 ml.kg.min(-1); BMI = 26 +/- 3 kg.m(2(-1))) ingested GTE (3x per day = 1,000 mg/d) or placebo (PLA) for 2 day in a double-blind, crossover design (each separated by a 1 week wash-out period). REE was assessed in the fasted state. Subjects then ingested a standardized breakfast (similar to 5.0 kcal.kg(-1)) and 90 min later performed a 60 min cycling bout at an intensity corresponding to individual maximal fat oxidation (44 +/- 11% VO(2)peak), followed by a 250 kJ TT. Results: REE, whole-body oxygen consumption (VO2) and substrate oxidation rates during steady-state exercise were not different between treatments. However, mean heart rate (HR) was lower in GTE vs. PLA (115 +/- 16 vs. 118 +/- 17 beats.min(-1); main effect, p = .049). Mixed venous blood [glycerol] was higher during rest and exercise after GTE vs. PLA (p = .006, main effect for treatment) but glucose, insulin and free-fatty acids were not different. Subsequent time trial performance was not different between treatments (GTE = 25:38 +/- 5:32 vs. PLA = 26:08 +/- 8:13 min; p = .75). Conclusion: GTE had minimal effects on whole-body substrate metabolism but significantly increased plasma glycerol and lowered heart rate during steady-state exercise, suggesting a potential increase in lipolysis and a cardiovascular effect that warrants further investigation.
C1 [Martin, Brian J.; Tan, Rachel B.; Gillen, Jenna B.; Percival, Michael E.; Gibala, Martin J.] McMaster Univ, Dept Kinesiol, Hamilton, ON, Canada.
C3 McMaster University
RP Gibala, MJ (corresponding author), McMaster Univ, Dept Kinesiol, Hamilton, ON, Canada.
EM gibalam@mcmaster.ca
OI Tan, Rachel/0000-0001-8669-168X
FU TAIYO International, Inc. Natural Sciences and Engineering Council
   (NSERC) of Canada
FX The GTE powder was an in-kind contribution provided by TAIYO
   International, Inc. Natural Sciences and Engineering Council (NSERC) of
   Canada provided funding for this project.
CR Achten J, 2002, MED SCI SPORT EXER, V34, P92, DOI 10.1097/00005768-200201000-00015
   Bell C, 2001, J CLIN ENDOCR METAB, V86, P4440, DOI 10.1210/jc.86.9.4440
   Bérubé-Parent S, 2005, BRIT J NUTR, V94, P432, DOI 10.1079/BJN20051502
   Boschmann M, 2007, J AM COLL NUTR, V26, p389S, DOI 10.1080/07315724.2007.10719627
   Burgomaster KA, 2006, J APPL PHYSIOL, V100, P2041, DOI 10.1152/japplphysiol.01220.2005
   Cabrera C, 2006, J AM COLL NUTR, V25, P79, DOI 10.1080/07315724.2006.10719518
   Call JA, 2008, J APPL PHYSIOL, V105, P923, DOI 10.1152/japplphysiol.00028.2008
   Chow HHS, 2005, CLIN CANCER RES, V11, P4627, DOI 10.1158/1078-0432.CCR-04-2549
   COYLE EF, 1985, J APPL PHYSIOL, V59, P429, DOI 10.1152/jappl.1985.59.2.429
   Dean S, 2009, INT J SPORT NUTR EXE, V19, P624, DOI 10.1123/ijsnem.19.6.624
   Dulloo AG, 2000, INT J OBESITY, V24, P252, DOI 10.1038/sj.ijo.0801101
   Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040
   Eichenberger P, 2009, INT J VITAM NUTR RES, V79, P24, DOI 10.1024/0300-9831.79.1.24
   FRAYN KN, 1983, J APPL PHYSIOL, V55, P628, DOI 10.1152/jappl.1983.55.2.628
   HETZLER RK, 1994, J APPL PHYSIOL, V76, P1043, DOI 10.1152/jappl.1994.76.3.1043
   Hodgson AB, 2013, J NUTR BIOCHEM, V24, P325, DOI 10.1016/j.jnutbio.2012.06.017
   Ihm SH, 2012, ATHEROSCLEROSIS, V224, P377, DOI 10.1016/j.atherosclerosis.2012.07.006
   Jeukendrup AE, 2005, INT J SPORTS MED, V26, pS28, DOI 10.1055/s-2004-830512
   Kao YH, 2006, MOL NUTR FOOD RES, V50, P188, DOI 10.1002/mnfr.200500109
   Khan N, 2007, LIFE SCI, V81, P519, DOI 10.1016/j.lfs.2007.06.011
   Lee MJ, 2002, CANCER EPIDEM BIOMAR, V11, P1025
   Lonac MC, 2011, OBESITY, V19, P298, DOI 10.1038/oby.2010.181
   Lu H, 2003, DRUG METAB DISPOS, V31, P572, DOI 10.1124/dmd.31.5.572
   Meyer T, 2007, APPL PHYSIOL NUTR ME, V32, P249, DOI 10.1139/H06-108
   Murase T, 2006, AM J PHYSIOL-REG I, V290, pR1550, DOI 10.1152/ajpregu.00752.2005
   Murase T, 2006, INT J OBESITY, V30, P561, DOI 10.1038/sj.ijo.0803135
   Murase T, 2005, AM J PHYSIOL-REG I, V288, pR708, DOI 10.1152/ajpregu.00693.2004
   Nogueira L, 2011, J PHYSIOL-LONDON, V589, P4615, DOI 10.1113/jphysiol.2011.209924
   Ramirez-Sanchez I, 2010, HYPERTENSION, V55, P1398, DOI 10.1161/HYPERTENSIONAHA.109.147892
   Randell RK, 2013, MED SCI SPORT EXER, V45, P883, DOI 10.1249/MSS.0b013e31827dd9d4
   Richards JC, 2010, MED SCI SPORT EXER, V42, P739, DOI 10.1249/MSS.0b013e3181bcab6c
   Sale D.G., 1991, PHYSIOLOGICAL TESTIN, P21
   Schneider C, 2009, AM FAM PHYSICIAN, V79, P591
   Shimotoyodome A, 2005, MED SCI SPORT EXER, V37, P1884, DOI 10.1249/01.mss.0000178062.66981.a8
   Stob NR, 2007, EXP PHYSIOL, V92, P823, DOI 10.1113/expphysiol.2007.038174
   Van Soeren MH, 1998, J APPL PHYSIOL, V85, P1493, DOI 10.1152/jappl.1998.85.4.1493
   Venables MC, 2008, AM J CLIN NUTR, V87, P778, DOI 10.1093/ajcn/87.3.778
NR 37
TC 13
Z9 15
U1 0
U2 43
PU HUMAN KINETICS PUBL INC
PI CHAMPAIGN
PA 1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA
SN 1526-484X
EI 1543-2742
J9 INT J SPORT NUTR EXE
JI Int. J. Sport Nutr. Exerc. Metab.
PD DEC
PY 2014
VL 24
IS 6
BP 656
EP 664
DI 10.1123/ijsnem.2013-0202
PG 9
WC Nutrition & Dietetics; Sport Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics; Sport Sciences
GA AZ4FZ
UT WOS:000348178500007
PM 24903465
DA 2025-04-28
ER

PT J
AU Romanos-Nanclares, A
   Tabung, FK
   Willett, WC
   Rosner, B
   Holmes, MD
   Chen, WY
   Tamimi, RM
   Eliassen, AH
AF Romanos-Nanclares, Andrea
   Tabung, Fred K.
   Willett, Walter C.
   Rosner, Bernard
   Holmes, Michelle D.
   Chen, Wendy Y.
   Tamimi, Rulla M.
   Eliassen, A. Heather
TI Insulinemic potential of diet and risk of total and subtypes of breast
   cancer among US females
SO AMERICAN JOURNAL OF CLINICAL NUTRITION
LA English
DT Article
DE breast cancer; epidemiology; diet; dietary patterns; hyperinsulinemia;
   cohort study
ID PLASMA C-PEPTIDE; DECAFFEINATED COFFEE; DIABETES RISK; PATTERNS;
   OBESITY; GROWTH; WOMEN; HOMOCYSTEINE; ASSOCIATION; VALIDATION
AB Background Insulin resistance and hyperinsulinemia play important roles in the progression of multiple chronic disease and conditions. Diet modulates insulin response; however, evidence is limited regarding whether diets with higher insulinemic potential increase the risk of invasive breast cancer. Objectives We aimed to prospectively evaluate the association between a food-based empirical dietary index for hyperinsulinemia (EDIH) and the incidence of invasive breast cancer. Methods We prospectively followed 76,686 women from the Nurses' Health Study (NHS; 1984-2016) and 93,287 women from the Nurses' Health Study II (NHSII; 1991-2017). Diet was assessed by food-frequency questionnaires every 4 y. The insulinemic potential of diet was evaluated using the previously established EDIH based on circulating C-peptide concentrations. Higher scores indicate higher insulinemic potential of the diet. Covariates included reproductive, hormonal, and anthropometric factors (height and BMI at age 18 y); race; socioeconomic status; total alcohol intake; total caloric intake; and physical activity. Results During 4,216,106 person-years of follow-up, we documented 10,602 breast cancer cases (6689 NHS, 3913 NHSII). In the pooled multivariable-adjusted analyses, women in the highest, compared with the lowest, EDIH quintile (Q) were at higher breast cancer risk (HRQ5 vs. Q1 = 1.15; 95% CI: 1.07, 1.24; P-trend < 0.01). Although heterogeneity by estrogen receptor (ER) status was nonsignificant, the strongest association between EDIH and breast cancer was observed for ER-negative tumors (HRQ5 vs. Q1 = 1.21; 95% CI: 1.00, 1.46; P-trend = 0.02). Among tumor molecular subtypes, the strongest associations were observed for human epidermal growth factor receptor 2 (HER2)-enriched tumors (HRQ5 vs. Q1 = 1.62; 95% CI: 1.01, 2.61; P-trend = 0.02). Conclusions A dietary pattern contributing to hyperinsulinemia and insulin resistance was associated with greater breast cancer risk, especially ER-negative and HER2-enriched tumors. Our findings suggest that dietary modifications to reduce insulinemic potential may reduce the risk of breast cancer.
C1 [Romanos-Nanclares, Andrea; Willett, Walter C.; Rosner, Bernard; Holmes, Michelle D.; Chen, Wendy Y.; Eliassen, A. Heather] Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA.
   [Romanos-Nanclares, Andrea; Willett, Walter C.; Rosner, Bernard; Holmes, Michelle D.; Chen, Wendy Y.; Eliassen, A. Heather] Harvard Med Sch, Boston, MA 02115 USA.
   [Tabung, Fred K.; Willett, Walter C.; Eliassen, A. Heather] Harvard TH Chan Sch Publ Hlth, Dept Nutr, Boston, MA USA.
   [Tabung, Fred K.] Ohio State Univ, Coll Med, Dept Internal Med, Div Med Oncol, Columbus, OH 43210 USA.
   [Tabung, Fred K.] Ohio State Univ, Comprehens Canc Ctr, Arthur G James Canc Hosp, Columbus, OH 43210 USA.
   [Tabung, Fred K.] Richard J Solove Res Inst, Columbus, OH USA.
   [Willett, Walter C.; Holmes, Michelle D.; Eliassen, A. Heather] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA.
   [Rosner, Bernard] Harvard TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA USA.
   [Chen, Wendy Y.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA.
   [Tamimi, Rulla M.] Weill Cornell Med, Dept Populat Hlth Sci, New York, NY USA.
C3 Harvard University; Harvard University Medical Affiliates; Brigham &
   Women's Hospital; Harvard University; Harvard Medical School; Harvard
   University; Harvard T.H. Chan School of Public Health; University System
   of Ohio; Ohio State University; University System of Ohio; Ohio State
   University; James Cancer Hospital & Solove Research Institute; James
   Cancer Hospital & Solove Research Institute; Harvard University; Harvard
   T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan
   School of Public Health; Harvard University; Harvard University Medical
   Affiliates; Dana-Farber Cancer Institute; Cornell University; Weill
   Cornell Medicine
RP Romanos-Nanclares, A (corresponding author), Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA.; Romanos-Nanclares, A (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.
EM nharo@channing.harvard.edu
RI Chen, WY/HKN-5931-2023; Willett, Walter/E-2352-2013; Holmes,
   Michelle/GLS-8692-2022; Tabung, Fred/AAQ-7823-2021
OI Tabung, Fred/0000-0001-8193-7150; Romanos-Nanclares,
   Andrea/0000-0002-9694-7607
FU National Institutes of Health [UM1 CA186107, U01 CA176726, P01 CA87969,
   R01 CA50385]; Breast Cancer Research Foundation; Ramon Areces
   Foundation; Susan G Komen Foundation; National Cancer Institute
   [U01CA176726] Funding Source: NIH RePORTER
FX Supported by grants UM1 CA186107, U01 CA176726, P01 CA87969, and R01
   CA50385 from the National Institutes of Health, the Breast Cancer
   Research Foundation, Ramon Areces Foundation and Susan G Komen
   Foundation. The funding sources did not participate in the design or
   conduct of the study; collection, management, analysis, or
   interpretation of the data; preparation, review, or approval of the
   manuscript; or decision to submit the manuscript for publication.
CR Ahern TP, 2013, CANCER EPIDEM BIOMAR, V22, P1786, DOI 10.1158/1055-9965.EPI-13-0375
   Aroke D, 2020, CANCER PREV RES, V13, P841, DOI 10.1158/1940-6207.CAPR-20-0236
   Barnard ME, 2015, BBA-REV CANCER, V1856, P73, DOI 10.1016/j.bbcan.2015.06.002
   Bobe G, 2010, CANCER EPIDEM BIOMAR, V19, P1441, DOI 10.1158/1055-9965.EPI-09-1082
   Cohen DH, 2012, ENDOCR-RELAT CANCER, V19, pF27, DOI 10.1530/ERC-11-0374
   Eliassen AH, 2012, JNCI-J NATL CANCER I, V104, P1905, DOI 10.1093/jnci/djs461
   Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879
   Farvid MS, 2018, INT J CANCER, V143, P2787, DOI 10.1002/ijc.31848
   Farvid MS, 2019, INT J CANCER, V144, P1496, DOI 10.1002/ijc.31653
   Fiolet T, 2018, BMJ-BRIT MED J, V360, DOI 10.1136/bmj.k322
   Fung TT, 2008, ARCH INTERN MED, V168, P713, DOI 10.1001/archinte.168.7.713
   Fung Teresa T, 2005, Am J Clin Nutr, V82, P163
   Fung TT, 2012, CANCER CAUSE CONTROL, V23, P959, DOI 10.1007/s10552-012-9969-y
   Fung TT, 2006, J NUTR, V136, P466, DOI 10.1093/jn/136.2.466
   Fung TT, 2001, AM J CLIN NUTR, V73, P61
   Giovannucci E, 2018, CANCER CAUSE CONTROL, V29, P1, DOI 10.1007/s10552-017-0975-y
   Giovannucci E, 2010, DIABETES CARE, V33, P1674, DOI 10.2337/dc10-0666
   Hamburg NM, 2007, ARTERIOSCL THROM VAS, V27, P2650, DOI 10.1161/ATVBAHA.107.153288
   Harris HR, 2016, CARCINOGENESIS, V37, P376, DOI 10.1093/carcin/bgw023
   Hirko KA, 2016, BREAST CANCER RES TR, V155, P579, DOI 10.1007/s10549-016-3706-2
   His M, 2019, BMC MED, V17, DOI 10.1186/s12916-019-1408-4
   Hu FB, 2002, CURR OPIN LIPIDOL, V13, P3, DOI 10.1097/00041433-200202000-00002
   Hu Y, 2021, JNCI-J NATL CANCER I, V113, P381, DOI 10.1093/jnci/djaa141
   Jensen MK, 2006, AM J CLIN NUTR, V83, P275
   Jin Q, 2021, DIABETES CARE, V44, P707, DOI 10.2337/dc20-2216
   Jun HJ, 2010, CANCER CAUSE CONTROL, V21, P1817, DOI 10.1007/s10552-010-9609-3
   Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482
   Kang JH, 2020, AM J CLIN NUTR, V112, P1492, DOI 10.1093/ajcn/nqaa268
   Lee DH, 2020, DIABETES CARE, V43, P2675, DOI 10.2337/dc20-0815
   Lee DH, 2019, JNCI CANCER SPECT, V3, DOI 10.1093/jncics/pkz025
   Li MW, 2020, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.553332
   Lin DY, 1997, STAT MED, V16, P1515, DOI 10.1002/(SICI)1097-0258(19970715)16:13<1515::AID-SIM572>3.3.CO;2-T
   Loopstra-Masters RC, 2011, DIABETOLOGIA, V54, P320, DOI 10.1007/s00125-010-1957-8
   LUNN M, 1995, BIOMETRICS, V51, P524, DOI 10.2307/2532940
   Michels K, 2020, EUR J EPIDEMIOL, V35, P807, DOI 10.1007/s10654-020-00658-9
   Moore SC, 2020, BMC MED, V18, DOI 10.1186/s12916-019-1484-5
   Morita M, 2013, CELL METAB, V18, P698, DOI 10.1016/j.cmet.2013.10.001
   Murphy LO, 2006, TRENDS BIOCHEM SCI, V31, P268, DOI 10.1016/j.tibs.2006.03.009
   Murphy N, 2020, ANN ONCOL, V31, P641, DOI 10.1016/j.annonc.2020.01.066
   Park Y, 2009, AM J CLIN NUTR, V90, P664, DOI 10.3945/ajcn.2009.27758
   Petimar J, 2019, AM J CLIN NUTR, V109, P1393, DOI 10.1093/ajcn/nqy392
   Pollak M, 2008, NAT REV CANCER, V8, P915, DOI 10.1038/nrc2536
   Rochefort H, 2003, ENDOCR-RELAT CANCER, V10, P261, DOI 10.1677/erc.0.0100261
   Romanos-Nanclares A, 2021, CANCER EPIDEM BIOMAR, V30, P1921, DOI 10.1158/1055-9965.EPI-21-0352
   Romanos-Nanclares A, 2021, J NUTR, V151, P2768, DOI 10.1093/jn/nxab172
   Romieu I, 2012, AM J CLIN NUTR, V96, P345, DOI 10.3945/ajcn.111.026724
   Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a
   SALVINI S, 1989, INT J EPIDEMIOL, V18, P858, DOI 10.1093/ije/18.4.858
   Sánchez-Quesada C, 2020, EUR J NUTR, V59, P3461, DOI 10.1007/s00394-020-02180-w
   Senapati P, 2019, EPIGENET CHROMATIN, V12, DOI 10.1186/s13072-019-0290-9
   Shi N, 2021, FRONT NUTR, V8, DOI 10.3389/fnut.2021.690428
   Simone V, 2016, ONCOLOGIST, V21, P404, DOI 10.1634/theoncologist.2015-0351
   Simpson L, 2001, EXP CELL RES, V264, P29, DOI 10.1006/excr.2000.5130
   STRYKER WS, 1988, AM J EPIDEMIOL, V127, P283, DOI 10.1093/oxfordjournals.aje.a114804
   Tabung FK, 2020, BMC CANCER, V20, DOI 10.1186/s12885-020-07288-0
   Tabung FK, 2019, METABOLITES, V9, DOI 10.3390/metabo9060120
   Tabung FK, 2019, J NUTR, V149, P804, DOI 10.1093/jn/nxy319
   Tabung FK, 2018, AM J CLIN NUTR, V108, P363, DOI 10.1093/ajcn/nqy093
   Tabung Fred K, 2016, Br J Nutr, V116, P1787, DOI 10.1017/S0007114516003755
   Tabung FK, 2016, J NUTR, V146, P1560, DOI 10.3945/jn.115.228718
   Tamimi RM, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2128
   Wang WK, 2018, JNCI CANCER SPECT, V2, DOI 10.1093/jncics/pky080
   WILLETT WC, 1985, AM J EPIDEMIOL, V122, P51, DOI 10.1093/oxfordjournals.aje.a114086
   World Cancer Research Fund/American Institute for Cancer Research, 2018, Continuous Update Project Expert Report 2018. Diet, nutrition, physical activity and breast cancer
   Wu TY, 2005, DIABETES CARE, V28, P1390, DOI 10.2337/diacare.28.6.1390
   Xiao YJ, 2019, BREAST CANCER RES, V21, DOI 10.1186/s13058-019-1096-1
   Yang WS, 2021, CANCER EPIDEM BIOMAR, V30, P789, DOI 10.1158/1055-9965.EPI-20-1329
   Yee LD, 2020, FRONT ENDOCRINOL, V11, DOI 10.3389/fendo.2020.00058
NR 68
TC 8
Z9 10
U1 0
U2 8
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0002-9165
EI 1938-3207
J9 AM J CLIN NUTR
JI Am. J. Clin. Nutr.
PD DEC 19
PY 2022
VL 116
IS 6
BP 1530
EP 1539
DI 10.1093/ajcn/nqac284
EA SEP 2022
PG 10
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA 7Y7UV
UT WOS:000875770800001
PM 36178066
OA Bronze, Green Published
DA 2025-04-28
ER

PT J
AU Chiu, YH
   Lin, WY
   Wang, PE
   Chen, YD
   Wang, TT
   Warwick, J
   Chen, THH
AF Chiu, Yueh-Hsia
   Lin, Wen-Yuan
   Wang, Po-En
   Chen, Yao-Der
   Wang, Ting-Ting
   Warwick, Jane
   Chen, Tony Hsiu-Hsi
TI Population-based family case-control proband study on familial
   aggregation of metabolic syndrome: Finding from Taiwanese people
   involved in Keelung community-based integrated screening (KCIS no. 5)
SO DIABETES RESEARCH AND CLINICAL PRACTICE
LA English
DT Article
DE metabolic syndrome; family case-control proband study; familial
   aggregation; environmental factors
ID INSULIN-RESISTANCE SYNDROME; TYPE-2 DIABETES-MELLITUS; YOUNG ADULTHOOD;
   RISK; OBESITY; ASSOCIATION; CHILDHOOD; EDUCATION; WOMEN; MODEL
AB A population-based case-control proband study was undertaken to elucidate familial aggregation, independent environmental factors, and the interaction between them. A total of 7308 metabolic syndrome (MET-S) cases were identified from the Keelung community-based integrated screening programme between 1999 and 2002. The study has a case-control/family sampling design. A total of 1417 case probands were randomly selected from 3225 metabolic syndrome cases and the corresponding 2458 controls selected from 16,519 subjects without metabolic syndrome by matching on sex, age ( 3 years) and place of residence. The generalized estimation equation model was used to estimate odds ratios and corresponding 95% confidence intervals. The risk for having metabolic syndrome among family members for cases versus control probands was 1.56-fold (1.29-1.89) after controlling for significant environmental factors. Higher risk of metabolic syndrome was found in parents than spouse. Low education against high education had 2.06-fold (1.36-3.13) risk for metabolic syndrome. Betel quid chewing was positively associated with the risk of MET-S, with 1.99-fold (1.13-3.53) risk for 1-9 pieces and 1.76-fold (0.96-3.23) risk for > 10 pieces compared with non-chewer. Moderate and high intensity of non-occupational exercise led to 2 1.0% (OR= 0.79 (0.63-0.98)) and 26.0% (OR= 0.74 (0.59-0.94)) reduction in the risk for metabolic syndrome, respectively. The frequent consumption of vegetable reduced 24.0% (OR = 0.76 (0.62-0.92)) risk for MET-S. The frequent consumption of coffee was associated the increased risk for metabolic syndrome (OR = 1.32 (1.07-1.64)). The present study confirmed the risk of metabolic syndrome not only has the tendency towards familial aggregation but is affected by independent effect of environmental or individual correlates. (c) 2006 Elsevier Ireland Ltd. All rights reserved.
C1 Natl Taiwan Univ, Div Biostat, Grad Inst Epidemiol, Inst Prevent Med,Coll Publ Hlth, Taipei 100, Taiwan.
   Hlth Bur Keelung City, Chilung, Taiwan.
   Hlth Bur Tainan Cty, Tainan, Taiwan.
   Canc Res UK Ctr Epidemiol Math & Stat, Wolfson Inst Prevent Med, London, England.
C3 National Taiwan University; Cancer Research UK; University of London;
   Queen Mary University London
RP Chen, THH (corresponding author), Natl Taiwan Univ, Div Biostat, Grad Inst Epidemiol, Inst Prevent Med,Coll Publ Hlth, Room 521,17 Hsuchow Rd, Taipei 100, Taiwan.
EM stony@episerv.cph.ntu.edu.tw
RI wang, tingting/AAK-2640-2020; Chen, Tony Hsiu-Hsi/JPY-2493-2023; Chen,
   Yu-Cheng/S-9905-2018; Warwick, Jane/C-1739-2013
OI Warwick, Jane/0000-0002-7320-6603; Chen, Tony
   Hsiu-Hsi/0000-0002-5799-6705
CR BAO WH, 1994, ARCH INTERN MED, V154, P1842
   Brancati FL, 1996, ANN EPIDEMIOL, V6, P67, DOI 10.1016/1047-2797(95)00095-X
   Brunner EJ, 1997, DIABETOLOGIA, V40, P1341, DOI 10.1007/s001250050830
   CARMELLI D, 1994, AM J HUM GENET, V55, P566
   Chen THH, 2006, AM J CLIN NUTR, V83, P688, DOI 10.1093/ajcn.83.3.688
   Chen THH, 2004, CANCER-AM CANCER SOC, V100, P1734, DOI 10.1002/cncr.20171
   Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486
   Eriksson J, 1997, DIABETOLOGIA, V40, P125
   Guh JY, 2006, AM J CLIN NUTR, V83, P1313, DOI 10.1093/ajcn/83.6.1313
   Hidvégi T, 2001, DIABETES CARE, V24, P2013, DOI 10.2337/diacare.24.11.2013-a
   Hong YL, 1997, AM J HUM GENET, V60, P143
   Katzmarzyk PT, 2001, J CLIN EPIDEMIOL, V54, P190, DOI 10.1016/S0895-4356(00)00315-2
   Koch R, 2001, HUM HERED, V52, P171, DOI 10.1159/000053373
   Liang KY, 1996, GENET EPIDEMIOL, V13, P253, DOI 10.1002/(SICI)1098-2272(1996)13:3<253::AID-GEPI3>3.0.CO;2-7
   Liese AD, 1997, DIABETOLOGIA, V40, P963, DOI 10.1007/s001250050775
   Loos RJF, 2003, J CLIN ENDOCR METAB, V88, P5935, DOI 10.1210/jc.2003-030553
   Mayer EJ, 1996, AM J EPIDEMIOL, V143, P323
   Pereira MA, 2002, JAMA-J AM MED ASSOC, V287, P2081, DOI 10.1001/jama.287.16.2081
   Poulsen P, 2001, DIABETOLOGIA, V44, P537, DOI 10.1007/s001250051659
   Rennie KL, 2003, INT J EPIDEMIOL, V32, P600, DOI 10.1093/ije/dyg179
   Sargeant LA, 2000, INT J OBESITY, V24, P1333, DOI 10.1038/sj.ijo.0801383
   Schoeller DA, 1997, AM J CLIN NUTR, V66, P551, DOI 10.1093/ajcn/66.3.551
   Tung TH, 2004, DIABETOLOGIA, V47, P1776, DOI 10.1007/s00125-004-1532-2
   van Dam RM, 2002, ANN INTERN MED, V136, P201, DOI 10.7326/0003-4819-136-3-200202050-00008
   Wamala SP, 1999, DIABETES CARE, V22, P1999, DOI 10.2337/diacare.22.12.1999
   WHO, 2000, WHO TECHN REP SER, V894
   *WHO, 2000, AS PERSP RED OB ITS
   Winkleby MA, 1998, JAMA-J AM MED ASSOC, V280, P356, DOI 10.1001/jama.280.4.356
   Yen AMF, 2006, AM J CLIN NUTR, V83, P1153, DOI 10.1093/ajcn/83.5.1153
NR 29
TC 15
Z9 16
U1 0
U2 2
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0168-8227
EI 1872-8227
J9 DIABETES RES CLIN PR
JI Diabetes Res. Clin. Pract.
PD MAR
PY 2007
VL 75
IS 3
BP 348
EP 356
DI 10.1016/j.diabres.2006.07.014
PG 9
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA 135OZ
UT WOS:000244164200013
PM 16935381
DA 2025-04-28
ER

PT J
AU Nasrallah, MP
   Elbejjani, M
   Nasreddine, L
   Chami, H
   Ismaeel, H
   Fleifel, M
   Chokor, FA
   Tamim, H
AF Nasrallah, Mona P.
   Elbejjani, Martine
   Nasreddine, Lara
   Chami, Hassan
   Ismaeel, Hussein
   Fleifel, Mohamad
   Chokor, Fatima Al Zahraa
   Tamim, Hani
TI Incidence of diabetes and its predictors in the Greater Beirut Area: a
   five-year longitudinal study
SO DIABETOLOGY & METABOLIC SYNDROME
LA English
DT Article
DE Type 2 Diabetes; Incidence; Lebanon; Beirut; MENA region; Predictors;
   Metabolic syndrome
ID COFFEE CONSUMPTION; ARABIC VERSION; BERLIN QUESTIONNAIRE; SLEEP-APNEA;
   LIFE-STYLE; RISK; MELLITUS; PREVALENCE; POPULATION; OBESITY
AB Background Type 2 Diabetes (T2D) remains a world epidemic. Obtaining accurate estimates of its incidence and their predictors will aid in targeting preventive measures, allocating resources, and strategizing its management. The Middle East North Africa region has high T2D prevalence and rates of rise. Few incidence studies exist for the region, and none from Lebanon. The current study objective was to determine diabetes incidence and diabetes predictors in a community-based Lebanese sample. A secondary objective was to describe the metabolic control over time in adults with preexisting diabetes. Methods This is a five-year (2014-2019) follow-up study on a random sample of 501 residents of the Greater Beirut area. Out of 478 people eligible to participate in the follow-up study, 198 returned (response rate 39.5%). Assessment included medical history, anthropometric measures, food frequency, sleep, and lifestyle questionnaires. Laboratory data included glycemic indices (fasting glucose and HbA1C) and other biological markers. The diagnosis of probable diabetes (PD) was based on one abnormal test for either fasting glucose >= 126 mg/dL or HbA1C >= 6.5% or having history of diabetes. Results The incidence of diabetes was 17.2 (95% CI 9.6-28.7) per 1000 person-years. Cardiometabolic risk factors independently associated with diabetes were: older age, higher BMI, family history of diabetes, metabolic syndrome, higher CRP and triglyceride level; whereas an independent predictor of diabetes was previous BMI. In addition, the 42 participants with preexisting diabetes had worsening of their metabolic profile over a five-year period. Conclusions The incidence of diabetes was high as compared to some reported world rates, and in line with the high prevalence in the MENA region. The risk was highest in those with positive family history and the presence of the metabolic syndrome or its components. Preventive measures should particularly target participants with that specific risk profile. This becomes particularly important when observing that metabolic control gets worse over time in individuals with diabetes.
C1 [Nasrallah, Mona P.; Fleifel, Mohamad] Amer Univ Beirut, Fac Med, Dept Internal Med, Div Endocrinol,Med Ctr, Beirut, Lebanon.
   [Nasrallah, Mona P.; Nasreddine, Lara; Ismaeel, Hussein] Amer Univ Beirut, Vasc Med Program, Beirut, Lebanon.
   [Elbejjani, Martine; Chokor, Fatima Al Zahraa; Tamim, Hani] Amer Univ Beirut, Fac Med, Clin Res Inst, Med Ctr, Beirut, Lebanon.
   [Elbejjani, Martine; Tamim, Hani] Amer Univ Beirut, Fac Med, Dept Internal Med, Med Ctr, Beirut, Lebanon.
   [Nasreddine, Lara; Chokor, Fatima Al Zahraa] Amer Univ Beirut, Fac Agr & Food Sci, Dept Nutr & Food Sci, Beirut, Lebanon.
   [Chami, Hassan] Amer Univ Beirut, Fac Med, Dept Internal Med, Div Pulm & Crit Care,Med Ctr, Beirut, Lebanon.
   [Ismaeel, Hussein] Amer Univ Beirut, Fac Med, Dept Internal Med, Div Cardiol, Beirut, Lebanon.
   [Tamim, Hani] Alfaisal Univ, Coll Med, Riyadh, Saudi Arabia.
C3 American University of Beirut; American University of Beirut; American
   University of Beirut; American University of Beirut; American University
   of Beirut; American University of Beirut; American University of Beirut;
   Alfaisal University
RP Tamim, H (corresponding author), Amer Univ Beirut, Fac Med, Clin Res Inst, Med Ctr, Beirut, Lebanon.; Tamim, H (corresponding author), Amer Univ Beirut, Fac Med, Dept Internal Med, Med Ctr, Beirut, Lebanon.; Tamim, H (corresponding author), Alfaisal Univ, Coll Med, Riyadh, Saudi Arabia.
EM htamim@alfaisal.edu
RI Chokor, Fatima Al Zahraa/KCY-7508-2024; Tamim, Hani/MXK-8650-2025
OI Ismaeel, Hussain/0009-0009-5385-8370; Fleifel,
   Mohamad/0000-0001-8050-3393; Chokor, Fatima Al
   Zahraa/0000-0002-0418-7146; Tamim, Hani/0000-0002-2019-4362
FU Medical Practice Plan of the American University of Beirut (MPP); Munib
   Shahid Development Fund
FX The study was supported by grants from the Medical Practice Plan of the
   American University of Beirut (MPP) and the Munib Shahid Development
   Fund.
CR Ahmad RE, 2020, NUTRIENTS, V12, DOI 10.3390/nu12113316
   Ahmed AE, 2014, J EPIDEMIOL GLOB HEA, V4, P297, DOI 10.1016/j.jegh.2014.04.004
   Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644
   [Anonymous], 2019, International Diabetes Federation Diabetes Atlas, V9th
   [Anonymous], 2020, DIABETES CARE, V43, pS14, DOI [DOI 10.2337/DC20-S002, 10.2337/dc20-S002]
   Boehme MWJ, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2188-1
   Cai L, 2012, EUR J CLIN NUTR, V66, P872, DOI 10.1038/ejcn.2012.68
   Centers for Disease Control and Prevention, 2020, National diabetes statistics report
   Choi HK, 2005, ARCH INTERN MED, V165, P997, DOI 10.1001/archinte.165.9.997
   Costanian C, 2014, DIABETES RES CLIN PR, V105, P408, DOI 10.1016/j.diabres.2014.06.005
   Derakhshan A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102563
   Derossi A, 2018, J SCI FOOD AGR, V98, P3198, DOI 10.1002/jsfa.8826
   Després JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488
   Ding M, 2014, DIABETES CARE, V37, P569, DOI 10.2337/dc13-1203
   Editorial, 2020, LANCET
   Fooladi MM, 2012, J ENVIRON PUBLIC HEA, V2012, DOI 10.1155/2012/235618
   FREEDMAN JL, 1975, CROWDING BEHAV, P111
   Helou K, 2017, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-017-4599-7
   Hirbli KI, 2005, DIABETES CARE, V28, P1262, DOI 10.2337/diacare.28.5.1262
   Hossain P, 2007, NEW ENGL J MED, V356, P213, DOI 10.1056/NEJMp068177
   Hu FB, 2001, NEW ENGL J MED, V345, P790, DOI 10.1056/NEJMoa010492
   IPAQ, 2004, The International Physical Activity Questionnaire
   Isma'eel HA, 2018, GLOB HEART, V13, P275, DOI 10.1016/j.gheart.2018.03.001
   Jaber LA, 2011, DIABETES RES CLIN PR, V91, P307, DOI 10.1016/j.diabres.2010.11.032
   Janghorbani M, 2017, DIABETES METAB SYND, V11, pS439, DOI 10.1016/j.dsx.2017.03.032
   Keith RJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157592
   Knowler William C, 2002, N Engl J Med, V346, P393, DOI 10.1056/NEJMoa012512
   Kolb H, 2017, BMC MED, V15, DOI 10.1186/s12916-017-0901-x
   Liu SM, 2006, DIABETES CARE, V29, P1579, DOI 10.2337/dc06-0256
   Livesey G, 2019, NUTRIENTS, V11, DOI 10.3390/nu11061280
   Maddatu J, 2017, TRANSL RES, V184, P101, DOI 10.1016/j.trsl.2017.02.004
   Magliano DJ, 2019, BMJ-BRIT MED J, V366, DOI 10.1136/bmj.l5003
   Majeed A, 2014, DIABETES RES CLIN PR, V103, P218, DOI 10.1016/j.diabres.2013.11.008
   MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883
   Miller Caroline, 2019, BMC Obes, V6, P1, DOI 10.1186/s40608-018-0224-2
   Mohsen H, 2019, ALEX ENG J, V58, P945, DOI 10.1016/j.aej.2019.08.009
   Morton SMB, 2012, AUST NZ J PUBL HEAL, V36, P106, DOI 10.1111/j.1753-6405.2012.00854.x
   Mouneimne Y, 2017, ENVIRON MONIT ASSESS, V189, DOI 10.1007/s10661-017-6216-8
   Nasrallah MP, 2017, ENDOCR PRACT, V23, P1091, DOI 10.4158/EP171876.OR
   Nasreddine L, 2006, PUBLIC HEALTH NUTR, V9, P194, DOI 10.1079/PHN2005855
   Nasreddine L, 2018, PUBLIC HEALTH NUTR, V21, P160, DOI 10.1017/S1368980017002130
   Netzer NC, 1999, ANN INTERN MED, V131, P485, DOI 10.7326/0003-4819-131-7-199910050-00002
   NHLBI,, 2020, PRACTICAL GUIDE IDEN
   Onat Altan, 2006, Anadolu Kardiyol Derg, V6, P314
   Regmi D, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2019-035813
   Saeedi P, 2019, DIABETES RES CLIN PR, V157, DOI 10.1016/j.diabres.2019.107843
   Saleh ABM, 2011, ANN THORAC MED, V6, P212, DOI 10.4103/1817-1737.84775
   Schulze MB, 2004, JAMA-J AM MED ASSOC, V292, P927, DOI 10.1001/jama.292.8.927
   Taleb N., 2008, Br J Diabetes Vasc Dis, V8, P80, DOI [DOI 10.1177/14746514080080020501, 10.1177/14746514080080020501]
   Valdés S, 2007, DIABETES CARE, V30, P2258, DOI 10.2337/dc06-2461
   Valdez R, 2007, DIABETES CARE, V30, P2517, DOI 10.2337/dc07-0720
   van Dam RM, 2005, JAMA-J AM MED ASSOC, V294, P97, DOI 10.1001/jama.294.1.97
   Vijayakumar G, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-6445-6
   Wang M, 2020, J DIABETES RES, V2020, DOI 10.1155/2020/2597953
   World Health Organization, 2012, World Health Organ Tech Rep Ser, P1
   Zreik RS., 2016, J DIAB MELL, V6, P307, DOI [10.4236/jdm.2016.64032, DOI 10.4236/JDM.2016.64032]
NR 56
TC 6
Z9 6
U1 2
U2 4
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1758-5996
J9 DIABETOL METAB SYNDR
JI Diabetol. Metab. Syndr.
PD MAY 4
PY 2022
VL 14
IS 1
AR 67
DI 10.1186/s13098-022-00833-w
PG 15
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA 0Z0TD
UT WOS:000790792600001
PM 35509100
OA Green Published, gold
DA 2025-04-28
ER

PT J
AU Lal, A
   Peeters, A
   Brown, V
   Nguyen, P
   Tran, HNQ
   Nguyen, T
   Tonmukayakul, U
   Sacks, G
   Calache, H
   Martin, J
   Moodie, M
   Ananthapavan, J
AF Lal, Anita
   Peeters, Anna
   Brown, Vicki
   Phuong Nguyen
   Huong Ngoc Quynh Tran
   Tan Nguyen
   Tonmukayakul, Utsana
   Sacks, Gary
   Calache, Hanny
   Martin, Jane
   Moodie, Marj
   Ananthapavan, Jaithri
TI The Modelled Population Obesity-Related Health Benefits of Reducing
   Consumption of Discretionary Foods in Australia
SO NUTRIENTS
LA English
DT Article
DE obesity; discretionary foods; sugar-sweetened beverages; healthcare
   costs
ID COST-EFFECTIVENESS; ITEM SIZES; TAX; MEXICO; SNACK; BMI
AB Over one third of Australians' daily energy intake is from discretionary foods and drinks. While many health promotion efforts seek to limit discretionary food intake, the population health impact of reductions in the consumption of different types of discretionary foods (e.g., sugar-sweetened beverages (SSBs), confectionery, sweet biscuits) has not been quantified. This study estimated the potential reductions in body weight, obesity-related disease incidence, and healthcare cost savings associated with consumption of one less serving per week of different discretionary foods. Reductions in the different types of discretionary food were modelled individually to estimate the impact on energy consumption and population body weight by 5-year age and sex groups. It was assumed that one serving of discretionary food each week was replaced with either a serving of fruit or popcorn, and a serving (375 mL) of SSBs was replaced with coffee, tea, or milk. Proportional multi-state multiple-cohort Markov modelling estimated likely resultant health adjusted life years (HALYs) gained and healthcare costs saved over the lifetime of the 2010 Australian population. A reduction of one serving of SSBs (375 mL) had the greatest potential impact in terms of weight reduction, particularly in ages 19-24 years (mean 0.31 kg, 95% UI: 0.23 kg to 0.37 kg) and overall healthcare cost savings of AUD 793.4 million (95% UI: 589.1 M to 976.1 M). A decrease of one serving of sweet biscuits had the second largest potential impact on weight change overall, with healthcare cost savings of $640.7 M (95% CI: $402.6 M to $885.8 M) and the largest potential weight reduction amongst those aged 75 years and over (mean 0.21 kg, 95% UI: 0.14 kg to 0.27 kg). The results demonstrate that small reductions in discretionary food consumption are likely to have substantial health benefits at the population level. Moreover, the study highlights that policy responses to improve population diets may need to be tailored to target different types of foods for different population groups.
C1 [Lal, Anita; Brown, Vicki; Phuong Nguyen; Huong Ngoc Quynh Tran; Tan Nguyen; Tonmukayakul, Utsana; Calache, Hanny; Moodie, Marj; Ananthapavan, Jaithri] Deakin Univ, Inst Hlth Transformat, Deakin Hlth Econ, Geelong, Vic 3220, Australia.
   [Lal, Anita; Peeters, Anna; Brown, Vicki; Phuong Nguyen; Huong Ngoc Quynh Tran; Sacks, Gary; Moodie, Marj; Ananthapavan, Jaithri] Deakin Univ, Global Obes Ctr Globe, Inst Hlth Transformat, Geelong, Vic 3220, Australia.
   [Martin, Jane] Canc Council Victoria, Obes Policy Coalit, Melbourne, Vic 3004, Australia.
C3 Deakin University; Deakin University; Cancer Council Victoria
RP Lal, A (corresponding author), Deakin Univ, Inst Hlth Transformat, Deakin Hlth Econ, Geelong, Vic 3220, Australia.; Lal, A (corresponding author), Deakin Univ, Global Obes Ctr Globe, Inst Hlth Transformat, Geelong, Vic 3220, Australia.
EM anita.lal@deakin.edu.au; anna.peeters@deakin.edu.au;
   vicki.brown@deakin.edu.au; phuong.nguyen@deakin.edu.au;
   michelle.tran@deakin.edu.au; tan.nguyen@deakin.edu.au;
   utsana.tonmukayakul@deakin.edu.au; gary.sacks@deakin.edu.au;
   hanny.calache@deakin.edu.au; jane.martin@cancervic.org.au;
   marj.moodie@deakin.edu.au; jaithri.ananthapavan@deakin.edu.au
RI Peeters, Anna/M-8284-2019; Lal, Anita/AAT-1076-2020; Brown,
   Victoria/B-8319-2019; Tonmukayakul, Utsana/V-6248-2019; Sacks,
   Gary/I-5731-2014; Nguyen, Tan Minh/AGW-4143-2022
OI Sacks, Gary/0000-0001-9736-1539; Lal, Anita/0000-0001-6921-6617; Nguyen,
   Tan Minh/0000-0002-9986-7629; Tran, Huong Ngoc
   Quynh/0000-0003-4892-8345; Nguyen, Phuong K/0000-0001-7669-8642;
   PEETERS, ANNA/0000-0003-4340-9132; Brown, Vicki/0000-0003-2891-9476
FU 2018 Health and Social Development School Research Grant, Deakin
   University [SRG18-04]; Deakin University; Baker Heart and Diabetes
   Institute; National Health and Medical Research Council (NHMRC)
   [APP1152968]; Dean's Postdoctoral Research Fellowship
FX This project is funded by a 2018 Health and Social Development School
   Research Grant, Deakin University (Grant number SRG18-04). AL is funded
   by a Dean's Postdoctoral Research Fellowship. P.N. has a joint PhD
   Scholarship from Deakin University and The Baker Heart and Diabetes
   Institute. J.A., M.M., G.S. and A.P. are supported by the National
   Health and Medical Research Council (NHMRC) funded Centre of Research
   Excellence in Food Retail Environments for Health (RE-FRESH)
   (APP1152968).
CR Ananthapavan J., 2018, ASESSSING COST EFFEC
   Ananthapavan J, 2019, INT J OBESITY, V43, P1102, DOI 10.1038/s41366-019-0341-0
   [Anonymous], 2014, Australian Health Survey: Nutrition first results-foods and nutrients
   [Anonymous], 2012, HLTH EXP AUSTR 2010
   Colchero MA, 2017, HEALTH AFFAIR, V36, P564, DOI 10.1377/hlthaff.2016.1231
   Australian Bureau of Statistics, 2013, AUSTR HLTH SURV 2011
   Australian Institute of Health and Welfare, 2016, AUSTR BURD DIS STUD
   Australian Institute of Health and Welfare, 2001, HLTH WELF EXP SER DI
   Brown V, 2018, NUTRIENTS, V10, DOI 10.3390/nu10050622
   Cancer Council, LIV LIGHT W AUSTR 20
   Cecchini M, 2010, LANCET, V376, P1775, DOI 10.1016/S0140-6736(10)61514-0
   Chen G, 2014, PEDIATRICS, V133, pE868, DOI 10.1542/peds.2013-0622
   Cobiac LJ, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002232
   Cobiac LJ, 2013, ANNU REV NUTR, V33, P373, DOI 10.1146/annurev-nutr-071812-161133
   Crino M, 2017, NUTRIENTS, V9, DOI 10.3390/nu9090983
   Food Standards Australia and New Zealand, 2019, AUSNUT 2011 13 DAT F
   Food Standards Australia and New Zealand, 2019, AUSNUT 2011 13 FOOD
   FSANZ, Australian Food Composition Database Downloadable Files
   GBD 2001 Country Collaboration, 2013, LANCET, V381, P965, DOI 10.1016/S0140-6736(13)60283-4
   Goris JM, 2010, PUBLIC HEALTH NUTR, V13, P1003, DOI 10.1017/S1368980009992850
   Goss J., 2008, Projection of Australian health care expenditure by disease, 2003 to 2033
   Grech A, 2017, HEALTHCARE-BASEL, V5, DOI 10.3390/healthcare5040070
   Grieger JA, 2016, INT J BEHAV NUTR PHY, V13, DOI 10.1186/s12966-016-0380-z
   Hall KD, 2013, LANCET DIABETES ENDO, V1, P97, DOI 10.1016/S2213-8587(13)70051-2
   Hall KD, 2011, LANCET, V378, P826, DOI 10.1016/S0140-6736(11)60812-X
   Lal A, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002326
   Long MW, 2015, AM J PREV MED, V49, P112, DOI 10.1016/j.amepre.2015.03.004
   Magnus A, 2009, INT J OBESITY, V33, P1094, DOI 10.1038/ijo.2009.156
   Marchiori D, 2012, J NUTR EDUC BEHAV, V44, P251, DOI 10.1016/j.jneb.2011.07.007
   Marchiori D, 2011, J AM DIET ASSOC, V111, P727, DOI 10.1016/j.jada.2011.02.008
   Mitton C, 2003, Health Serv Manage Res, V16, P96, DOI 10.1258/095148403321591410
   Morley BC, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-019574
   Mytton OT, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2931
   National Health and Medical Research Council, 2013, AUSTR DIET GUID SUMM
   Patel BP, 2013, J FOOD SCI, V78, pA5, DOI 10.1111/1750-3841.12070
   Sacks G, 2011, INT J OBESITY, V35, P1001, DOI 10.1038/ijo.2010.228
   Scheelbeek PFD, 2019, BMJ-BRIT MED J, V366, DOI 10.1136/bmj.l4786
   Sonneville KR, 2015, AM J PREV MED, V49, P124, DOI 10.1016/j.amepre.2015.02.026
   Stroebele N, 2009, APPETITE, V52, P793, DOI 10.1016/j.appet.2009.02.015
   Taillie LS, 2017, PREV MED, V105, pS37, DOI 10.1016/j.ypmed.2017.07.009
   Veerman JL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151460
NR 41
TC 26
Z9 26
U1 0
U2 4
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2072-6643
J9 NUTRIENTS
JI Nutrients
PD MAR
PY 2020
VL 12
IS 3
AR 649
DI 10.3390/nu12030649
PG 14
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA LL8VB
UT WOS:000531831000058
PM 32121199
OA gold, Green Published
DA 2025-04-28
ER

PT J
AU Kontochristopoulou, AM
   Karatzi, K
   Karaglani, E
   Cardon, G
   Kivelä, J
   Wikström, K
   Iotova, V
   Tsochev, K
   Tankova, T
   Rurik, I
   Radone, AS
   Liatis, S
   Makrilakis, K
   Moreno, LA
   Manios, Y
AF Kontochristopoulou, Aikaterini M.
   Karatzi, Kalliopi
   Karaglani, Eva
   Cardon, Greet
   Kivela, Jemina
   Wikstrom, Katja
   Iotova, Violeta
   Tsochev, Kaloyan
   Tankova, Tsvetalina
   Rurik, Imre
   Radone, Anett S.
   Liatis, Stavros
   Makrilakis, Konstantinos
   Moreno, Luis A.
   Manios, Yannis
TI Sociodemographic, anthropometric, and lifestyle correlates of
   prediabetes and type 2 diabetes in europe: The Feel4Diabetes study
SO NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
LA English
DT Article
DE Feel4Diabetes; Prevention; Prediabetes; Type 2 diabetes; Risk factors
ID IMPAIRED GLUCOSE-TOLERANCE; COFFEE CONSUMPTION; RISK-FACTORS;
   METAANALYSIS; HEALTH; FISH
AB Background and aims: The current work aimed to identify the predominant correlates of prediabetes and T2DM among a variety of socio-demographic, anthropometric and lifestyle indices, in a large sample of adults from families at high risk for T2DM.
   Methods and results: In this cross-sectional study, 2816 adults were recruited from low-socioeconomic areas in high-income countries (HICs) (Belgium-Finland), HICs under austerity measures (Greece-Spain), and low/middle-income countries (LMICs) (Bulgaria-Hungary). A positive association between the male sex (OR, 95% C.I.2.77 (1.69-4.54)) and prediabetes was revealed compared to females, while there was a negative association between younger age (<45 years) (OR, 95% C.I. 0.58 (0.37-0.92)), and low/medium levels of waist circumference (OR, 95% Cl. 0.44 (0.22-0.89)) with prediabetes compared to older age and high levels of waist circumference, respectively. Concerning T2DM, 0-0.5 cups/day of fruits and berries (OR, 95% C.I.2. 13 (1.16-3.91)) and 150-300 g fish/week (OR, 95% C.I. 2.55 (1.01-6.41)) have a positive association compared to higher consumptions, respectively. Conversely, <1 cup/week legumes (OR, 95% C.I. 0.55 (0.31-0.99) as well as 0-0.5 servings (OR, 95% CI. 0.34 (0.12-0.95) and 0.5-1 servings (OR, 95% CI. 0.37 (0.19-0.71) of full-fat dairy/day have a negative association compared to higher consumptions, respectively.
   Conclusion: These findings indicate the need for diabetes prevention measures targeting young adults and especially men, above 45 years of age, with central obesity and poor dietary habits and prioritize vulnerable groups and populations living in LMICs. (C) 2022 The Italian Diabetes Society, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition and the Department of Clinical Medicine and Surgery, Federico II University. Published by Elsevier B.V. All rights reserved.
C1 [Kontochristopoulou, Aikaterini M.; Karaglani, Eva; Manios, Yannis] Harokopio Univ, Dept Nutr & Dietet, 70 El Venizelou Ave, Athens 17671, Greece.
   [Karatzi, Kalliopi] Agr Univ Athens, Sch Food & Nutr Sci, Dept Food Sci Ea Human Nutr, Lab Dietet & Qual Life, 75 Iera Odos, Athens 11855, Greece.
   [Cardon, Greet] Univ Ghent, Dept Movement & Sport Sci, Ghent, Belgium.
   [Kivela, Jemina; Wikstrom, Katja] Finnish Inst Hlth & Welf, Populat Hlth Unit Helsinki, Helsinki, Finland.
   [Iotova, Violeta; Tsochev, Kaloyan] Med Univ Varna, Dept Pediat, Varna, Bulgaria.
   [Tankova, Tsvetalina] Med Univ Sofia, Clin Ctr Endocrinol & Gerontol, Sofia, Bulgaria.
   [Rurik, Imre; Radone, Anett S.] Univ Debrecen, Dept Family & Occupat Med, Debrecen, Hungary.
   [Liatis, Stavros; Makrilakis, Konstantinos] Natl & Kapodistrian Univ Athens Med Sch, Laiko Gen Hosp, Med Sch, Dept Propaedeut Med 1, Athens, Greece.
   [Moreno, Luis A.] Univ Zaragoza, Sch Hlth Sci EUCS, Growth Exercise Nutr & Dev Res Grp, Zaragoza, Spain.
C3 Harokopio University Athens; Agricultural University of Athens; Ghent
   University; Medical University Varna; Medical University Sofia;
   University of Debrecen; National & Kapodistrian University of Athens;
   Laiko General Hospital; University of Zaragoza
RP Manios, Y (corresponding author), Harokopio Univ, Dept Nutr & Dietet, 70 El Venizelou Ave, Athens 17671, Greece.
EM manios@hua.gr
RI Tankova, Tsvetalina/AEP-2827-2022; Manios, Yannis/AAM-8953-2021; Moreno,
   Luis/S-1780-2019; Iotova, Violeta/AAO-2387-2021; Karatzi,
   Kalliopi/AGJ-2400-2022; Cardon, Greet/AEK-0110-2022
OI Manios, Yannis/0000-0001-6486-114X; Karaglani, Eva/0000-0001-5395-7023;
   Tankova, Tsvetalina/0000-0002-7572-1131; Cardon,
   Greet/0000-0003-4983-6557; Moreno Aznar, Luis A./0000-0003-0454-653X;
   Karatzi, Kalliopi/0000-0001-5453-898X
FU European Union [643708]
FX The Feel4Diabetes-study has received funding from the European Union's
   Horizon 2020 Research and Innovation Program [Grant Agreement: no
   643708]. The content of this article reflects the authors' views only
   and the European Community is not liable for any use that may be made of
   the information contained therein. The funding body had no role in the
   design of this study and collection, analysis, and interpretation of the
   data, and in the writing of this manuscript.
CR Afshin A, 2014, AM J CLIN NUTR, V100, P278, DOI 10.3945/ajcn.113.076901
   Agardh EE, 2004, J INTERN MED, V255, P645, DOI 10.1111/j.1365-2796.2004.01331.x
   Agardh E, 2011, INT J EPIDEMIOL, V40, P804, DOI 10.1093/ije/dyr029
   Amer Diabet Assoc, 2018, DIABETES CARE, V41, pS13, DOI 10.2337/dc18-S002
   Amitani M, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00051
   [Anonymous], 1985, WHO TECH REP SER, P1
   Asif Mohammad, 2014, J Educ Health Promot, V3, P1, DOI 10.4103/2277-9531.127541
   Astrup A, 2010, PHYSIOL BEHAV, V100, P67, DOI 10.1016/j.physbeh.2010.01.039
   Hassimotto NMA, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/146716
   Bardenheier BH, 2013, DIABETES CARE, V36, P2655, DOI 10.2337/dc12-2608
   Bellou V, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194127
   Bocquet V, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-022206
   Bonilla GS, 2016, JAMA INTERN MED, V176, P1053, DOI 10.1001/jamainternmed.2016.2952
   Brouwer-Brolsma EM, 2018, BRIT J NUTR, V119, P442, DOI [10.1017/S0007114517003762, 10.1017/s0007114517003762]
   Chen GC, 2014, OBES REV, V15, P134, DOI 10.1111/obr.12088
   Díaz-Redondo A, 2015, BMC FAM PRACT, V16, DOI 10.1186/s12875-014-0216-3
   Fan MY, 2020, NUTRIENTS, V12, DOI 10.3390/nu12123827
   FANELLI C, 1993, J CLIN INVEST, V92, P1617, DOI 10.1172/JCI116746
   Haw JS, 2017, JAMA INTERN MED, V177, P1808, DOI 10.1001/jamainternmed.2017.6040
   Hill JO, 2013, DIABETES CARE, V36, P2430, DOI 10.2337/dc13-1161
   Hostalek Ulrike, 2019, Clin Diabetes Endocrinol, V5, P5, DOI 10.1186/s40842-019-0080-0
   Jaffiol C, 2013, DIABETES METAB, V39, P56, DOI 10.1016/j.diabet.2012.09.002
   Jakubowicz D, 2013, J NUTR BIOCHEM, V24, P1, DOI [10.1016/j.jnutbio.2012.07.008, 10.1016/j.jnutbio.2013.06.003]
   Jorgensen T, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3617
   Kaushik M, 2009, AM J CLIN NUTR, V90, P613, DOI 10.3945/ajcn.2008.27424
   Kautzky-Willer A, 2016, ENDOCR REV, V37, P278, DOI 10.1210/er.2015-1137
   Kumari M, 2004, ARCH INTERN MED, V164, P1873, DOI 10.1001/archinte.164.17.1873
   Kyrou I, 2020, BMC ENDOCR DISORD, V20, DOI 10.1186/s12902-019-0463-3
   Li M, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005497
   Li SS, 2009, JAMA-J AM MED ASSOC, V302, P179, DOI 10.1001/jama.2009.976
   Manios Y, 2018, PUBLIC HEALTH NUTR, V21, P3281, DOI 10.1017/S1368980018002136
   Neuenschwander M, 2019, BMJ-BRIT MED J, V366, DOI 10.1136/bmj.l2368
   Pearce Matthew, 2021, J Nutr, V151, P1231, DOI 10.1093/jn/nxaa447
   Sacks DB, 2011, CLIN CHEM, V57, pE1, DOI 10.1373/clinchem.2010.161596
   Schellenberg ES, 2013, ANN INTERN MED, V159, P543, DOI 10.7326/0003-4819-159-8-201310150-00007
   Schiebinger L., 2015, Z. Geschlecht Kult. Ges, V7, P29, DOI 10.3224/gender.v7i2.19311
   Serrano R, 2013, REV ESP SALUD PUBLIC, V87, P121, DOI 10.4321/S1135-57272013000200003
   Siddiqui S, 2020, DIAB MET SYND CLIN R, V14, P1243, DOI 10.1016/j.dsx.2020.06.069
   Slurink IAL, 2022, EUR J NUTR, V61, P183, DOI 10.1007/s00394-021-02626-9
   Tobias DK, 2016, INT J OBESITY, V40, P1748, DOI 10.1038/ijo.2016.156
   van Dam RM, 2004, DIABETOLOGIA, V47, P2152, DOI 10.1007/s00125-004-1573-6
   Wang PY, 2016, J DIABETES INVEST, V7, P56, DOI 10.1111/jdi.12376
   Weng LC, 2012, J FORMOS MED ASSOC, V111, P651, DOI 10.1016/j.jfma.2012.07.038
   WHO, 2020, World Health Organ Tech Rep Ser
   World Health Organization, 2015, RAIS FAST BLOOD GLUC
   Yang MH, 2015, INT J ENDOCRINOL, V2015, DOI 10.1155/2015/806257
   Yoshioka K, 2003, LANCET, V361, P703, DOI 10.1016/S0140-6736(03)12585-8
   Zhang M, 2013, INT J ENDOCRINOL, V2013, DOI 10.1155/2013/501015
   Zheng Y, 2018, NAT REV ENDOCRINOL, V14, P88, DOI 10.1038/nrendo.2017.151
   Zhou YP, 2012, BRIT J NUTR, V108, P408, DOI 10.1017/S0007114512002036
   Zhu B, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-219
NR 51
TC 4
Z9 4
U1 1
U2 5
PU ELSEVIER SCI LTD
PI London
PA 125 London Wall, London, ENGLAND
SN 0939-4753
EI 1590-3729
J9 NUTR METAB CARDIOVAS
JI Nutr. Metab. Carbiovasc. Dis.
PD AUG
PY 2022
VL 32
IS 8
BP 1851
EP 1862
DI 10.1016/j.numecd.2022.03.021
EA JUL 2022
PG 12
WC Cardiac & Cardiovascular Systems; Endocrinology & Metabolism; Nutrition
   & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cardiovascular System & Cardiology; Endocrinology & Metabolism;
   Nutrition & Dietetics
GA 4L6EQ
UT WOS:000852723700005
PM 35610084
OA Green Published
DA 2025-04-28
ER

PT J
AU Kerr, J
   Frank, L
   Sallis, JF
   Saelens, B
   Glanz, K
   Chapman, J
AF Kerr, Jacqueline
   Frank, Lawrence
   Sallis, James F.
   Saelens, Brian
   Glanz, Karen
   Chapman, Jim
TI Predictors of trips to food destinations
SO INTERNATIONAL JOURNAL OF BEHAVIORAL NUTRITION AND PHYSICAL ACTIVITY
LA English
DT Article
DE Built environment; Food environment; Urban form; Travel; Nutrition;
   Obesity
ID PHYSICAL-ACTIVITY; NEIGHBORHOOD CHARACTERISTICS; STORE AVAILABILITY;
   ENVIRONMENT; OBESITY; ASSOCIATIONS; ACCESS; DISPARITIES; LOCATION;
   DIETARY
AB Background: Food environment studies have focused on ethnic and income disparities in food access. Few studies have investigated distance travelled for food and did not aim to inform the geographic scales at which to study the relationship between food environments and obesity. Further, studies have not considered neighborhood design as a predictor of food purchasing behavior.
   Methods: Atlanta residents (N = 4800) who completed a travel diary and reported purchasing or consuming food at one of five food locations were included in the analyses. A total of 11,995 food-related trips were reported. Using mixed modeling to adjust for clustering of trips by participants and households, person-level variables (e.g. demographics), neighborhood-level urban form measures, created in GIS, and trip characteristics (e.g. time of day, origin and destination) were investigated as correlates of distance travelled for food and frequency of grocery store and fast food outlet trips.
   Results: Mean travel distance for food ranged from 4.5 miles for coffee shops to 6.3 miles for superstores. Type of store, urban form, type of tour, day of the week and ethnicity were all significantly related to distance travelled for food. Origin and destination environment, type of tour, day of week, age, gender, income, ethnicity, vehicle access and obesity status were all significantly related to visiting a grocery store. Home neighborhood environment, day of week, type of tour, gender, income, education level, age, and obesity status were all significantly related to likelihood of visiting a fastfood outlet.
   Conclusions: The present study demonstrated that people travel sizeable distances for food and this distance is related to urban. Results suggest that researchers need to employ different methods to characterize food environments than have been used to assess urban form in studies of physical activity. Food is most often purchased while traveling from locations other than home, so future studies should assess the food environment around work, school or other frequently visited destinations, as well as along frequently traveled routes.
C1 [Kerr, Jacqueline; Sallis, James F.] Univ Calif San Diego, San Diego, CA 92103 USA.
   [Frank, Lawrence] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada.
   [Sallis, James F.] San Diego State Univ, San Diego, CA 92182 USA.
   [Saelens, Brian] Seattle Childrens Res Inst, Washington, DC USA.
   [Saelens, Brian] Univ Washington, Washington, DC USA.
   [Glanz, Karen] Univ Penn, Philadelphia, PA 19104 USA.
   [Chapman, Jim] Urban Design Hlth, Washington, DC USA.
C3 University of California System; University of California San Diego;
   University of British Columbia; California State University System; San
   Diego State University; University of Washington; University of
   Pennsylvania
RP Kerr, J (corresponding author), Univ Calif San Diego, San Diego, CA 92103 USA.
EM jkerr@ucsd.edu
RI KERR, JACQUELINE/H-2537-2016; Frank, Lawrence/ADA-3137-2022; Sallis,
   James F/D-3001-2014
OI Sallis, James F/0000-0003-2555-9452; Saelens, Brian/0000-0001-6998-6339
CR Alwitt LF, 1997, J CONSUM AFF, V31, P139, DOI 10.1111/j.1745-6606.1997.tb00830.x
   [Anonymous], 1949, Human Behaviour and the Principle of Least-Effort
   Austin SB, 2005, AM J PUBLIC HEALTH, V95, P1575, DOI 10.2105/AJPH.2004.056341
   Block D, 2006, PUBLIC HEALTH NUTR, V9, P837, DOI 10.1017/PHN2005924
   Booth KM, 2005, J AM DIET ASSOC, V105, pS110, DOI 10.1016/j.jada.2005.02.045
   Bowman JL, 2001, TRANSPORT RES A-POL, V35, P1, DOI 10.1016/S0965-8564(99)00043-9
   Braza M, 2004, AM J HEALTH PROMOT, V19, P128, DOI 10.4278/0890-1171-19.2.128
   Cummins S, 2006, INT J EPIDEMIOL, V35, P100, DOI 10.1093/ije/dyi276
   Fleischhacker SE, 2011, OBES REV, V12, pe460, DOI 10.1111/j.1467-789X.2010.00715.x
   Ford PB, 2008, NUTR REV, V66, P216, DOI 10.1111/j.1753-4887.2008.00026.x
   Frank L, 2009, BRIT J SPORT MED, V43, P124, DOI 10.1136/bjsm.2008.055533
   Frank L., 2020, Can J Public Health
   Frank L, 2008, TRANSPORTATION, V35, P37, DOI 10.1007/s11116-007-9136-6
   Frank LD, 2006, J AM PLANN ASSOC, V72, P75, DOI 10.1080/01944360608976725
   Frank LD, 2004, AM J PREV MED, V27, P87, DOI 10.1016/j.amepre.2004.04.011
   Frank LD, 2005, AM J PREV MED, V28, P117, DOI 10.1016/j.amepre.2004.11.001
   Frank LD, 2007, BERKELEY PLANNING J, V19, P31
   Galvez MP, 2008, PUBLIC HEALTH NUTR, V11, P624, DOI 10.1017/S1368980007001097
   Gebel K, 2007, AM J PREV MED, V32, P361, DOI 10.1016/j.amepre.2007.01.020
   Giskes K, 2007, PUBLIC HEALTH NUTR, V10, P1005, DOI 10.1017/S1368980007665525
   Glanz K, 2005, AM J HEALTH PROMOT, V19, P330, DOI 10.4278/0890-1171-19.5.330
   Glanz K, 2007, AM J PREV MED, V32, P282, DOI 10.1016/j.amepre.2006.12.019
   Hannes Els, 2009, ENV BEHAV, V41
   Heath Gregory W, 2006, J Phys Act Health, V3, pS55, DOI 10.1123/jpah.3.s1.s55
   Jago R, 2006, AM J HEALTH PROMOT, V20, P422, DOI 10.4278/0890-1171-20.6.422
   James WPT, 2008, OBES REV, V9, P6, DOI 10.1111/j.1467-789X.2007.00432.x
   Kelly B, 2011, HEALTH PLACE, V17, P1284, DOI 10.1016/j.healthplace.2011.08.014
   Liese AD, 2007, J AM DIET ASSOC, V107, P1916, DOI 10.1016/j.jada.2007.08.012
   Matthews SA, 2008, AM J PREV MED, V34, P257, DOI 10.1016/j.amepre.2007.12.001
   Moore LV, 2008, AM J EPIDEMIOL, V167, P917, DOI 10.1093/aje/kwm394
   Moore LV, 2006, AM J PUBLIC HEALTH, V96, P325, DOI 10.2105/AJPH.2004.058040
   Morland K, 2002, AM J PREV MED, V22, P23, DOI 10.1016/S0749-3797(01)00403-2
   Pereira CAN, 2010, HEALTH PLACE, V16, P934, DOI 10.1016/j.healthplace.2010.05.007
   Powell LM, 2007, PREV MED, V44, P189, DOI 10.1016/j.ypmed.2006.08.008
   Raja S, 2008, J PLAN EDUC RES, V27, P469, DOI 10.1177/0739456X08317461
   Roemmich JN, 2006, PREV MED, V43, P437, DOI 10.1016/j.ypmed.2006.07.007
   Saelens BE, 2008, MED SCI SPORT EXER, V40, pS550, DOI 10.1249/MSS.0b013e31817c67a4
   Sallis J.F., 2006, RES DIGEST, V7, P1
   Sallis JF, 2009, MILBANK Q, V87, P123, DOI 10.1111/j.1468-0009.2009.00550.x
   Sharkey JR, 2008, J NUTR, V138, P620, DOI 10.1093/jn/138.3.620
   Story M, 2008, ANNU REV PUBL HEALTH, V29, P253, DOI 10.1146/annurev.publhealth.29.020907.090926
   Timmermans HJP., 2003, J TRANSP GEOGR, V11, P37, DOI [DOI 10.1016/S0966-6923(02)00050-9, 10.1016/S0966-6923(02)00050-9]
   Walker RE, 2010, HEALTH PLACE, V16, P876, DOI 10.1016/j.healthplace.2010.04.013
   Wang MC, 2006, INT J BEHAV NUTR PHY, V3, DOI 10.1186/1479-5868-3-15
   Weber CL, 2008, ENVIRON SCI TECHNOL, V42, P3508, DOI 10.1021/es702969f
   Zenk SN, 2011, HEALTH PLACE, V17, P1150, DOI 10.1016/j.healthplace.2011.05.001
   Zenk SN, 2006, ETHNIC DIS, V16, P275
NR 47
TC 79
Z9 91
U1 0
U2 42
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1479-5868
J9 INT J BEHAV NUTR PHY
JI Int. J. Behav. Nutr. Phys. Act.
PD MAY 20
PY 2012
VL 9
AR 58
DI 10.1186/1479-5868-9-58
PG 10
WC Nutrition & Dietetics; Physiology
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Nutrition & Dietetics; Physiology
GA 987CB
UT WOS:000307392900001
PM 22607218
OA Green Published, gold
DA 2025-04-28
ER

PT J
AU Zou, HY
   Ye, HQ
   Kamaraj, R
   Zhang, TH
   Zhang, J
   Pavek, P
AF Zou, Haoyang
   Ye, Haiqing
   Kamaraj, Rajamanikkam
   Zhang, Tiehua
   Zhang, Jie
   Pavek, Petr
TI A review on pharmacological activities and synergistic effect of
   quercetin with small molecule agents
SO PHYTOMEDICINE
LA English
DT Review
DE Quercetin; Pharmacological activities; Synergistic effect; Combination
   therapy
ID PRIMARY LIVER-CANCER; CELL-CYCLE ARREST; OXIDATIVE STRESS; FLAVONOID
   QUERCETIN; ENHANCED INHIBITION; PLANT FLAVONOIDS; TUMOR-GROWTH;
   IN-VITRO; COMBINATION; RESVERATROL
AB Background: Quercetin is a natural flavonoid, which widely exists in nature, such as tea, coffee, apples, and onions. Numerous studies have showed that quercetin has multiple biological activities such as anti-oxidation, anti-inflammatory, and anti-aging. Hence, quercetin has a significant therapeutic effect on cancers, obesity, diabetes, and other diseases. In the past decades, a large number of studies have shown that quercetin combined with other agents can significantly improve the overall therapeutic effect, compared to single use.
   Purpose: This work reviews the pharmacological activities of quercetin and its derivatives. In addition, this work also summarizes both in vivo and in vitro experimental evidence for the synergistic effect of quercetin against cancers and metabolic diseases.
   Methods: An extensive systematic search for pharmacological activities and synergistic effect of quercetin was performed considering all the relevant literatures published until August 2021 through the databases including NCBI PubMed, Scopus, Web of Science, and Google Scholar. The relevant literatures were extracted from the databases with following keyword combinations: "pharmacological activities" OR "biological activities" OR "synergistic effect" OR "combined" OR "combination" AND "quercetin" as well as free-text words.
   Results: Quercetin and its derivatives possess multiple pharmacological activities including anti-cancer, antioxidant, anti-inflammatory, anti-cardiovascular, anti-aging, and neuroprotective activities. In addition, the synergistic effect of quercetin with small molecule agents against cancers and metabolic diseases has also been confirmed.
   Conclusion: Quercetin cooperates with agents to improve the therapeutic effect by regulating signal molecules and blocking cell cycle. Synergistic therapy can reduce the dose of agents and avoid the possible toxic and side effects in the treatment process. Although quercetin treatment has some potential side effects, it is safe under the expected use conditions. Hence, quercetin has application value and potential strength as a clinical drug. Furthermore, quercetin, as the main effective therapeutic ingredient in traditional Chinese medicine, may effectively treat and prevent coronavirus disease 2019 (COVID-19).
C1 [Zou, Haoyang; Ye, Haiqing; Zhang, Tiehua; Zhang, Jie] Jilin Univ, Coll Food Sci & Engn, Changchun 130062, Peoples R China.
   [Kamaraj, Rajamanikkam; Pavek, Petr] Charles Univ Prague, Fac Pharm, Dept Pharmacol & Toxicol, Heyrovskeho 1203, CZ-50005 Hradec Kralove, Czech Republic.
C3 Jilin University; Charles University Prague
RP Zhang, J (corresponding author), Jilin Univ, Coll Food Sci & Engn, Changchun 130062, Peoples R China.; Pavek, P (corresponding author), Charles Univ Prague, Fac Pharm, Dept Pharmacol & Toxicol, Heyrovskeho 1203, CZ-50005 Hradec Kralove, Czech Republic.
EM zhangjie83@jlu.edu.cn; petr.pavek@faf.cuni.cz
RI Pavek, Petr/U-1066-2017; Zhang, Tiehua/AAL-2623-2020; Kamaraj,
   Rajamanikkam/J-6574-2019
OI Zhang, Jie/0000-0002-6944-2021; Kamaraj,
   Rajamanikkam/0000-0001-7115-0178
FU National Natural Science Foundation of China [31972160]; Science and
   Technology Development Project Foundation of Jilin Province
   [20200201204JC]; Student Project of Charles University [SVV 260 549]
FX This work was supported by the National Natural Science Foundation of
   China (31972160), the Science and Technology Development Project
   Foundation of Jilin Province (20200201204JC), and the Student Project of
   Charles University (SVV 260 549).
CR Abdel-Diam MM, 2019, ENVIRON SCI POLLUT R, V26, P3659, DOI 10.1007/s11356-018-3907-9
   Aeschbacher H U, 1982, Nutr Cancer, V4, P90, DOI 10.1080/01635588209513744
   Al Humayed S, 2019, ULTRASTRUCT PATHOL, V43, P162, DOI 10.1080/01913123.2019.1680585
   Amanzadeh E, 2019, REV NEUROSCIENCE, V30, P555, DOI 10.1515/revneuro-2018-0080
   Andres S, 2018, MOL NUTR FOOD RES, V62, DOI 10.1002/mnfr.201700447
   Ansari MA, 2009, J NUTR BIOCHEM, V20, P269, DOI 10.1016/j.jnutbio.2008.03.002
   Aoyagi T, 2015, WORLD J GASTRO ONCOL, V7, P17, DOI 10.4251/wjgo.v7.i4.17
   Aranaz P, 2020, FOOD FUNCT, V11, P4512, DOI 10.1039/d0fo00504e
   Arias N, 2016, EUR J NUTR, V55, P341, DOI 10.1007/s00394-015-0854-9
   Ayissi VBO, 2014, MOL NUTR FOOD RES, V58, P22, DOI 10.1002/mnfr.201300195
   Azevedo MI, 2013, MOL PAIN, V9, DOI 10.1186/1744-8069-9-53
   Babenkova IV, 2018, B EXP BIOL MED+, V165, P347, DOI 10.1007/s10517-018-4167-x
   Bachevski D, 2020, DERMATOL THER, V33, DOI 10.1111/dth.13780
   Baksi R, 2018, BIOMED PHARMACOTHER, V106, P1513, DOI 10.1016/j.biopha.2018.07.106
   Baran I, 2014, LEUKEMIA RES, V38, P836, DOI 10.1016/j.leukres.2014.04.010
   Bester L, 2014, J MED IMAG RADIAT ON, V58, P341, DOI 10.1111/1754-9485.12163
   Bischoff SC, 2008, CURR OPIN CLIN NUTR, V11, P733, DOI 10.1097/MCO.0b013e32831394b8
   BJELDANES LF, 1977, SCIENCE, V197, P577, DOI 10.1126/science.327550
   Bosch FX, 2004, GASTROENTEROLOGY, V127, pS5, DOI 10.1053/j.gastro.2004.09.011
   Brito AF, 2016, NUTR CANCER, V68, P250, DOI 10.1080/01635581.2016.1145245
   CARIA H, 1995, MUTAT RES-GENET TOX, V343, P85, DOI 10.1016/0165-1218(95)90075-6
   Carrasco-Pozo C, 2019, J MED FOOD, V22, P753
   Carrasco-Torres G, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/2734976
   Carullo G, 2017, FUTURE MED CHEM, V9, P79, DOI 10.4155/fmc-2016-0186
   Chen FY, 2015, MOL MED REP, V11, P341, DOI 10.3892/mmr.2014.2734
   Chen LC, 2016, INT J NANOMED, V11, P1557, DOI 10.2147/IJN.S103681
   Chondrogianni N, 2010, EXP GERONTOL, V45, P763, DOI 10.1016/j.exger.2010.07.001
   Chuang CH, 2019, CHEM-BIOL INTERACT, V306, P54, DOI 10.1016/j.cbi.2019.04.006
   Chung HY, 2002, MICROSC RES TECHNIQ, V59, P264, DOI 10.1002/jemt.10203
   Coldiron AD, 2002, J BIOCHEM MOL TOXIC, V16, P197, DOI 10.1002/jbt.10035
   Coldman AJ, 2003, CAN MED ASSOC J, V168, P31
   Dajas F, 2012, J ETHNOPHARMACOL, V143, P383, DOI 10.1016/j.jep.2012.07.005
   Das N, 2013, FOOD FUNCT, V4, P889, DOI 10.1039/c3fo30241e
   Del Follo-Martinez A, 2013, NUTR CANCER, V65, P494, DOI 10.1080/01635581.2012.725194
   Deng X., 2021, J ETHNOPHARMACOL, V278
   Desrini S, 2017, BANGLADESH J MED SCI, V16, P91, DOI 10.3329/bjms.v16i1.31139
   DiLoreto R, 2015, MOL BIOL CELL, V26, P4524, DOI 10.1091/mbc.E14-06-1084
   DUNNICK JK, 1992, FUND APPL TOXICOL, V19, P423, DOI 10.1016/0272-0590(92)90181-G
   Egert S, 2009, BRIT J NUTR, V102, P1065, DOI 10.1017/S0007114509359127
   Elkady MA, 2019, HUM EXP TOXICOL, V38, P1283, DOI 10.1177/0960327119865588
   Ferry DR, 1996, CLIN CANCER RES, V2, P659
   Geng LL, 2019, PROTEIN CELL, V10, P417, DOI 10.1007/s13238-018-0567-y
   Ghosh A, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0057735, 10.1371/journal.pone.0082529]
   Hädrich G, 2016, PHARM RES-DORDR, V33, P983, DOI 10.1007/s11095-015-1844-6
   HARDIGREE AA, 1978, MUTAT RES, V58, P231, DOI 10.1016/0165-1218(78)90014-9
   Hashemzaei M, 2017, ONCOL REP, V38, P819, DOI 10.3892/or.2017.5766
   Heng HHQ, 2010, J CELL BIOCHEM, V109, P1072, DOI 10.1002/jcb.22497
   Hermánková E, 2019, FREE RADICAL BIO MED, V143, P240, DOI 10.1016/j.freeradbiomed.2019.08.001
   Hickson LJ, 2019, EBIOMEDICINE, V47, P446, DOI 10.1016/j.ebiom.2019.08.069
   Hsieh TC, 2009, ANTICANCER RES, V29, P4025
   Jaishree V, 2020, BIOMED PHARMACOTHER, V130, DOI 10.1016/j.biopha.2020.110561
   Jakaria M, 2019, J CLIN MED, V8, DOI 10.3390/jcm8111789
   Jalili-Baleh L, 2018, EUR J MED CHEM, V152, P570, DOI 10.1016/j.ejmech.2018.05.004
   Jiang ML, 2019, J DRUG DELIV SCI TEC, V54, DOI 10.1016/j.jddst.2019.101316
   Khurana S, 2013, NUTRIENTS, V5, P3779, DOI 10.3390/nu5103779
   Kleemann R, 2011, ATHEROSCLEROSIS, V218, P44, DOI 10.1016/j.atherosclerosis.2011.04.023
   Langner E, 2019, J FOOD BIOCHEM, V43, DOI 10.1111/jfbc.12802
   Leng EN, 2018, BMC COMPLEM ALTERN M, V18, DOI 10.1186/s12906-018-2189-6
   Leng Y, 2021, FOOD CHEM TOXICOL, V155, DOI 10.1016/j.fct.2021.112413
   Lespade L, 2016, CHEM PHYS, V475, P32, DOI 10.1016/j.chemphys.2016.06.006
   Li W, 2014, ONCOL REP, V31, P117, DOI 10.3892/or.2013.2811
   Li YY, 2014, ACTA BIOCH BIOPH SIN, V46, P460, DOI 10.1093/abbs/gmu023
   Lin CF, 2016, MOLECULES, V21, DOI 10.3390/molecules21030334
   Liu RH, 2004, J NUTR, V134, p3479S, DOI 10.1093/jn/134.12.3479S
   Liu S, 2020, MOL PHARMACEUT, V17, P1415, DOI 10.1021/acs.molpharmaceut.0c00138
   Lu J, 2018, MED SCI MONITOR, V24, P2583, DOI 10.12659/MSM.906172
   Luo ED, 2020, CHIN MED-UK, V15, DOI 10.1186/s13020-020-00317-x
   Luo JM, 2017, FOOD RES INT, V100, P579, DOI 10.1016/j.foodres.2017.07.019
   Ma ZS, 2004, INT J ONCOL, V24, P1297
   Magar RT, 2020, J MICROBIOL BIOTECHN, V30, P11, DOI 10.4014/jmb.1907.07003
   Mansourizadeh F, 2020, COLLOID SURFACE B, V191, DOI 10.1016/j.colsurfb.2020.110982
   Maurya Vimal K., 2020, VirusDisease, V31, P179, DOI 10.1007/s13337-020-00598-8
   Mbikay M, 2014, FEBS OPEN BIO, V4, P755, DOI 10.1016/j.fob.2014.08.003
   Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201
   Mehrbod P, 2021, BIOMOLECULES, V11, DOI 10.3390/biom11010010
   Mertens-Talcott SU, 2005, CANCER LETT, V218, P141, DOI 10.1016/j.canlet.2004.06.007
   Miclea I., 2015, Bulletin of University of Agricultural Sciences and Veterinary Medicine Cluj-Napoca. Animal Science and Biotechnologies, V72, P182
   Miltonprabu S, 2017, FOOD CHEM TOXICOL, V108, P365, DOI 10.1016/j.fct.2016.08.034
   Mukhopadhyay P, 2015, RSC ADV, V5, P97547, DOI 10.1039/c5ra18896b
   Noh HJ, 2014, J MED FOOD, V17, P550
   Okamoto T, 2005, INT J MOL MED, V16, P275
   Ortega MG, 2010, ARCH BIOCHEM BIOPHYS, V498, P105, DOI 10.1016/j.abb.2010.04.014
   Park HJ, 2008, J MED FOOD, V11, P773, DOI 10.1089/jmf.2008.0077
   Patel RV, 2018, EUR J MED CHEM, V155, P889, DOI 10.1016/j.ejmech.2018.06.053
   Pham TND, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20174293
   Prabu S.M., 2011, EUR REV MED PHARM, V14, P903
   Quagliariello V, 2016, J CELL PHYSIOL, V231, P1784, DOI 10.1002/jcp.25283
   Rauf A, 2018, PHYTOTHER RES, V32, P2109, DOI 10.1002/ptr.6155
   Redondo A, 2012, FREE RADICAL RES, V46, P619, DOI 10.3109/10715762.2012.660527
   Refat MS, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0246265
   Ren KW, 2017, INT J ONCOL, V50, P1299, DOI 10.3892/ijo.2017.3886
   Ren L, 2021, FOOD CHEM, V340, DOI 10.1016/j.foodchem.2020.127933
   RiceEvans CA, 1997, TRENDS PLANT SCI, V2, P152, DOI 10.1016/S1360-1385(97)01018-2
   Rubio S, 2007, CARCINOGENESIS, V28, P2105, DOI 10.1093/carcin/bgm131
   Russo M, 2012, BIOCHEM PHARMACOL, V83, P6, DOI 10.1016/j.bcp.2011.08.010
   SAHU RK, 1981, MUTAT RES, V89, P69, DOI 10.1016/0165-1218(81)90132-4
   Sahyon HA, 2019, PHARM CHEM J+, V53, P803, DOI 10.1007/s11094-019-02083-z
   Sargiacomo C, 2020, AGING-US, V12, P6511, DOI 10.18632/aging.103001
   Schlachterman A, 2008, TRANSL ONCOL, V1, P19, DOI 10.1593/tlo.07100
   Serri C, 2019, J CELL PHYSIOL, V234, P4959, DOI 10.1002/jcp.27297
   Serwer P, 2018, MED HYPOTHESES, V110, P60, DOI 10.1016/j.mehy.2017.11.001
   Shao Y, 2016, RSC ADV, V6, P12235, DOI 10.1039/c5ra16493a
   Sharma A, 2018, PHARM PAT ANAL, V7, P15, DOI 10.4155/ppa-2017-0030
   Shi GJ, 2019, BIOMED PHARMACOTHER, V109, P1085, DOI 10.1016/j.biopha.2018.10.130
   Shi YX, 2019, ONCOL LETT, V18, P153, DOI 10.3892/ol.2019.10299
   Shih YL, 2010, J AGR FOOD CHEM, V58, P235, DOI 10.1021/jf9031684
   Sohal RS, 2002, FREE RADICAL BIO MED, V33, P575, DOI 10.1016/S0891-5849(02)00886-9
   Spencer JPE, 2003, BIOCHEM J, V372, P173, DOI 10.1042/BJ20021972
   Srivastava Rakesh K, 2011, Front Biosci (Elite Ed), V3, P515, DOI 10.2741/e266
   Staedler D, 2011, CANCER CHEMOTH PHARM, V68, P1161, DOI 10.1007/s00280-011-1596-x
   Suganthy N, 2016, BIOMED PHARMACOTHER, V84, P892, DOI 10.1016/j.biopha.2016.10.011
   Takahama U, 2011, FOOD CHEM, V126, P1808, DOI 10.1016/j.foodchem.2010.12.009
   TEOFILI L, 1992, LEUKEMIA RES, V16, P497, DOI 10.1016/0145-2126(92)90176-8
   Tohge T, 2017, J EXP BOT, V68, P4013, DOI 10.1093/jxb/erx177
   Vijg J, 2005, ANNU REV MED, V56, P193, DOI 10.1146/annurev.med.56.082103.104617
   Wang GD, 2013, ONCOL REP, V30, P357, DOI 10.3892/or.2013.2469
   Wang PW, 2015, MOL NUTR FOOD RES, V59, P250, DOI 10.1002/mnfr.201400558
   Wang PW, 2014, J NUTR BIOCHEM, V25, P73, DOI 10.1016/j.jnutbio.2013.09.005
   Wang PW, 2012, NUTR CANCER, V64, P580, DOI 10.1080/01635581.2012.661514
   Wang YP, 2021, FOOD FUNCT, V12, P2468, DOI [10.1039/d0fo02894k, 10.1039/D0FO02894K]
   Wong MY, 2010, ANTI-CANCER DRUG, V21, P401, DOI 10.1097/CAD.0b013e328336e940
   Yang FY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128277
   Yang H, 2019, FEBS J, V286, P5030, DOI 10.1111/febs.15172
   Yang JY, 2008, LIFE SCI, V82, P1032, DOI 10.1016/j.lfs.2008.03.003
   Yang ML, 2020, IND CROP PROD, V143, DOI 10.1016/j.indcrop.2019.05.082
   YEH YA, 1995, LIFE SCI, V57, P1285, DOI 10.1016/0024-3205(95)02085-W
   Yohanathan L, 2019, SURG ONCOL CLIN N AM, V28, P229, DOI 10.1016/j.soc.2018.11.003
   Zhang J., 2020, EFOOD, V1, P392
   Zhang J, 2021, FOOD CHEM TOXICOL, V155, DOI 10.1016/j.fct.2021.112379
   Zhang TH, 2020, FOOD CHEM TOXICOL, V135, DOI 10.1016/j.fct.2019.111017
   Zhang TH, 2020, CRIT REV FOOD SCI, V60, P94, DOI [10.1080/10408398.2018.1514580, 10.1155/2018/9707581]
   Zhao JQ, 2021, FOOD CHEM TOXICOL, V155, DOI 10.1016/j.fct.2021.112411
   Zhao L, 2017, EXP THER MED, V14, P5942, DOI 10.3892/etm.2017.5331
   Zhao L, 2017, FOOD FUNCT, V8, P4644, DOI [10.1039/C7FO01383C, 10.1039/c7fo01383c]
   Zhou J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172838
   Zhou J, 2016, ONCOL LETT, V12, P516, DOI 10.3892/ol.2016.4639
   Zhou MM, 2012, J PROTEOME RES, V11, P4961, DOI 10.1021/pr3004826
NR 137
TC 118
Z9 121
U1 30
U2 188
PU ELSEVIER GMBH
PI MUNICH
PA HACKERBRUCKE 6, 80335 MUNICH, GERMANY
SN 0944-7113
EI 1618-095X
J9 PHYTOMEDICINE
JI Phytomedicine
PD NOV
PY 2021
VL 92
AR 153736
DI 10.1016/j.phymed.2021.153736
EA SEP 2021
PG 10
WC Plant Sciences; Chemistry, Medicinal; Integrative & Complementary
   Medicine; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Plant Sciences; Pharmacology & Pharmacy; Integrative & Complementary
   Medicine
GA WB8NI
UT WOS:000703823800021
PM 34560520
DA 2025-04-28
ER

PT J
AU Robinson, E
   Burton, S
   Gough, T
   Jones, A
   Haynes, A
AF Robinson, Eric
   Burton, Sam
   Gough, Tom
   Jones, Andrew
   Haynes, Ashleigh
TI Point of choice kilocalorie labelling in the UK eating out of home
   sector: a descriptive study of major chains
SO BMC PUBLIC HEALTH
LA English
DT Article
DE Kilocalorie labelling; Food environment; Eating out; Restaurant food;
   Nutrition information; Obesity; Kcals
ID FOOD CHOICES
AB BackgroundEating out is now common and food served out of the home is often of low nutritional quality. Kilocalorie (kcal) labelling of food and drink products sold in restaurant chains in the US is now mandatory, although in store kcal labelling practices among major UK restaurant and takeaway chains have not been examined.MethodsDuring August 2018, we contacted, visited the website and/or retail outlets of major eating out and takeaway food chains in the UK, including full-service and fast-food restaurants, cafes and coffee shops, some of which had previously made a voluntary pledge to provide kcal labelling. We examined the proportion of chains providing kcal information to customers at point of choice in store and the extent to which kcal information provision adhered to labelling recommendations. We also examined the proportion of chains that did not have point of choice kcal labelling but were able to provide kcal information on request. The study protocol was pre-registered on the Open Science Framework.ResultsOf the 104 eligible chains, only a small minority (18 chains, 17%) provided in store kcal labelling. Of those that did, provision of kcal information tended not to adhere to recommended labelling practices. Of the 16 eligible chains that had previously committed to a voluntary public health pledge to provide point of choice kcal labelling, labelling did not meet recommendations and 4 (25%) did not provide kcal labelling. Of the 86 chains that did not provide kcal labelling in store, kcal information was available on request from 43 (50%) chains.ConclusionsIt is rare for eating out and takeaway chains in the UK to provide point of choice kcal labelling and when labelling is provided it does not adhere to recommended labelling practices. Chains that previously volunteered to provide kcal labelling as part of an industry and public health partnership do so inadequately. Voluntary policies have not resulted in adequate kcal labelling in the UK eating out of home sector.
C1 [Robinson, Eric; Burton, Sam; Gough, Tom; Jones, Andrew; Haynes, Ashleigh] Univ Liverpool, Inst Psychol Hlth & Soc, Liverpool L69 7ZA, Merseyside, England.
C3 University of Liverpool
RP Robinson, E (corresponding author), Univ Liverpool, Inst Psychol Hlth & Soc, Liverpool L69 7ZA, Merseyside, England.
EM eric.robinson@liv.ac.uk
RI Jones, Andy/ABB-9742-2021; Haynes, Ashleigh/F-7824-2015; Burton,
   Sam/LXA-0766-2024
OI Robinson, Eric/0000-0003-3586-5533; Burton, Sam/0000-0003-3823-3275;
   Gough, Thomas/0000-0003-0093-9723; Jones, Andrew/0000-0001-5951-889X;
   Haynes, Ashleigh/0000-0002-3616-6673
FU MRC [MR/N00218/1]; MRC [MR/N000218/1] Funding Source: UKRI
FX The MRC (MR/N00218/1) part fund ER's salary. The views expressed in this
   publication are those of the authors and not necessarily those of the
   MRC.
CR Adams J, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0210-8
   [Anonymous], 2018, CAL RED SCOP AMB ACT
   [Anonymous], 2018, KANTAR WORLD PANEL G
   Bezerra IN, 2012, NUTR REV, V70, P65, DOI 10.1111/j.1753-4887.2011.00459.x
   Block JP, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2907
   Block JP, 2018, N ENGL J MED
   Cleveland LP, 2018, AM J PUBLIC HEALTH, V108, P1099, DOI 10.2105/AJPH.2018.304513
   Crocketta RA, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009315.pub2
   Department of Health, TECHN GUID VOL CAL L
   Department of Health, OUT HOM EN LAB PLEDG
   Department of Health and Social Care, CHILDH OB PLAN ACT 2
   Elbel B, 2011, OBESITY, V19, P1971, DOI 10.1038/oby.2011.214
   Food Standards Agency, FOOD YOU WAV 4
   Jebb SA, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d4502
   Knai C, 2015, FOOD POLICY, V54, P1, DOI 10.1016/j.foodpol.2015.04.002
   Littlewood JA, 2016, PUBLIC HEALTH NUTR, V19, P2106, DOI 10.1017/S1368980015003468
   Mintel. Mintel Market Sizes Fast Food and Takeaways in UK, 2016, REP ACC VIA U LIV LI
   Mintel. Mintel Market Sizes Restaurants in UK, 2017, REP ACC VIA U LIV LI
   Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8
   Roberto CA, 2014, INT J OBESITY, V38, pS25, DOI 10.1038/ijo.2014.86
   Roberto CA, 2010, AM J PUBLIC HEALTH, V100, P312, DOI 10.2105/AJPH.2009.160226
   Robinson E, 2018, BMJ-BRIT MED J, V363, DOI 10.1136/bmj.k4982
   Smith KJ, 2009, INT J BEHAV NUTR PHY, V6, DOI 10.1186/1479-5868-6-29
   Swinburn B, 2009, AM J CLIN NUTR, V90, P1453, DOI 10.3945/ajcn.2009.28595
   Urban LE, 2016, J ACAD NUTR DIET, V116, P590, DOI 10.1016/j.jand.2015.11.009
   Vandevijvere S, 2015, B WORLD HEALTH ORGAN, V93, P446, DOI 10.2471/BLT.14.150565
   Ziauddeen N, 2017, NUTRIENTS, V9, DOI 10.3390/nu9121315
   Zlatevska N, 2018, J RETAILING, V94, P89, DOI 10.1016/j.jretai.2017.09.007
NR 28
TC 15
Z9 15
U1 1
U2 8
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-2458
J9 BMC PUBLIC HEALTH
JI BMC Public Health
PD MAY 28
PY 2019
VL 19
AR 649
DI 10.1186/s12889-019-7017-5
PG 6
WC Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Public, Environmental & Occupational Health
GA IA1TZ
UT WOS:000469346700009
PM 31138179
OA Green Published, gold
DA 2025-04-28
ER

PT J
AU Lucan, SC
   Maroko, AR
   Sanon, OC
   Schechter, CB
AF Lucan, Sean C.
   Maroko, Andrew R.
   Sanon, Omar C.
   Schechter, Clyde B.
TI Unhealthful Food-and-Beverage Advertising in Subway Stations: Targeted
   Marketing, Vulnerable Groups, Dietary Intake, and Poor Health
SO JOURNAL OF URBAN HEALTH-BULLETIN OF THE NEW YORK ACADEMY OF MEDICINE
LA English
DT Article
DE Food and Beverages; Advertising; Nutrition; Vulnerable groups;
   Latino/Hispanic; Black-African American; Children; Socio-economic
   status; Fruits and vegetables; Sugar-sweetened beverages; Obesity;
   Diabetes; Hypertension; Dyslipidemia; Diet-related diseases
ID ALCOHOL; PREVALENCE; ADVERTISEMENTS; EXPOSURE; OBESITY; SCHOOLS
AB Unhealthful food-and-beverage advertising often targets vulnerable groups. The extent of such advertising in subway stations has not been reported and it is not clear how ad placement may relate to subway ridership or community demographics, or what the implications might be for diets and diet-related health in surrounding communities. Riding all subway lines (n = 7) in the Bronx, NY, USA, investigators systematically assessed all print ads (n = 1586) in all stations (n = 68) in 2012. Data about subway ridership came from the Metropolitan Transportation Authority. Demographic data on surrounding residential areas came from the U.S. Census Bureau. Data on dietary intake and diet-related conditions came from a city health-department survey. There were no ads promoting "more-healthful" food-or-beverage items (i.e., fruits, vegetables, whole grains, nuts, water or milk). There were many ads for "less-healthful" items (e.g., candies, chips, sugary cereals, frozen pizzas, "energy" drinks, coffee confections, hard alcohol, and beer). Ad placement did not relate to the number of riders entering at stations. Instead, exposure to food-or-beverage ads generally, and to "less-healthful" ads particularly (specifically ads in Spanish, directed at youth, and/or featuring minorities), was directly correlated with poverty, lower high-school graduation rates, higher percentages of Hispanics, and/or higher percentages of children in surrounding residential areas. Correlations were robust to sensitivity analyses. Additional analyses suggested correlations between ad exposures and sugary-drink consumption, fruit-and-vegetable intake, and diabetes, hypertension, and high-cholesterol rates. Subway-station ads for "less-healthful" items were located disproportionately in areas home to vulnerable populations facing diet and diet-related-health challenges. The fact that uneven ad placement did not relate to total rider counts suggests ads were not directed at the largest possible audiences but rather targeted to specific groups.
C1 [Lucan, Sean C.; Schechter, Clyde B.] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Family & Social Med, 1300 Morris Pk Ave,Block Bldg,Room 410, Bronx, NY 10461 USA.
   [Maroko, Andrew R.] CUNY, Dept Hlth Sci, Lehman Coll, Bronx, NY USA.
   [Sanon, Omar C.] NYU, Coll Arts & Sci, New York, NY USA.
C3 Yeshiva University; Montefiore Medical Center; Albert Einstein College
   of Medicine; City University of New York (CUNY) System; Lehman College
   (CUNY); New York University
RP Lucan, SC (corresponding author), Montefiore Med Ctr, Albert Einstein Coll Med, Dept Family & Social Med, 1300 Morris Pk Ave,Block Bldg,Room 410, Bronx, NY 10461 USA.
EM slucan@yahoo.com
RI Lucan, Sean/B-3815-2009
OI Maroko, Andrew/0000-0002-9398-2386
FU Eunice Kennedy Shriver National Institute of Child Health and Human
   Development of the National Institutes of Health [K23HD079606]; Hispanic
   Center of Excellence at the Albert Einstein College of Medicine
FX The authors would like to offer sincere posthumous thanks to Hope M.
   Spano for intern coordination and project assistance. SL is supported by
   the Eunice Kennedy Shriver National Institute of Child Health and Human
   Development of the National Institutes of Health under award
   K23HD079606. The content of this manuscript is solely the responsibility
   of SL and does not necessarily represent the official views of the
   National Institutes of Health. OS received a student stipend to
   participate in this research from the Hispanic Center of Excellence at
   the Albert Einstein College of Medicine, which had no role in the study
   design; collection, analysis, or interpretation of data; writing the
   report; or the decision to submit the report for publication. SL
   conceived the study, performed the literature review, designed the data
   collection protocol, oversaw primary data collection, performed all
   analyses, and drafted the manuscript, including tables and figures. AM
   retrieved all secondary sources of data (from the MTA, the U.S. Census
   Bureau, and the city health department), assisted with analyses and data
   interpretation, created all maps, and helped revise the manuscript. OS
   performed primary data collection (in the subway system), assisted with
   data analysis and interpretation, and helped revise the manuscript. CS
   oversaw and assisted with data analysis and helped revise the
   manuscript. SL serves as a member of the Scientific and Nutritional
   Advisory Board for Epicure. None of the other authors have any
   disclosures. The authors would like to thank Andrew Carmona and Mamadou
   Bah for their help with data collection.
CR [Anonymous], American Community Survey, 5-Year Summary File
   [Anonymous], 2016, Dietary guidelines for Americans, 2015-2020
   [Anonymous], 2019, 2010 CENS AM COMM SU
   Cheyne A, 2013, FOOD BEVERAGE MARKET
   Federal Trade Commission, 2012, REV FOOC MARK CHILDR
   Gentry E, 2011, AM J PUBLIC HEALTH, V101, P1936, DOI 10.2105/AJPH.2011.300159
   Hackbarth DP, 2001, PUBLIC HEALTH REP, V116, P558, DOI 10.1093/phr/116.6.558
   Harris JL, 2013, ADV COMMUNICATION RE, DOI [10.1007/978-1-4614-5511-0_7, DOI 10.1007/978-1-4614-5511-0_7]
   Hillier A, 2009, HEALTH PLACE, V15, P935, DOI 10.1016/j.healthplace.2009.02.014
   Isgor Z, 2016, HEALTH PLACE, V39, P43, DOI 10.1016/j.healthplace.2016.02.008
   Kelly B, 2008, AUST NZ J PUBL HEAL, V32, P522, DOI 10.1111/j.1753-6405.2008.00303.x
   Kunkel D, 2013, J HLTH COMMUN
   Kwate NOA, 2007, ALCOHOL ALCOHOLISM, V42, P635, DOI 10.1093/alcalc/agm053
   Kwate NOA, 2009, AM J PUBLIC HEALTH, V99, P228, DOI 10.2105/AJPH.2007.132217
   Lesser LI, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-20
   Lowery BC, 2014, AM J PUBLIC HEALTH, V104, P658, DOI 10.2105/AJPH.2013.301694
   MTA, MTA ADV STAND
   MTA, INTR SUBW RID
   Nyborn Justin A, 2009, Am J Public Health, V99 Suppl 3, pS644, DOI 10.2105/AJPH.2008.149906
   NYC Health, BES DAT REL FLOWCH
   Ohri-Vachaspati P, 2014, AM J PREV MED
   Pasch KE, 2007, J STUD ALCOHOL DRUGS, V68, P587, DOI 10.15288/jsad.2007.68.587
   Quealy K., 2016, NY TIMES
   Scott MM, 2008, AM J PREV MED, V35, P203, DOI 10.1016/j.amepre.2008.05.026
   Yancey AK, 2009, MILBANK Q, V87, P155, DOI 10.1111/j.1468-0009.2009.00551.x
NR 25
TC 52
Z9 58
U1 0
U2 57
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1099-3460
EI 1468-2869
J9 J URBAN HEALTH
JI J. Urban Health
PD APR
PY 2017
VL 94
IS 2
BP 220
EP 232
DI 10.1007/s11524-016-0127-9
PG 13
WC Public, Environmental & Occupational Health; Medicine, General &
   Internal
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Public, Environmental & Occupational Health; General & Internal Medicine
GA ES6MF
UT WOS:000399661500008
PM 28271237
OA Bronze, Green Published
DA 2025-04-28
ER

PT J
AU Bagheri, A
   Hashemi, R
   Heshmat, R
   Motlagh, AD
   Esmaillzadeh, A
AF Bagheri, Amir
   Hashemi, Rezvan
   Heshmat, Ramin
   Motlagh, Ahmadreza Dorosty
   Esmaillzadeh, Ahmad
TI Patterns of Nutrient Intake in Relation to Sarcopenia and Its Components
SO FRONTIERS IN NUTRITION
LA English
DT Article
DE nutrient patterns; sarcopenia; muscle mass; muscle strength; gait speed
ID SKELETAL-MUSCLE MASS; DIETARY PATTERNS; OLDER-ADULTS; HANDGRIP STRENGTH;
   NATIONAL-HEALTH; GRIP STRENGTH; GAIT SPEED; ASSOCIATIONS; CONSENSUS;
   OBESITY
AB Background: Despite the associations between individual nutrients and sarcopenia, we are aware of no information about the link between patterns of nutrient intake and odds of sarcopenia and its components. The present study aimed to examine the association between nutrient-based dietary patterns and sarcopenia and its components among the Iranian adult population.
   Methods: In this population-based, cross-sectional study, we enrolled 300 elderly adults (150 men and 150 women) aged >= 55 years by using a cluster random sampling method. Dietary intakes of the study population were assessed using a validated food frequency questionnaire. Principal component analysis was conducted to derive nutrient patterns based on a daily intake of 33 nutrients. Muscle mass, muscle strength, and gait speed were measured according to standard methods. Sarcopenia and its components were defined based on the European Working Group on Sarcopenia.
   Results: Three major nutrient-based dietary patterns were identified: (1) the "pro-vit pattern" that was high in pantothenic (B5), cobalamin (B12), calcium, protein, phosphor, riboflavin (B2), zinc, cholesterol, saturated fat, folate, niacin (B3), selenium, vitamin D, vitamin K, and vitamin A; (2) the "anti-inflammatory" pattern, which was rich in polyunsaturated fat, monounsaturated fat, copper, vitamin E, omega-3, magnesium, iron, pyridoxine (B6), sodium, and caffeine; and (3) the "carbo-vit" patternm which is characterized by high intake of fructose, glucose, dietary fiber, biotin, potassium, thiamin (B1), vitamin C, and chromium. After adjusting for confounders, subjects in the top tertile of the anti-inflammatory pattern had lower odds of sarcopenia (OR 0.25; 95% CI 0.10-0.63) and low muscle strength (OR: 0.46; 95% CI: 0.22-0.96) than those in the bottom tertile. Greater adherence to the carbo-vit pattern was inversely associated with the odds of low gait speed (OR: 0.46; 95% CI: 0.235-0.93).
   Conclusion: Major nutrient-based dietary patterns were significantly associated with sarcopenia and its components. Further studies are required to confirm our findings.
C1 [Bagheri, Amir; Motlagh, Ahmadreza Dorosty; Esmaillzadeh, Ahmad] Univ Tehran Med Sci, Dept Community Nutr, Sch Nutrit Sci & Dietet, Tehran, Iran.
   [Hashemi, Rezvan] Univ Tehran Med Sci, Ziaeian Hosp, Dept Geriatr Med, Tehran, Iran.
   [Heshmat, Ramin] Univ Tehran Med Sci, Chron Dis Res Ctr CDRC, Endocrinol & Metab Populat Sci Inst, Tehran, Iran.
   [Esmaillzadeh, Ahmad] Univ Tehran Med Sci, Endocrinol & Metab Mol Cellular Sci Inst, Obes & Eating Habits Res Ctr, Tehran, Iran.
   [Esmaillzadeh, Ahmad] Isfahan Univ Med Sci, Dept Community Nutr, Esfahan, Iran.
C3 Tehran University of Medical Sciences; Tehran University of Medical
   Sciences; Tehran University of Medical Sciences; Tehran University of
   Medical Sciences; Isfahan University of Medical Sciences
RP Esmaillzadeh, A (corresponding author), Univ Tehran Med Sci, Dept Community Nutr, Sch Nutrit Sci & Dietet, Tehran, Iran.; Hashemi, R (corresponding author), Univ Tehran Med Sci, Ziaeian Hosp, Dept Geriatr Med, Tehran, Iran.; Esmaillzadeh, A (corresponding author), Univ Tehran Med Sci, Endocrinol & Metab Mol Cellular Sci Inst, Obes & Eating Habits Res Ctr, Tehran, Iran.; Esmaillzadeh, A (corresponding author), Isfahan Univ Med Sci, Dept Community Nutr, Esfahan, Iran.
EM r_hashemi@tums.ac.ir; a-esmaillzadeh@tums.ac.ir
RI Hashemi, Rezvan/AAU-9419-2021; Heshmat, Ramin/S-7435-2017; bagheri,
   Amir/JEF-8606-2023; Arero, Godana/JGL-9109-2023; Esmaillzadeh,
   Ahmad/N-5704-2014; Hashemi, Rezvan/J-5639-2018
OI Bagheri, Amir/0000-0002-8289-3484; Hashemi, Rezvan/0000-0002-4354-7378
FU Tehran Endocrine and Metabolism Research Center; Tehran University of
   Medical Science
FX The financial support for this study comes from the Tehran Endocrine and
   Metabolism Research Center and the Tehran University of Medical Science.
CR Bagheri A, 2020, NUTR J, V19, DOI 10.1186/s12937-020-00649-2
   Beaudart C, 2019, AGING CLIN EXP RES, V31, P815, DOI 10.1007/s40520-019-01186-7
   Bibiloni MD, 2017, NUTRIENTS, V9, DOI 10.3390/nu9070704
   Bloom I, 2018, NUTRIENTS, V10, DOI 10.3390/nu10030308
   Carmeli E, 2002, EXP GERONTOL, V37, P477, DOI 10.1016/S0531-5565(01)00220-0
   Chan R, 2016, J AM MED DIR ASSOC, V17, P336, DOI 10.1016/j.jamda.2015.12.004
   Chen LK, 2014, J AM MED DIR ASSOC, V15, P95, DOI 10.1016/j.jamda.2013.11.025
   Committee IR., 2005, GUIDELINES DATA PROC
   Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034
   De Stefani E, 2008, ANTICANCER RES, V28, P2499
   Edefonti V, 2020, NUTRIENTS, V12, DOI 10.3390/nu12061584
   Flood A, 2014, CLIN NUTR, V33, P106, DOI 10.1016/j.clnu.2013.03.003
   Gedmantaite A, 2020, MECH AGEING DEV, V189, DOI 10.1016/j.mad.2020.111269
   Granic A, 2019, NUTRIENTS, V11, DOI 10.3390/nu11040745
   Granic A, 2020, CLIN NUTR, V39, P166, DOI 10.1016/j.clnu.2019.01.009
   Hashemi R, 2012, J DIABETES METAB DIS, V11, DOI 10.1186/2251-6581-11-23
   HEYMSFIELD SB, 1990, AM J CLIN NUTR, V52, P214, DOI 10.1093/ajcn/52.2.214
   Iwasaki Y, 2019, NUTRIENTS, V11, DOI 10.3390/nu11050990
   Ji C, 2018, LIPIDS HEALTH DIS, V17, DOI 10.1186/s12944-018-0734-4
   Jochem C, 2019, J AM MED DIR ASSOC, V20, P1213, DOI 10.1016/j.jamda.2019.05.015
   Kim MK, 2011, J CLIN ENDOCR METAB, V96, P3250, DOI 10.1210/jc.2011-1602
   Kim M, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16091491
   Li SX, 2018, PEDIATR DIABETES, V19, P375, DOI 10.1111/pedi.12596
   Mahan L.K., 2016, Krause's Food and the Nutrition Care Process-E-Book, P1370
   McClure R, 2019, CLIN NUTR ESPEN, V32, P33, DOI 10.1016/j.clnesp.2019.05.009
   McKenzie D, 2002, EUR J BIOCHEM, V269, P2010, DOI 10.1046/j.1432-1033.2002.02867.x
   Merkies ISJ, 2000, MUSCLE NERVE, V23, P1393, DOI 10.1002/1097-4598(200009)23:9<1393::AID-MUS10>3.0.CO;2-O
   Mirmiran P, 2010, PUBLIC HEALTH NUTR, V13, P654, DOI 10.1017/S1368980009991698
   Mohseni R, 2017, AGING CLIN EXP RES, V29, P1241, DOI 10.1007/s40520-016-0721-4
   Morley J.E., 2004, Cytokine-related aging process
   Newby PK, 2004, NUTR REV, V62, P177, DOI 10.1301/rn.2004.may.177-203
   Peel NM, 2019, J GERONTOL A-BIOL, V74, P943, DOI 10.1093/gerona/gly140
   Perera S, 2016, J GERONTOL A-BIOL, V71, P63, DOI 10.1093/gerona/glv126
   Rondanelli M, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/524948
   Salehi-Abargouei A, 2019, CLIN NUTR, V38, P940, DOI 10.1016/j.clnu.2018.02.002
   Salehi-Abargouei A, 2016, EUR J NUTR, V55, P505, DOI 10.1007/s00394-015-0867-4
   Schaap LA, 2006, AM J MED, V119, DOI 10.1016/j.amjmed.2005.10.049
   Scott D, 2010, J AM GERIATR SOC, V58, P2129, DOI 10.1111/j.1532-5415.2010.03147.x
   Shafiee G, 2019, J DIABETES METAB DIS, V18, P665, DOI 10.1007/s40200-019-00452-9
   Smith GI, 2015, AM J CLIN NUTR, V102, P115, DOI 10.3945/ajcn.114.105833
   ter Borg S, 2016, J AM MED DIR ASSOC, V17, P393, DOI 10.1016/j.jamda.2015.12.015
   Thomas DR, 2007, CLIN NUTR, V26, P389, DOI 10.1016/j.clnu.2007.03.008
   Veronese N, 2018, J AM MED DIR ASSOC, V19, P981, DOI 10.1016/j.jamda.2018.06.007
   Willett W., 2012, NUTR EPIDEMIOLOGY, VThird, DOI 10.1093/acprof:oso/9780199754038.001.0001
NR 44
TC 16
Z9 17
U1 2
U2 27
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 2296-861X
J9 FRONT NUTR
JI Front. Nutr.
PD APR 27
PY 2021
VL 8
AR 645072
DI 10.3389/fnut.2021.645072
PG 10
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA RZ8WY
UT WOS:000648881600001
PM 33987198
OA Green Published, gold
DA 2025-04-28
ER

PT J
AU Wigle, DT
   Turner, MC
   Gomes, J
   Parent, ME
AF Wigle, Donald T.
   Turner, Michelle C.
   Gomes, James
   Parent, Marie-Elise
TI Role of hormonal and other factors in human prostate cancer
SO JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART B-CRITICAL REVIEWS
LA English
DT Review
ID RECEPTOR GENE POLYMORPHISMS; OCCUPATIONAL RISK-FACTORS; ENDOGENOUS
   SEX-HORMONES; BODY-MASS INDEX; GROWTH-FACTOR-I; EXCISION-REPAIR
   CAPACITY; META-REGRESSION ANALYSIS; LARGE PROSPECTIVE COHORT; RETINOL
   EFFICACY TRIAL; IGF BINDING PROTEIN-3
AB American men have a lifetime risk of about 18% for prostate cancer diagnosis. Large international variations in prostate cancer risks and increased risks among migrants from low- to high-risk countries indicate important roles for environmental factors. Major known risk factors include age, family history, and country/ethnicity. Type 2 diabetes appears to reduce risk, while high birth weight and adult height are linked to increased risk of aggressive prostate cancer. Limited evidence supports an association with a history of sexually transmitted infections. A previous meta-analysis of eight cohort studies indicated no associations with plasma androgen, estrogen, or sex hormone binding globulin (SHBG) levels. However, there were dose-response relationships with baseline plasma testosterone levels in two studies that adjusted for other serum hormones and obesity. Finasteride (a drug that blocks testosterone activation) reduced prostate cancer risk by 25%. Low-frequency genes linked to familial prostate cancer only explain a small fraction of all cases. Sporadic cases were linked to relatively common polymorphisms of genes involved in (1) androgen synthesis, activation, inactivation and excretion, (2) hormone and vitamin D receptors, (3) carcinogen metabolism, and (4) DNA repair. Epidemiologic evidence supports protective roles for dietary selenium, vitamin E, pulses, tomatoes/lycopene, and soy foods, and high plasma 1,25-diliydroxyvitamin D levels. There is inadequate evidence that vegetables, fruit, carotenoids, and vitamins A and C reduce risk and that animal fat, alpha-linoleic acid, meat, coffee, and tea increase risk. Two major cohort studies found dose-response relationships with dietary calcium intake. Total dietary energy intake may enhance risk. Limited evidence supports a protective role for physical activity and elevated risk for farmers and other men with occupational pesticide exposure, particularly to organochlorine compounds and phenoxy herbicides. There is inadequate evidence for a relationship with alcohol or smoking. Most known or suspected external risk factors may act through hormonal mechanisms, but our review found little supporting evidence, and substantial further research is needed.
C1 [Wigle, Donald T.; Turner, Michelle C.] Univ Ottawa, Inst Populat Hlth, McLaughlin Ctr Populat Hlth Risk Assessment, Ottawa, ON K1N 6N5, Canada.
   [Gomes, James] Univ Ottawa, Fac Hlth Sci, Ottawa, ON K1N 6N5, Canada.
   [Parent, Marie-Elise] Univ Quebec, INRS Inst Armand Frappier, Laval, PQ, Canada.
C3 University of Ottawa; University of Ottawa; University of Quebec;
   Institut national de la recherche scientifique (INRS)
RP Wigle, DT (corresponding author), Univ Ottawa, Inst Populat Hlth, McLaughlin Ctr Populat Hlth Risk Assessment, Room 318B,1 Stewart St, Ottawa, ON K1N 6N5, Canada.
EM don.wigle@sympatico.ca
RI Gomes, James/R-8363-2017; Parent, Marie-Elise/LCE-1267-2024; Turner,
   Michelle C/F-7659-2017
OI Parent, Marie-Elise/0000-0002-4196-3773; Turner, Michelle
   C/0000-0002-6431-1997
CR Adami HO, 2003, CANCER EPIDEM BIOMAR, V12, P872
   Agalliu I, 2006, PROSTATE, V66, P146, DOI 10.1002/pros.20305
   Ahonen MH, 2000, CANCER CAUSE CONTROL, V11, P847, DOI 10.1023/A:1008923802001
   Alavanja MCR, 2003, AM J EPIDEMIOL, V157, P800, DOI 10.1093/aje/kwg040
   Alavanja MCR, 2005, SCAND J WORK ENV HEA, V31, P39
   *AM CANC SOC, 2006, CANC FACTS FIG 2006
   [Anonymous], NIH PUB
   Antognelli C, 2005, PROSTATE, V63, P240, DOI 10.1002/pros.20184
   Aronson KJ, 1996, AM J EPIDEMIOL, V143, P363
   Astorg P, 2004, CANCER CAUSE CONTROL, V15, P367, DOI 10.1023/B:CACO.0000027498.94238.a3
   Baglietto L, 2006, INT J CANCER, V119, P1501, DOI 10.1002/ijc.21983
   Ballard T, 2000, AVIAT SPACE ENVIR MD, V71, P216
   BARRETTCONNOR E, 1990, CANCER RES, V50, P169
   Bernal-Delgado E, 1998, FERTIL STERIL, V70, P191, DOI 10.1016/S0015-0282(98)00142-3
   Berndt SI, 2006, J UROLOGY, V175, P1613, DOI 10.1016/S0022-5347(05)00958-4
   Berndt SI, 2005, NUTRITION, V21, P686, DOI 10.1016/j.nut.2004.11.012
   Binnie MC, 2005, PROSTATE, V63, P309, DOI 10.1002/pros.20178
   Bonovas S, 2004, DIABETOLOGIA, V47, P1071, DOI 10.1007/s00125-004-1415-6
   Bosland M C, 2000, J Natl Cancer Inst Monogr, P39
   BRAUN MM, 1995, CANCER CAUSE CONTROL, V6, P235, DOI 10.1007/BF00051795
   Brouwer IA, 2004, J NUTR, V134, P919, DOI 10.1093/jn/134.4.919
   Bruner DW, 2003, INT J CANCER, V107, P797, DOI 10.1002/ijc.11466
   BRUSICK D, 1986, MUTAT RES, V169, P105, DOI 10.1016/0165-1218(86)90089-3
   Buxton JA, 1999, AM J IND MED, V35, P82, DOI 10.1002/(SICI)1097-0274(199901)35:1<82::AID-AJIM11>3.0.CO;2-E
   Cáceres DD, 2005, EUR J EPIDEMIOL, V20, P79, DOI 10.1007/s10654-004-1632-9
   Chan JM, 2001, AM J CLIN NUTR, V74, P549
   Chang BL, 2002, CANCER RES, V62, P1784
   Charles LE, 2003, AM J EPIDEMIOL, V157, P683, DOI 10.1093/aje/kwg044
   Chen C, 2003, CANCER EPIDEM BIOMAR, V12, P1410
   Chu KC, 2003, CANCER-AM CANCER SOC, V97, P1507, DOI 10.1002/cncr.11212
   Cicek MS, 2004, PROSTATE, V59, P69, DOI 10.1002/pros.10358
   COMSTOCK GW, 1993, CANCER EPIDEM BIOMAR, V2, P219
   Costa I, 2005, PROSTATE, V64, P246, DOI 10.1002/pros.20241
   Culig Z, 2000, UROL RES, V28, P211, DOI 10.1007/s002400000111
   Dagnelie PC, 2004, BJU INT, V93, P1139, DOI 10.1111/j.1464-410X.2004.04795.x
   Dennis LK, 2002, PROSTATE CANCER P D, V5, P193, DOI 10.1038/sj.pcan.4500586
   Dennis LK, 2002, EPIDEMIOLOGY, V13, P72, DOI 10.1097/00001648-200201000-00012
   Dennis LK, 2000, PROSTATE, V42, P56
   Dillner J, 1998, INT J CANCER, V75, P564, DOI 10.1002/(SICI)1097-0215(19980209)75:4<564::AID-IJC12>3.0.CO;2-9
   Ding EL, 2006, JAMA-J AM MED ASSOC, V295, P1288, DOI 10.1001/jama.295.11.1288
   Dong XY, 2003, AM J HUM GENET, V72, P270, DOI 10.1086/346094
   DONN AS, 1985, B CANCER, V72, P381
   Dorgan JP, 1998, CANCER EPIDEM BIOMAR, V7, P1069
   Douglas JA, 2005, CANCER EPIDEM BIOMAR, V14, P2035, DOI 10.1158/1055-9965.EPI-05-0170
   Eaton NE, 1999, BRIT J CANCER, V80, P930, DOI 10.1038/sj.bjc.6690445
   Ellem S J, 2006, Minerva Endocrinol, V31, P1
   Ellison LF, 2000, EUR J CANCER PREV, V9, P125, DOI 10.1097/00008469-200004000-00009
   Engeland A, 2003, BRIT J CANCER, V89, P1237, DOI 10.1038/sj.bjc.6601206
   Enokida H, 2006, CANCER-AM CANCER SOC, V106, P79, DOI 10.1002/cncr.21577
   Enokida H, 2004, CANCER RES, V64, P5956, DOI 10.1158/0008-5472.CAN-04-0081
   Etminan M, 2005, CANCER CAUSE CONTROL, V16, P1125, DOI 10.1007/s10552-005-0334-2
   Etminan M, 2004, CANCER EPIDEM BIOMAR, V13, P340
   Farnham JM, 2005, HUM GENET, V116, P179, DOI 10.1007/s00439-004-1220-9
   Friedenreich CM, 2002, J NUTR, V132, p3456S, DOI 10.1093/jn/132.11.3456S
   Fukatsu T, 2004, ANTICANCER RES, V24, P2431
   Gann PH, 1996, J NATL CANCER I, V88, P1118, DOI 10.1093/jnci/88.16.1118
   Gao X, 2005, JNCI-J NATL CANCER I, V97, P1768, DOI 10.1093/jnci/dji402
   Gayther SA, 2000, CANCER RES, V60, P4513
   Giles GG, 2001, ANN ONCOL, V12, P761, DOI 10.1023/A:1011131105617
   Giovannucci E, 2006, CANCER EPIDEM BIOMAR, V15, P203, DOI 10.1158/1055-9965.EPI-05-0586
   Giovannucci E, 2004, INT J EPIDEMIOL, V33, P217, DOI 10.1093/ije/dyh020
   Giovannucci EL, 2005, ARCH INTERN MED, V165, P1005, DOI 10.1001/archinte.165.9.1005
   Goldacre MJ, 2005, FERTIL STERIL, V84, P1438, DOI 10.1016/j.fertnstert.2005.04.052
   Gonzalez CA, 2006, PUBLIC HEALTH NUTR, V9, P124, DOI 10.1079/PHN2005934
   Govannucci E, 2007, GASTROENTEROLOGY, V132, P2208, DOI 10.1053/j.gastro.2007.03.050
   Grimberg A, 2000, J CELL PHYSIOL, V183, P1, DOI 10.1002/(SICI)1097-4652(200004)183:1<1::AID-JCP1>3.0.CO;2-J
   Gsur A, 2004, WORLD J UROL, V21, P414, DOI 10.1007/s00345-003-0378-4
   Guess HA, 1997, CANCER EPIDEM BIOMAR, V6, P21
   Gun RT, 2006, OCCUP ENVIRON MED, V63, P476, DOI 10.1136/oem.2005.023796
   Härkönen PL, 2004, J STEROID BIOCHEM, V92, P297, DOI 10.1016/j.jsbmb.2004.10.016
   Hayes RB, 1999, CANCER EPIDEM BIOMAR, V8, P25
   Hedelin M, 2006, CANCER CAUSE CONTROL, V17, P169, DOI 10.1007/s10552-005-0342-2
   Heikkilä R, 1999, CANCER, V86, P312, DOI 10.1002/(SICI)1097-0142(19990715)86:2<312::AID-CNCR15>3.3.CO;2-Z
   HEILBRUN LK, 1986, BRIT J CANCER, V54, P677, DOI 10.1038/bjc.1986.226
   Hemminki K, 2002, CANCER EPIDEM BIOMAR, V11, P1638
   Henderson BE, 2000, CARCINOGENESIS, V21, P427, DOI 10.1093/carcin/21.3.427
   Hickey K, 2001, EPIDEMIOL REV, V23, P115, DOI 10.1093/oxfordjournals.epirev.a000776
   Hirayama T, 1979, Natl Cancer Inst Monogr, P149
   Ho GYF, 2003, BRIT J CANCER, V88, P263, DOI 10.1038/sj.bjc.6600747
   Hodge AM, 2004, CANCER CAUSE CONTROL, V15, P11, DOI 10.1023/B:CACO.0000016568.25127.10
   Hsing AW, 2001, JNCI-J NATL CANCER I, V93, P783, DOI 10.1093/jnci/93.10.783
   Hsing AW, 2002, J NATL CANCER I, V94, P1648, DOI 10.1093/jnci/94.21.1648
   Hsing AW, 2002, CANCER EPIDEM BIOMAR, V11, P337
   HSING AW, 1993, CANCER EPIDEM BIOMAR, V2, P27
   Hsing AW, 2000, CANCER EPIDEM BIOMAR, V9, P1335
   Hu JJ, 2004, CANCER RES, V64, P1197, DOI 10.1158/0008-5472.CAN-03-2670
   Huang HY, 2003, AM J EPIDEMIOL, V157, P335, DOI 10.1093/aje/kwf210
   Huang LW, 2004, J ANDROL, V25, P330
   Huang XK, 2005, CANCER RES, V65, P3470, DOI 10.1158/0008-5472.CAN-04-2807
   Hubbard JS, 2004, UROLOGY, V63, P253, DOI 10.1016/j.urology.2003.09.060
   *INT AG RES CANC, 2005, GLOB 2002 CANC INC M
   *INT AG RES CANC, 1994, BER CADM MERC EXP GL
   Jacobs ET, 2004, J STEROID BIOCHEM, V89-90, P533, DOI 10.1016/j.jsbmb.2004.03.063
   Jain MG, 1998, INT J CANCER, V78, P707, DOI 10.1002/(SICI)1097-0215(19981209)78:6<707::AID-IJC7>3.0.CO;2-2
   Janssen JAMJL, 2004, J CLIN ENDOCR METAB, V89, P4391, DOI 10.1210/jc.2004-0232
   Ji Q, 2005, MOL CELL ENDOCRINOL, V229, P103, DOI 10.1016/j.mce.2004.08.012
   Jian L, 2005, INT J CANCER, V113, P1010, DOI 10.1002/ijc.20667
   Jian L, 2004, INT J CANCER, V108, P130, DOI 10.1002/ijc.11550
   John EM, 2005, CANCER RES, V65, P5470, DOI 10.1158/0008-5472.CAN-04-3134
   Johns LE, 2003, BJU INT, V91, P789, DOI 10.1046/j.1464-410X.2003.04232.x
   Kasper JS, 2006, CANCER EPIDEM BIOMAR, V15, P2056, DOI 10.1158/1055-9965.EPI-06-0410
   Keshava C, 2004, AM J EPIDEMIOL, V160, P825, DOI 10.1093/aje/kwh294
   King IB, 2005, CANCER EPIDEM BIOMAR, V14, P988, DOI 10.1158/1055-9965.EPI-04-0517
   Kolonel LN, 1996, CANCER CAUSE CONTROL, V7, P83, DOI 10.1007/BF00115640
   Kolonel LN, 2000, CANCER EPIDEM BIOMAR, V9, P795
   Korodi Z, 2005, CANCER EPIDEM BIOMAR, V14, P2952, DOI 10.1158/1055-9965.EPI-05-0602
   Kraft P, 2005, PLOS GENET, V1, P603, DOI 10.1371/journal.pgen.0010068
   Krstev S, 1998, AM J IND MED, V34, P421, DOI 10.1002/(SICI)1097-0274(199811)34:5<421::AID-AJIM2>3.0.CO;2-T
   Krüger S, 2005, LANCET ONCOL, V6, P566, DOI 10.1016/S1470-2045(05)70253-9
   Kumazawa T, 2004, INT J CANCER, V110, P140, DOI 10.1002/ijc.20070
   Lau KM, 2000, CANCER RES, V60, P3175
   LE ML, 1994, EPIDEMIOLOGY, V5, P276
   Leitzmann MF, 2004, AM J CLIN NUTR, V80, P204
   Li LC, 2004, BIOCHEM BIOPH RES CO, V321, P455, DOI 10.1016/j.bbrc.2004.06.164
   Li LC, 2001, J UROLOGY, V166, P705, DOI 10.1016/S0022-5347(05)66047-8
   Li SF, 2003, ANN NY ACAD SCI, V983, P161, DOI 10.1111/j.1749-6632.2003.tb05971.x
   Low YL, 2005, J NUTR, V135, P2680, DOI 10.1093/jn/135.11.2680
   Lynge E, 2002, J UROLOGY, V168, P488, DOI 10.1016/S0022-5347(05)64664-2
   MacInnis RJ, 2003, CANCER EPIDEM BIOMAR, V12, P1417
   MacInnis RJ, 2006, CANCER CAUSE CONTROL, V17, P989, DOI 10.1007/s10552-006-0049-z
   MacLean CH, 2006, JAMA-J AM MED ASSOC, V295, P403, DOI 10.1001/jama.295.4.403
   Malila N, 2006, EUR J CANCER PREV, V15, P103, DOI 10.1097/01.cej.0000197448.49239.60
   Marchesani M, 2003, JNCI-J NATL CANCER I, V95, P812, DOI 10.1093/jnci/95.11.812
   Mononen N, 2006, CANCER RES, V66, P743, DOI 10.1158/0008-5472.CAN-05-1723
   Mori T, 1996, JPN J CANCER RES, V87, P570, DOI 10.1111/j.1349-7006.1996.tb00261.x
   Muir KR, 2005, SCAND J WORK ENV HEA, V31, P55
   Murata M, 2001, CANCER LETT, V165, P171, DOI 10.1016/S0304-3835(01)00398-6
   Nam RK, 2003, CANCER EPIDEM BIOMAR, V12, P1429
   Negri E, 2005, INT J CANCER, V114, P648, DOI 10.1002/ijc.20755
   Nelson WG, 2001, ANN NY ACAD SCI, V952, P135, DOI 10.1111/j.1749-6632.2001.tb02734.x
   Neuhausen SL, 2005, PROSTATE, V64, P168, DOI 10.1002/pros.20216
   Nilsen TIL, 2005, INT J CANCER, V113, P1002, DOI 10.1002/ijc.20674
   Nock NL, 2006, CANCER EPIDEM BIOMAR, V15, P756, DOI 10.1158/1055-9965.EPI-05-0826
   Nock NL, 2006, CARCINOGENESIS, V27, P1842, DOI 10.1093/carcin/bgl022
   Nojima D, 2001, CANCER, V92, P2076, DOI 10.1002/1097-0142(20011015)92:8<2076::AID-CNCR1548>3.0.CO;2-A
   Nomura AM, 2001, EPIDEMIOL REV, V23, P126, DOI 10.1093/oxfordjournals.epirev.a000777
   Nomura AMY, 1996, CANCER EPIDEM BIOMAR, V5, P621
   Nomura AMY, 1998, CANCER CAUSE CONTROL, V9, P425, DOI 10.1023/A:1008875819232
   Nomura AMY, 1997, CANCER EPIDEM BIOMAR, V6, P487
   Noonan-Wheeler FC, 2006, PROSTATE, V66, P49, DOI 10.1002/pros.20320
   Ntais C, 2003, CANCER EPIDEM BIOMAR, V12, P1395
   Ntais C, 2005, CANCER EPIDEM BIOMAR, V14, P176
   Ntais C, 2003, CANCER EPIDEM BIOMAR, V12, P120
   Ogishima T, 2005, CLIN CANCER RES, V11, P1028
   Parent MÉ, 2001, EPIDEMIOL REV, V23, P138, DOI 10.1093/oxfordjournals.epirev.a000779
   Patel AV, 2005, CANCER EPIDEM BIOMAR, V14, P275
   PEEHL DM, 1986, IN VITRO CELL DEV B, V22, P82
   Plaskon LA, 2003, CANCER EPIDEM BIOMAR, V12, P604
   Platz EA, 2004, CANCER CAUSE CONTROL, V15, P255, DOI 10.1023/B:CACO.0000024245.24880.8a
   Platz EA, 2004, AM J EPIDEMIOL, V159, P444, DOI 10.1093/aje/kwh062
   Platz EA, 2003, CANCER RES, V63, P8542
   Platz EA, 1998, AM J EPIDEMIOL, V147, P1140
   Platz EA, 2002, J NUTR, V132, p3471S, DOI 10.1093/jn/132.11.3471S
   Pollak M, 1998, CANCER METAST REV, V17, P383, DOI 10.1023/A:1006154108619
   POTOSKY AL, 1995, JAMA-J AM MED ASSOC, V273, P548, DOI 10.1001/jama.273.7.548
   Pukkala E, 2002, BRIT MED J, V325, P567, DOI 10.1136/bmj.325.7364.567
   Quiñones LA, 2006, ASIAN J ANDROL, V8, P349, DOI 10.1111/j.1745-7262.2006.00135.x
   REICHMAN ME, 1990, CANCER RES, V50, P2311
   Ren CZ, 2004, CANCER RES, V64, P969, DOI 10.1158/0008-5472.CAN-03-2592
   Renehan AG, 2004, LANCET, V363, P1346, DOI 10.1016/S0140-6736(04)16044-3
   Reynolds P, 1999, AM J IND MED, V36, P271, DOI 10.1002/(SICI)1097-0274(199908)36:2<271::AID-AJIM6>3.3.CO;2-9
   Rhodes DR, 2002, CANCER RES, V62, P4427
   Ritchey JD, 2005, CANCER EPIDEM BIOMAR, V14, P1703, DOI 10.1158/1055-9965.EPI-04-0809
   Rodriguez C, 2005, AM J EPIDEMIOL, V161, P147, DOI 10.1093/aje/kwh334
   Rodriguez C, 2001, CANCER EPIDEM BIOMAR, V10, P345
   Rodriguez C, 2004, CANCER EPIDEM BIOMAR, V13, P378
   Rohrmann S, 2005, CANCER CAUSE CONTROL, V16, P1189, DOI 10.1007/s10552-005-0304-8
   Rovito PM, 2005, PROSTATE CANCER P D, V8, P69, DOI 10.1038/sj.pcan.4500780
   Rubin MA, 2004, CANCER RES, V64, P3814, DOI 10.1158/0008-5472.CAN-03-3881
   Rusiecki JA, 2006, INT J CANCER, V118, P3118, DOI 10.1002/ijc.21758
   Rusiecki JA, 2004, JNCI-J NATL CANCER I, V96, P1375, DOI 10.1093/jnci/djh264
   Salam MT, 2005, UROL ONCOL-SEMIN ORI, V23, P246, DOI 10.1016/j.urolonc.2004.12.014
   Schaid DJ, 2004, HUM MOL GENET, V13, pR103, DOI 10.1093/hmg/ddh072
   Schuurman AG, 1999, BRIT J CANCER, V80, P1107, DOI 10.1038/sj.bjc.6690472
   Schuurman AG, 2002, CANCER CAUSE CONTROL, V13, P573, DOI 10.1023/A:1016332208339
   Schuurman AG, 1999, CANCER CAUSE CONTROL, V10, P597, DOI 10.1023/A:1008925103542
   Sesso HD, 2001, INT J EPIDEMIOL, V30, P749, DOI 10.1093/ije/30.4.749
   Severi G, 2006, CANCER EPIDEM BIOMAR, V15, P86, DOI 10.1158/1055-9965.EPI-05-0633
   Shaneyfelt T, 2000, J CLIN ONCOL, V18, P847, DOI 10.1200/JCO.2000.18.4.847
   Sharma-Wagner S, 2000, J OCCUP ENVIRON MED, V42, P517, DOI 10.1097/00043764-200005000-00010
   Sharpe CR, 2002, EUR J CANCER PREV, V11, P497, DOI 10.1097/00008469-200210000-00013
   Sharpe CR, 2001, EPIDEMIOLOGY, V12, P546, DOI 10.1097/00001648-200109000-00014
   Sharpe RM, 1998, ENVIRON HEALTH PERSP, V106, pA220, DOI 10.2307/3433998
   Shi R, 2001, BRIT J CANCER, V85, P991, DOI 10.1054/bjoc.2001.1961
   Sieh W, 2006, CANCER CAUSE CONTROL, V17, P187, DOI 10.1007/s10552-005-0454-8
   Silig Y, 2006, CANCER INVEST, V24, P41, DOI 10.1080/07357900500449579
   SLATTERY ML, 1993, CANCER CAUSE CONTROL, V4, P559, DOI 10.1007/BF00052432
   Soffritti M, 2002, ANN NY ACAD SCI, V982, P46, DOI 10.1111/j.1749-6632.2002.tb04924.x
   Stattin P, 2004, J CLIN ONCOL, V22, P3104, DOI 10.1200/JCO.2004.10.105
   Stattin P, 2000, J NATL CANCER I, V92, P1910, DOI 10.1093/jnci/92.23.1910
   Stattin P, 2004, CANCER CAUSE CONTROL, V15, P1095, DOI 10.1007/s10552-004-1480-7
   Stattin P, 2004, INT J CANCER, V108, P418, DOI 10.1002/ijc.11572
   Stevens VL, 2005, CANCER CAUSE CONTROL, V16, P643, DOI 10.1007/s10552-005-0384-5
   Stewart RE, 1999, J OCCUP ENVIRON MED, V41, P1079, DOI 10.1097/00043764-199912000-00012
   Suzuki K, 2003, CANCER-AM CANCER SOC, V98, P1411, DOI 10.1002/cncr.11639
   Taylor ML, 2005, FAM MED, V37, P506
   Thellenberg-Karlsson C, 2006, CLIN CANCER RES, V12, P1936, DOI 10.1158/1078-0432.CCR-05-0269
   Thompson IM, 2003, NEW ENGL J MED, V349, P215, DOI 10.1056/NEJMoa030660
   Tokizane T, 2005, CLIN CANCER RES, V11, P5793, DOI 10.1158/1078-0432.CCR-04-2545
   Trummer H, 2002, HUM REPROD, V17, P1554, DOI 10.1093/humrep/17.6.1554
   Tseng M, 2005, AM J CLIN NUTR, V81, P1147
   Tuohimaa P, 2005, J STEROID BIOCHEM, V93, P183, DOI 10.1016/j.jsbmb.2004.12.009
   Tuohimaa P, 2004, INT J CANCER, V108, P104, DOI 10.1002/ijc.11375
   van den Brandt PA, 2003, CANCER EPIDEM BIOMAR, V12, P866
   van Gils CH, 2002, CANCER EPIDEM BIOMAR, V11, P1279
   van Maele-Fabry G, 2006, CANCER CAUSE CONTROL, V17, P353, DOI 10.1007/s10552-005-0443-y
   Van Maele-Fabry G, 2004, INT ARCH OCC ENV HEA, V77, P559, DOI 10.1007/s00420-004-0548-8
   vanderGulden JWJ, 1997, PROSTATE, V30, P107, DOI 10.1002/(SICI)1097-0045(19970201)30:2<107::AID-PROS6>3.0.CO;2-L
   Vatten LJ, 1997, CANCER EPIDEM BIOMAR, V6, P967
   Verougstraete V, 2003, J TOXICOL ENV HEAL B, V6, P227, DOI 10.1080/10937400306465
   Wadelius M, 1999, PHARMACOGENETICS, V9, P333, DOI 10.1097/00008571-199906000-00008
   Wahle KWJ, 2004, PROG LIPID RES, V43, P553, DOI 10.1016/j.plipres.2004.08.002
   Weinstein SJ, 2005, JNCI-J NATL CANCER I, V97, P396, DOI 10.1093/jnci/dji045
   Weston T L, 2000, Int J Occup Environ Health, V6, P194
   Wong O, 2000, REGUL TOXICOL PHARM, V32, P78, DOI 10.1006/rtph.2000.1410
   Xu JF, 2002, CANCER RES, V62, P2253
   Yan L, 2005, INT J CANCER, V117, P667, DOI 10.1002/ijc.21266
   Zeegers MP, 2004, CANCER EPIDEM BIOMAR, V13, P1765
   Zeegers MPA, 2005, CANCER EPIDEM BIOMAR, V14, P1490, DOI 10.1158/1055-9965.EPI-04-0771
   Zeegers MPA, 2004, J OCCUP ENVIRON MED, V46, P271, DOI 10.1097/01.jom.0000116961.48464.6b
   Zeigler-Johnson C, 2004, CANCER RES, V64, P8461, DOI 10.1158/0008-5472.CAN-04-1651
   Zhao H, 2005, CANCER-AM CANCER SOC, V104, P44, DOI 10.1002/cncr.21135
   Zhu K, 2004, AM J EPIDEMIOL, V159, P978, DOI 10.1093/aje/kwh139
NR 223
TC 43
Z9 57
U1 0
U2 31
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 1093-7404
EI 1521-6950
J9 J TOXICOL ENV HEAL B
JI J. Toxicol. Env. Health-Pt b-Crit. Rev.
PD MAR-APR
PY 2008
VL 11
IS 3-4
BP 242
EP 259
DI 10.1080/10937400701873548
PG 18
WC Environmental Sciences; Public, Environmental & Occupational Health;
   Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health; Toxicology
GA 299JZ
UT WOS:000255753200007
PM 18368555
DA 2025-04-28
ER

PT J
AU Sanlier, N
   Gokcen, BB
   Altug, M
AF Sanlier, Nevin
   Gokcen, Busra Basar
   Altug, Mehmet
TI Tea consumption and disease correlations
SO TRENDS IN FOOD SCIENCE & TECHNOLOGY
LA English
DT Review
DE Black tea; Green tea; Oolong tea; White tea; Cancer; Obesity; Diabetes
   mellitus; Cardiovascular diseases; Other diseases
ID COLORECTAL-CANCER RISK; GREEN TEA; BLACK TEA; BREAST-CANCER; WHITE TEA;
   SKIN-CANCER; LUNG-CANCER; CAMELLIA-SINENSIS; DIETARY POLYPHENOLS;
   IN-VITRO
AB Tea is the most widely consumed beverage in the world next to water and is obtained from the leaves Camellia sinensis. In recent years, the potential health benefits and effect mechanisms of tea have attracted a lot of interest. The potential health benefits of tea have been attributed to its various phenolic compounds with unique biological properties found in tea. These phenolic compounds are especially catethins and their derivatives, which constitute at most 30% of the dry weight of the tea. Tea is a new and effective strategy for reducing the severity of neurological diseases and for protecting against obesity, cardiovascular disease, type 2 diabetes and certain types of cancer (ovaryum, lung, skin, breast, endometrial, prostate, bladder, oral and colorectal cancers).
   Overall, the study that supports the health benefits of tea is increasing. But, the amounts of and the frequency of tea consumption that is associated with potential health benefits vary greatly from work to work and this situation creates difficulty in determining the optimal consumption amount and frequency that tea can exhibit health benefits. For this reason, we aimed to examine the health effect of the tea and how much consumption is to investigate whether it meets the claimed health benefits.
   Within that frame, there is a need for more studies on the possible health effects of tea. While studying on that effect, the effects of various doses, forms (in synthetic or natural product matrix), exposure in different periods (short or long term) on health should be studied. However, currently the conducted studies are promising for tea is a bioactive component like polyphenol, theaflavins, thearubigins, caffeine and mineral. In addition, although the fact intake with diet proved to be reliable at the end of the conducted acute and chronic toxicity test is another positive part, safety of bioactive component in tea should be supported through further studies.
C1 [Sanlier, Nevin] Lokman Hekim Univ, Nutr & Dietet Dept, Fac Hlth Sci, Ankara, Turkey.
   [Gokcen, Busra Basar] Gazi Univ, Fac Hlth Sci, Dept Nutr & Dietet, Ankara, Turkey.
   [Altug, Mehmet] Lokman Hekim Univ, Fac Med, Dept Med Biochem, Ankara, Turkey.
C3 Lokman Hekim University; Gazi University; Lokman Hekim University
RP Sanlier, N (corresponding author), Lokman Hekim Univ, Nutr & Dietet Dept, Fac Hlth Sci, Ankara, Turkey.
EM nevintekgul@gmail.com
RI Sanlier, Nevin/W-7657-2018; GÖKCEN, Büşra/AAA-3726-2021
OI Basar Gokcen, Busra/0000-0002-5628-3658
CR Agostoni C, 2012, EFSA J, V10, DOI 10.2903/j.efsa.2012.3000
   Agostoni C, 2011, EFSA J, V9, DOI 10.2903/j.efsa.2011.2055
   Agostoni C, 2010, EFSA J, V8, DOI 10.2903/j.efsa.2010.1463
   Almajano MP, 2011, NEUROTOX RES, V20, P372, DOI 10.1007/s12640-011-9252-0
   Alves MG, 2015, J FUNCT FOODS, V14, P102, DOI 10.1016/j.jff.2015.01.019
   Amin ARMR, 2013, TEA IN HEALTH AND DISEASE PREVENTION, P751, DOI 10.1016/B978-0-12-384937-3.00063-X
   Anderson RA, 2002, J AGR FOOD CHEM, V50, P7182, DOI 10.1021/jf020514c
   [Anonymous], AM FAMILY PHYS
   Arab L, 2013, AM J CLIN NUTR, V98, p1651S, DOI 10.3945/ajcn.113.059345
   Ardisson Korat Andres V, 2014, Curr Nutr Rep, V3, P345
   Asgari MM, 2011, NUTR CANCER, V63, P314, DOI 10.1080/01635581.2011.523496
   Asif Mohammad, 2014, J Educ Health Promot, V3, P1, DOI 10.4103/2277-9531.127541
   Baker JA, 2007, INT J GYNECOL CANCER, V17, P50, DOI 10.1111/j.1525-1438.2006.00773.x
   Quintana JLB, 2009, J AM COLL NUTR, V28, P1
   Bhardwaj P, 2013, CHIN J NAT MEDICINES, V11, P345, DOI 10.1016/S1875-5364(13)60051-5
   Bhoo-Pathy N, 2013, EUR J CANCER, V49, P703, DOI 10.1016/j.ejca.2012.09.014
   Bombak A., 2014, J INFORM, V104
   Bresson JL, 2015, EFSA J, V13, DOI 10.2903/j.efsa.2015.4251
   Brown SB, 2015, STEROIDS, V99, P8, DOI 10.1016/j.steroids.2014.12.013
   Butler LM, 2011, MOL NUTR FOOD RES, V55, P931, DOI 10.1002/mnfr.201100058
   Butt MS, 2014, CRIT REV FOOD SCI, V54, P1002, DOI 10.1080/10408398.2011.623198
   Capellino S, 2014, ANN NY ACAD SCI, V1317, P24, DOI 10.1111/nyas.12398
   Cappelletti S, 2015, CURR NEUROPHARMACOL, V13, P71, DOI 10.2174/1570159X13666141210215655
   Carneiro BM, 2016, VIROLOGY, V496, P215, DOI 10.1016/j.virol.2016.06.012
   Caruana M., 2015, TEA POLYPHENOLS PARK, P117
   Chacko Sabu M, 2010, Chin Med, V5, P13, DOI 10.1186/1749-8546-5-13
   Chan EWC, 2011, PHARMACOGN RES, V3, P266, DOI 10.4103/0974-8490.89748
   Chan RSM, 2010, INT J ENV RES PUB HE, V7, P765, DOI 10.3390/ijerph7030765
   Chen S, 2015, BIOCHEM BIOPH RES CO, V461, P1, DOI 10.1016/j.bbrc.2015.03.158
   Chen ZM, 2015, J ZHEJIANG UNIV-SC B, V16, P87, DOI 10.1631/jzus.B1500001
   Cheng M, 2017, FOOD RES INT, V92, P9, DOI 10.1016/j.foodres.2016.12.008
   Chumsri S, 2011, J STEROID BIOCHEM, V125, P13, DOI 10.1016/j.jsbmb.2011.02.001
   Cole L., 2016, ALZHEIMERS DIS HUMAN, P215
   Conney A. H., 2012, INHIBITION UVB INDUC, P61
   Cooper R, 2012, INT J FOOD SCI NUTR, V63, P90, DOI 10.3109/09637486.2011.629180
   Coppock R. W., 2016, GREEN TEA EXTRACT A2
   Crews L, 2010, HUM MOL GENET, V19, pR12, DOI 10.1093/hmg/ddq160
   Dai Q, 2010, ANN EPIDEMIOL, V20, P74, DOI 10.1016/j.annepidem.2009.09.005
   de Oliveira A, 2013, FOOD CHEM TOXICOL, V52, P207, DOI 10.1016/j.fct.2012.11.006
   Deka A, 2011, PHARMACOL RES, V64, P136, DOI 10.1016/j.phrs.2011.03.009
   Dela Cruz CS, 2011, CLIN CHEST MED, V32, P605, DOI 10.1016/j.ccm.2011.09.001
   Dias PM, 2014, J AGR FOOD CHEM, V62, P6655, DOI 10.1021/jf501611w
   Djalalinia S, 2015, PAK J MED SCI, V31, P239, DOI 10.12669/pjms.311.7033
   Dominianni C, 2013, BRIT J CANCER, V109, P1352, DOI 10.1038/bjc.2013.434
   Donepudi MS, 2014, J CANCER RES THER, V10, P506, DOI 10.4103/0973-1482.137927
   Dragicevic N, 2011, J ALZHEIMERS DIS, V26, P507, DOI 10.3233/JAD-2011-101629
   Du GJ, 2012, NUTRIENTS, V4, P1679, DOI 10.3390/nu4111679
   Dutta D, 2015, NEUROCHEM INT, V89, P181, DOI 10.1016/j.neuint.2015.08.005
   Eilat-Adar S, 2013, NUTRIENTS, V5, P3646, DOI 10.3390/nu5093646
   Feng L., 2015, TEA COGNITIVE HLTH F, P903
   Feng L, 2012, J NUTR HEALTH AGING, P1
   Feng WY, 2006, CURR DRUG METAB, V7, P755, DOI 10.2174/138920006778520552
   Figueroa TTH, 2004, ARCH LATINOAM NUTR, V54, P380
   Files J. A., 2010, MAYO CLIN P
   Firoz CK, 2015, SAUDI J BIOL SCI, V22, P19, DOI 10.1016/j.sjbs.2014.09.003
   Fleming M, 2012, J GASTROINTEST ONCOL, V3, P153, DOI 10.3978/j.issn.2078-6891.2012.030
   Fu QY, 2017, MOLECULES, V22, DOI 10.3390/molecules22050849
   Fuhrman BJ, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-25
   Fukazawa H., 2012, BIOL PHARM B, V35
   Gao Jing, 2005, Zhonghua Liu Xing Bing Xue Za Zhi, V26, P323
   Gao Y, 2016, ANTICANCER RES, V36, P643
   Glisan SL, 2017, FOOD CHEM, V216, P296, DOI 10.1016/j.foodchem.2016.08.052
   Goel AK, 2015, WORLD J CLIN CASES, V3, P20, DOI 10.12998/wjcc.v3.i1.20
   Gomez-Pinilla F, 2008, SURG NEUROL, V70, P333, DOI 10.1016/j.surneu.2008.05.023
   Gomez-Pinilla Fernando, 2011, Nutrition and Health (Bicester), V20, P165
   Gomez-Pinilla F, 2011, PM&R, V3, pS111, DOI 10.1016/j.pmrj.2011.03.001
   Gondoin A, 2010, FOOD RES INT, V43, P1537, DOI 10.1016/j.foodres.2010.04.029
   Green CJ, 2014, J EPIDEMIOL, V24, P146, DOI 10.2188/jea.JE20130063
   Hajiaghaalipour F, 2015, FOOD CHEM, V169, P401, DOI 10.1016/j.foodchem.2014.07.005
   Hanamura T, 2018, BREAST CANCER-TOKYO, V25, P379, DOI 10.1007/s12282-017-0772-1
   Hanson C, 2014, INT J CHRONIC OBSTR, V9, P723, DOI 10.2147/COPD.S50111
   He RR, 2009, CHIN J INTEGR MED, V15, P34, DOI 10.1007/s11655-009-0034-8
   Heber D, 2014, J NUTR, V144, P1385, DOI 10.3945/jn.114.191007
   Hintzpeter J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084468
   Ho Y., 2013, TEA HLTH DIS PREVENT
   Ho YS, 2013, TEA IN HEALTH AND DISEASE PREVENTION, P691, DOI 10.1016/B978-0-12-384937-3.00058-6
   Hodgson JM, 2008, ASIA PAC J CLIN NUTR, V17, P288
   Hoshino T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076306
   Hu G, 2007, MOVEMENT DISORD, V22, P2242, DOI 10.1002/mds.21706
   Huang J, 2014, EUR J CLIN NUTR, V68, P1075, DOI 10.1038/ejcn.2014.143
   Hunn J, 2012, CLIN OBSTET GYNECOL, V55, P3, DOI 10.1097/GRF.0b013e31824b4611
   Hursel R, 2009, INT J OBESITY, V33, P956, DOI 10.1038/ijo.2009.135
   Ide K, 2014, NUTRIENTS, V6, P4032, DOI 10.3390/nu6104032
   Inoue M, 2009, CANCER EPIDEM BIOMAR, V18, P1746, DOI 10.1158/1055-9965.EPI-08-0923
   Islam MS, 2011, PHYTOMEDICINE, V19, P25, DOI 10.1016/j.phymed.2011.06.025
   Iwasaki M., 2010, BREAST CANCER RES, V12, P1
   Je Y, 2015, NUTR CANCER, V67, P825, DOI 10.1080/01635581.2015.1040521
   Jing YL, 2009, J GEN INTERN MED, V24, P557, DOI 10.1007/s11606-009-0929-5
   Jochmann N, 2008, CURR OPIN CLIN NUTR, V11, P758, DOI 10.1097/MCO.0b013e328314b68b
   Johnson JJ, 2010, PHYTOMEDICINE, V17, P3, DOI 10.1016/j.phymed.2009.09.011
   Jowko E., 2014, ANTIOXIDANTS SPORT N, V123
   Kanchan T., 2016, SUDDEN NATURAL DEATH
   Katiyar SK, 2011, ARCH BIOCHEM BIOPHYS, V508, P152, DOI 10.1016/j.abb.2010.11.015
   Katiyar S, 2007, J NUTR BIOCHEM, V18, P287, DOI 10.1016/j.jnutbio.2006.08.004
   Khan N, 2013, CURR PHARM DESIGN, V19, P6141, DOI 10.2174/1381612811319340008
   Khan N, 2010, CANCER LETT, V293, P133, DOI 10.1016/j.canlet.2009.12.013
   Khan SI, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-91
   Kharroubi AT, 2015, WORLD J DIABETES, V6, P850, DOI 10.4239/wjd.v6.i6.850
   Kim YC, 2015, J VET SCI, V16, P135, DOI [10.4142/jvs.2015.16.2., 10.4142/jvs.2015.16.2.135]
   Kotsopoulos J, 2009, CANCER-AM CANCER SOC, V115, P2765, DOI 10.1002/cncr.24328
   Kumar D, 2015, ARCH PHYSIOL BIOCHEM, V121, P109, DOI 10.3109/13813455.2015.1043308
   Kumar G, 2010, MINI-REV MED CHEM, V10, P492, DOI 10.2174/138955710791384063
   Kumar Y., 2014, Polyphenols in human health and disease, P643, DOI [10.1016/B978-0-12-398456-2.00049-9, DOI 10.1016/B978-0-12-398456-2.00049-9]
   Kuriyama S, 2006, AM J CLIN NUTR, V83, P355
   Lambert JD, 2010, ARCH BIOCHEM BIOPHYS, V501, P65, DOI 10.1016/j.abb.2010.06.013
   Larsson SC, 2009, CANCER CAUSE CONTROL, V20, P2039, DOI 10.1007/s10552-009-9396-x
   Lee AH, 2013, CANCER EPIDEMIOL, V37, P54, DOI 10.1016/j.canep.2012.10.003
   Lee HJ, 2012, POULTRY SCI, V91, P66, DOI 10.3382/ps.2011-01645
   Leekha S., 2011, MAYO CLIN P
   Leong H, 2008, BREAST CANCER RES TR, V107, P359, DOI 10.1007/s10549-007-9568-x
   Leung ACY, 2016, CANCER EPIDEMIOL, V45, P119, DOI 10.1016/j.canep.2016.10.010
   Li Chia-Chun, 2016, Hu Li Za Zhi, V63, P5, DOI 10.6224/JN.63.5.5
   Li FJ, 2012, SCI WORLD J, DOI 10.1100/2012/923464
   Li M, 2016, CANCER EPIDEMIOL, V40, P73, DOI 10.1016/j.canep.2015.11.013
   Li Shenwei, 2011, Antiviral Chemistry & Chemotherapy, V21, P239, DOI 10.3851/IMP1774
   Li X., 2016, Encyclopedia of Food and Health, P279, DOI [10.1016/B978-0-12-384947-2.00684-X, DOI 10.1016/B978-0-12-384947-2.00684-X]
   Liang WB, 2007, EVID-BASED COMPL ALT, V4, P17, DOI 10.1093/ecam/nel066
   Liu H, 2013, J ZHEJIANG UNIV-SC B, V14, P47, DOI 10.1631/jzus.B1200218
   Lorenz M, 2013, AM J CLIN NUTR, V98, p1642S, DOI 10.3945/ajcn.113.058230
   Lu CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038332
   Lustosa BB, 2016, INT J CARDIOL, V225, P147, DOI 10.1016/j.ijcard.2016.09.092
   Ma QP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165861
   MacKenzie T, 2007, METABOLISM, V56, P1340, DOI 10.1016/j.metabol.2007.05.018
   Malongane F, 2017, J SCI FOOD AGR, V97, P4679, DOI 10.1002/jsfa.8472
   Mao J. T., 2013, WHITE TEA PLANTS PRO
   Mao JT, 2010, CANCER PREV RES, V3, P1132, DOI 10.1158/1940-6207.CAPR-09-0264
   Mao YS, 2016, SURG ONCOL CLIN N AM, V25, P439, DOI 10.1016/j.soc.2016.02.001
   Massano J, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a008870
   Matsumoto K, 2011, BMC COMPLEM ALTERN M, V11, DOI 10.1186/1472-6882-11-15
   Matthews C. M., 2010, BAYL U MED CTR P
   McCann SE, 2009, INT J CANCER, V124, P1650, DOI 10.1002/ijc.24125
   Meeran SM, 2009, J INVEST DERMATOL, V129, P1258, DOI 10.1038/jid.2008.354
   Meeusen R, 2014, SPORTS MED, V44, P47, DOI 10.1007/s40279-014-0150-5
   Meydani M, 2010, NUTRIENTS, V2, P737, DOI 10.3390/nu2070737
   Miao M, 2015, FOOD CHEM, V186, P20, DOI 10.1016/j.foodchem.2015.02.049
   Miller PE, 2017, AM J MED, V130, P188, DOI 10.1016/j.amjmed.2016.08.038
   Mineharu Y, 2011, J EPIDEMIOL COMMUN H, V65, P230, DOI 10.1136/jech.2009.097311
   Miura K, 2015, NUTR CANCER, V67, P1049, DOI 10.1080/01635581.2015.1073759
   Mo H., 2013, OXIDATIVE MED CELLUL, V2013
   Moore RJ, 2009, BRIT J NUTR, V102, P1790, DOI 10.1017/S0007114509991218
   Moseley VR, 2013, ANTICANCER RES, V33, P5325
   Mousavi A, 2013, J RES MED SCI, V18, P1080
   Munday R., 2016, TEA HLTH EFFECTS ENC, P273
   Nagini S, 2013, TEA IN HEALTH AND DISEASE PREVENTION, P737, DOI 10.1016/B978-0-12-384937-3.00062-8
   Naito Y, 2009, J CARDIOVASC PHARM, V54, P385, DOI 10.1097/FJC.0b013e3181b6e7a1
   Nandakumar V, 2011, CARCINOGENESIS, V32, P537, DOI 10.1093/carcin/bgq285
   Ng TP, 2008, AM J CLIN NUTR, V88, P224, DOI 10.1093/ajcn/88.1.224
   Noguchi-Shinohara M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096013
   Norval M, 2011, PHOTOCH PHOTOBIO SCI, V10, P199, DOI 10.1039/c0pp90044c
   Odegaard AO, 2008, AM J CLIN NUTR, V88, P979, DOI 10.1093/ajcn/88.4.979
   Oh H, 2017, BREAST CANCER RES, V19, DOI 10.1186/s13058-017-0810-0
   Onakpoya I, 2014, NUTR METAB CARDIOVAS, V24, P823, DOI 10.1016/j.numecd.2014.01.016
   Oppeneer SJ, 2011, NUTR CANCER, V63, P817, DOI 10.1080/01635581.2011.594210
   Pan HB, 2016, MOLECULES, V21, DOI 10.3390/molecules21121659
   Pan TH, 2003, DRUG AGING, V20, P711, DOI 10.2165/00002512-200320100-00001
   Pang HH, 2016, J CLIN ONCOL, V34, P3992, DOI 10.1200/JCO.2016.67.7088
   Pil L, 2016, PREV MED, V93, P177, DOI 10.1016/j.ypmed.2016.10.005
   Pillai SK, 2015, HEALTH SECUR, V13, P355, DOI 10.1089/hs.2015.0033
   Prediger RDS, 2010, J ALZHEIMERS DIS, V20, pS205, DOI 10.3233/JAD-2010-091459
   Qi GY, 2017, J FUNCT FOODS, V34, P168, DOI 10.1016/j.jff.2017.04.031
   Rafieian-Kopaei Mahmoud, 2017, Electron Physician, V9, P3838, DOI 10.19082/3838
   Rafieian-Kopaei Mahmoud, 2014, J Nephropharmacol, V3, P21
   Rains TM, 2011, J NUTR BIOCHEM, V22, P1, DOI 10.1016/j.jnutbio.2010.06.006
   Rees JR, 2007, J AM ACAD DERMATOL, V56, P781, DOI 10.1016/j.jaad.2006.11.038
   Reygaert W, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00162
   Reygaert WC, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00434
   Roghani Mehrdad, 2010, Pathophysiology, V17, P55, DOI 10.1016/j.pathophys.2009.07.004
   Saito E, 2015, ANN EPIDEMIOL, V25, P512, DOI 10.1016/j.annepidem.2015.03.007
   Samanta T, 2015, J FOOD SCI TECH MYS, V52, P2387, DOI 10.1007/s13197-013-1230-5
   Sampath C, 2017, BIOMED PHARMACOTHER, V87, P73, DOI 10.1016/j.biopha.2016.12.082
   Satoh T, 2015, J ETHNOPHARMACOL, V161, P147, DOI 10.1016/j.jep.2014.12.009
   Schmidt A, 2014, PSYCHOPHARMACOLOGY, V231, P3879, DOI 10.1007/s00213-014-3526-1
   Seebaluck-Sandoram R, 2017, MEDICINAL SPICES AND VEGETABLES FROM AFRICA: THERAPEUTIC POTENTIAL AGAINST METABOLIC, INFLAMMATORY, INFECTIOUS AND SYSTEMIC DISEASES, P133, DOI 10.1016/B978-0-12-809286-6.00005-4
   Seib K. L., 2016, EPIGENETICS INFECT D
   Seidl SE, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00036
   Selena Ahmed J. R. S., 2012, GREEN TEA PLANTS PRO
   Serafini M., 2011, HLTH BENEFITS HERBAL
   Shah R, 2014, WORLD J CLIN ONCOL, V5, P283, DOI 10.5306/wjco.v5.i3.283
   Sharangi AB, 2009, FOOD RES INT, V42, P529, DOI 10.1016/j.foodres.2009.01.007
   Shen W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137781
   Shrubsole MJ, 2009, J NUTR, V139, P310, DOI 10.3945/jn.108.098699
   Shukla AP, 2015, J CARDIOPULM REHABIL, V35, P81, DOI 10.1097/HCR.0000000000000112
   Siegel R, 2014, CA-CANCER J CLIN, V64, P104, DOI [10.3322/caac.21220, 10.3322/caac.21395]
   Sing MF, 2011, EUR J CANCER PREV, V20, P157, DOI 10.1097/CEJ.0b013e3283447497
   Singh NA, 2016, NUTR J, V15, DOI 10.1186/s12937-016-0179-4
   Sinha D., 2017, SEM CANC BIOL
   Sinha R., 2012, AM J CLIN NUTR AJCN
   Sinreih M, 2017, DATA BRIEF, V12, P632, DOI 10.1016/j.dib.2017.04.050
   Sisti JS, 2015, CANCER EPIDEM BIOMAR, V24, P1174, DOI 10.1158/1055-9965.EPI-15-0246
   Smith P J, 2016, J Prev Alzheimers Dis, V3, P53
   Song FJ, 2012, CANCER RES, V72, P3282, DOI 10.1158/0008-5472.CAN-11-3511
   Steinmann J, 2013, BRIT J PHARMACOL, V168, P1059, DOI 10.1111/bph.12009
   Striegel Lisa, 2015, Front Nutr, V2, P3, DOI 10.3389/fnut.2015.00003
   Su LJ, 2002, PUBLIC HEALTH NUTR, V5, P419, DOI 10.1079/PHN2001314
   Suzuki Y, 2005, J EPIDEMIOL, V15, P118, DOI 10.2188/jea.15.118
   Suzuki Y, 2012, P JPN ACAD B-PHYS, V88, P88, DOI 10.2183/pjab.88.88
   Suzuki-Sugihara N, 2016, NUTR RES, V36, P16, DOI 10.1016/j.nutres.2015.10.012
   Tam JHK, 2017, CEREBRAL CORTEX IN NEURODEGENERATIVE AND NEUROPSYCHIATRIC DISORDERS: EXPERIMENTAL APPROACHES TO CLINICAL ISSUES, P83, DOI 10.1016/B978-0-12-801942-9.00004-5
   Tang NP, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.07.030
   Tang NP, 2009, LUNG CANCER, V65, P274, DOI 10.1016/j.lungcan.2008.12.002
   Tang WP, 2013, J FUNCT FOODS, V5, P1784, DOI 10.1016/j.jff.2013.08.007
   Tarride Jean-Eric, 2009, Can J Cardiol, V25, pe195
   Taylor Peter W, 2005, Food Sci Technol Bull, V2, P71, DOI 10.1616/1476-2137.14184
   Tenore GC, 2015, FOOD CHEM, V169, P320, DOI 10.1016/j.foodchem.2014.08.006
   Tenore GC, 2013, FOOD CHEM, V141, P2379, DOI 10.1016/j.foodchem.2013.04.128
   Thakur VS, 2012, CURR PHARM BIOTECHNO, V13, P191
   Tomata Y, 2016, AM J GERIAT PSYCHIAT, V24, P881, DOI 10.1016/j.jagp.2016.07.009
   Trudel D, 2012, GYNECOL ONCOL, V126, P491, DOI 10.1016/j.ygyno.2012.04.048
   Tucci SA, 2010, PHARMACEUTICALS-BASE, V3, P748, DOI 10.3390/ph3030748
   Türközü D, 2017, CRIT REV FOOD SCI, V57, P254, DOI 10.1080/10408398.2014.986672
   Uchiyama S, 2011, NUTRITION, V27, P287, DOI 10.1016/j.nut.2010.01.019
   Unno T, 2009, J NUTR SCI VITAMINOL, V55, P447, DOI 10.3177/jnsv.55.447
   Ustun C., 2013, MERSIN U TIP FAKULTE, V3, P8
   van Dieren S, 2009, DIABETOLOGIA, V52, P2561, DOI 10.1007/s00125-009-1516-3
   Velayutham P, 2008, CURR MED CHEM, V15, P1840
   Venkateswara Babu, 2011, J Indian Soc Periodontol, V15, P18, DOI 10.4103/0972-124X.82258
   Vernarelli JA, 2013, EUR J NUTR, V52, P1039, DOI 10.1007/s00394-012-0410-9
   Wang LF, 2014, NUTRITION, V30, P1122, DOI 10.1016/j.nut.2014.02.023
   Wang S, 2014, J NUTR BIOCHEM, V25, P1, DOI 10.1016/j.jnutbio.2013.09.001
   Wang WC, 2014, ORAL ONCOL, V50, P276, DOI 10.1016/j.oraloncology.2013.12.014
   Wang Y., 2016, SCI REPORTS, V6
   Wang YP, 2012, LUNG CANCER, V78, P169, DOI 10.1016/j.lungcan.2012.08.009
   Wang Y, 2009, J AGR FOOD CHEM, V57, P8109, DOI 10.1021/jf804025c
   Wang ZJ, 2013, WORLD J GASTROENTERO, V19, P2683, DOI 10.3748/wjg.v19.i17.2683
   Westerterp-Plantenga MS, 2010, PHYSIOL BEHAV, V100, P42, DOI 10.1016/j.physbeh.2010.02.005
   White M., 2014, ROLE OXIDATIVE STRES
   Wile J., 2009, NUTR METAB, V6, P1
   Wu AH, 2003, INT J CANCER, V106, P574, DOI 10.1002/ijc.11259
   Wu Y., 2013, DATE BLACK TEA GREEN, V2, P1
   Xia EH, 2017, MOL PLANT, V10, P866, DOI 10.1016/j.molp.2017.04.002
   Xiang LP, 2016, NUTRIENTS, V8, DOI 10.3390/nu8080458
   Yajima H., 2014, PREVENTION DIET INDU, V12
   Yang G, 2011, CARCINOGENESIS, V32, P1684, DOI 10.1093/carcin/bgr186
   Yang J, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005632
   Yang TO, 2015, AM J CLIN NUTR, V101, P570, DOI 10.3945/ajcn.113.081836
   Yang TT, 2017, BIOCHEM BIOPH RES CO, V489, P96, DOI 10.1016/j.bbrc.2017.05.095
   Yang XP, 2016, J SCI FOOD AGR, V96, P777, DOI 10.1002/jsfa.7147
   Yasui K, 2010, BIOMED RES-TOKYO, V31, P183, DOI 10.2220/biomedres.31.183
   Ye P, 2009, J HUAZHONG U SCI-MED, V29, P169, DOI 10.1007/s11596-009-0206-1
   Yu Y, 2014, APOPTOSIS, V19, P1, DOI 10.1007/s10495-013-0908-5
   Yuan JM, 2011, MOL NUTR FOOD RES, V55, P886, DOI 10.1002/mnfr.201000637
   Zhan X., 2017, TEA CONSUMPTION RISK
   Zhang M, 2002, CANCER EPIDEM BIOMAR, V11, P713
   Zhang XB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025822
   Zhang YW, 2013, WORLD J GASTROENTERO, V19, P5598, DOI 10.3748/wjg.v19.i34.5598
   Zhong W, 2015, EXP THER MED, V9, P405, DOI 10.3892/etm.2014.2135
   Zhou JY, 2016, BJOG-INT J OBSTET GY, V123, P90, DOI 10.1111/1471-0528.14007
   Zhou JB, 2007, P NATL ACAD SCI USA, V104, P16158, DOI 10.1073/pnas.0702596104
NR 248
TC 111
Z9 118
U1 7
U2 225
PU ELSEVIER SCIENCE LONDON
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 0924-2244
J9 TRENDS FOOD SCI TECH
JI Trends Food Sci. Technol.
PD AUG
PY 2018
VL 78
BP 95
EP 106
DI 10.1016/j.tifs.2018.05.026
PG 12
WC Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology
GA GP6BC
UT WOS:000440960900008
DA 2025-04-28
ER

PT J
AU Aldhirgham, TM
   Almutairi, LA
   Alraqea, AS
   Alqahtani, AS
AF Aldhirgham, Tahrir M. M.
   Almutairi, Lulu A. A.
   Alraqea, Atheer S. S.
   Alqahtani, Amani S. S.
TI Online Arabic Beverage Frequency Questionnaire (ABFQ): evaluation of
   validity and reliability
SO NUTRITION JOURNAL
LA English
DT Article
DE Online questionnaire; Validity; Reliability; Fluid; Beverage; Arabic;
   MENA-region
ID SUGAR-SWEETENED BEVERAGES; SAUDI-ARABIA; CONSUMPTION; HYDRATION;
   OBESITY; RISK; ADULTS; CHILDREN; WATER; ADOLESCENTS
AB BackgroundObesity and chronic diseases are significant public health issues in the Middle East and North Africa region. A robust body of evidence demonstrated the association between beverage consumption, obesity, and chronic diseases. Therefore, the assessment of beverage consumption is gaining more interest in health policy development, food industry partnerships, research expansion and community involvement. Although beverage-consumption assessment tools have been developed for various populations, none were developed for the Arabic population. In this study, we developed and validated an online Arabic Beverage Frequency Questionnaire (ABFQ) to assess the total beverage intake among Arabic speaking population.MethodsA cross-sectional validation study was conducted among healthy adults aged between 18 and 55 years. Participants (n = 49) completed a 24-item ABFQ on two occasions and provided one 24-h urine sample. For validity, total beverage consumption (ABFQ1) was assessed against a 24-h urine sample using an osmolality test and correlation analysis. Reliability was assessed by comparing the participants' consumption in total and for every 24 individual items from ABFQ1 with the total and individual items in ABFQ2 using correlation and paired sample t-test.ResultsThe average daily consumption of beverages was 1504 ml/day, while the average urine osmolality/kg was 614. The validity assessment between ABFQ and urine osmolality indicates a negative correlation. However, the correlation was week and not statistically significant (r(s) = -0.2, p = 0.12). In reliability test, correlation analysis was positive and acceptable in all beverage categories (r(s) = 0.4 - 0.9; all p < 0.05) except flavored milk (r(s) = 0.2; p < 0.181) and sweetened coffee (r(s) = 0.3; p < 0.022). Furthermore, no significant differences were found between the means of total consumption in both ABFQ1 and ABFQ2.ConclusionsThe finding of this study suggest that the ABFQ is a reliable reproducible tool for assessing beverage consumption among Arabic-speaking consumers. However, the survey could not be validated using 24-h urine osmolality only and other methods such as multi dietary records may use in future re-assessment.
C1 [Aldhirgham, Tahrir M. M.; Almutairi, Lulu A. A.; Alraqea, Atheer S. S.; Alqahtani, Amani S. S.] Saudi Food & Drug Author SFDA, Execut Dept Res & Studies, Northern Ring Branch Rd, Riyadh 714813513, Saudi Arabia.
RP Aldhirgham, TM (corresponding author), Saudi Food & Drug Author SFDA, Execut Dept Res & Studies, Northern Ring Branch Rd, Riyadh 714813513, Saudi Arabia.
EM tmdhirgham@sfda.gov.sa
RI aldhirgham, tahrir/MDS-9933-2025
OI Almutairi, Lulu/0000-0001-9140-8666; Aldhirgham,
   Tahrir/0000-0001-6524-8443
CR Al Otaibi HH., 2017, BIOMED RES-TOKYO, V28, P8484
   Al-Ansari B, 2016, ADDICTION, V111, P1703, DOI 10.1111/add.13159
   Alfawaz HA, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17197020
   Ali HI, 2019, NUTRIENTS, V11, DOI 10.3390/nu11092110
   Alsubaie ASR, 2017, SAUDI MED J, V38, P1045, DOI 10.15537/smj.2017.10.19849
   Alzaman N, 2016, J TAIBAH UNIV MED SC, V11, P301, DOI 10.1016/j.jtumed.2016.03.009
   [Anonymous], Noncommunicable Diseases
   [Anonymous], NUTR BOD MASS IND
   [Anonymous], Population total, Middle East & North Africa
   [Anonymous], FOODDATA CENTR
   Armstrong LE, 2012, CLIN OBES, V2, P115, DOI 10.1111/cob.12006
   Bello LL, 2006, INT J PAEDIATR DENT, V16, P168, DOI 10.1111/j.1365-263X.2006.00715.x
   Benajiba N., 2019, Pakistan Journal of Nutrition, V18, P401, DOI [10.3923/pjn.2019.401.407, DOI 10.3923/PJN.2019.401.407]
   Borys JM, 2014, OBESITY FACTS, V7, P37, DOI 10.1159/000360748
   Brunkwall L, 2020, EUR J NUTR, V59, P3715, DOI 10.1007/s00394-020-02202-7
   Cade J, 2002, PUBLIC HEALTH NUTR, V5, P567, DOI 10.1079/PHN2001318
   Cooperation Council for the Arab States of the Gulf, 2021, GCC
   Ho DKN, 2020, CLIN NUTR, V39, P2945, DOI 10.1016/j.clnu.2020.08.002
   Della Torre SB, 2016, J ACAD NUTR DIET, V116, P638, DOI 10.1016/j.jand.2015.05.020
   El Bcheraoui C, 2015, NUTR DIET SUPPL, V7, P41, DOI 10.2147/NDS.S77460
   Fausnacht AG, 2020, J HUM NUTR DIET, V33, P729, DOI 10.1111/jhn.12749
   Ferreira-Pêgo C, 2016, NUTRIENTS, V8, DOI 10.3390/nu8080475
   Forouzanfar MH, 2015, LANCET, V386, P2287, DOI 10.1016/S0140-6736(15)00128-2
   Guelinckx I, 2016, NUTRIENTS, V8, DOI 10.3390/nu8100630
   Hedrick VE, 2012, J ACAD NUTR DIET, V112, P840, DOI 10.1016/j.jand.2012.01.023
   Hedrick VE, 2010, J AM DIET ASSOC, V110, P1227, DOI 10.1016/j.jada.2010.05.005
   Hu FB, 2010, PHYSIOL BEHAV, V100, P47, DOI 10.1016/j.physbeh.2010.01.036
   International Diabetes Federation, 2019, IDF Diabetes Atlas, Vninth
   Islam MA, 2020, SAUDI PHARM J, V28, P1635, DOI 10.1016/j.jsps.2020.10.010
   Lafontan M, 2014, OBESITY FACTS, V7, P1, DOI 10.1159/000360666
   Lemetais G, 2018, EUR J NUTR, V57, P1883, DOI 10.1007/s00394-017-1471-6
   Malik VS, 2013, AM J CLIN NUTR, V98, P1084, DOI 10.3945/ajcn.113.058362
   Malik VS, 2010, DIABETES CARE, V33, P2477, DOI 10.2337/dc10-1079
   Malisova O, 2012, INT J FOOD SCI NUTR, V63, P138, DOI 10.3109/09637486.2011.607799
   Manolis AA, 2021, CURR MED CHEM, P28
   Manz F, 2002, J PEDIATR-US, V141, P587, DOI 10.1067/mpd.2002.128031
   Montenegro-Bethancourt G, 2013, AM J CLIN NUTR, V98, P1103, DOI 10.3945/ajcn.112.051490
   Moradi-Lakeh M, 2017, PUBLIC HEALTH NUTR, V20, P1075, DOI [10.1017/S1368980016003141, 10.1017/s1368980016003141]
   Morenga LT, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e7492
   Musaiger AO, 1998, J ROY SOC HEALTH, V118, P146, DOI 10.1177/146642409811800304
   Neuhouser ML, 2009, J AM DIET ASSOC, V109, P1587, DOI 10.1016/j.jada.2009.06.365
   Nissensohn M, 2015, NUTR HOSP, V31, P62, DOI 10.3305/nh.2015.31.sup3.8753
   Pagana K., 2020, Mosbys Diagnostic and Laboratory Test Reference, V15, P1088
   Perrier E, 2013, EUR J APPL PHYSIOL, V113, P2143, DOI 10.1007/s00421-013-2649-0
   Perrier ET, 2015, DIS MARKERS, V2015, DOI 10.1155/2015/231063
   Pooneh J., 2020, J COMMUNITY MED HEAL, V1, P018, DOI [10.29328/journal.jcmhs.1001002, DOI 10.29328/JOURNAL.JCMHS.1001002]
   Popkin BM, 2010, NUTR REV, V68, P439, DOI 10.1111/j.1753-4887.2010.00304.x
   Rodríguez-Artalejo F, 2018, J AGR FOOD CHEM, V66, P5257, DOI 10.1021/acs.jafc.7b04506
   Satija A, 2015, ADV NUTR, V6, P5, DOI 10.3945/an.114.007492
   Savvaidis I N., 2022, Food Safety in the Middle East, P1, DOI [DOI 10.1016/B978-0-12-821285-1.00021-X, DOI 10.1016/B978-0-12-822417-5.00009-X]
   Shim JS, 2014, EPIDEMIOL HEALTH, V36, DOI 10.4178/epih/e2014009
   Swithers SE, 2021, NUTRIENTS, V13, DOI 10.3390/nu13082703
   Te Morenga LA, 2014, AM J CLIN NUTR, V100, P65, DOI 10.3945/ajcn.113.081521
   U.S. Department of Agriculture, ARS WWEIA NHANES OV
   Van Rompay MI, 2015, J NUTR, V145, P2389, DOI 10.3945/jn.115.212662
   Vanderlee L, 2018, NUTR J, V17, DOI 10.1186/s12937-018-0380-8
   Vartanian LR, 2007, AM J PUBLIC HEALTH, V97, P667, DOI 10.2105/AJPH.2005.083782
   WHO, 2011, PLAN ACT PREV CONTR
   Xi B, 2015, BRIT J NUTR, V113, P709, DOI 10.1017/S0007114514004383
NR 59
TC 1
Z9 1
U1 0
U2 8
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1475-2891
J9 NUTR J
JI Nutr. J.
PD MAR 22
PY 2023
VL 22
IS 1
AR 20
DI 10.1186/s12937-022-00830-9
PG 10
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA 9Z5RC
UT WOS:000951197100001
PM 36944984
OA gold, Green Published
DA 2025-04-28
ER

PT J
AU Heber, D
   Zhang, YJ
   Yang, JP
   Ma, JE
   Henning, SM
   Li, ZP
AF Heber, David
   Zhang, Yanjun
   Yang, Jieping
   Ma, Janice E.
   Henning, Susanne M.
   Li, Zhaoping
TI Green Tea, Black Tea, and Oolong Tea Polyphenols Reduce Visceral Fat and
   Inflammation in Mice Fed High-Fat, High-Sucrose Obesogenic Diets
SO JOURNAL OF NUTRITION
LA English
DT Article
ID EPITHELIUM-DERIVED FACTOR; PU-ERH TEA; ADIPOSE-TISSUE; METABOLIC
   SYNDROME; INDUCED OBESITY; GALLIC ACID; IN-VITRO; CAMELLIA-SINENSIS;
   EXPRESSION; EXTRACT
AB Green tea (GT) and caffeine in combination were shown to increase energy expenditure and fat oxidation, but less is known about the effects of black tea (BT) and oolong tea (OT). This study investigated whether decaffeinated polyphenol extracts from GT, BT, and OT decrease body fat and inflammation in male C57BL/6J mice fed high-fat/high-sucrose [HF/HS (32% energy from fat, 25% energy from sucrose)] diets. Mice were fed either an HF/HS diet with 0.25% of polyphenol from GT, OT, or BT or a low-fat/high-sucrose [LF/HS (10.6% energy from fat, 25% energy from sucrose)] diet for 20 wk. Monomeric tea polyphenols were found in the liver and adipose tissue of mice fed the HF/HS diet with GT polyphenols (GTPs) and OT polyphenols (OTPs) but not BT polyphenols (BTPs). Treatment with GTPs, OTPs, BTPs, and an LF/HS diet led to significantly lower body weight, total visceral fat volume by MRI, and liver lipid weight compared with mice in the HF/HS control group. Only GTPs reduced food intake significantly by similar to 10%. GTP, BTP, and LF/HS-diet treatments significantly reduced serum monocyte chemotactic protein-1 (MCP-1) compared with HF/HS controls. In mesenteric fat, monocyte chemotactic protein-1 (Mcp1) gene expression was significantly decreased by treatment with GTPs, BTPs, OTPs, and an LF/HS diet and in liver tissue by GTP and BTP treatments. Mcp1 gene expression in epididymal fat was significantly decreased by the BTP and LF/HS diet interventions. In epididymal fat, consistent with an anti-inflammatory effect, adiponectin gene expression was significantly increased by GTPs and OTPs. Angiogenesis during adipose tissue expansion is anti-inflammatory by maintaining adipocyte perfusion. We observed significantly increased gene expression of vascular endothelial growth factor A by GTPs and vascular endothelial growth factor receptor 2 by BTPs and the LF/HS diet and a decrease in pigment epithelium-derived factor gene expression by OTPs and BTPs. In summary, all 3 tea polyphenol extracts induced weight loss and anti-inflammatory and angiogenic effects, although the tissue content of polyphenols differed significantly.
C1 [Heber, David; Zhang, Yanjun; Yang, Jieping; Ma, Janice E.; Henning, Susanne M.; Li, Zhaoping] Univ Calif Los Angeles, David Geffen Sch Med, Ctr Human Nutr, Los Angeles, CA 90095 USA.
C3 University of California System; University of California Los Angeles;
   University of California Los Angeles Medical Center; David Geffen School
   of Medicine at UCLA
RP Heber, D (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Ctr Human Nutr, Los Angeles, CA 90095 USA.
RI Zhaoping, Li/HLQ-0173-2023
FU Center for Human Nutrition, Department of Medicine, David Geffen School
   of Medicine, University of California, Los Angeles
FX Supported by departmental funds from the Center for Human Nutrition,
   Department of Medicine, David Geffen School of Medicine, University of
   California, Los Angeles.
CR Aprahamian TR, 2013, METABOLISM, V62, P1730, DOI 10.1016/j.metabol.2013.07.010
   BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911
   Bose M, 2008, J NUTR, V138, P1677, DOI 10.1093/jn/138.9.1677
   Chader GJ, 2001, P NATL ACAD SCI USA, V98, P2122, DOI 10.1073/pnas.061024098
   Chen YK, 2011, J AGR FOOD CHEM, V59, P11862, DOI 10.1021/jf2029016
   Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040
   Elayappan B, 2011, ANGIOGENESIS, V14, P407, DOI 10.1007/s10456-011-9224-2
   Elayappan B, 2009, ANGIOGENESIS, V12, P313, DOI 10.1007/s10456-009-9153-5
   Elias I, 2012, DIABETES, V61, P1801, DOI 10.2337/db11-0832
   Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5
   Gray KK, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001529
   Grove KA, 2012, OBESITY, V20, P2311, DOI 10.1038/oby.2011.139
   Grove KA, 2010, J NUTR, V140, P446, DOI 10.3945/jn.109.115972
   Han LK, 1999, INT J OBESITY, V23, P98, DOI 10.1038/sj.ijo.0800766
   Hodgson JM, 2000, J AGR FOOD CHEM, V48, P2276, DOI 10.1021/jf000089s
   Huang HC, 2012, FOOD FUNCT, V3, P170, DOI 10.1039/c1fo10157a
   Hursel R, 2011, OBES REV, V12, pE573, DOI 10.1111/j.1467-789X.2011.00862.x
   Hursel R, 2009, AM J CLIN NUTR, V89, P822, DOI 10.3945/ajcn.2008.27043
   Juhel C, 2000, J NUTR BIOCHEM, V11, P45, DOI 10.1016/S0955-2863(99)00070-4
   Kao YH, 2000, ENDOCRINOLOGY, V141, P980, DOI 10.1210/en.141.3.980
   Kuhnert N, 2010, RAPID COMMUN MASS SP, V24, P3387, DOI 10.1002/rcm.4778
   Lee MS, 2009, ANN NUTR METAB, V54, P151, DOI 10.1159/000214834
   Lu H, 2003, DRUG METAB DISPOS, V31, P572, DOI 10.1124/dmd.31.5.572
   Lu QY, 2009, J AGR FOOD CHEM, V57, P10408, DOI 10.1021/jf901839h
   Maki KC, 2009, J NUTR, V139, P264, DOI 10.3945/jn.108.098293
   Malik VS, 2010, CIRCULATION, V121, P1356, DOI 10.1161/CIRCULATIONAHA.109.876185
   Mehlem A, 2013, NAT PROTOC, V8, P1149, DOI 10.1038/nprot.2013.055
   Mendoza JA, 2007, DIABETES CARE, V30, P974, DOI 10.2337/dc06-2188
   Meng XF, 2002, CHEM RES TOXICOL, V15, P1042, DOI 10.1021/tx010184a
   Mulder TPJ, 2001, J CHROMATOGR B, V760, P271, DOI 10.1016/S0378-4347(01)00285-7
   Oi Y, 2012, PHYTOTHER RES, V26, P475, DOI 10.1002/ptr.3602
   Pafumi Y, 2002, J BIOL CHEM, V277, P28070, DOI 10.1074/jbc.M202839200
   Panee J, 2012, CYTOKINE, V60, P1, DOI 10.1016/j.cyto.2012.06.018
   Rains TM, 2011, J NUTR BIOCHEM, V22, P1, DOI 10.1016/j.jnutbio.2010.06.006
   Rupnick MA, 2002, P NATL ACAD SCI USA, V99, P10730, DOI 10.1073/pnas.162349799
   Sharma V, 2009, CRIT REV FOOD SCI, V49, P379, DOI 10.1080/10408390802068066
   Shrestha S, 2009, J NUTR, V139, P640, DOI 10.3945/jn.108.103341
   Singleton V L, 1969, Adv Food Res Suppl, V1, P1
   Subramanian N, 1999, J AGR FOOD CHEM, V47, P2571, DOI 10.1021/jf981042y
   Sun K, 2012, P NATL ACAD SCI USA, V109, P5874, DOI 10.1073/pnas.1200447109
   Sung HK, 2013, CELL METAB, V17, P61, DOI 10.1016/j.cmet.2012.12.010
   Tchernof A, 2013, PHYSIOL REV, V93, P359, DOI 10.1152/physrev.00033.2011
   Uchiyama S, 2011, NUTRITION, V27, P287, DOI 10.1016/j.nut.2010.01.019
   Visioli Francesco, 2006, Nutrition and Health (Bicester), V18, P127
   Wang P, 2008, EUR J ENDOCRINOL, V159, P713, DOI 10.1530/EJE-08-0521
   Wang PW, 2010, CANCER PREV RES, V3, P985, DOI 10.1158/1940-6207.CAPR-09-0210
   Wang YX, 2003, OBES RES, V11, P930, DOI 10.1038/oby.2003.128
   Yamagishi SI, 2007, HORM METAB RES, V39, P233, DOI 10.1055/s-2007-970425
   Yoon CH, 2013, JOINT BONE SPINE, V80, P274, DOI 10.1016/j.jbspin.2012.08.010
   Yuda N, 2012, J FOOD SCI, V77, pH254, DOI 10.1111/j.1750-3841.2012.02967.x
   Zhou AL, 2012, LIPIDS, V47, P1119, DOI 10.1007/s11745-012-3729-3
NR 51
TC 105
Z9 120
U1 3
U2 113
PU AMER SOC NUTRITION-ASN
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0022-3166
EI 1541-6100
J9 J NUTR
JI J. Nutr.
PD SEP
PY 2014
VL 144
IS 9
BP 1385
EP 1393
DI 10.3945/jn.114.191007
PG 9
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA AN6VK
UT WOS:000340736300006
PM 25031332
OA Bronze
DA 2025-04-28
ER

PT J
AU Wu, Y
   Zhang, D
   Jiang, X
   Jiang, W
AF Wu, Y.
   Zhang, D.
   Jiang, X.
   Jiang, W.
TI Fruit and vegetable consumption and risk of type 2 diabetes mellitus: A
   dose-response meta-analysis of prospective cohort studies
SO NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
LA English
DT Article
DE Fruit; Vegetable; Type 2 diabetes mellitus; Prospective cohort studies;
   Dose-response analysis
ID HEART-DISEASE; DIETARY FIBER; OBESITY; ASSOCIATION; PREVALENCE;
   PREVENTION; VALIDITY; COFFEE; BIAS; MEN
AB Background and aims: We conducted a dose-response meta-analysis to summarize the evidence from prospective cohort studies regarding the association of fruit and vegetable consumption with risk of type 2 diabetes mellitus (T2DM).
   Methods and results: Pertinent studies were identified by searching Embase and PubMed through June 2014. Study-specific results were pooled using a random-effect model. The dose-response relationship was assessed by the restricted cubic spline model and the multivariate randomeffect meta-regression. We standardized all data using a standard portion size of 106 g. The Relative Risk (95% confidence interval) [RR (95% CI)] of T2DM was 0.99 (0.98-1.00) for every 1 serving/day increment in fruit and vegetable (FV) (P = 0.18), 0.98 (0.95-1.01) for vegetable (P = 0.12), and 0.99 (0.97-1.00) for fruit (P = 0.05). The RR (95% CI) of T2DM was 0.99 (0.97-1.01), 0.98 (0.96-1.01), 0.97 (0.93-1.01), 0.96 (0.92-1.01), 0.96 (0.91-1.01) and 0.96 (0.91-1.01) for 1, 2, 3, 4, 5 and 6 servings/day of FV (Pfor non-linearity = 0.44). The T2DM risk was 0.96 (0.95-0.99), 0.94 (0.90-0.98), 0.94 (0.89-0.98), 0.96 (0.91-1.01), 0.98 (0.92-1.05) and 1.00 (0.93-1.08) for 1, 2, 3, 4, 5 and 6 servings/day of vegetable (Pfor non-linearity < 0.01). The T2DM risk was 0.95 (0.93-0.97), 0.91 (0.89-0.94), 0.88 (0.85-0.92), 0.92 (0.88-0.96) and 0.96 (0.92-1.01) for 0.5, 1, 2, 3 and 4 servings/day of fruit (Pfor non-linearity < 0.01).
   Conclusions: Two-three servings/day of vegetable and 2 servings/day of fruit conferred a lower risk of T2DM than other levels of vegetable and fruit consumption, respectively. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Wu, Y.; Zhang, D.; Jiang, X.; Jiang, W.] Qingdao Univ, Dept Epidemiol & Hlth Stat, Coll Med, Qingdao 266021, Shandong, Peoples R China.
C3 Qingdao University
RP Zhang, D (corresponding author), Qingdao Univ, Dept Epidemiol & Hlth Stat, Dongzhou Rd 38, Qingdao 266021, Shandong, Peoples R China.
EM zhangdf1962@aliyun.com
FU National Natural Science Foundation of China [818302485]
FX The authors receive grants from National Natural Science Foundation of
   China (818302485).
CR Alinia S, 2009, OBES REV, V10, P639, DOI 10.1111/j.1467-789X.2009.00582.x
   Aune D, 2014, NUTR METAB CARDIOVAS, V24, P107, DOI 10.1016/j.numecd.2013.10.028
   Aune D, 2013, AM J CLIN NUTR, V98, P1066, DOI 10.3945/ajcn.113.059030
   Bazzano LA, 2008, DIABETES CARE, V31, P1311, DOI 10.2337/dc08-0080
   BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446
   Boeing H, 2012, EUR J NUTR, V51, P637, DOI 10.1007/s00394-012-0380-y
   Bountziouka V, 2012, NUTR METAB CARDIOVAS, V22, P659, DOI 10.1016/j.numecd.2010.10.015
   Bruno G, 2012, NUTR METAB CARDIOVAS, V22, P684, DOI 10.1016/j.numecd.2011.04.007
   Capewell S, 2012, NUTR METAB CARDIOVAS, V22, P307, DOI 10.1016/j.numecd.2012.01.005
   Carter P, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4229
   Chatterjee R, 2012, DIABETOLOGIA, V55, P1295, DOI 10.1007/s00125-012-2487-3
   Cooper AJ, 2012, EUR J CLIN NUTR, V66, P1082, DOI 10.1038/ejcn.2012.85
   Cooper AJ, 2012, DIABETES CARE, V35, P1293, DOI 10.2337/dc11-2388
   Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X
   Dauchet L, 2006, J NUTR, V136, P2588, DOI 10.1093/jn/136.10.2588
   De Berardis G, 2012, NUTR METAB CARDIOVAS, V22, P605, DOI 10.1016/j.numecd.2010.10.016
   Desquilbet L, 2010, STAT MED, V29, P1037, DOI 10.1002/sim.3841
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629
   Elwood P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081877
   Esposito K, 2014, ENDOCRINE, V47, P107, DOI 10.1007/s12020-014-0264-4
   Ford ES, 2001, PREV MED, V32, P33, DOI 10.1006/pmed.2000.0772
   Fulton SL, 2011, P NUTR SOC, V70, pE66, DOI 10.1017/S0029665111001066
   Guariguata L, 2014, DIABETES RES CLIN PR, V103, P137, DOI 10.1016/j.diabres.2013.11.002
   Hartling L., 2012, Validity and Inter-Rater Reliability Testing of Quality Assessment Instruments, P1
   Higgins J., 2009, Cochrane Handbook for Systematic Reviews of Interventions
   Higgins JPT, 2004, STAT MED, V23, P1663, DOI 10.1002/sim.1752
   Higgins JPT, 2003, BMJ-BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557
   HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503
   Holt EM, 2009, J AM DIET ASSOC, V109, P414, DOI 10.1016/j.jada.2008.11.036
   Huxley R, 2009, ARCH INTERN MED, V169, P2053, DOI 10.1001/archinternmed.2009.439
   Jackson D, 2010, STAT MED, V29, P1282, DOI 10.1002/sim.3602
   Jiang XB, 2014, EUR J NUTR, V53, P25, DOI 10.1007/s00394-013-0603-x
   Kodama S, 2012, AM J EPIDEMIOL, V176, P959, DOI 10.1093/aje/kws172
   Kuroda Kensuke, 2012, Bioinorg Chem Appl, V2012, P730693, DOI 10.1155/2012/730693
   Li SS, 2009, JAMA-J AM MED ASSOC, V302, P179, DOI 10.1001/jama.2009.976
   Liu SM, 2004, DIABETES CARE, V27, P2993, DOI 10.2337/diacare.27.12.2993
   Margetts BM, 1997, INT J EPIDEMIOL, V26, pS1, DOI 10.1093/ije/26.suppl_1.S1
   Meyer KA, 2000, AM J CLIN NUTR, V71, P921
   Michels KB, 2005, AM J EPIDEMIOL, V161, P987, DOI 10.1093/aje/kwi115
   Montonen J, 2005, EUR J CLIN NUTR, V59, P441, DOI 10.1038/sj.ejcn.1602094
   Moreno JA, 2013, NUTR METAB CARDIOVAS, V23, P536, DOI 10.1016/j.numecd.2011.10.008
   Muraki I, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5001
   Mursu J, 2014, AM J CLIN NUTR, V99, P328, DOI 10.3945/ajcn.113.069641
   Orsini N, 2006, STATA J, V6, P40, DOI 10.1177/1536867X0600600103
   Orsini N, 2012, AM J EPIDEMIOL, V175, P66, DOI 10.1093/aje/kwr265
   Orsini N, 2011, STATA J, V11, P1
   Sauvageot N, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-143
   Shu XO, 2004, EUR J CLIN NUTR, V58, P17, DOI 10.1038/sj.ejcn.1601738
   Stanhope KL, 2013, CURR OPIN LIPIDOL, V24, P198, DOI 10.1097/MOL.0b013e3283613bca
   Stanhope KL, 2012, ANNU REV MED, V63, P329, DOI 10.1146/annurev-med-042010-113026
   Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008
   Uusitupa M, 2011, NUTR METAB CARDIOVAS, V21, P380, DOI 10.1016/j.numecd.2010.12.007
   Villegas R, 2008, J NUTR, V138, P574, DOI 10.1093/jn/138.3.574
   von Ruesten A, 2013, EUR J CLIN NUTR, V67, P412, DOI 10.1038/ejcn.2013.7
   Wang X, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4490
   Woodside JV, 2013, P NUTR SOC, V72, P236, DOI 10.1017/S0029665112003059
   Xi B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093471
   Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292
   Yao BD, 2014, EUR J EPIDEMIOL, V29, P79, DOI 10.1007/s10654-013-9876-x
NR 60
TC 105
Z9 124
U1 0
U2 41
PU ELSEVIER SCI LTD
PI London
PA 125 London Wall, London, ENGLAND
SN 0939-4753
EI 1590-3729
J9 NUTR METAB CARDIOVAS
JI Nutr. Metab. Carbiovasc. Dis.
PD FEB
PY 2015
VL 25
IS 2
BP 140
EP 147
DI 10.1016/j.numecd.2014.10.004
PG 8
WC Cardiac & Cardiovascular Systems; Endocrinology & Metabolism; Nutrition
   & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cardiovascular System & Cardiology; Endocrinology & Metabolism;
   Nutrition & Dietetics
GA CB1QL
UT WOS:000349402700002
PM 25456152
OA Bronze
DA 2025-04-28
ER

PT J
AU Mihrshahi, S
   Vaughan, L
   Fa'avale, N
   Weliange, SD
   Manu-Sione, I
   Schubert, L
AF Mihrshahi, Seema
   Vaughan, Lisa
   Fa'avale, Nicola
   Weliange, Shreenika De Silva
   Manu-Sione, Inez
   Schubert, Lisa
TI Evaluation of the Good Start Program: a healthy eating and
   physical activity intervention for Maori and Pacific Islander children
   living in Queensland, Australia
SO BMC PUBLIC HEALTH
LA English
DT Article
DE Evaluation; Maori and Pacific Islander; Interventions to reduce obesity;
   Obesity; Children; Healthy eating; Physical activity
ID OBESITY PREVENTION; SCHOOL
AB Background: Reducing the prevalence of obesity and chronic disease are important priorities. Maori and Pacific Islander communities living in Australia have higher rates of obesity and chronic disease than the wider Australian population. This study aims to assess the effectiveness of the Good Start program, which aims to improve knowledge, attitudes and practices related to healthy eating and physical activity amongst Maori and Pacific Islander communities living in Queensland.
   Methods: The intervention was delivered to children aged 6-19 years (N = 375) in schools by multicultural health workers. Class activities focused on one message each term related to healthy eating and physical activity using methods such as cooking sessions and cultural dance. The evaluation approach was a quantitative uncontrolled pre-post design. Data were collected each term pre- and post-intervention using a short questionnaire.
   Results: There were significant increases in knowledge of correct servings of fruit and vegetables, knowledge of sugar and caffeine content of common sugar-sweetened drinks, recognition of the consequences of marketing and upsizing, and the importance of controlling portion size (all P < 0.05). There was also increases in knowledge of physical activity recommendations (P < 0.001), as well as the importance of physical activity for preventing heart disease (P < 0.001) and improving self-esteem (P < 0.001). In terms of attitudes, there were significant improvements in some attitudes to vegetables (P = 0.02), and sugar-sweetened drinks (P < 0.05). In terms of practices and behaviours, although the reported intake of vegetables increased significantly (P < 0.001), the proportion of children eating discretionary foods regularly did not change significantly, suggesting that modifying the program with an increased emphasis on reducing intake of junk food may be beneficial.
   Conclusion: The study has shown that the Good Start Program was effective in engaging children from Maori and Pacific Island backgrounds and in improving knowledge, and some attitudes and practices, related to healthy eating and physical activity. The evaluation contributes valuable information about components and impacts of this type of intervention, and considerations relevant to this population in order to successfully change behaviours and reduce the burden of chronic disease.
C1 [Mihrshahi, Seema; Vaughan, Lisa; Fa'avale, Nicola; Weliange, Shreenika De Silva; Schubert, Lisa] Univ Queensland, Sch Publ Hlth, Fac Med & Biomed Sci, Brisbane, Qld 4006, Australia.
   [Mihrshahi, Seema] Univ Sydney, Charles Perkins Ctr D17, Prevent Res Collaborat, Sydney Med Sch, Level 6, Sydney, NSW 2006, Australia.
   [Mihrshahi, Seema] Univ Sydney, Charles Perkins Ctr D17, Sydney Sch Publ Hlth, Level 6, Sydney, NSW 2006, Australia.
   [Fa'avale, Nicola] Massey Univ, SHORE, Auckland, New Zealand.
   [Fa'avale, Nicola] Massey Univ, Whariki Res Ctr, Coll Hlth, Auckland, New Zealand.
   [Weliange, Shreenika De Silva] Univ Colombo, Fac Med, Dept Community Med, Colombo, Sri Lanka.
   [Manu-Sione, Inez] Childrens Hlth Queensland Hosp & Hlth Serv, Good Start Program, Child & Youth Community Hlth Serv, Brisbane, Qld 4006, Australia.
   [Manu-Sione, Inez] Griffith Univ, Sch Profess Studies & Educ, Brisbane, Qld 4122, Australia.
C3 University of Queensland; University of Sydney; University of Sydney;
   Massey University; Massey University; University of Colombo; Childrens
   Health Queensland Hospital & Health Service; Griffith University
RP Mihrshahi, S (corresponding author), Univ Queensland, Sch Publ Hlth, Fac Med & Biomed Sci, Brisbane, Qld 4006, Australia.; Mihrshahi, S (corresponding author), Univ Sydney, Charles Perkins Ctr D17, Prevent Res Collaborat, Sydney Med Sch, Level 6, Sydney, NSW 2006, Australia.; Mihrshahi, S (corresponding author), Univ Sydney, Charles Perkins Ctr D17, Sydney Sch Publ Hlth, Level 6, Sydney, NSW 2006, Australia.
EM seema.mihrshahi@sydney.edu.au
RI Fainga'a-Manusione, Inez/KTF-3188-2024; Schubert, Lisa/G-2280-2012;
   Mihrshahi, Seema/A-9877-2009
OI Schubert, Lisa/0000-0001-5392-4221; Mihrshahi,
   Seema/0000-0001-6567-9884; De silva Weliange,
   Shreenika/0000-0003-2429-8860; Fainga'a-Manusione,
   Inez/0000-0002-4479-5509
FU Queensland Health under the Preventative Health Unit
FX The evaluation was funded by Queensland Health under the Preventative
   Health Unit. Queensland Health had no role in the analysis or
   interpretation of data associated with the evaluation or in the writing
   of this manuscript.
CR Australian Curriculm Assessment and Reporting Authority, 2015, IND COMM SOC ADV ICS
   Australian Government & Preventive Health Taskforce, 2009, OB AUSTR NEED URG AC
   Children's Health Queensland, 2014, GOOD START PROGR BRI
   Cook-Cottone C, 2009, PSYCHOL SCHOOLS, V46, P695, DOI 10.1002/pits.20409
   Department of Health Public Health and Clinical Systems Division, 2011, EAT WELL BE ACT STRA
   Hawley NL, 2015, CURR DIABETES REP, V15, DOI 10.1007/s11892-015-0594-5
   Health Research Council of New Zealand, 2014, PAC HLTH RES GUID 20
   Khambalia AZ, 2012, OBES REV, V13, P214, DOI 10.1111/j.1467-789X.2011.00947.x
   Kropski JA, 2008, OBESITY, V16, P1009, DOI 10.1038/oby.2008.29
   Macpherson C., 2001, Tangata O Te Moana Nui
   McRae J., 2000, MAORI ORAL TRADITION
   New Zealand Ministry of Health, 2015, ANN UPD KEY FIND 201
   Queensland Government, 2014, PAC ISL MAOR POP SIZ
   Queensland Health, 2011, QUEENSL HLTH RESP PA
   Queensland Health Multicultural Services, 2012, GUID MULT HLTH POL I
   Rush E, 2013, J PAEDIATR CHILD H, V49, pE324, DOI 10.1111/jpc.12015
   Rush E, 2012, BRIT J NUTR, V107, P581, DOI 10.1017/S0007114511003151
   Vaioleti T. M., 2016, Waikato Journal of Education, V12, P21, DOI [10.15663/wje.v12i1.296, DOI 10.15663/WJE.V12I1.296]
NR 18
TC 22
Z9 25
U1 0
U2 25
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1471-2458
J9 BMC PUBLIC HEALTH
JI BMC Public Health
PD JAN 13
PY 2017
VL 17
AR 77
DI 10.1186/s12889-016-3977-x
PG 10
WC Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Public, Environmental & Occupational Health
GA EJ0DF
UT WOS:000392878100009
PM 28086843
OA Green Published, gold
DA 2025-04-28
ER

PT J
AU Winkvist, A
   Hörnell, A
   Hallmans, G
   Lindahl, B
   Weinehall, L
   Johansson, I
AF Winkvist, Anna
   Hornell, Agneta
   Hallmans, Goran
   Lindahl, Bernt
   Weinehall, Lars
   Johansson, Ingegerd
TI More distinct food intake patterns among women than men in northern
   Sweden: a population-based survey
SO NUTRITION JOURNAL
LA English
DT Article
ID LOW-ENERGY REPORTERS; DIETARY PATTERNS; CLUSTER-ANALYSIS; VALIDATION;
   DISEASE; ADULTS; HEALTH
AB Background: The need to promote a healthy diet to curb the current obesity epidemic has today been recognized by most countries. A prerequisite for planning and evaluating interventions on dietary intake is the existence of valid information on long-term average dietary intake in a population. Few large, population-based studies of dietary intake have been carried out in Sweden. The largest to date is the Vasterbotten Intervention Program ( VIP), which was initiated in 1985, with data collection still ongoing. This paper reports on the first comprehensive analyses of the dietary data and presents dietary intake patterns among over 60,000 women and men in northern Sweden during 1992-2005.
   Methods: Between 1992 and 2005, 71,367 inhabitants in Vasterbotten county aged 30, 40, 50, and 60 years visited their local health care center as part of the VIP. Participants of VIP filled in an 84- or 64-item food frequency questionnaire (FFQ) and provided sociodemographic information. Complete and realistic information on consumption frequency was provided by 62,531 individuals. Food intake patterns were analyzed using K-means cluster analyses.
   Results: The mean daily energy intake was 6,83 (+/- 1,77) MJ among women and 8,71 (+/- 2,26) MJ among men. More than half of both women and men were classified as Low Energy Reporters ( defined as individuals reporting a food intake level below the lower 95% confidence interval limit of the physical activity level). Larger variation in frequency of daily intake was seen among women than among men for most food groups. Among women, four dietary clusters were identified, labeled "Fruit and vegetables", "High fat", "Coffee and sandwich", and "Tea and ice cream". Among men, three dietary clusters were identified, labeled "Fruit and vegetables", "High fat", and "Tea, soda and cookies".
   Conclusion: More distinct food intake patterns were seen among women than men in this study in northern Sweden. Due to large proportions of Low Energy Reporters, our results on dietary intake may not be suitable for comparisons with recommended intake levels. However, the results on food intake patterns should still be valid and useful as a basis for targeting interventions to groups most in need.
C1 [Winkvist, Anna] Univ Gothenburg, Sahlgrenska Acad, Dept Clin Nutr, Gothenburg, Sweden.
   [Hornell, Agneta] Umea Univ, Dept Food & Nutr, Umea, Sweden.
   [Hallmans, Goran] Umea Univ, Dept Publ Hlth & Clin Med, Umea, Sweden.
   [Lindahl, Bernt; Weinehall, Lars] Umea Univ, Dept Publ Hlth & Clin Med, Umea, Sweden.
   [Weinehall, Lars] Vasterbotten Cty Council, Dept Community Med, Umea, Sweden.
   [Johansson, Ingegerd] Umea Univ, Dept Odontol, Umea, Sweden.
C3 University of Gothenburg; Umea University; Umea University; Umea
   University; Umea University
RP Winkvist, A (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Dept Clin Nutr, Gothenburg, Sweden.
EM anna.winkvist@nutrition.gu.se; Agneta.Hornell@kost.umu.se;
   Goran.Hallmans@nutrires.umu.se; Bernt.Lindahl@medicin.umu.se;
   Lars.Weinehall@epiph.umu.se; Ingegerd.Johansson@odont.umu.se
RI Hörnell, Agneta/AAZ-2206-2021; Winkvist, Anna/AAC-6178-2021; Hornell,
   Agneta/H-9058-2016
OI Winkvist, Anna/0000-0001-9122-7240; Weinehall, Lars/0000-0003-3025-2690;
   Hornell, Agneta/0000-0002-5464-5686
FU Swedish Council for Working Life and Social Research; Swedish Cancer
   Society; Swedish Research Council; Wallenberg Foundation; Vasterbotten
   County Council, Sweden
FX This work was supported by the Swedish Council for Working Life and
   Social Research; the Swedish Cancer Society, the Swedish Research
   Council; the Wallenberg Foundation and the Vasterbotten County Council,
   Sweden. We gratefully acknowledge Salmir Nasic for his help with the
   statistical analysis.
CR [Anonymous], 2004, GLOB STRAT DIET PHYS
   Bailey RL, 2007, J AM DIET ASSOC, V107, P64, DOI 10.1016/j.jada.2006.10.009
   Bergstrom L., 1991, Var Foda, V43, P439
   Cade J, 2002, PUBLIC HEALTH NUTR, V5, P567, DOI 10.1079/PHN2001318
   Dodd KW, 2006, J AM DIET ASSOC, V106, P1640, DOI 10.1016/j.jada.2006.07.011
   FAO/WHO/UNU, 1985, Technical report series, V724
   Gnardellis C, 1998, PUBLIC HEALTH NUTR, V1, P131, DOI 10.1079/PHN19980020
   GOLDBERG GR, 1991, EUR J CLIN NUTR, V45, P569
   HEITMANN BL, 1995, BRIT MED J, V311, P986
   Johansson G, 2008, INT J OBESITY, V32, P1031, DOI 10.1038/ijo.2008.42
   Johansson I, 2002, PUBLIC HEALTH NUTR, V5, P487, DOI 10.1079/PHN2001315
   Leite MLC, 2003, EUR J CLIN NUTR, V57, P1514, DOI 10.1038/sj.ejcn.1601719
   *LIVSM, 2002, DIET HAB NUTR INT SW
   *LIVSM, 1999, WEIGHT TABL
   Newby P, 2003, AM J CLIN NUTR, V77, P1417, DOI 10.1093/ajcn/77.6.1417
   *NORD COUNC MIN, 2006, NORD PLAN ACT BETT H
   Price GM, 1997, BRIT J NUTR, V77, P833, DOI 10.1079/BJN19970083
   Pryer JA, 1997, INT J EPIDEMIOL, V26, P146, DOI 10.1093/ije/26.1.146
   SCHOFIELD WN, 1985, HUM NUTR CLIN N C S1, V39, P1
   Villegas R, 2004, PUBLIC HEALTH NUTR, V7, P1017, DOI 10.1079/PHN2004638
   Weinehall L, 1998, SCAND J PRIM HEALTH, V16, P171
   WHO, 2003, WHO TECH REP SER, V916, P1
   *WHO, 2008, C REP 2007 COP DENM
   Wirfält E, 2000, PUBLIC HEALTH NUTR, V3, P159, DOI 10.1017/S1368980000000197
   World Cancer Research Fund, 2007, FOOD NUTR PHYS ACT P
NR 25
TC 39
Z9 39
U1 0
U2 5
PU BIOMED CENTRAL LTD
PI LONDON
PA CURRENT SCIENCE GROUP, MIDDLESEX HOUSE, 34-42 CLEVELAND ST, LONDON W1T
   4LB, ENGLAND
SN 1475-2891
J9 NUTR J
JI Nutr. J.
PD FEB 19
PY 2009
VL 8
AR 12
DI 10.1186/1475-2891-8-12
PG 9
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA 424YV
UT WOS:000264605100001
PM 19228378
OA gold, Green Published
DA 2025-04-28
ER

PT J
AU Drewnowski, A
   Rehm, CD
   Constant, F
AF Drewnowski, Adam
   Rehm, Colin D.
   Constant, Florence
TI Water and beverage consumption among children age 4-13y in the United
   States: analyses of 2005-2010 NHANES data
SO NUTRITION JOURNAL
LA English
DT Article
DE Drinking water; Water consumption; Children; Adequate hydration;
   Beverages; Dietary surveillance
ID YOUTH PHYSICAL-ACTIVITY; DIETARY ENERGY DENSITY; DRINKING-WATER;
   ESSENTIAL NUTRIENT; NATIONAL-HEALTH; BODY-WEIGHT; HYDRATION; NUTRITION;
   ADOLESCENTS; OBESITY
AB Background: Few studies have examined water consumption patterns among US children. Additionally, recent data on total water consumption as it relates to the Dietary Reference Intakes (DRI) are lacking. This study evaluated the consumption of plain water (tap and bottled) and other beverages among US children by age group, gender, income-to -poverty ratio, and race/ethnicity. Comparisons were made to DRI values for water consumption from all sources.
   Methods: Data from two non-consecutive 24-hour recalls from 3 cycles of NHANES (2005-2006, 2007-2008 and 2009-2010) were used to assess water and beverage consumption among 4,766 children age 4-13y. Beverages were classified into 9 groups: water (tap and bottled), plain and flavored milk, 100% fruit juice, soda/soft drinks (regular and diet), fruit drinks, sports drinks, coffee, tea, and energy drinks. Total water intakes from plain water, beverages, and food were compared to DRIs for the US. Total water volume per 1,000 kcal was also examined.
   Results: Water and other beverages contributed 70-75% of dietary water, with 25-30% provided by moisture in foods, depending on age. Plain water, tap and bottled, contributed 25-30% of total dietary water. In general, tap water represented 60% of drinking water volume whereas bottled water represented 40%. Non-Hispanic white children consumed the most tap water, whereas Mexican-American children consumed the most bottled water. Plain water consumption (bottled and tap) tended to be associated with higher incomes. No group of US children came close to satisfying the DRIs for water. At least 75% of children 4-8y, 87% of girls 9-13y, and 85% of boys 9-13y did not meet DRIs for total water intake. Water volume per 1,000 kcal, another criterion of adequate hydration, was 0.85-0.95 L/1,000 kcal, short of the desirable levels of 1.0-1.5 L/1,000 kcal.
   Conclusions: Water intakes at below-recommended levels may be a cause for concern. Data on water and beverage intake for the population and by socio-demographic group provides useful information to target interventions for increasing water intake among children.
C1 [Drewnowski, Adam] Univ Paris 06, Grp Hosp Pitie Salpetriere, F-75013 Paris, France.
   [Drewnowski, Adam; Rehm, Colin D.] Univ Washington, Ctr Publ Hlth Nutr, Seattle, WA 98195 USA.
   [Constant, Florence] Nestle Waters France, F-92130 Issy Les Moulineaux, France.
C3 Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire
   Pitie-Salpetriere - APHP; Sorbonne Universite; University of Washington;
   University of Washington Seattle
RP Drewnowski, A (corresponding author), Univ Paris 06, Grp Hosp Pitie Salpetriere, 47 Blvd Hop, F-75013 Paris, France.
EM adamdrew@uw.edu
RI REHM, COLIN/J-1215-2019; Drewnowski, Adam/HCI-4117-2022
OI REHM, COLIN/0000-0002-7644-0040
FU Nestle Waters MT
FX Study supported by Nestle Waters MT.
CR [Anonymous], 2010, Dietary Guidelines for Americans
   [Anonymous], 2010, Report of the Dietary Guidelines Advisory Committee on the Dietary Guidelines for Americans
   ARMSTRONG LE, 1994, INT J SPORT NUTR, V4, P265, DOI 10.1123/ijsn.4.3.265
   Armstrong LE, 2010, P 1 HYDR HLTH SCI M, V45, P45
   Campbell SM, 2007, J AM COLL NUTR, V26, p585S, DOI 10.1080/07315724.2007.10719662
   Centers for Disease Control and Prevention, The National Health and Nutrition Examination Survey
   Centers for Disease Control and Prevention, LOW EN DENS FOOD WEI
   D'Anci KE, 2006, NUTR REV, V64, P457, DOI [10.1301/nr.2006.oct.457-464, 10.1111/j.1753-4887.2006.tb00176.x]
   Drewnowski A, 1998, NUTR REV, V56, P347, DOI 10.1111/j.1753-4887.1998.tb01677.x
   EFSA, 2016, EFSA J, V8, DOI [10.2903/j.efsa.2010.1459, DOI 10.2903/J.EFSA.2010.1459, 10.2903/J.EFSA.2010.1459]
   Ello-Martin JA, 2007, AM J CLIN NUTR, V85, P1465, DOI 10.1093/ajcn/85.6.1465
   [Food and Nutrition Board Institute of Medicine], 2004, DIET REF INT WAT POT
   Fulgoni VL III, 2012, NUTR J, V11, DOI 10.1186/1475-2891-11-92
   Grandjean AC, 2003, NUTR REV, V61, P261, DOI 10.1301/nr.2003.aug.261-271
   Jéquier E, 2010, EUR J CLIN NUTR, V64, P115, DOI 10.1038/ejcn.2009.111
   Kant AK, 2010, AM J CLIN NUTR, V92, P887, DOI 10.3945/ajcn.2010.29708
   Kant AK, 2009, AM J CLIN NUTR, V90, P655, DOI 10.3945/ajcn.2009.27749
   Kenefick RW, 2012, NUTR REV, V70, pS137, DOI 10.1111/j.1753-4887.2012.00523.x
   Malik VS, 2010, CIRCULATION, V121, P1356, DOI 10.1161/CIRCULATIONAHA.109.876185
   Manz F, 2002, J PEDIATR-US, V141, P587, DOI 10.1067/mpd.2002.128031
   Manz F, 2007, J AM COLL NUTR, V26, p562S, DOI 10.1080/07315724.2007.10719659
   Muckelbauer R, 2009, PEDIATRICS, V123, pE661, DOI 10.1542/peds.2008-2186
   O'Connor TM, 2006, PEDIATRICS, V118, pE1010, DOI 10.1542/peds.2005-2348
   Oza-Frank R, 2012, J ACAD NUTR DIET, V112, P1390, DOI 10.1016/j.jand.2012.05.011
   Park S, 2012, J ACAD NUTR DIET, V112, P1421, DOI 10.1016/j.jand.2012.04.014
   Park S, 2011, J AM DIET ASSOC, V111, P1211, DOI 10.1016/j.jada.2011.05.006
   Patel AI, 2011, PREV CHRONIC DIS, V8
   Pérez-Escamilla R, 2012, J ACAD NUTR DIET, V112, P671, DOI 10.1016/j.jand.2012.01.020
   Sawka MN, 2005, NUTR REV, V63, pS30, DOI [10.1301/nr.2005.jun.S30-S39, 10.1111/j.1753-4887.2005.tb00152.x]
   Stookey J. D., 2010, Nutrition Today, V45, pS7, DOI 10.1097/NT.0b013e3181fe15a8
   Stookey JD, 2012, PUBLIC HEALTH NUTR, V15, P2148, DOI 10.1017/S1368980011003648
   Taras HL, 2004, PEDIATRICS, V113, P152
NR 32
TC 93
Z9 108
U1 1
U2 8
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1475-2891
J9 NUTR J
JI Nutr. J.
PD JUN 19
PY 2013
VL 12
AR 85
DI 10.1186/1475-2891-12-85
PG 9
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA 174JO
UT WOS:000321151700001
PM 23782914
OA Green Published, gold
DA 2025-04-28
ER

PT J
AU Murakami, K
   Livingstone, MBE
   Sasaki, S
AF Murakami, Kentaro
   Livingstone, M. Barbara E.
   Sasaki, Satoshi
TI Meal-specific dietary patterns and their contribution to overall dietary
   patterns in the Japanese context: Findings from the 2012 National Health
   and Nutrition Survey, Japan
SO NUTRITION
LA English
DT Article
DE Breakfast; Lunch; Dinner; Dietary pattern; Nutrient intake; Japan
ID BASAL METABOLIC-RATE; ENERGY-INTAKE; CARDIOVASCULAR-DISEASE; NUTRIENT
   INTAKE; RISK-FACTORS; ADULTS; FOOD; ASSOCIATIONS; OBESITY; HYPERTENSION
AB Objective: Most studies on dietary patterns have focused on the total daily intake of foods without differentiating intake at specific eating occasions. The aim of this study was to identify meal-specific (breakfast, lunch, and dinner) dietary patterns and examine their contribution to overall dietary patterns, using data from the 2012 National Health and Nutrition Survey, Japan.
   Methods: Dietary intake was assessed with a 1-d weighed dietary record for 15 618 Japanese adults >= 20 y of age.
   Results: Using principal component analysis based on daily consumption of 22 food groups, four overall dietary patterns were identified: vegetable/fruit/fish/pulse, bread/dairy, meat/fat, and noodle/seasoning patterns. Four meal-specific dietary patterns, which were independently identified in the same manner based on consumption at each eating occasion, were as follows:
   Breakfast: rice/vegetable/fish/pulse/seasoning, bread/dairy/fruit/sugar, meat/egg/fat, and tea/coffee patterns;
   Lunch: bread/dairy, noodle/seasoning, meat/fat, and vegetable/pulse/potato/sugar patterns; and
   Dinner: meat/vegetable/seasoning, noodle/alcoholic beverage, fish/sugar/alcoholic beverage, and other grains/fat patterns,
   The major contributors to interindividual variation in the vegetable/fruit/fish/pulse overall dietary pattern included the rice/vegetable/fish/pulse/seasoning breakfast (28%), the vegetable/pulse/pota/sugar lunch (15%), and the fish/sugar/alcoholic beverage dinner (19%). For other overall dietary patterns, the major contributors were generally patterns with similar characteristics, namely the bread/dairy/fruit/sugar breakfast (33%) and the bread/dairy lunch (24%) for the bread/dairy overall dietary pattern; the meat/egg/fat breakfast (13%), the meat/fat lunch (33%), the meat/vegetable/seasoning dinner (28%), and the other grains/fat dinner (11%) for the meat/fat overall dietary pattern; and the noodle/seasoning lunch (51%) and the noodle/alcoholic beverage dinner (25%) for the noodle/seasoning overall dietary pattern.
   Conclusion: Major meal-specific dietary patterns were identified in the Japanese context, which differentially contributed to major overall dietary patterns. (C) 2018 Elsevier Inc. All rights reserved.
C1 [Murakami, Kentaro] Univ Tokyo, Interfac Initiat Informat Studies, Tokyo, Japan.
   [Livingstone, M. Barbara E.] Ulster Univ, Northern Ireland Ctr Food & Hlth, Coleraine, Londonderry, North Ireland.
   [Sasaki, Satoshi] Univ Tokyo, Sch Publ Hlth, Dept Social & Prevent Epidemiol, Tokyo, Japan.
C3 University of Tokyo; Ulster University; University of Tokyo
RP Murakami, K (corresponding author), Univ Tokyo, Interfac Initiat Informat Studies, Tokyo, Japan.
EM Kenmrkm@m.u-tokyo.ac.jp
FU Health and Labour Sciences Research Grant [H29-jyunkankitou-ippan-006];
   Ministry of Health, Labour and Welfare, Japan
FX This work was supported in part by the Health and Labour Sciences
   Research Grant (no. H29-jyunkankitou-ippan-006) from the Ministry of
   Health, Labour and Welfare, Japan. The Ministry of Health, Labour and
   Welfare had no role in the design, analysis or writing of this article.
   KM designed the study, analyzed and interpreted the data, and wrote the
   manuscript. MBEL and SS helped in the writing of the manuscript. All
   authors read and approved the final manuscript. The authors have no
   conflicts of interest to declare.
CR Akter S, 2013, NUTR METAB, V10, DOI 10.1186/1743-7075-10-30
   Almoosawi S, 2016, P NUTR SOC, V75, P487, DOI 10.1017/S0029665116000306
   [Anonymous], 2014, NATL HLTH NUTR SURVE
   Ax E, 2016, BRIT J NUTR, V115, P95, DOI 10.1017/S0007114515004110
   Beck KL, 2018, EUR J NUTR, V57, P1421, DOI 10.1007/s00394-017-1421-3
   Bell LK, 2015, NUTRIENTS, V7, P6491, DOI 10.3390/nu7085295
   Bertin M, 2016, J HUM NUTR DIET, V29, P241, DOI 10.1111/jhn.12315
   Black AE, 2000, INT J OBESITY, V24, P1119, DOI 10.1038/sj.ijo.0801376
   Fujiwara A, 2016, PUBLIC HEALTH NUTR, V19, P2580, DOI 10.1017/S1368980016000641
   Ganpule AA, 2007, EUR J CLIN NUTR, V61, P1256, DOI 10.1038/sj.ejcn.1602645
   Gibson S, 2011, PUBLIC HEALTH NUTR, V14, P1323, DOI 10.1017/S1368980011000875
   Hearty AP, 2009, BRIT J NUTR, V101, P598, DOI 10.1017/S0007114508014128
   Hearty AP, 2008, AM J CLIN NUTR, V88, P1632, DOI 10.3945/ajcn.2008.26619
   Heidemann C, 2011, BRIT J NUTR, V106, P1253, DOI 10.1017/S0007114511001504
   Hosseini Z, 2016, NUTR RES REV, V29, P152, DOI 10.1017/S095442241600007X
   Htun NC, 2017, NUTR J, V16, DOI 10.1186/s12937-017-0284-z
   Hu FB, 2002, CURR OPIN LIPIDOL, V13, P3, DOI 10.1097/00041433-200202000-00002
   Ikeda N, 2015, INT J EPIDEMIOL, V44, P1842, DOI 10.1093/ije/dyv152
   Ikeda N, 2011, LANCET, V378, P1094, DOI 10.1016/S0140-6736(11)61055-6
   Iwaoka H, 2001, J NUTR SCI VITAMINOL, V47, P222, DOI 10.3177/jnsv.47.222
   Jacobs DR, 2003, AM J CLIN NUTR, V78, p508S, DOI 10.1093/ajcn/78.3.508S
   Kant AK, 2004, J AM DIET ASSOC, V104, P615, DOI 10.1016/j.jada.2004.01.010
   Kerver JM, 2003, AM J CLIN NUTR, V78, P1103, DOI 10.1093/ajcn/78.6.1103
   Knudsen VK, 2014, EUR J CLIN NUTR, V68, P736, DOI 10.1038/ejcn.2014.38
   Kuriyama N, 2016, J NUTR SCI, V5, DOI 10.1017/jns.2016.36
   Livingstone MBE, 2003, J NUTR, V133, p895S, DOI 10.1093/jn/133.3.895S
   Maruyama K, 2013, NUTR METAB CARDIOVAS, V23, P519, DOI 10.1016/j.numecd.2011.10.007
   Mensink RP, 2003, AM J CLIN NUTR, V77, P1146, DOI 10.1093/ajcn/77.5.1146
   Micha R, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008705
   Miyake R, 2011, J NUTR SCI VITAMINOL, V57, P224, DOI 10.3177/jnsv.57.224
   Murakami K, 2018, ASIA PAC J CLIN NUTR, V27, P441, DOI 10.6133/apjcn.042017.11
   Murakami K, 2017, J NUTR, V147, P2093, DOI 10.3945/jn.117.254896
   Murakami K, 2017, NUTR RES, V44, P67, DOI 10.1016/j.nutres.2017.06.005
   Murakami K, 2017, BRIT J NUTR, V117, P161, DOI 10.1017/S0007114516004451
   Murakami K, 2016, NUTR RES, V36, P1153, DOI 10.1016/j.nutres.2016.09.003
   Murakami K, 2015, BRIT J NUTR, V114, P1294, DOI 10.1017/S0007114515002706
   Nakamura M, 2013, J EPIDEMIOL, V23, P28, DOI 10.2188/jea.JE20120032
   Okubo H, 2015, NUTR J, V14, DOI 10.1186/s12937-015-0047-7
   Okubo H, 2010, PUBLIC HEALTH NUTR, V13, P1080, DOI 10.1017/S1368980009993211
   Rezagholizadeh F, 2017, NUTR RES, V41, P1, DOI 10.1016/j.nutres.2017.01.006
   Rodríguez-Monforte M, 2017, EUR J NUTR, V56, P925, DOI 10.1007/s00394-016-1305-y
   Santos RD, 2015, BRIT J NUTR, V114, P822, DOI 10.1017/S0007114515002445
   Sasaki S, 2011, LANCET, V378, P1205, DOI 10.1016/S0140-6736(11)61220-8
   Schwedhelm C, 2018, AM J CLIN NUTR, V107, P227, DOI 10.1093/ajcn/nqx027
   Science and Technology Agency, 2005, STAND TABL FOOD COMP
   Shi ZM, 2017, BRIT J NUTR, V118, P53, DOI 10.1017/S000711451700174X
   Shimazu T, 2007, INT J EPIDEMIOL, V36, P600, DOI 10.1093/ije/dym005
   Shin JY, 2013, NUTR RES PRACT, V7, P224, DOI 10.4162/nrp.2013.7.3.224
   Varraso R, 2012, AM J CLIN NUTR, V96, P1079, DOI 10.3945/ajcn.112.038109
   Wang D, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-925
   Woolhead C, 2015, AM J CLIN NUTR, V102, P316, DOI 10.3945/ajcn.114.106112
NR 51
TC 35
Z9 36
U1 1
U2 21
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0899-9007
EI 1873-1244
J9 NUTRITION
JI Nutrition
PD MAR
PY 2019
VL 59
BP 108
EP 115
DI 10.1016/j.nut.2018.07.110
PG 8
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA HK6MU
UT WOS:000458095600016
PM 30471523
DA 2025-04-28
ER

PT J
AU Abizari, AR
   Ali, Z
AF Abizari, Abdul-Razak
   Ali, Zakari
TI Dietary patterns and associated factors of schooling Ghanaian
   adolescents
SO JOURNAL OF HEALTH POPULATION AND NUTRITION
LA English
DT Article
DE Adolescents; Dietary pattern; School children; Anthropometric status;
   Ghana
ID MICRONUTRIENT ADEQUACY; NUTRITION TRANSITION; PRESCHOOL-CHILDREN; MAJOR
   PATTERNS; DIVERSITY; OBESITY; INDICATORS; INDEXES
AB Assessment of single nutrients or foods does not normally reflect the diet of population groups. Dietary pattern analyses are useful in understanding the overall diet and its relationship with disease conditions. The objective of the present study was to determine the dietary patterns and associated factors among schooling adolescents in Northern Ghana.
   A cross-sectional study involving 366 pupils in 10 junior high schools in the Tamale metropolis was conducted. A Food Frequency Questionnaire (FFQ) which consisted of 60 commonly consumed foods was used to assess pupils' 7-day intake. Foods grouped (14) from FFQ data based on shared nutritional value were used to identify dietary patterns using principal component analysis (PCA). Bivariate and multivariate logistic regression analyses were used to determine the association between identified patterns and sociodemographic, anthropometric status, and household characteristics of pupils.
   Half of the pupils were female (50.3%) and average age was 15.6 +/- 2.0 years. PCA identified two dietary patterns which in total explained 49.7% of the variability of the diet of pupils. The patterns were sweet tooth pattern (STP) with high factor loadings for sugar sweetened snacks, energy and soft drinks, sweets, tea and coffee, and milk and milk products, and a traditional pattern (TP) which showed high factor loadings for cereals and grains, local beverages, nuts, seeds and legumes, vegetables, and fish and seafood. Logistic regression showed that pupils who lived with their parents [AOR = 1.95; 95% CI (1.1-3.4); p = 0.019], those who went to school with pocket money [AOR = 4.73; 95% CI (1.5-15.0); p = 0.008], and those who lived in the wealthiest homes [AOR = 3.4; 95% CI (1.6-7.5); p = 0.002)] had higher odds of following the STP. The TP was associated with high dietary diversity (p = 0.035) and household wealth [AOR = 3.518; 95% CI (1.763-7.017); p < 0.001)]. None of the patterns was associated with anthropometric status of pupils.
   Adolescents in the present study followed a sweet tooth or a traditional diet pattern which associated more with household- and individual-level factors but not anthropometric status.
C1 [Abizari, Abdul-Razak; Ali, Zakari] Univ Dev Studies, Sch Allied Hlth Sci, Dept Nutr Sci, POB 1883, Tamale, Ghana.
C3 University for Development Studies
RP Abizari, AR (corresponding author), Univ Dev Studies, Sch Allied Hlth Sci, Dept Nutr Sci, POB 1883, Tamale, Ghana.
EM abizaria@yahoo.com; ali.zakari@yahoo.com
RI Ali, Zakari/ABB-6962-2020
OI Ali, Zakari/0000-0002-8129-2230
CR Abizari AR, 2014, BRIT J NUTR, V112, P1019, DOI 10.1017/S0007114514001585
   Abrahams Z, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-801
   Abubakari A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162285
   Adamu A, 2012, EFFECTS DIETARY PATT
   Alangea DO, 2018, BMC NUTR, V4, DOI 10.1186/s40795-018-0230-2
   Ali Z, 2018, NUTR J, V17, DOI 10.1186/s12937-018-0386-2
   [Anonymous], NUTR TRANS GLOB ITS
   [Anonymous], 2014, 2010 Population and Housing Census. District Analytical Report. Bawku West District
   [Anonymous], 1995, PHYS STAT UINT ANT
   Arimond M, 2010, J NUTR, V140, p2059S, DOI 10.3945/jn.110.123414
   Bygbjerg IC, 2012, SCIENCE, V337, P1499, DOI 10.1126/science.1223466
   Craig LCA, 2010, BRIT J NUTR, V103, P319, DOI 10.1017/S0007114509991942
   Cutler GJ, 2012, BRIT J NUTR, V108, P349, DOI 10.1017/S0007114511005435
   Cutler GJ, 2011, J AM DIET ASSOC, V111, P230, DOI 10.1016/j.jada.2010.10.052
   de Lanerolle-Dias M., 2015, BMC Nutrition, V1, P1, DOI [10.1186/s40795-015-0027-5, DOI 10.1186/S40795-015-0027-5]
   de Onis M, 2000, AM J CLIN NUTR, V72, P1032
   Field A., 2009, Discovering statistics with SPSS, V3rd
   Goody J., 1995, CAMBRID J ANTHR, V18, P1
   HEITMANN BL, 1995, BRIT MED J, V311, P986
   Hinnig PD, 2018, NUTRIENTS, V10, DOI 10.3390/nu10040436
   Howe LD, 2008, EMERG THEMES EPIDEMI, V5, DOI 10.1186/1742-7622-5-3
   Hu FB, 2002, CURR OPIN LIPIDOL, V13, P3, DOI 10.1097/00041433-200202000-00002
   Johnson L, 2008, AM J CLIN NUTR, V87, P846, DOI 10.1093/ajcn/87.4.846
   KAISER HF, 1960, EDUC PSYCHOL MEAS, V20, P141, DOI 10.1177/001316446002000116
   Kennedy G., 2011, Food and Agriculture Organization of the United Nations
   Kennedy Gina, 2013, Guidelines for Measuring Household and Individual Dietary Diversity
   Kennedy GL, 2007, J NUTR, V137, P472, DOI 10.1093/jn/137.2.472
   Kiefte-de Jong JC, 2013, BRIT J NUTR, V109, P137, DOI 10.1017/S0007114512000682
   Kubik MY, 2003, AM J PUBLIC HEALTH, V93, P1168, DOI 10.2105/AJPH.93.7.1168
   Kumah DB, 2015, J NUTR METAB, V2015, DOI 10.1155/2015/613207
   Leroy JL, 2008, J NUTR, V138, P2258, DOI 10.3945/jn.108.092437
   Manyanga T, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-887
   McNaughton SA, 2008, J NUTR, V138, P364, DOI 10.1093/jn/138.2.364
   Melaku YA, 2017, NUTRIENTS, V9, DOI 10.3390/nu9111198
   Ochola S, 2014, ANN NUTR METAB, V64, P24, DOI 10.1159/000365125
   Popkin BM, 2006, AM J CLIN NUTR, V84, P289, DOI 10.1093/ajcn/84.2.289
   Popkin BM, 2012, NUTR REV, V70, P3, DOI 10.1111/j.1753-4887.2011.00456.x
   Richter A, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-35
   Ruan Y, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-6003-7
   Shang XW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043183
   Shi ZM, 2018, ASIA PAC J CLIN NUTR, V27, P406, DOI 10.6133/apjcn.032017.19
   Thompson F.E., 2013, Nutrition in the prevention and treatment of disease, V3rd, P3, DOI [10.1016/B978-0-12-391884-0.00001-9, DOI 10.1016/B978-0-12-391884-0.00001-9]
   Utter J, 2007, INT J BEHAV NUTR PHY, V4, DOI 10.1186/1479-5868-4-40
   Vorster HH, 2011, NUTRIENTS, V3, P429, DOI 10.3390/nu3040429
   Vyas S, 2006, HEALTH POLICY PLANN, V21, P459, DOI 10.1093/heapol/czl029
   Willett WC, 1998, NUTR EPIDEMIOLOGY
   Zhen SH, 2018, NUTR J, V17, DOI 10.1186/s12937-018-0372-8
NR 47
TC 27
Z9 27
U1 1
U2 4
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1606-0997
EI 2072-1315
J9 J HEALTH POPUL NUTR
JI J. Heatlh Popul. Nutr.
PD FEB 6
PY 2019
VL 38
AR 5
DI 10.1186/s41043-019-0162-8
PG 10
WC Environmental Sciences; Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health
GA HL2FY
UT WOS:000458521000001
PM 30728067
OA Green Accepted, Green Published, gold
DA 2025-04-28
ER

PT J
AU Hursel, R
   Westerterp-Plantenga, MS
AF Hursel, Rick
   Westerterp-Plantenga, Margriet S.
TI Consumption of Milk-Protein Combined with Green Tea Modulates
   Diet-Induced Thermogenesis
SO NUTRIENTS
LA English
DT Article
DE obesity; catechins; polyphenol-protein complexes; energy expenditure
ID BLACK TEA; ANTIOXIDANT CAPACITY; ENERGY-EXPENDITURE; FAT OXIDATION;
   BODY-WEIGHT; POLYPHENOLS; CAFFEINE; FLAVONOIDS; EXTRACTS; HUMANS
AB Green tea and protein separately are able to increase diet-induced thermogenesis. Although their effects on long-term weight-maintenance were present separately, they were not additive. Therefore, the effect of milk-protein (MP) in combination with green tea on diet-induced thermogenesis (DIT) was examined in 18 subjects (aged 18-60 years; BMI: 23.0 +/- 2.1 kg/m(2)). They participated in an experiment with a randomized, 6 arms, crossover design, where energy expenditure and respiratory quotient (RQ) were measured. Green tea (GT) vs. placebo (PL) capsules were either given in combination with water or with breakfasts containing milk protein in two different dosages: 15 g (15 MP) (energy% P/C/F: 15/47/38; 1.7 MJ/500 mL), and 3.5 g (3.5 MP) (energy% P/C/F: 41/59/0; 146.4 kJ/100 mL). After measuring resting energy expenditure (REE) for 30 min, diet-induced energy expenditure was measured for another 3.5 h after the intervention. There was an overall significant difference observed between conditions (p < 0.001). Post-hoc, areas under the curve (AUCs) for diet-induced energy expenditure were significantly different (P <= 0.001) for GT + water (41.11 [91.72] kJ.3.5 h) vs. PL + water (10.86 [28.13] kJ.3.5 h), GT + 3.5 MP (10.14 [54.59] kJ.3.5 h) and PL + 3.5 MP (12.03 [34.09] kJ.3.5 h), but not between GT + 3.5 MP, PL + 3.5 MP and PL + water, indicating that MP inhibited DIT following GT. DIT after GT + 15 MP (167.69 [141.56] kJ.3.5 h) and PL + 15 MP (168.99 [186.56] kJ.3.5 h) was significantly increased vs. PL + water (P < 0.001), but these were not different from each other indicating that 15 g MP stimulated DIT, but inhibited the GT effect on DIT. No significant differences in RQ were seen between conditions for baseline and post-treatment. In conclusion, consumption of milk-protein inhibits the effect of green tea on DIT.
C1 [Hursel, Rick; Westerterp-Plantenga, Margriet S.] Maastricht Univ, Dept Human Biol, Nutr & Toxicol Res Inst Maastricht NUTRIM, NL-6200 MD Maastricht, Netherlands.
C3 Maastricht University
RP Hursel, R (corresponding author), Maastricht Univ, Dept Human Biol, Nutr & Toxicol Res Inst Maastricht NUTRIM, POB 616, NL-6200 MD Maastricht, Netherlands.
EM rick.hursel@maastrichtuniversity.nl;
   m.westerterp@maastrichtuniversity.nl
FU FrieslandCampina
FX We would like to acknowledge FrieslandCampina for sponsoring the study
   and providing us the dairy drinks. RH and MSW-P designed the study. RH
   collected and analyzed the data. RH wrote the manuscript and MSW-P
   contributed to the interpretation of the data and reviewed the
   manuscript. The study was executed under the supervision of MSW-P.
CR Arts MJTJ, 2002, J AGR FOOD CHEM, V50, P1184, DOI 10.1021/jf010855a
   Arts MJTJ, 2001, FOOD CHEM TOXICOL, V39, P787, DOI 10.1016/S0278-6915(01)00020-5
   Auvichayapat P, 2008, PHYSIOL BEHAV, V93, P486, DOI 10.1016/j.physbeh.2007.10.009
   Bérubé-Parent S, 2005, BRIT J NUTR, V94, P432, DOI 10.1079/BJN20051502
   Boirie Y, 1997, P NATL ACAD SCI USA, V94, P14930, DOI 10.1073/pnas.94.26.14930
   BROWN PJ, 1963, J CHROMATOGR, V11, P504, DOI 10.1016/S0021-9673(01)80953-5
   Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040
   Harris JA, 1918, P NATL ACAD SCI USA, V4, P370, DOI 10.1073/pnas.4.12.370
   HASLAM E, 1974, BIOCHEM J, V139, P285, DOI 10.1042/bj1390285
   Hollman PCH, 2001, FREE RADICAL RES, V34, P297, DOI 10.1080/10715760100300261
   Hursel R, 2010, BRIT J NUTR, V103, P775, DOI 10.1017/S0007114509992352
   Hursel R, 2009, AM J CLIN NUTR, V89, P822, DOI 10.3945/ajcn.2008.27043
   Jöbstl E, 2006, J AGR FOOD CHEM, V54, P4077, DOI 10.1021/jf053259f
   Krul C, 2001, MUTAT RES-FUND MOL M, V474, P71, DOI 10.1016/S0027-5107(00)00158-5
   Langley-Evans SC, 2000, INT J FOOD SCI NUTR, V51, P181, DOI 10.1080/09637480050029683
   Leenen R, 2000, EUR J CLIN NUTR, V54, P87, DOI 10.1038/sj.ejcn.1600900
   Lorenz M, 2007, EUR HEART J, V28, P219, DOI 10.1093/eurheartj/ehl442
   LUCK G, 1994, PHYTOCHEMISTRY, V37, P357, DOI 10.1016/0031-9422(94)85061-5
   MCCARTY MF, 1994, MED HYPOTHESES, V42, P215, DOI 10.1016/0306-9877(94)90120-1
   Palmatier MA, 1999, BIOL PSYCHIAT, V46, P557, DOI 10.1016/S0006-3223(99)00098-0
   Reddy VC, 2005, ANN NUTR METAB, V49, P189, DOI 10.1159/000087071
   Schoffelen PFM, 1997, J APPL PHYSIOL, V83, P2064, DOI 10.1152/jappl.1997.83.6.2064
   SEIDELL JC, 1995, OBES RES, V3, pS89, DOI 10.1002/j.1550-8528.1995.tb00451.x
   Serafini M, 1996, EUR J CLIN NUTR, V50, P28
   Siebert KJ, 1996, J AGR FOOD CHEM, V44, P80, DOI 10.1021/jf9502459
   STUNKARD AJ, 1985, J PSYCHOSOM RES, V29, P71, DOI 10.1016/0022-3999(85)90010-8
   van het Hof KH, 1998, EUR J CLIN NUTR, V52, P356, DOI 10.1038/sj.ejcn.1600568
   WEIR JBD, 1949, J PHYSIOL-LONDON, V109, P1, DOI 10.1113/jphysiol.1949.sp004363
   WESTERTERP KR, 1995, BRIT J NUTR, V73, P337, DOI 10.1079/BJN19950037
   Westerterp-Plantenga MS, 2005, OBES RES, V13, P1195, DOI 10.1038/oby.2005.142
NR 30
TC 10
Z9 11
U1 0
U2 15
PU MDPI AG
PI BASEL
PA POSTFACH, CH-4005 BASEL, SWITZERLAND
SN 2072-6643
J9 NUTRIENTS
JI Nutrients
PD AUG
PY 2011
VL 3
IS 8
BP 725
EP 733
DI 10.3390/nu3080725
PG 9
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA 864NQ
UT WOS:000298247300001
PM 22254119
OA Green Submitted, gold, Green Published
DA 2025-04-28
ER

PT J
AU Park, S
   Onufrak, S
   Blanck, HM
   Sherry, B
AF Park, Sohyun
   Onufrak, Stephen
   Blanck, Heidi M.
   Sherry, Bettylou
TI Characteristics Associated with Consumption of Sports and Energy Drinks
   among US Adults: National Health Interview Survey, 2010
SO JOURNAL OF THE ACADEMY OF NUTRITION AND DIETETICS
LA English
DT Article
DE Sports drinks; Energy drinks; Sugar-sweetened beverages; Behaviors;
   Adults
ID SWEETENED BEVERAGE CONSUMPTION; BODY-WEIGHT; DIETARY; RISK; ADOLESCENTS;
   PATTERNS
AB Sales of sports and energy drinks have increased dramatically, but there is limited information on regular consumers of sports and energy drinks. Characteristics associated with sports and energy drink intake were examined among a sample representing the civilian noninstitutionalized US adult population. The 2010 National Health Interview Survey data for 25,492 adults (18 years of age or older; 48% males) were used. Nationwide, 31.3% of adults were sports and energy drink consumers during the past 7 days, with 21.5% consuming sports and energy drinks one or more times per week and 11.5% consuming sports and energy drinks three or more times per week. Based on multivariable logistic regression, younger adults, males, non-Hispanic blacks and Hispanics, not-married individuals, adults with higher family income, those who lived in the South or West, adults who engaged in leisure-time physical activity, current smokers, and individuals whose satisfaction with their social activities/relationships was excellent had significantly higher odds for drinking sports and energy drinks one or more times per week. In this model, the factor most strongly associated with weekly sports and energy. drink consumption was age (odds ratio [OR]=10.70 for 18- to 24-year-olds, OR=6.40 for 25- to 39-year-olds, OR=3.17 for 40- to 59-year-olds vs 60 years or older). Lower odds for consuming sports and energy drinks one or more times per week were associated with other/multiracial (OR=0.80 vs non-Hispanic white) and obesity (OR=0.87 vs underweight/normal weight). Separate modeling of the association between other beverage intake and sports and energy drink intake showed that higher intake of regular soda, sweetened coffee/tea drinks, fruit drinks, milk, 100% fruit juice, and alcohol were significantly associated with greater odds for drinking sports and energy drinks one or more times per week. These findings can help medical care providers and public health officials identify adults most in need of encouragement to reduce sports and energy drink intake and increase healthier beverage intake. J Acad Nutr Diet. 2013;113:112-119.
C1 [Park, Sohyun; Onufrak, Stephen; Blanck, Heidi M.; Sherry, Bettylou] Ctr Dis Control & Prevent, Div Nutr Phys Act & Obes, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30341 USA.
C3 Centers for Disease Control & Prevention - USA
RP Park, S (corresponding author), Ctr Dis Control & Prevent, Div Nutr Phys Act & Obes, Natl Ctr Chron Dis Prevent & Hlth Promot, 4770 Buford Highway,Mailstop K26, Atlanta, GA 30341 USA.
EM spark3@cdc.gov
OI Park, Sohyun/0000-0002-8192-7048
FU Intramural CDC HHS [CC999999] Funding Source: Medline
CR [Anonymous], 2011, USDA NAT NUTR DAT ST
   [Anonymous], 1998, NIH PUBL
   Attila S, 2011, NUTRITION, V27, P316, DOI 10.1016/j.nut.2010.02.008
   Berger AJ, 2009, MED J AUSTRALIA, V190, P41, DOI 10.5694/j.1326-5377.2009.tb02263.x
   Berger LK, 2011, ADDICT BEHAV, V36, P516, DOI 10.1016/j.addbeh.2010.12.027
   Bleich SN, 2009, AM J CLIN NUTR, V89, P372, DOI 10.3945/ajcn.2008.26883
   Burt B A, 2001, J Dent Educ, V65, P1017
   Burt BA, 2006, CARIES RES, V40, P473, DOI 10.1159/000095645
   Carrillo JA, 2000, CLIN PHARMACOKINET, V39, P127, DOI 10.2165/00003088-200039020-00004
   Centers for Disease Control and Prevention US Department of Health and Human Services, 2011, 2010 NAT HLTH INT SU
   Clauson KA, 2008, J AM PHARM ASSOC, V48, pE55, DOI 10.1331/JAPhA.2008.07055
   Coombes JS, 2000, SPORTS MED, V29, P181, DOI 10.2165/00007256-200029030-00004
   de Koning L, 2011, AM J CLIN NUTR, V93, P1321, DOI 10.3945/ajcn.110.007922
   Duffey KJ, 2010, AM J CLIN NUTR, V92, P954, DOI 10.3945/ajcn.2010.29478
   Ebbeling CB, 2006, PEDIATRICS, V117, P673, DOI 10.1542/peds.2005-0983
   Gibson S, 2008, HYPERTENSION, V51, pE54, DOI 10.1161/HYPERTENSIONAHA.108.112763
   Grocery and Gourmet Food, GROC GOURM FOOD
   Hall KD, 2011, LANCET, V378, P826, DOI 10.1016/S0140-6736(11)60812-X
   Hedrick VE, 2010, J AM DIET ASSOC, V110, P1227, DOI 10.1016/j.jada.2010.05.005
   Higgins JP, 2010, MAYO CLIN PROC, V85, P1033, DOI 10.4065/mcp.2010.0381
   Institute of Medicine Food and Nutrition Board, 2005, DIET REF INT EN CARB, DOI DOI 10.17226/10490
   Iyadurai SJP, 2007, EPILEPSY BEHAV, V10, P504, DOI 10.1016/j.yebeh.2007.01.009
   Kleiman S, 2012, OBES REV, V13, P258, DOI 10.1111/j.1467-789X.2011.00949.x
   Libuda L, 2009, CURR OPIN CLIN NUTR, V12, P596, DOI 10.1097/MCO.0b013e32833189f6
   Malik VS, 2006, AM J CLIN NUTR, V84, P274
   Malik VS, 2010, DIABETES CARE, V33, P2477, DOI 10.2337/dc10-1079
   Malinauskas BM, 2007, NUTR J, V6, DOI 10.1186/1475-2891-6-35
   Miller KE, 2008, J ADOLESCENT HEALTH, V43, P490, DOI 10.1016/j.jadohealth.2008.03.003
   National Policy and Legal Analysis Network to Prevent Childhood Obesity, 2011, BREAK CHAIN GUID SOF
   Price SR, 2010, DRUG ALCOHOL REV, V29, P331, DOI 10.1111/j.1465-3362.2009.00163.x
   Ranjit N, 2010, PEDIATRICS, V126, pE754, DOI 10.1542/peds.2010-1229
   Reissig CJ, 2009, DRUG ALCOHOL DEPEN, V99, P1, DOI 10.1016/j.drugalcdep.2008.08.001
   Schneider MB, 2011, PEDIATRICS, V127, P1182, DOI 10.1542/peds.2011-0965
   Stanhope KL, 2011, J CLIN ENDOCR METAB, V96, pE1596, DOI 10.1210/jc.2011-1251
   Venables MC, 2005, MED SCI SPORT EXER, V37, P39, DOI 10.1249/01.MSS.0000150017.74892.F5
   West DS, 2006, OBESITY, V14, P1825, DOI 10.1038/oby.2006.210
   Worthley MI, 2010, AM J MED, V123, P184, DOI 10.1016/j.amjmed.2009.09.013
NR 37
TC 48
Z9 52
U1 1
U2 70
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 2212-2672
EI 2212-2680
J9 J ACAD NUTR DIET
JI J. Acad. Nutr. Diet.
PD JAN
PY 2013
VL 113
IS 1
BP 112
EP 119
DI 10.1016/j.jand.2012.09.019
PG 8
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Nutrition & Dietetics
GA 107SZ
UT WOS:000316242400012
PM 23260728
OA Green Accepted
DA 2025-04-28
ER

PT J
AU Bode, D
   Semmler, L
   Wakula, P
   Hegemann, N
   Primessnig, U
   Beindorff, N
   Powell, D
   Dahmen, R
   Ruetten, H
   Oeing, C
   Alogna, A
   Messroghli, D
   Pieske, BM
   Heinzel, FR
   Hohendanner, F
AF Bode, David
   Semmler, Lukas
   Wakula, Paulina
   Hegemann, Niklas
   Primessnig, Uwe
   Beindorff, Nicola
   Powell, David
   Dahmen, Raphael
   Ruetten, Hartmut
   Oeing, Christian
   Alogna, Alessio
   Messroghli, Daniel
   Pieske, Burkert M.
   Heinzel, Frank R.
   Hohendanner, Felix
TI Dual SGLT-1 and SGLT-2 inhibition improves left atrial dysfunction in
   HFpEF
SO CARDIOVASCULAR DIABETOLOGY
LA English
DT Article
DE Atrial cardiomyopathy; Heart failure with preserved ejection fraction;
   SGLT inhibition; Atrial remodeling; Left atrial cardiomyocytes; Calcium
   cycling; Mitochondria
AB Background: Sodium-glucose linked transporter type 2 (SGLT-2) inhibition has been shown to reduce cardiovascular mortality in heart failure independently of glycemic control and prevents the onset of atrial arrhythmias, a common co-morbidity in heart failure with preserved ejection fraction (HFpEF). The mechanism behind these effects is not fully understood, and it remains unclear if they could be further enhanced by additional SGLT-1 inhibition. We investigated the effects of chronic treatment with the dual SGLT-1&2 inhibitor sotagliflozin on left atrial (LA) remodeling and cellular arrhythmogenesis (i.e. atrial cardiomyopathy) in a metabolic syndrome-related rat model of HFpEF.
   Methods: 17 week-old ZSF-1 obese rats, a metabolic syndrome-related model of HFpEF, and wild type rats (Wistar Kyoto), were fed 30 mg/kg/d sotagliflozin for 6 weeks. At 23 weeks, LA were imaged in-vivo by echocardiography. In-vitro, Ca2+ transients (CaT; electrically stimulated, caffeine-induced) and spontaneous Ca2+ release were recorded by ratiometric microscopy using Ca2+-sensitive fluorescent dyes (Fura-2) during various experimental protocols. Mitochondrial structure (dye: Mitotracker), Ca2+ buffer capacity (dye: Rhod-2), mitochondrial depolarization (dye: TMRE) and production of reactive oxygen species (dye: H2DCF) were visualized by confocal microscopy. Statistical analysis was performed with 2-way analysis of variance followed by post-hoc Bonferroni and student's t-test, as applicable.
   Results: Sotagliflozin ameliorated LA enlargement in HFpEF in-vivo. In-vitro, LA cardiomyocytes in HFpEF showed an increased incidence and amplitude of arrhythmic spontaneous Ca2+ release events (SCaEs). Sotagliflozin significantly reduced the magnitude of SCaEs, while their frequency was unaffected. Sotagliflozin lowered diastolic [Ca2+] of CaT at baseline and in response to glucose influx, possibly related to a similar to 50% increase of sodium sodium-calcium exchanger (NCX) forward-mode activity. Sotagliflozin prevented mitochondrial swelling and enhanced mitochondrial Ca2+ buffer capacity in HFpEF. Sotagliflozin improved mitochondrial fission and reactive oxygen species (ROS) production during glucose starvation and averted Ca2+ accumulation upon glycolytic inhibition.
   Conclusion: The SGLT-1&2 inhibitor sotagliflozin ameliorated LA remodeling in metabolic HFpEF. It also improved distinct features of Ca2+-mediated cellular arrhythmogenesis in-vitro (i.e. magnitude of SCaEs, mitochondrial Ca2+ buffer capacity, diastolic Ca2+ accumulation, NCX activity). The safety and efficacy of combined SGLT-1&2 inhibition for the treatment and/or prevention of atrial cardiomyopathy associated arrhythmias should be further evaluated in clinical trials.
C1 [Bode, David; Semmler, Lukas; Wakula, Paulina; Hegemann, Niklas; Primessnig, Uwe; Oeing, Christian; Alogna, Alessio; Messroghli, Daniel; Pieske, Burkert M.; Heinzel, Frank R.; Hohendanner, Felix] Charite, Dept Internal Med & Cardiol, Campus Virchow Klinikum,Augustenburgerpl 1, D-13353 Berlin, Germany.
   [Bode, David; Semmler, Lukas; Wakula, Paulina; Hegemann, Niklas; Primessnig, Uwe; Oeing, Christian; Alogna, Alessio; Messroghli, Daniel; Pieske, Burkert M.; Heinzel, Frank R.; Hohendanner, Felix] German Ctr Cardiovasc Res DZHK, Berlin, Germany.
   [Powell, David] Lexicon Pharmaceut, Metab Res, Houston, TX USA.
   [Dahmen, Raphael; Ruetten, Hartmut] Sanofi Aventis Deutschland GmbH, Res & Dev, D-65926 Frankfurt, Germany.
   [Messroghli, Daniel; Pieske, Burkert M.] German Heart Ctr Berlin, Dept Internal Med & Cardiol, D-13353 Berlin, Germany.
   [Bode, David; Primessnig, Uwe; Oeing, Christian; Alogna, Alessio; Hohendanner, Felix] Berlin Inst Hlth BIH, Berlin, Germany.
   [Beindorff, Nicola] Charite Univ Med Berlin, Berlin Expt Radionuclide Imaging Ctr BERIC, Berlin, Germany.
C3 Berlin Institute of Health; Free University of Berlin; Humboldt
   University of Berlin; Charite Universitatsmedizin Berlin; German Centre
   for Cardiovascular Research; Lexicon Pharmaceuticals; Sanofi-Aventis;
   Sanofi Germany; German Heart Center Berlin; Berlin Institute of Health;
   Berlin Institute of Health; Free University of Berlin; Humboldt
   University of Berlin; Charite Universitatsmedizin Berlin
RP Hohendanner, F (corresponding author), Charite, Dept Internal Med & Cardiol, Campus Virchow Klinikum,Augustenburgerpl 1, D-13353 Berlin, Germany.; Hohendanner, F (corresponding author), German Ctr Cardiovasc Res DZHK, Berlin, Germany.; Hohendanner, F (corresponding author), Berlin Inst Hlth BIH, Berlin, Germany.
EM felix.hohendanner@charite.de
RI Bode, David/M-7603-2015; Oeing, Christian/AFT-8798-2022; Pieske,
   Burkert/M-8089-2016
OI Pieske, Burkert/0000-0002-6466-5306; Beindorff,
   Nicola/0000-0001-9126-3356; Oeing, Christian/0000-0002-0816-4443; Bode,
   David/0000-0003-4077-111X; Semmler, Lukas/0000-0003-2933-7566; Alogna,
   Alessio/0000-0001-5988-2720; Messroghli, Daniel/0000-0003-1331-5004;
   Heinzel, Frank R./0000-0002-4529-5282
FU Projekt DEAL; Else-Kroner-Fresenius-Foundation; DZHK (German Centre for
   Cardiovascular Research); Berlin Institute of Health
FX Open Access funding enabled and organized by Projekt DEAL. Support for
   this study was provided by the Else-Kroner-Fresenius-Foundation (FH).
   The authors were supported by grants from the DZHK (German Centre for
   Cardiovascular Research; DB, FH) and the Berlin Institute of Health (DB,
   FH, UP, AA).
CR Abdul-Ghani MA, 2013, DIABETES, V62, P3324, DOI 10.2337/db13-0604
   Banerjee SK, 2009, CARDIOVASC RES, V84, P111, DOI 10.1093/cvr/cvp190
   Bilan VP, 2011, J ENDOCRINOL, V210, P293, DOI 10.1530/JOE-11-0122
   Bode D, 2018, JOVE-J VIS EXP, DOI 10.3791/57953
   Bonora BM, 2020, DIABET METAB SYND OB, V13, P161, DOI 10.2147/DMSO.S233538
   Bowen TS, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.006416
   Brown DA, 2010, CARDIOVASC RES, V88, P241, DOI 10.1093/cvr/cvq231
   Cefalo CMA, 2019, CARDIOVASC DIABETOL, V18, DOI 10.1186/s12933-019-0828-y
   Connelly KA, 2018, CARDIOVASC DIABETOL, V17, DOI 10.1186/s12933-018-0741-9
   de Boer RA, 2020, BRIT J CLIN PHARMACO, V86, P1346, DOI 10.1111/bcp.14248
   Drago I, 2012, P NATL ACAD SCI USA, V109, P12986, DOI 10.1073/pnas.1210718109
   Fillmore N, 2018, MOL MED, V24, DOI 10.1186/s10020-018-0005-x
   Goette A, 2016, J ARRYTHM, V32, P247, DOI 10.1016/j.joa.2016.05.002
   Hamdani N, 2013, CIRC-HEART FAIL, V6, P1239, DOI 10.1161/CIRCHEARTFAILURE.113.000539
   Hohendanner F, 2018, ESC HEART FAIL, V5, P211, DOI 10.1002/ehf2.12260
   Hohendanner F, 2018, J MOL CELL CARDIOL, V115, P10, DOI 10.1016/j.yjmcc.2017.12.012
   Hohendanner F, 2018, HEART FAIL REV, V23, P27, DOI 10.1007/s10741-017-9657-9
   Hohendanner F, 2015, CHANNELS, V9, P129, DOI 10.1080/19336950.2015.1040966
   Hohendanner F, 2015, J PHYSIOL-LONDON, V593, P1459, DOI 10.1113/jphysiol.2014.283226
   Hohendanner F, 2013, CIRC RES, V113, P527, DOI 10.1161/CIRCRESAHA.113.300895
   Kashiwagi Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130605
   Kohlhaas M, 2017, J PHYSIOL-LONDON, V595, P3753, DOI 10.1113/JP273609
   Kolijn D, 2021, CARDIOVASC RES, V117, P495, DOI 10.1093/cvr/cvaa123
   Lambert R, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.115.002183
   Lemasters JJ, 2009, BBA-BIOENERGETICS, V1787, P1395, DOI 10.1016/j.bbabio.2009.06.009
   Leong HS, 2002, AM J PHYSIOL-ENDOC M, V282, pE1039, DOI 10.1152/ajpendo.00507.2001
   Li Z, 2019, CARDIOVASC RES, V115, P1646, DOI 10.1093/cvr/cvz037
   Lindman BR, 2014, J AM COLL CARDIOL, V64, P541, DOI 10.1016/j.jacc.2014.05.030
   Maack C, 2006, CIRC RES, V99, P172, DOI 10.1161/01.RES.0000232546.92777.05
   Marrouche NF, 2018, NEW ENGL J MED, V378, P417, DOI 10.1056/NEJMoa1707855
   Maxwell JT, 2018, JOVE-J VIS EXP, DOI 10.3791/57225
   McMurray JJV, 2019, NEW ENGL J MED, V381, P1995, DOI 10.1056/NEJMoa1911303
   Miranda-Silva D, 2020, ACTA PHYSIOL, V228, DOI 10.1111/apha.13378
   Piao L, 2013, J MOL MED, V91, P333, DOI 10.1007/s00109-012-0982-0
   Powell DR, 2020, J CLIN ENDOCR METAB, V105, DOI 10.1210/clinem/dgz258
   Powell DR, 2014, J PHARMACOL EXP THER, V350, P232, DOI 10.1124/jpet.114.214304
   Primessnig U, 2019, EUR J HEART FAIL, V21, P1543, DOI 10.1002/ejhf.1619
   Sabatino J, 2020, CARDIOVASC DIABETOL, V19, DOI 10.1186/s12933-020-01040-5
   Schweitzer Maria K, 2017, JACC Basic Transl Sci, V2, P737, DOI 10.1016/j.jacbts.2017.06.008
   Seidelmann SB, 2018, J AM COLL CARDIOL, V72, P1763, DOI 10.1016/j.jacc.2018.07.061
   Shao QM, 2019, CARDIOVASC DIABETOL, V18, DOI 10.1186/s12933-019-0964-4
   Tsimihodimos V, 2018, EUR J PHARMACOL, V838, P153, DOI 10.1016/j.ejphar.2018.09.019
   Uthman L, 2018, DIABETOLOGIA, V61, P722, DOI 10.1007/s00125-017-4509-7
   Voigt N, 2014, CIRCULATION, V129, P145, DOI 10.1161/CIRCULATIONAHA.113.006641
   Voigt N, 2012, CIRCULATION, V125, P2059, DOI 10.1161/CIRCULATIONAHA.111.067306
   Yoshii A, 2019, CARDIOVASC DIABETOL, V18, DOI 10.1186/s12933-019-0889-y
   Zambrowicz B, 2012, CLIN PHARMACOL THER, V92, P158, DOI 10.1038/clpt.2012.58
   Zelniker TA, 2020, CIRCULATION, V141, P1227, DOI 10.1161/CIRCULATIONAHA.119.044183
NR 48
TC 78
Z9 83
U1 0
U2 26
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1475-2840
J9 CARDIOVASC DIABETOL
JI Cardiovasc. Diabetol.
PD JAN 7
PY 2021
VL 20
IS 1
AR 7
DI 10.1186/s12933-020-01208-z
PG 14
WC Cardiac & Cardiovascular Systems; Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cardiovascular System & Cardiology; Endocrinology & Metabolism
GA PS9YC
UT WOS:000608278200002
PM 33413413
OA Green Published, gold
DA 2025-04-28
ER

PT J
AU Park, S
   Lee, SH
   Yaroch, AL
   Blanck, HM
AF Park, Sohyun
   Lee, Seung Hee
   Yaroch, Amy L.
   Blanck, Heidi M.
TI Reported Changes in Eating Habits Related to Less Healthy Foods and
   Beverages during the COVID-19 Pandemic among US Adults
SO NUTRIENTS
LA English
DT Article
DE added sugars; unhealthy snacks; desserts; sugar-sweetened beverage;
   COVID-19 pandemic; US adults; diet
ID STRESS
AB Background: The COVID-19 pandemic has triggered stress, anxiety, and disruption to many individuals' daily lives, which might impact eating habits. Objective: To examine changes in eating habits related to less healthy foods and beverages during the early phase of the COVID-19 pandemic among US adults. Design: Cross-sectional study. Participants/setting: Authors used SummerStyles data gathered in June 2020 among 3916 US adults (>= 18 years). Main outcome measures: The outcome of interest was the reported frequency of consuming more (1) unhealthy snacks and desserts including chips, cookies, and ice cream and (2) sugar-sweetened beverages (SSBs) like regular soda, fruit drinks, sports/energy drinks, sweetened coffee/teas during the COVID-19 pandemic. Responses were categorized as Never/Rarely, Sometimes, or Often/Always. Explanatory variables were sociodemographics, weight status, and census regions. Statistical analyses performed: We used multinomial regressions to calculate adjusted odds ratios (AOR) for Sometimes or Often/Always consuming more unhealthy snacks/desserts (vs. Never/Rarely); and Sometimes or Often/Always more SSBs (vs. Never/Rarely). Results: Overall, 36% of adults reported sometimes consuming more unhealthy snacks/desserts; 16% did so often/always. Twenty-two percent of adults reported sometimes drinking more SSBs; 10% did so often/always. Factors significantly associated with higher odds of reporting often/always consuming more unhealthy snacks/desserts were younger adults (AOR range = 1.51-2.86 vs. adults >= 65 years), females (AOR = 1.58 vs. males), non-Hispanic Black (AOR = 1.89 vs. non-Hispanic White), lower household income (AOR = 2.01 for <USD 35,000 vs. >= USD 100,000), and obesity (AOR = 1.56 vs. underweight/healthy weight). Factors significantly associated with odds of Often/Always drinking more SSBs were being younger (AOR range = 2.26-4.39 vs. adults >= 65 years), non-Hispanic Black (AOR = 3.25 vs. non-Hispanic White), Hispanic (AOR = 1.75 vs. non-Hispanic White), non-Hispanic Other race/ethnicity (AOR = 2.41 vs. non-Hispanic White), lower education (AOR = 2.03 for <= high school; AOR = 1.80 for some college vs. college graduate), lower household income (AOR range = 1.64-3.15 vs. >= USD 100,000), and obesity (AOR = 1.61 vs. underweight/healthy weight). Conclusions: Consuming more sugary foods and SSBs during the first phase of the pandemic was higher in younger adults, lower-income adults, people of racial/ethnic minority groups, and adults with obesity. Dietary shifts to less healthy foods and drinks may influence metabolic health if sustained long-term. Implementing strategies to support individual's healthy eating habits during the ongoing pandemic and the pandemic recovery may benefit health and wellness.
C1 [Park, Sohyun; Lee, Seung Hee; Blanck, Heidi M.] Ctr Dis Control & Prevent, Div Nutr Phys Act & Obes, Natl Ctr Chron Dis Prevent & Hlth Promot, 4770 Buford Highway NE, Atlanta, GA 30341 USA.
   [Yaroch, Amy L.] Gretchen Swanson Ctr Nutr, 14301 FNB Pkwy,Suite 100, Omaha, NE 68154 USA.
C3 Centers for Disease Control & Prevention - USA
RP Park, S (corresponding author), Ctr Dis Control & Prevent, Div Nutr Phys Act & Obes, Natl Ctr Chron Dis Prevent & Hlth Promot, 4770 Buford Highway NE, Atlanta, GA 30341 USA.
EM spark3@cdc.gov; xde5@cdc.go; ayaroch@centerfornutrition.org;
   hcb3@cdc.gov
OI Park, Sohyun/0000-0002-8192-7048
CR Adam TC, 2007, PHYSIOL BEHAV, V91, P449, DOI 10.1016/j.physbeh.2007.04.011
   [Anonymous], CENS REG DIV US
   Bambra C, 2020, J EPIDEMIOL COMMUN H, V74, P964, DOI 10.1136/jech-2020-214401
   Bemanian M, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18010130
   Blaszczyk-Bebenek E, 2020, NUTRIENTS, V12, DOI 10.3390/nu12103084
   Bowman S.A., 2019, NHANES 2015 2016, P1
   Bowman S.A., 2020, Food Patterns Equivalents Database 2017-2018: Methodology and User Guide
   Cecchetto C, 2021, APPETITE, V160, DOI 10.1016/j.appet.2021.105122
   Chevinsky JR, 2021, PREV CHRONIC DIS, V18, DOI 10.5888/pcd18.200434
   Cosgrove K, 2021, NUTRIENTS, V13, DOI 10.3390/nu13062097
   Cummings JR, 2021, APPETITE, V162, DOI 10.1016/j.appet.2021.105163
   Di Renzo L, 2020, J TRANSL MED, V18, DOI 10.1186/s12967-020-02399-5
   Dunford EK, 2022, J NUTR, V152, P492, DOI 10.1093/jn/nxab205
   Figueroa JF., 2021, HEALTHCARE-J DEL SCI, V9, P100495, DOI [10.1016/j.hjdsi.2020.100495, DOI 10.1016/J.HJDSI.2020.100495]
   Holingue C, 2020, PREV MED, V139, DOI 10.1016/j.ypmed.2020.106231
   Kim H, 2019, PUBLIC HEALTH NUTR, V22, P1777, DOI 10.1017/S1368980018003890
   Kompaniyets L, 2021, MMWR-MORBID MORTAL W, V70, P355, DOI 10.15585/mmwr.mm7010e4
   Lane MM, 2021, OBES REV, V22, DOI 10.1111/obr.13146
   Lippi G, 2020, DIAGNOSIS, V7, P85, DOI 10.1515/dx-2020-0041
   Liu JX, 2021, AM J CLIN NUTR, V114, P1039, DOI 10.1093/ajcn/nqab129
   Mackey K, 2021, ANN INTERN MED, V174, P362, DOI 10.7326/M20-6306
   McGinty EE, 2020, JAMA-J AM MED ASSOC, V324, P93, DOI 10.1001/jama.2020.9740
   Miller S, 2021, APPETITE, V166, DOI 10.1016/j.appet.2021.105586
   Nicola M, 2020, INT J SURG, V78, P185, DOI 10.1016/j.ijsu.2020.04.018
   Pfefferbaum B, 2020, NEW ENGL J MED, V383, P510, DOI 10.1056/NEJMp2008017
   Pi-Sunyer FX, 1998, OBES RES, V6, p51S
   Porter N., PORTER NOVELLI STYLE
   Puhl RM, 2020, ANN BEHAV MED, V54, P738, DOI 10.1093/abm/kaaa077
   Robinson E, 2021, APPETITE, V156, DOI 10.1016/j.appet.2020.104853
   Sadler JR, 2021, NUTRIENTS, V13, DOI 10.3390/nu13030901
   Shen W, 2020, NUTRIENTS, V12, DOI 10.3390/nu12092712
   Smith KR, 2021, APPETITE, V163, DOI 10.1016/j.appet.2021.105233
   Sominsky L, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00434
   Torres SJ, 2007, NUTRITION, V23, P887, DOI 10.1016/j.nut.2007.08.008
   Wolfson JA, 2020, NUTRIENTS, V12, DOI 10.3390/nu12061648
   Yang QH, 2020, AM J PREV MED, V59, pE197, DOI 10.1016/j.amepre.2020.06.013
NR 36
TC 31
Z9 34
U1 0
U2 12
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2072-6643
J9 NUTRIENTS
JI Nutrients
PD FEB
PY 2022
VL 14
IS 3
AR 526
DI 10.3390/nu14030526
PG 10
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA ZF3XW
UT WOS:000759505200001
PM 35276885
OA Green Published, gold
DA 2025-04-28
ER

PT J
AU Caro, JC
   Ng, SW
   Taillie, LS
   Popkin, BM
AF Caro, Juan Carlos
   Ng, Shu Wen
   Taillie, Lindsey Smith
   Popkin, Barry M.
TI Designing a tax to discourage unhealthy food and beverage purchases: The
   case of Chile
SO FOOD POLICY
LA English
DT Article
DE Price elasticity; Food tax options; Junk food tax; SSB tax; Nutrient
   tradeoffs; Almost ideal demand system
ID SUGAR-SWEETENED BEVERAGES; DEMAND SYSTEMS; PRICE ELASTICITY; SOFT
   DRINKS; OBESITY; CONSUMPTION; POLICY; PRODUCTS; DISEASES; HEALTH
AB The global shift towards diets high in sugar-sweetened beverages (SSBs) and energy dense ultra-processed foods is linked to higher prevalence of obesity, diabetes and most other non-communicable diseases (NCDs), causing significant costs to societies and individuals. Chile has the highest SSB consumption in the world, very high junk food intake and very rapid increases in these poor components of the diet plus obesity prevalence. This study's purpose is to compare the effect of different tax policies for SSBs and ultra-processed foods on nutrient availability, utilizing price-elasticities, which are estimated from a Quadratic Almost Ideal Demand System model, using the 2011-2012 Income and Expenditure survey from Chile. We take into account the high proportion of households not purchasing various food and beverage groups (censored nature of data) and endogeneity on total expenditures. The food groups considered were: sweets and desserts; salty snacks and chips; meat products and fats; fruits, vegetables and seafood; grain-based staples; ready-to-drink SSB; SSB from concentrate; plain water, coffee and tea; and milk, which together represent 90% of food expenditures. The simulated taxes were: (1) 18% price tax on all foods and beverages exceeding thresholds on sodium, saturated fat, and added sugar and for which marketing is restricted (based on a Chilean law, effective June 16, 2016); (2) 40% tax on SSBs (22% above the current tax level); and (3) a 1 Chilean peso (0.2 US cents) per gram of sugar tax on products with added sugar. Unhealthy beverages and foods are price-elastic (1.95 for salty snacks and chips, 1.30 for ready-to drink SSBs, and 1.27 for SSBs from concentrate), meaning that the change in consumption is proportionally larger with respect to a change in price. Results are robust to different model specification, and consistent among different socioeconomic sub-populations. Overall, the tax on foods and beverages high in fat, salt and sugar is associated with the largest reduction in household purchases of sodium, added sugar, saturated fat and calorie purchases. Chile is unique in currently having instituted a small current SSB tax as well as marketing controls and front-of-package labelling of unhealthy foods and beverages. The design of a more comprehensive tax to enhance the overall effect of these policies on healthier diets is a next critical step. This study shows that a tax on the same foods and beverages already delineated as unhealthy by the marketing controls and front-of-pack labelling should promote a healthier diet.
C1 [Caro, Juan Carlos] Univ Chile, Natl Inst Nutr & Food Technol INTA, Santiago, Chile.
   [Caro, Juan Carlos] Univ N Carolina, Sch Publ Hlth, Dept Health Policy & Management, Chapel Hill, NC USA.
   [Ng, Shu Wen; Taillie, Lindsey Smith; Popkin, Barry M.] Univ N Carolina, Sch Publ Hlth, Carolina Populat Ctr, Chapel Hill, NC USA.
   [Ng, Shu Wen; Taillie, Lindsey Smith; Popkin, Barry M.] Univ N Carolina, Sch Publ Hlth, Dept Nutr, Chapel Hill, NC USA.
C3 Universidad de Chile; University of North Carolina; University of North
   Carolina Chapel Hill; University of North Carolina; University of North
   Carolina Chapel Hill; University of North Carolina; University of North
   Carolina Chapel Hill
RP Popkin, BM (corresponding author), Carolina Populat Ctr, 206 West Franklin St,Rm 208, Chapel Hill, NC 27516 USA.
EM Bjuancaro@live.unc.edu; shuwen@unc.edu; lindsey.smith@unc.edu;
   popkin@unc.edu
RI Caro, Juan/IQW-6436-2023; Popkin, Barry/T-6633-2019
OI Caro, Juan C/0000-0002-1124-2617
FU Bloomberg Philanthropies; International Development Research Center [CPC
   P2C HD050924]
FX Funding for this research comes predominantly from Bloomberg
   Philanthropies with added funding from the International Development
   Research Center and CPC P2C HD050924.
CR Allais O, 2010, AM J AGR ECON, V92, P228, DOI 10.1093/ajae/aap004
   Anand SS, 2015, J AM COLL CARDIOL, V66, P1590, DOI 10.1016/j.jacc.2015.07.050
   Andreyeva T, 2010, AM J PUBLIC HEALTH, V100, P216, DOI 10.2105/AJPH.2008.151415
   [Anonymous], 2013, BMJ BRIT MED J, DOI DOI 10.1136/BMJ.F6189
   [Anonymous], 2015, INFORMAS: Benchmarking Food Environments
   [Anonymous], 2015, P IEEE ULTR S
   Colchero MA, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.h6704
   Colchero MA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144408
   Banks J, 1997, REV ECON STAT, V79, P527, DOI 10.1162/003465397557015
   Batis C, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002057
   Biblioteca del Congreso Nacional de Chile, 2015, BIBLIOTECA C NACL CH
   Bíró A, 2015, FOOD POLICY, V54, P107, DOI 10.1016/j.foodpol.2015.05.003
   Bonnet C., 2012, 4 TRANSFOP EUR COMM
   Bonnet C, 2013, J PUBLIC ECON, V106, P77, DOI 10.1016/j.jpubeco.2013.06.010
   Bonnet C, 2011, HEALTH ECON, V20, P1012, DOI 10.1002/hec.1721
   Chen X, 2015, FOOD POLICY, V56, P13, DOI 10.1016/j.foodpol.2015.07.006
   Chouinard H., 2005, 1007 CUDARE
   Colchero MA, 2015, ECON HUM BIOL, V19, P129, DOI 10.1016/j.ehb.2015.08.007
   Cornelsen L, 2015, HEALTH ECON, V24, P1548, DOI 10.1002/hec.3107
   Corvalán C, 2013, OBES REV, V14, P79, DOI 10.1111/obr.12099
   Corvalán C, 2010, AM J CLIN NUTR, V91, P166, DOI 10.3945/ajcn.2009.27547
   Corvalán C, 2009, AM J CLIN NUTR, V90, P547, DOI 10.3945/ajcn.2008.27318
   Crovetto M, 2014, REV MED CHILE, V142, P1530, DOI 10.4067/S0034-98872014001200006
   Crovetto M, 2014, REV MED CHILE, V142, P850, DOI 10.4067/S0034-98872014000700005
   DEATON A, 1980, AM ECON REV, V70, P312
   DEATON A, 1988, AM ECON REV, V78, P418
   Dharmasena S, 2011, JOINT ANN M AGR APPL
   Euromonitor, 2015, EUROMONITOR INT
   Fletcher J, 2013, PREV CHRONIC DIS, V10, DOI 10.5888/pcd10.120195
   Food and Agriculture Organization of the United Nations. United Nations University. & World Health Organization, 2004, HUM EN REQ REP JOINT
   Green R, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3703
   Gundersen C, 2015, FUTURE CHILD, V25, P91, DOI 10.1353/foc.2015.0004
   Gustavsen GW, 2011, APPL ECON, V43, P707, DOI 10.1080/00036840802599776
   Haag B. R., 2009, WORKING PAPERS
   Harding M., 2014, WORKING PAPERS
   Härkänen T, 2014, FOOD POLICY, V49, P196, DOI 10.1016/j.foodpol.2014.07.001
   Hawkes C, 2007, AM J PUBLIC HEALTH, V97, P1962, DOI 10.2105/AJPH.2006.101162
   HEIEN D, 1990, J BUS ECON STAT, V8, P365, DOI 10.2307/1391973
   Huang K., 2000, ESTIMATION FOOD DEMA, DOI 10.22004/ag.econ.33579
   Institute Nacional de Estadistica de Chile, 2013, 7 ENC PRES FAM MET
   Jaacks LM, 2015, J NUTR, V145, P352, DOI 10.3945/jn.114.203562
   Jou J, 2012, HEALTH POLICY, V107, P83, DOI 10.1016/j.healthpol.2012.05.011
   Juhl HJ, 2014, FOOD POLICY, V46, P178, DOI 10.1016/j.foodpol.2014.03.008
   JUNAEB, 2014, MAP NUTR
   JUNAEB, 2015, PROGR AL ESC
   Kwan GF, 2016, CIRCULATION, V133, P2561, DOI 10.1161/CIRCULATIONAHA.116.008731
   Lecocq S, 2015, STATA J, V15, P554, DOI 10.1177/1536867X1501500214
   Lin BH, 2011, ECON HUM BIOL, V9, P329, DOI 10.1016/j.ehb.2011.08.007
   Malik VS, 2013, NAT REV ENDOCRINOL, V9, P13, DOI 10.1038/nrendo.2012.199
   Malik VS, 2010, DIABETES CARE, V33, P2477, DOI 10.2337/dc10-1079
   Ministerio de Salud, 2011, REP VIG ENF NO TRANS
   Monteiro CA, 2013, OBES REV, V14, P21, DOI 10.1111/obr.12107
   MORENGA LT, 2013, BMJ-BRIT MED J, V346, DOI DOI 10.1136/BMJ.E7492
   Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61729-2
   National Treasury Republic of South Africa, 2016, TAX SUG SWEET BEV PO
   Nnoaham KE, 2009, INT J EPIDEMIOL, V38, P1324, DOI 10.1093/ije/dyp214
   OECD, 2014, OB UPD 2014
   Paraje G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152260
   Pittman G.F., 2004, Drivers of demand, interrelationships, and nutritional impacts within the non-alcoholic beverage complex
   Poi BP, 2008, STATA J, V8, P554, DOI 10.1177/1536867X0800800407
   Popkin BM, 2016, LANCET DIABETES ENDO, V4, P174, DOI 10.1016/S2213-8587(15)00419-2
   Popkin BM, 2012, NUTR REV, V70, P3, DOI 10.1111/j.1753-4887.2011.00456.x
   Poti JM, 2014, AM J CLIN NUTR, V99, P162, DOI [10.3945/ajcn.114.100925, 10.3945/ajcn.113.071928]
   Sacks G, 2011, INT J OBESITY, V35, P1001, DOI 10.1038/ijo.2010.228
   Schanzenbach D., 2014, NBER WORKING PAPER S, P1
   Servicio de Impuestos Internos, 2014, REF TRIB
   Sharma A, 2014, HEALTH ECON, V23, P1159, DOI 10.1002/hec.3070
   Shonkwiler JS, 1999, AM J AGR ECON, V81, P972, DOI 10.2307/1244339
   Smed S., 2016, EUR J CLIN NUTR
   Smed S, 2007, FOOD POLICY, V32, P624, DOI 10.1016/j.foodpol.2007.03.002
   Smith Travis A., 2010, USDA-ERS Economic Research Report
   Snowdon W, 2013, OBES REV, V14, P150, DOI 10.1111/obr.12090
   Tavares LF, 2012, PUBLIC HEALTH NUTR, V15, P82, DOI 10.1017/S1368980011001571
   Thow AM, 2014, NUTR REV, V72, P551, DOI 10.1111/nure.12123
   U. S. Department of Agriculture, 2015, COMP FOODS RAW PROC
   Universidad de Chile, 1992, TABL COMP QUIM AL CH
   Withrow D, 2011, OBES REV, V12, P131, DOI 10.1111/j.1467-789X.2009.00712.x
   World Health Organization (WHO), 2015, Guideline: Sugars Intake for Adults and Children
   Yen ST, 2003, AM J AGR ECON, V85, P458, DOI 10.1111/1467-8276.00134
   Zhen C, 2014, AM J AGR ECON, V96, P1, DOI 10.1093/ajae/aat049
   Zhen C, 2011, AM J AGR ECON, V93, P175, DOI 10.1093/ajae/aaq155
NR 81
TC 76
Z9 80
U1 0
U2 91
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0306-9192
EI 1873-5657
J9 FOOD POLICY
JI Food Policy
PD AUG
PY 2017
VL 71
BP 86
EP 100
DI 10.1016/j.foodpol.2017.08.001
PG 15
WC Agricultural Economics & Policy; Economics; Food Science & Technology;
   Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Agriculture; Business & Economics; Food Science & Technology; Nutrition
   & Dietetics
GA FH6RS
UT WOS:000411305000009
PM 29375180
OA Green Accepted, Green Submitted
DA 2025-04-28
ER

PT J
AU Rashti, SL
   Ratamess, NA
   Kang, J
   Faigenbaum, AD
   Chilakos, A
   Hoffman, JR
AF Rashti, Stefanie L.
   Ratamess, Nicholas A.
   Kang, Jie
   Faigenbaum, Avery D.
   Chilakos, Aristomen
   Hoffman, Jay R.
TI Thermogenic effect of meltdown RTD™ energy drink in young healthy women:
   a double blind, cross-over design study
SO LIPIDS IN HEALTH AND DISEASE
LA English
DT Article
ID METABOLIC-RATE; BETA-PHENYLETHYLAMINE; SUPPLEMENT MELTDOWN; HERBAL
   SUPPLEMENT; BODY-WEIGHT; CAFFEINE; EXPENDITURE; LIPOLYSIS; OBESITY;
   GLUCOSE
AB Background: The purpose of this study was to examine the acute metabolic effects of a high-energy drink in healthy, physically-active women.
   Methods: Ten women (20.4 +/- 0.70 y; 166.9 +/- 7.2 cm; 67.0 +/- 7.0 kg; 29.6 +/- 6.5% body fat) underwent two testing sessions administered in a randomized and double-blind fashion. Subjects reported to the laboratory in a 3-hr post-absorptive state and were provided either 140 ml of the high-energy drink (SUP; commercially marketed as Meltdown RTD (TM) or placebo (P). Subjects consumed two 70 ml doses of SUP or P, separated by 30 min and rested in a semi-recumbent position for 3 hours. Resting oxygen consumption (VO2) and heart rate (HR) were determined every 5 min during the first 30 min and every 10 min during the next 150 min. Blood pressure (BP) was determined every 15 min during the first 30 min and every 30 min thereafter. Area under the curve (AUC) analysis was computed for VO2, whereas a 3-hour average and hourly averages were calculated for respiratory quotient (RQ), total kcal, HR, BP, and profile of mood states (POMS).
   Results: AUC analysis revealed a 10.8% difference (p = 0.03) in VO2 between SUP and P. No difference in VO2 was seen between the groups in the first hour, but VO2 in SUP was significantly greater than P in the second (13.9%, p = 0.01) and third hours (11.9%, p = 0.03). A difference (p = 0.03) in energy expenditure was seen between SUP (1.09 +/- 0.10 kcal.min(-1)) and P (0.99 +/- 0.09 kcal.min(-1)) for the 3-hour period. Although no difference in energy expenditure was seen in the first hour, significant differences between SUP and P were observed in the second (1.10 +/- 0.11 kcal.min(-1) and 0.99 +/- 0.09 kcal.min(-1), respectively; p = 0.02) and third hour (1.08 +/- 0.11 kcal.min(-1) and 0.99 +/- 0.09 kcal.min(-1), respectively; p = 0.05). Average systolic BP was significantly higher (p = 0.007) for SUP (110.0 +/- 3.9 mmHg) compared to P (107.3 +/- 4.4 mmHg). No differences were seen in HR, diastolic BP, or POMS at any time point.
   Conclusions: Results showed a significant increase in energy expenditure in young, healthy women following an acute ingestion of a high-energy drink.
C1 [Rashti, Stefanie L.; Ratamess, Nicholas A.; Kang, Jie; Faigenbaum, Avery D.; Chilakos, Aristomen; Hoffman, Jay R.] Coll New Jersey, Ewing, NJ 08628 USA.
C3 College of New Jersey
RP Hoffman, JR (corresponding author), Coll New Jersey, Ewing, NJ 08628 USA.
EM rashti2@tcnj.edu; ratamess@tcnj.edu; kang@tcnj.edu; faigenba@tcnj.edu;
   chilako@tcnj.edu; hoffmanj@tcnj.edu
RI Hoffman, Jay/AAF-2005-2019
OI Hoffman, Jay/0000-0002-0073-6603
FU Vital Pharmaceuticals, Inc
FX This study was funded by Vital Pharmaceuticals, Inc. dba VPX/Meltdown
   RTD. The authors would like to thank Steve Anderson, Adam Gonzalez, Neil
   Kelly and Mike Stec for their contribution to data collection.
CR ACHESON KJ, 1980, AM J CLIN NUTR, V33, P989, DOI 10.1093/ajcn/33.5.989
   Bell A, 2004, J ADOLESCENT HEALTH, V34, P508, DOI 10.1016/j.jadohealth.2003.07.024
   Belza A, 2009, EUR J CLIN NUTR, V63, P57, DOI 10.1038/sj.ejcn.1602901
   BERLAN M, 1993, BRIT J PHARMACOL, V108, P927, DOI 10.1111/j.1476-5381.1993.tb13488.x
   Bloomer RJ, 2009, LIPIDS HEALTH DIS, V8, DOI 10.1186/1476-511X-8-32
   Bloomer RJ, 2009, J INT SOC SPORT NUTR, V6, DOI 10.1186/1550-2783-6-4
   Dodge TL, 2006, J ADOLESCENT HEALTH, V39, P367, DOI 10.1016/j.jadohealth.2005.12.025
   DOURISH CT, 1981, PROG NEURO-PSYCHOPHA, V5, P411, DOI 10.1016/0364-7722(81)90093-X
   DULLOO AG, 1989, AM J CLIN NUTR, V49, P44, DOI 10.1093/ajcn/49.1.44
   Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040
   Finnegan D., 2003, Nutrition Bulletin, V28, P147, DOI 10.1046/j.1467-3010.2003.00345.x
   Fugh-Berman A, 2004, EXP BIOL MED, V229, P698, DOI 10.1177/153537020422900802
   GALITZKY J, 1988, EUR J CLIN INVEST, V18, P587, DOI 10.1111/j.1365-2362.1988.tb01272.x
   Galuska D. A., 2008, Morbidity and Mortality Weekly Report, V57, P765
   Greenway FL, 2004, OBES RES, V12, P1152, DOI 10.1038/oby.2004.144
   Haller CA, 2004, CLIN PHARMACOL THER, V75, P259, DOI 10.1016/j.clpt.2003.11.375
   Heck CI, 2007, J FOOD SCI, V72, pR138, DOI 10.1111/j.1750-3841.2007.00535.x
   Hoffman JR, 2008, MED SCI SPORT EXER, V40, P15, DOI 10.1249/mss.0b013e31815a5181
   Hoffman JR, 2009, J INT SOC SPORT NUTR, V6, DOI 10.1186/1550-2783-6-2
   Hoffman JR, 2009, J INT SOC SPORT NUTR, V6, DOI 10.1186/1550-2783-6-1
   Hoffman Jay R, 2006, J Int Soc Sports Nutr, V3, P35, DOI 10.1186/1550-2783-3-1-35
   HOFSTETTER R, 1985, ARZNEIMITTEL-FORSCH, V35-2, P1844
   Jitomir J, 2008, J INT SOC SPORT NUTR, V5, DOI 10.1186/1550-2783-5-23
   LAFONTAN M, 1992, AM J CLIN NUTR, V55, P219
   Li C, 2007, OBESITY, V15, P216, DOI 10.1038/oby.2007.505
   Martyn-Nemeth P, 2009, RES NURS HEALTH, V32, P96, DOI 10.1002/nur.20304
   McNair D., 1971, Manual for the profile of mood states, DOI DOI 10.5665/SLEEP.1272
   Nakamura M, 1998, EUR J PHARMACOL, V349, P163, DOI 10.1016/S0014-2999(98)00191-5
   Pang J, 2008, ARCH BIOCHEM BIOPHYS, V476, P178, DOI 10.1016/j.abb.2008.02.019
   Pittler MH, 2004, AM J CLIN NUTR, V79, P529
   Roberts AT, 2005, ALTERN MED REV, V10, P321
   Sabelli H, 1996, J NEUROPSYCH CLIN N, V8, P168
   Scholey AB, 2004, PSYCHOPHARMACOLOGY, V176, P320, DOI 10.1007/s00213-004-1935-2
   Smit HJ, 2004, NUTR NEUROSCI, V7, P127, DOI 10.1080/10284150400003041
   Smith A, 2002, FOOD CHEM TOXICOL, V40, P1243, DOI 10.1016/S0278-6915(02)00096-0
   Vaagenes H, 1999, BIOCHEM PHARMACOL, V58, P1133, DOI 10.1016/S0006-2952(99)00198-7
   Vukovich MD, 2005, CLIN EXP PHARMACOL P, V32, P47, DOI 10.1111/j.1440-1681.2005.04152.x
   Yach D, 2006, NAT MED, V12, P62, DOI 10.1038/nm0106-62
NR 38
TC 23
Z9 26
U1 0
U2 9
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1476-511X
J9 LIPIDS HEALTH DIS
JI Lipids Health Dis.
PD DEC 17
PY 2009
VL 8
AR 57
DI 10.1186/1476-511X-8-57
PG 7
WC Biochemistry & Molecular Biology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Nutrition & Dietetics
GA 543SN
UT WOS:000273598800002
PM 20017916
OA Green Published, gold
DA 2025-04-28
ER

PT J
AU Nasreddine, L
   Hwalla, N
   Sibai, A
   Hamzé, M
   Parent-Massin, D
AF Nasreddine, L
   Hwalla, N
   Sibai, A
   Hamzé, M
   Parent-Massin, D
TI Food consumption patterns in an adult urban population in Beirut,
   Lebanon
SO PUBLIC HEALTH NUTRITION
LA English
DT Article
DE individual dietary survey; quantitative food-frequency questionnaire;
   dietary pattern; Lebanon
ID NUTRITIONAL-STATUS; CHILDREN
AB Objectives To investigate, measure and assess the food consumption pattern of the adult population living in Beirut, Lebanon, and to identify inadequate or excessive intake of food groups particularly linked to non-communicable diseases.
   Design A cross-sectional food consumption survey was conducted in 2001. Dietary habits were assessed by means of a quantitative food-frequency questionnaire.
   Setting Dietary survey of the urban population (Beirut).
   Subjects Random sample of 444 adult subjects (aged 25-54 years) in Beirut.
   Results The mean consumption of food by the study population was estimated to be 3030 g day(-1), providing an energy intake of 2523.57 kcal day(-1). Fat contributed 38.9% to the average daily energy intake, protein 13.4% and carbohydrates 47.2%. Mean consumption of fruits and vegetables was approximately 367 g day(-1) and 45.3% of subjects consumed less than the recommended 400 g daily. Cereals contributed 324.5 g day(-1), providing 35.0% of daily energy intake, with bread being the most highly consumed (146.2 g day(-1)) in this food group. The mean intake of meat and poultry products was 91.7 g day(-1) and provided 8.8% of daily energy intake, with consumption of butchery products especially beef being the highest (47.6 g day(-1)) followed by poultry (36.1 g day(-1)). A low consumption of fish was noted (19.7 g day(-1)), with 73.6% of subjects consuming less than the recommended 2 servings of fish per week. Dairy products contributed 243.1 g day(-1) or 10.9% of daily energy intake, and milk was the least consumed dairy product (56.8% of consumers). The intake of added fats and oils, excluding those in cooked recipes, was 20.4 g day(-1); olive oil was not used in cooking but was added solely at the table and its mean intake was 5 g day(-1). The consumption of butter was low (0.86 g day(-1)) and vegetable oil was the type of fat mostly used in cooking. The average intake of alcoholic beverages was low (33.6 g day(-1)), accounting for 0.7% of total energy intake. Women had significantly higher intakes of milk, dairy products, vegetables and coffee than men (P < 0.05). The percentage of women who reported the use of low-fat items was significantly higher than that of men. Younger people (25-34 years) ate significantly more meat, sugar, alcoholic beverages and soft drinks, and consumed significantly less cooked vegetables and legumes, than older ones (P < 0.05).
   Conclusions The rather high contribution of fat to daily energy intake, the low intake of fish and the relatively high percentage of people consuming less than the recommended amount of fruits and vegetables observed in this study suggest that the adult Lebanese population is at increased risk of cardiovascular diseases, obesity and other non-communicable diseases, which provides the basis for recommending increased intakes of fish, particularly fatty fish, and fruits and vegetables.
C1 Amer Univ Beirut, Fac Agr & Food Sci, Dept Nutr & Food Sci, Beirut 1107 2020, Lebanon.
   Lebanese Council Sci Res, Beirut, Lebanon.
   UBO, ESMISAB, Lab Toxicol Alimentaire, F-29280 Plouzane, France.
   Amer Univ Beirut, Fac Hlth Sci, Dept Epidemiol & Populat Hlth, Beirut, Lebanon.
C3 American University of Beirut; Universite de Bretagne Occidentale;
   American University of Beirut
RP Amer Univ Beirut, Fac Agr & Food Sci, Dept Nutr & Food Sci, POB 11-0236,Riad El Salh, Beirut 1107 2020, Lebanon.
EM nahla@aub.edu.lb
RI Hwalla, Nahla/MIO-6582-2025
OI Sibai, Abla/0000-0002-1851-5606; Hwalla, Nahla/0000-0002-0685-6323;
   Nasreddine, Lara/0000-0003-3707-8218
CR *1 DAT BANK INC, NUTR PRO SOFTW VERS
   *ADM CENTR STAT, 1998, ET STAT ADM CENTR ST, V9
   [Anonymous], WHO OFFS PUBL
   [Anonymous], ZO EET NED 1992 RES
   [Anonymous], 1998, WHOFSFFOS983
   Aranceta J, 1998, PUBLIC HEALTH NUTR, V1, P185, DOI 10.1079/PHN19980029
   ARANCETA J, 1994, 18 DIR GEN PREV PROM
   BABA N, 1994, ECOL FOOD NUTR, V32, P247, DOI 10.1080/03670244.1994.9991405
   Baba N, 1996, J HUM NUTR DIET, V9, P89, DOI 10.1046/j.1365-277X.1996.00435.x
   BABA NH, RIV ANTROPOLOGIA, V76, P193
   Brandstetter BR, 1999, ANN NUTR METAB, V43, P246, DOI 10.1159/000012791
   BRIEFEL RR, 1992, J AM DIET ASSOC, V92, P959
   Committee on Diet and Health, 1989, DIET HLTH IMPL RED C
   COWAN JW, 1964, J AM DIET ASSOC, V30, P753
   ELABIDINE SZ, 1996, THESIS AM U BEIRUT B
   Fagerli RA, 1999, APPETITE, V32, P171, DOI 10.1006/appe.1998.0188
   *FAO, 1995, NUTR COUNTR PROF SEL
   FLEGAL KM, 1988, AM J EPIDEMIOL, V128, P749, DOI 10.1093/oxfordjournals.aje.a115028
   FLEGAL KM, 1990, AM J EPIDEMIOL, V131, P1046, DOI 10.1093/oxfordjournals.aje.a115596
   GREGORY J, 1990, DIET NUTR SURVEY BRI
   Horwath C. C., 1990, Australian Journal of Nutrition and Dietetics, V47, P71
   Hu FB, 2003, AM J CLIN NUTR, V78, p544S, DOI 10.1093/ajcn/78.3.544S
   *IFN, 1996, AB METH ENQ CONS AL
   *INT COMM NUTR NAT, 1962, REP LEB NUTR SURV 19
   KAMAL S, 1995, AB ALTABKH
   Krauss RM, 2000, CIRCULATION, V102, P2284
   Kris-Etherton PM, 2002, CIRCULATION, V106, P2747, DOI 10.1161/01.CIR.0000038493.65177.94
   Kroes R, 2002, FOOD CHEM TOXICOL, V40, P327, DOI 10.1016/S0278-6915(01)00113-2
   KUSHI LH, 1994, AM J CLIN NUTR, V59, p180S, DOI 10.1093/ajcn/59.1.180S
   LEEHAN H, 1989, J CLIN EPIDEMIOL, V42, P269, DOI 10.1016/0895-4356(89)90062-0
   PETERSEN BJ, 1994, AM J CLIN NUTR, V59, p240S, DOI 10.1093/ajcn/59.1.240S
   SABRY J, 1963, CANADIAN NUTR, V19, P121
   Saleh ZA, 1998, FOOD CHEM, V63, P535, DOI 10.1016/S0308-8146(98)00005-3
   WANDEL M, 1995, INT J FOOD SCI NUTR, V46, P291, DOI 10.3109/09637489509012561
   WHO, 2003, WHO TECHN REP SER
   Worsley A., 1988, International Journal of Biosocial Research, V10, P107
NR 36
TC 104
Z9 110
U1 0
U2 10
PU CAMBRIDGE UNIV PRESS
PI CAMBRIDGE
PA EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND
SN 1368-9800
EI 1475-2727
J9 PUBLIC HEALTH NUTR
JI Public Health Nutr.
PD APR
PY 2006
VL 9
IS 2
BP 194
EP 203
DI 10.1079/PHN2005855
PG 10
WC Public, Environmental & Occupational Health; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Public, Environmental & Occupational Health; Nutrition & Dietetics
GA 027AZ
UT WOS:000236386700005
PM 16571173
OA Bronze
DA 2025-04-28
ER

EF